Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-04-01
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| CCL5 | 6.117218 |
| AP000787.1 | -6.108836 |
| HLA-DPA1 | 5.626509 |
| CTNNA3 | -5.296589 |
| SESN3 | -5.155054 |
| HLA-DPB1 | 5.078913 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 13653 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 10688 |
| num_profile_genes_not_in_sets | 2965 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets: c5.go.v2023.2.Hs.symbols.gmt| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 4790 |
| num_genesets_included | 5671 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 2.64e-20 | -0.865 | 3.65e-17 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 1.19e-03 | 0.837 | 2.53e-02 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 9.48e-27 | -0.834 | 2.61e-23 |
| GOMF T CELL RECEPTOR BINDING | 10 | 8.15e-06 | 0.815 | 3.74e-04 |
| GOBP GAS TRANSPORT | 5 | 1.82e-03 | 0.805 | 3.56e-02 |
| GOBP OXYGEN TRANSPORT | 5 | 1.82e-03 | 0.805 | 3.56e-02 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 2.13e-03 | 0.793 | 3.96e-02 |
| GOCC MCM COMPLEX | 8 | 1.09e-04 | 0.790 | 3.62e-03 |
| GOCC IKAPPAB KINASE COMPLEX | 5 | 2.27e-03 | 0.788 | 4.14e-02 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 6 | 1.03e-03 | -0.774 | 2.23e-02 |
| GOMF TAP BINDING | 7 | 4.35e-04 | 0.768 | 1.15e-02 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 1.38e-03 | 0.754 | 2.87e-02 |
| GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 3.55e-03 | 0.753 | 5.69e-02 |
| GOCC IGM IMMUNOGLOBULIN COMPLEX | 5 | 3.65e-03 | -0.751 | 5.79e-02 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 6 | 1.54e-03 | 0.747 | 3.09e-02 |
| GOCC POLYSOMAL RIBOSOME | 29 | 4.12e-12 | -0.744 | 9.58e-10 |
| GOCC CYTOSOLIC RIBOSOME | 109 | 4.30e-40 | -0.734 | 3.55e-36 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 11 | 2.87e-05 | 0.728 | 1.14e-03 |
| GOMF MHC CLASS IB PROTEIN BINDING | 6 | 2.03e-03 | 0.728 | 3.82e-02 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 3.86e-04 | -0.725 | 1.05e-02 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 4.59e-04 | 0.715 | 1.19e-02 |
| GOCC CONDENSIN COMPLEX | 8 | 4.59e-04 | 0.715 | 1.19e-02 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 2.04e-04 | 0.715 | 6.15e-03 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 4.90e-04 | 0.712 | 1.25e-02 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 8 | 5.37e-04 | 0.707 | 1.36e-02 |
| GOCC IGA IMMUNOGLOBULIN COMPLEX | 5 | 6.39e-03 | -0.704 | 8.49e-02 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 2.91e-03 | -0.702 | 4.92e-02 |
| GOBP MIDDLE EAR MORPHOGENESIS | 6 | 3.08e-03 | -0.698 | 5.16e-02 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 5 | 7.07e-03 | 0.696 | 9.10e-02 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 8 | 6.80e-04 | 0.694 | 1.65e-02 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 5 | 7.29e-03 | 0.693 | 9.31e-02 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 6 | 3.35e-03 | -0.692 | 5.45e-02 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 11 | 8.25e-05 | 0.686 | 2.89e-03 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 8 | 7.93e-04 | 0.685 | 1.83e-02 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 5 | 8.09e-03 | -0.684 | 9.98e-02 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 8.16e-03 | 0.683 | 1.00e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 7 | 1.90e-03 | 0.678 | 3.67e-02 |
| GOBP PROTEIN AUTOPROCESSING | 14 | 1.16e-05 | 0.677 | 5.15e-04 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 8.99e-03 | 0.675 | 1.07e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 13 | 2.70e-05 | 0.672 | 1.09e-03 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 9.81e-03 | -0.667 | 1.12e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 9.99e-03 | 0.665 | 1.14e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 6 | 4.85e-03 | 0.664 | 7.13e-02 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 1.21e-03 | 0.661 | 2.56e-02 |
| GOBP ZYMOGEN INHIBITION | 6 | 5.17e-03 | 0.659 | 7.40e-02 |
| GOBP RESPONSE TO CORTICOSTERONE | 5 | 1.09e-02 | -0.658 | 1.20e-01 |
| GOCC REPLISOME | 14 | 2.06e-05 | 0.657 | 8.65e-04 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 5.89e-03 | 0.649 | 8.04e-02 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 1.21e-02 | 0.648 | 1.27e-01 |
| GOCC PROTEASOME CORE COMPLEX | 19 | 1.10e-06 | 0.646 | 6.69e-05 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 2.64e-20 | -8.65e-01 | 3.65e-17 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 1.19e-03 | 8.37e-01 | 2.53e-02 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 9.48e-27 | -8.34e-01 | 2.61e-23 |
| GOMF T CELL RECEPTOR BINDING | 10 | 8.15e-06 | 8.15e-01 | 3.74e-04 |
| GOBP GAS TRANSPORT | 5 | 1.82e-03 | 8.05e-01 | 3.56e-02 |
| GOBP OXYGEN TRANSPORT | 5 | 1.82e-03 | 8.05e-01 | 3.56e-02 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 2.13e-03 | 7.93e-01 | 3.96e-02 |
| GOCC MCM COMPLEX | 8 | 1.09e-04 | 7.90e-01 | 3.62e-03 |
| GOCC IKAPPAB KINASE COMPLEX | 5 | 2.27e-03 | 7.88e-01 | 4.14e-02 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 6 | 1.03e-03 | -7.74e-01 | 2.23e-02 |
| GOMF TAP BINDING | 7 | 4.35e-04 | 7.68e-01 | 1.15e-02 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 1.38e-03 | 7.54e-01 | 2.87e-02 |
| GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 3.55e-03 | 7.53e-01 | 5.69e-02 |
| GOCC IGM IMMUNOGLOBULIN COMPLEX | 5 | 3.65e-03 | -7.51e-01 | 5.79e-02 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 6 | 1.54e-03 | 7.47e-01 | 3.09e-02 |
| GOCC POLYSOMAL RIBOSOME | 29 | 4.12e-12 | -7.44e-01 | 9.58e-10 |
| GOCC CYTOSOLIC RIBOSOME | 109 | 4.30e-40 | -7.34e-01 | 3.55e-36 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 11 | 2.87e-05 | 7.28e-01 | 1.14e-03 |
| GOMF MHC CLASS IB PROTEIN BINDING | 6 | 2.03e-03 | 7.28e-01 | 3.82e-02 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 3.86e-04 | -7.25e-01 | 1.05e-02 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 4.59e-04 | 7.15e-01 | 1.19e-02 |
| GOCC CONDENSIN COMPLEX | 8 | 4.59e-04 | 7.15e-01 | 1.19e-02 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 2.04e-04 | 7.15e-01 | 6.15e-03 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 4.90e-04 | 7.12e-01 | 1.25e-02 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 8 | 5.37e-04 | 7.07e-01 | 1.36e-02 |
| GOCC IGA IMMUNOGLOBULIN COMPLEX | 5 | 6.39e-03 | -7.04e-01 | 8.49e-02 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 2.91e-03 | -7.02e-01 | 4.92e-02 |
| GOBP MIDDLE EAR MORPHOGENESIS | 6 | 3.08e-03 | -6.98e-01 | 5.16e-02 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 5 | 7.07e-03 | 6.96e-01 | 9.10e-02 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 8 | 6.80e-04 | 6.94e-01 | 1.65e-02 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 5 | 7.29e-03 | 6.93e-01 | 9.31e-02 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 6 | 3.35e-03 | -6.92e-01 | 5.45e-02 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 11 | 8.25e-05 | 6.86e-01 | 2.89e-03 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 8 | 7.93e-04 | 6.85e-01 | 1.83e-02 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 5 | 8.09e-03 | -6.84e-01 | 9.98e-02 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 8.16e-03 | 6.83e-01 | 1.00e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 7 | 1.90e-03 | 6.78e-01 | 3.67e-02 |
| GOBP PROTEIN AUTOPROCESSING | 14 | 1.16e-05 | 6.77e-01 | 5.15e-04 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 8.99e-03 | 6.75e-01 | 1.07e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 13 | 2.70e-05 | 6.72e-01 | 1.09e-03 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 9.81e-03 | -6.67e-01 | 1.12e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 9.99e-03 | 6.65e-01 | 1.14e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 6 | 4.85e-03 | 6.64e-01 | 7.13e-02 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 1.21e-03 | 6.61e-01 | 2.56e-02 |
| GOBP ZYMOGEN INHIBITION | 6 | 5.17e-03 | 6.59e-01 | 7.40e-02 |
| GOBP RESPONSE TO CORTICOSTERONE | 5 | 1.09e-02 | -6.58e-01 | 1.20e-01 |
| GOCC REPLISOME | 14 | 2.06e-05 | 6.57e-01 | 8.65e-04 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 5.89e-03 | 6.49e-01 | 8.04e-02 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 1.21e-02 | 6.48e-01 | 1.27e-01 |
| GOCC PROTEASOME CORE COMPLEX | 19 | 1.10e-06 | 6.46e-01 | 6.69e-05 |
| GOCC KNL1 SPC105 COMPLEX | 6 | 6.31e-03 | 6.44e-01 | 8.43e-02 |
| GOMF STEROL ESTERASE ACTIVITY | 5 | 1.28e-02 | 6.43e-01 | 1.31e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 6 | 6.44e-03 | -6.42e-01 | 8.53e-02 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 1.36e-02 | 6.37e-01 | 1.37e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 6 | 6.89e-03 | 6.37e-01 | 8.96e-02 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 6 | 6.89e-03 | 6.37e-01 | 8.96e-02 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 6 | 6.97e-03 | 6.36e-01 | 9.02e-02 |
| GOBP REGULATION OF HEAT GENERATION | 7 | 3.59e-03 | -6.36e-01 | 5.74e-02 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 7.03e-03 | 6.35e-01 | 9.05e-02 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 6 | 7.22e-03 | -6.33e-01 | 9.25e-02 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 1.43e-02 | 6.33e-01 | 1.40e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 5.34e-04 | 6.32e-01 | 1.36e-02 |
| GOBP NEURON FATE SPECIFICATION | 6 | 7.35e-03 | 6.32e-01 | 9.35e-02 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 3.98e-03 | 6.28e-01 | 6.11e-02 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 1.50e-02 | 6.28e-01 | 1.44e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 7.93e-03 | 6.26e-01 | 9.91e-02 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 6 | 8.14e-03 | -6.24e-01 | 1.00e-01 |
| GOBP MALE SEX DETERMINATION | 5 | 1.61e-02 | -6.21e-01 | 1.51e-01 |
| GOCC CILIARY ROOTLET | 10 | 7.25e-04 | -6.17e-01 | 1.73e-02 |
| GOCC GAMMA DELTA T CELL RECEPTOR COMPLEX | 6 | 9.26e-03 | 6.13e-01 | 1.09e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 145 | 3.41e-37 | -6.12e-01 | 1.41e-33 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 10 | 8.07e-04 | 6.12e-01 | 1.85e-02 |
| GOBP ENDOSOMAL VESICLE FUSION | 11 | 4.57e-04 | 6.10e-01 | 1.19e-02 |
| GOCC CMG COMPLEX | 11 | 4.62e-04 | 6.10e-01 | 1.19e-02 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 7 | 5.30e-03 | 6.09e-01 | 7.53e-02 |
| GOBP REGULATION OF RECEPTOR BINDING | 6 | 9.93e-03 | 6.08e-01 | 1.13e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 5 | 1.90e-02 | 6.06e-01 | 1.66e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 1.03e-02 | 6.05e-01 | 1.16e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 1.95e-02 | 6.03e-01 | 1.68e-01 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 1.97e-02 | 6.02e-01 | 1.69e-01 |
| GOBP L LYSINE TRANSPORT | 5 | 1.97e-02 | -6.02e-01 | 1.69e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.97e-02 | -6.02e-01 | 1.69e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 18 | 1.03e-05 | 6.01e-01 | 4.59e-04 |
| GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH | 5 | 2.03e-02 | -5.99e-01 | 1.73e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 2.08e-02 | 5.97e-01 | 1.74e-01 |
| GOCC SPERMATOPROTEASOME COMPLEX | 5 | 2.08e-02 | 5.97e-01 | 1.74e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 7 | 6.35e-03 | 5.96e-01 | 8.46e-02 |
| GOBP GLYCINE METABOLIC PROCESS | 9 | 2.00e-03 | 5.95e-01 | 3.78e-02 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 6 | 1.18e-02 | -5.93e-01 | 1.26e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 2.19e-02 | 5.92e-01 | 1.79e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 1.25e-02 | 5.89e-01 | 1.30e-01 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 2.32e-02 | 5.86e-01 | 1.87e-01 |
| GOBP COBALT ION TRANSPORT | 5 | 2.35e-02 | -5.85e-01 | 1.89e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 15 | 8.84e-05 | 5.85e-01 | 3.07e-03 |
| GOBP OSTEOCLAST PROLIFERATION | 6 | 1.32e-02 | -5.84e-01 | 1.34e-01 |
| GOBP CHROMOSOME CONDENSATION | 27 | 1.50e-07 | 5.84e-01 | 1.21e-05 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 2.38e-02 | 5.84e-01 | 1.89e-01 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 9 | 2.43e-03 | -5.84e-01 | 4.35e-02 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 5 | 2.42e-02 | -5.82e-01 | 1.92e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 6 | 1.36e-02 | 5.82e-01 | 1.37e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 6 | 1.36e-02 | -5.82e-01 | 1.37e-01 |
| GOCC AXOLEMMA | 9 | 2.53e-03 | -5.81e-01 | 4.43e-02 |
| GOCC MHC PROTEIN COMPLEX | 21 | 4.06e-06 | 5.81e-01 | 2.09e-04 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 1.39e-02 | 5.80e-01 | 1.39e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 24 | 9.13e-07 | 5.79e-01 | 5.76e-05 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 6 | 1.41e-02 | -5.79e-01 | 1.40e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 7 | 8.05e-03 | -5.78e-01 | 9.97e-02 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 8 | 4.64e-03 | 5.78e-01 | 6.86e-02 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 1.44e-02 | 5.77e-01 | 1.41e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 6 | 1.48e-02 | 5.75e-01 | 1.42e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 26 | 4.37e-07 | 5.72e-01 | 3.11e-05 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 1.53e-02 | 5.72e-01 | 1.46e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 5 | 2.70e-02 | 5.71e-01 | 2.03e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 1.57e-02 | 5.70e-01 | 1.48e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 8 | 5.28e-03 | -5.69e-01 | 7.52e-02 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 9 | 3.23e-03 | 5.67e-01 | 5.32e-02 |
| GOMF RS DOMAIN BINDING | 5 | 2.86e-02 | -5.65e-01 | 2.10e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 7 | 9.60e-03 | 5.65e-01 | 1.11e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 9.70e-03 | 5.65e-01 | 1.12e-01 |
| GOCC CYTOLYTIC GRANULE | 13 | 4.34e-04 | 5.64e-01 | 1.15e-02 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 12 | 7.27e-04 | 5.63e-01 | 1.73e-02 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 8 | 5.83e-03 | 5.63e-01 | 8.00e-02 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 8 | 5.89e-03 | 5.62e-01 | 8.04e-02 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 5 | 2.95e-02 | -5.62e-01 | 2.14e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 12 | 7.58e-04 | 5.61e-01 | 1.79e-02 |
| GOMF CD4 RECEPTOR BINDING | 6 | 1.73e-02 | 5.61e-01 | 1.58e-01 |
| GOBP HEAT GENERATION | 9 | 3.76e-03 | -5.58e-01 | 5.91e-02 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 1.07e-02 | 5.57e-01 | 1.18e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 3.10e-02 | 5.57e-01 | 2.20e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 7 | 1.11e-02 | 5.54e-01 | 1.21e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.46e-03 | 5.53e-01 | 4.37e-02 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 23 | 4.48e-06 | 5.53e-01 | 2.27e-04 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 9 | 4.19e-03 | 5.51e-01 | 6.33e-02 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 10 | 2.63e-03 | 5.49e-01 | 4.59e-02 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 5 | 3.37e-02 | 5.48e-01 | 2.31e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 5 | 3.37e-02 | 5.48e-01 | 2.31e-01 |
| GOBP CELL CYCLE DNA REPLICATION INITIATION | 5 | 3.39e-02 | 5.48e-01 | 2.31e-01 |
| GOBP FEVER GENERATION | 5 | 3.45e-02 | -5.46e-01 | 2.34e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 3.55e-02 | 5.43e-01 | 2.38e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 3.58e-02 | 5.42e-01 | 2.38e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 7 | 1.30e-02 | -5.42e-01 | 1.33e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 6 | 2.15e-02 | 5.42e-01 | 1.78e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 7.98e-03 | -5.42e-01 | 9.94e-02 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 8 | 7.98e-03 | -5.42e-01 | 9.94e-02 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 2.16e-02 | 5.42e-01 | 1.78e-01 |
| GOCC EKC KEOPS COMPLEX | 5 | 3.62e-02 | 5.41e-01 | 2.38e-01 |
| GOCC CORVET COMPLEX | 7 | 1.35e-02 | 5.39e-01 | 1.37e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 3.69e-02 | -5.39e-01 | 2.40e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 1.39e-02 | 5.37e-01 | 1.39e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 7 | 1.44e-02 | 5.34e-01 | 1.41e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 7 | 1.44e-02 | -5.34e-01 | 1.41e-01 |
| GOBP DETECTION OF BACTERIUM | 8 | 9.19e-03 | 5.32e-01 | 1.08e-01 |
| GOCC TORC1 COMPLEX | 6 | 2.43e-02 | 5.31e-01 | 1.92e-01 |
| GOCC HOPS COMPLEX | 9 | 5.86e-03 | 5.30e-01 | 8.02e-02 |
| GOMF WNT PROTEIN BINDING | 8 | 9.51e-03 | -5.29e-01 | 1.10e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 6 | 2.49e-02 | 5.29e-01 | 1.95e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 5 | 4.08e-02 | 5.28e-01 | 2.50e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 9.94e-03 | 5.26e-01 | 1.13e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 4.23e-02 | 5.24e-01 | 2.56e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 6 | 2.62e-02 | 5.24e-01 | 2.01e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 2.65e-02 | 5.23e-01 | 2.02e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 6 | 2.66e-02 | 5.23e-01 | 2.02e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 7 | 1.70e-02 | 5.21e-01 | 1.56e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 26 | 4.66e-06 | 5.19e-01 | 2.34e-04 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 17 | 2.14e-04 | 5.19e-01 | 6.39e-03 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 4.47e-02 | 5.18e-01 | 2.64e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 8 | 1.12e-02 | 5.18e-01 | 1.22e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 14 | 8.14e-04 | 5.17e-01 | 1.86e-02 |
| GOCC FILOPODIUM MEMBRANE | 9 | 7.45e-03 | 5.15e-01 | 9.44e-02 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.92e-02 | -5.14e-01 | 2.13e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 4.90e-03 | 5.14e-01 | 7.16e-02 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 17 | 2.47e-04 | 5.14e-01 | 7.13e-03 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 7 | 1.89e-02 | -5.12e-01 | 1.66e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 2.16e-03 | -5.11e-01 | 3.99e-02 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 11 | 3.34e-03 | -5.11e-01 | 5.45e-02 |
| GOMF DYNACTIN BINDING | 10 | 5.16e-03 | 5.11e-01 | 7.40e-02 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 5 | 4.83e-02 | 5.10e-01 | 2.77e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 3.46e-03 | 5.09e-01 | 5.58e-02 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 5 | 4.92e-02 | 5.08e-01 | 2.79e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 6 | 3.13e-02 | 5.08e-01 | 2.20e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 13 | 1.58e-03 | 5.06e-01 | 3.14e-02 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 2.06e-02 | 5.05e-01 | 1.73e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 5 | 5.04e-02 | -5.05e-01 | 2.82e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 6 | 3.24e-02 | -5.04e-01 | 2.25e-01 |
| GOBP REGULATION OF URINE VOLUME | 5 | 5.09e-02 | 5.04e-01 | 2.83e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 6 | 3.26e-02 | 5.04e-01 | 2.26e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 11 | 3.89e-03 | -5.03e-01 | 6.00e-02 |
| GOCC CILIARY TRANSITION FIBER | 7 | 2.17e-02 | 5.01e-01 | 1.78e-01 |
| GOBP DNA STRAND ELONGATION | 35 | 2.94e-07 | 5.01e-01 | 2.19e-05 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 5.26e-02 | 5.01e-01 | 2.88e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 5 | 5.26e-02 | -5.00e-01 | 2.88e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 5.27e-02 | 5.00e-01 | 2.88e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 10 | 6.21e-03 | 5.00e-01 | 8.37e-02 |
| GOCC CHROMOCENTER | 12 | 2.76e-03 | 4.99e-01 | 4.73e-02 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 3.45e-02 | 4.98e-01 | 2.34e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 1.46e-02 | 4.98e-01 | 1.41e-01 |
| GOBP PYROPTOSIS | 27 | 7.75e-06 | 4.97e-01 | 3.61e-04 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 6 | 3.50e-02 | -4.97e-01 | 2.36e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 8 | 1.51e-02 | 4.96e-01 | 1.45e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 5 | 5.49e-02 | 4.96e-01 | 2.94e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 6 | 3.57e-02 | -4.95e-01 | 2.38e-01 |
| GOCC OUTER KINETOCHORE | 19 | 1.88e-04 | 4.95e-01 | 5.75e-03 |
| GOCC AP 2 ADAPTOR COMPLEX | 6 | 3.62e-02 | 4.94e-01 | 2.38e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 3.63e-02 | 4.94e-01 | 2.38e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 18 | 2.89e-04 | 4.94e-01 | 8.16e-03 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 6 | 3.67e-02 | -4.92e-01 | 2.40e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 2.43e-02 | 4.92e-01 | 1.92e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 2.15e-03 | 4.92e-01 | 3.98e-02 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 11 | 4.91e-03 | 4.90e-01 | 7.17e-02 |
| GOCC U7 SNRNP | 7 | 2.49e-02 | 4.90e-01 | 1.94e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 5 | 5.82e-02 | 4.89e-01 | 3.04e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 6 | 3.82e-02 | -4.89e-01 | 2.42e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 19 | 2.30e-04 | 4.88e-01 | 6.73e-03 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 3.85e-02 | -4.88e-01 | 2.43e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 6 | 3.85e-02 | 4.88e-01 | 2.44e-01 |
| GOCC PARANODE REGION OF AXON | 6 | 3.87e-02 | -4.88e-01 | 2.44e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 16 | 7.41e-04 | 4.87e-01 | 1.75e-02 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 12 | 3.48e-03 | 4.87e-01 | 5.59e-02 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 9 | 1.16e-02 | 4.86e-01 | 1.25e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 6 | 3.95e-02 | 4.85e-01 | 2.46e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 3.97e-02 | 4.85e-01 | 2.47e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 6.04e-02 | 4.85e-01 | 3.11e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 5 | 6.10e-02 | 4.84e-01 | 3.14e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 6.15e-02 | 4.83e-01 | 3.15e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 7 | 2.71e-02 | -4.82e-01 | 2.04e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 13 | 2.61e-03 | 4.82e-01 | 4.56e-02 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 8 | 1.82e-02 | 4.82e-01 | 1.63e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 8 | 1.84e-02 | -4.81e-01 | 1.64e-01 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 8 | 1.85e-02 | 4.81e-01 | 1.64e-01 |
| GOCC BRISC COMPLEX | 6 | 4.16e-02 | 4.80e-01 | 2.53e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 13 | 2.72e-03 | 4.80e-01 | 4.68e-02 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 5 | 6.30e-02 | -4.80e-01 | 3.18e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 12 | 4.03e-03 | 4.79e-01 | 6.17e-02 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 2.84e-02 | 4.78e-01 | 2.10e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 7 | 2.85e-02 | -4.78e-01 | 2.10e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 10 | 8.86e-03 | 4.78e-01 | 1.07e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 7 | 2.86e-02 | 4.78e-01 | 2.10e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 15 | 1.37e-03 | -4.77e-01 | 2.85e-02 |
| GOCC DNA POLYMERASE COMPLEX | 19 | 3.19e-04 | 4.77e-01 | 8.82e-03 |
| GOCC MEIOTIC SPINDLE | 8 | 1.95e-02 | 4.77e-01 | 1.68e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 6 | 4.34e-02 | -4.76e-01 | 2.60e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 6.55e-02 | 4.76e-01 | 3.25e-01 |
| GOBP MAST CELL MIGRATION | 9 | 1.36e-02 | -4.75e-01 | 1.37e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 6 | 4.40e-02 | 4.75e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 6.62e-02 | 4.74e-01 | 3.27e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 4.43e-02 | 4.74e-01 | 2.62e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 5 | 6.69e-02 | -4.73e-01 | 3.27e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 8 | 2.06e-02 | 4.73e-01 | 1.73e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 5 | 6.72e-02 | -4.73e-01 | 3.27e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 6.81e-02 | -4.71e-01 | 3.29e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 4.61e-02 | 4.70e-01 | 2.69e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 5 | 6.88e-02 | 4.70e-01 | 3.31e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 8 | 2.15e-02 | 4.69e-01 | 1.78e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 8 | 2.16e-02 | 4.69e-01 | 1.78e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 6.97e-02 | 4.68e-01 | 3.33e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 12 | 4.97e-03 | 4.68e-01 | 7.22e-02 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 6.98e-02 | -4.68e-01 | 3.33e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 7.01e-02 | 4.68e-01 | 3.34e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 6 | 4.75e-02 | 4.67e-01 | 2.75e-01 |
| GOBP MAST CELL CHEMOTAXIS | 7 | 3.28e-02 | -4.66e-01 | 2.27e-01 |
| GOBP SECONDARY HEART FIELD SPECIFICATION | 6 | 4.84e-02 | -4.65e-01 | 2.77e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 5 | 7.19e-02 | 4.65e-01 | 3.37e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 7.19e-02 | 4.65e-01 | 3.37e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 15 | 1.84e-03 | 4.64e-01 | 3.58e-02 |
| GOBP MITOTIC SISTER CHROMATID COHESION CENTROMERIC | 5 | 7.24e-02 | 4.64e-01 | 3.38e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 9 | 1.62e-02 | 4.63e-01 | 1.51e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 12 | 5.53e-03 | -4.63e-01 | 7.75e-02 |
| GOBP HEART FIELD SPECIFICATION | 8 | 2.36e-02 | -4.62e-01 | 1.89e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 7.41e-02 | -4.61e-01 | 3.42e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 5 | 7.43e-02 | -4.61e-01 | 3.42e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 8 | 2.42e-02 | 4.60e-01 | 1.92e-01 |
| GOBP VESICLE UNCOATING | 6 | 5.10e-02 | 4.60e-01 | 2.83e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 7.48e-02 | -4.60e-01 | 3.43e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 7.48e-02 | 4.60e-01 | 3.43e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 9 | 1.70e-02 | -4.59e-01 | 1.56e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 13 | 4.16e-03 | 4.59e-01 | 6.31e-02 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 42 | 2.64e-07 | 4.59e-01 | 2.02e-05 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 6 | 5.20e-02 | -4.58e-01 | 2.86e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 14 | 3.00e-03 | 4.58e-01 | 5.05e-02 |
| GOCC BBAF COMPLEX | 9 | 1.74e-02 | 4.58e-01 | 1.58e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 9 | 1.74e-02 | 4.58e-01 | 1.58e-01 |
| GOCC INNER KINETOCHORE | 17 | 1.09e-03 | 4.58e-01 | 2.34e-02 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 7 | 3.62e-02 | 4.57e-01 | 2.38e-01 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 5 | 7.69e-02 | 4.57e-01 | 3.47e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 2.19e-03 | 4.57e-01 | 4.03e-02 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 5 | 7.72e-02 | 4.56e-01 | 3.48e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 9 | 1.78e-02 | -4.56e-01 | 1.60e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 2.55e-02 | 4.56e-01 | 1.98e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 6.24e-03 | 4.56e-01 | 8.37e-02 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 12 | 6.26e-03 | 4.56e-01 | 8.38e-02 |
| GOMF DNA CLAMP LOADER ACTIVITY | 9 | 1.79e-02 | 4.56e-01 | 1.60e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 1.80e-02 | 4.56e-01 | 1.60e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 6 | 5.33e-02 | 4.56e-01 | 2.90e-01 |
| GOCC NUCLEAR REPLICATION FORK | 30 | 1.58e-05 | 4.55e-01 | 6.85e-04 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 7 | 3.70e-02 | -4.55e-01 | 2.40e-01 |
| GOBP STRAND INVASION | 6 | 5.37e-02 | 4.55e-01 | 2.91e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 17 | 1.18e-03 | 4.55e-01 | 2.50e-02 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 11 | 9.15e-03 | 4.54e-01 | 1.08e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 1.84e-02 | 4.54e-01 | 1.64e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 6 | 5.44e-02 | 4.54e-01 | 2.93e-01 |
| GOBP SEX DETERMINATION | 7 | 3.78e-02 | -4.53e-01 | 2.42e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 6 | 5.45e-02 | 4.53e-01 | 2.94e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 5 | 7.93e-02 | 4.53e-01 | 3.53e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 5.47e-02 | -4.53e-01 | 2.94e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 5.48e-02 | 4.53e-01 | 2.94e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 11 | 9.35e-03 | 4.53e-01 | 1.09e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 32 | 9.81e-06 | 4.52e-01 | 4.47e-04 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 6 | 5.60e-02 | 4.51e-01 | 2.96e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 13 | 4.99e-03 | 4.50e-01 | 7.22e-02 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 8 | 2.76e-02 | 4.50e-01 | 2.06e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 5 | 8.19e-02 | -4.49e-01 | 3.60e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 6 | 5.69e-02 | 4.49e-01 | 2.99e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 7 | 3.99e-02 | 4.49e-01 | 2.48e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 10 | 1.41e-02 | 4.48e-01 | 1.40e-01 |
| GOBP PROTEIN REPAIR | 6 | 5.83e-02 | 4.46e-01 | 3.04e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 8.40e-02 | -4.46e-01 | 3.65e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 5 | 8.41e-02 | 4.46e-01 | 3.65e-01 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 5 | 8.42e-02 | -4.46e-01 | 3.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 1.06e-02 | 4.45e-01 | 1.18e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 4.17e-02 | 4.44e-01 | 2.54e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 12 | 7.85e-03 | 4.43e-01 | 9.84e-02 |
| GOBP L SERINE METABOLIC PROCESS | 8 | 3.00e-02 | 4.43e-01 | 2.17e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 11 | 1.09e-02 | 4.43e-01 | 1.20e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 6 | 6.02e-02 | 4.43e-01 | 3.10e-01 |
| GOBP NOSE DEVELOPMENT | 5 | 8.66e-02 | -4.43e-01 | 3.70e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 5 | 8.67e-02 | 4.42e-01 | 3.70e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 5 | 8.71e-02 | 4.42e-01 | 3.71e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 5 | 8.76e-02 | 4.41e-01 | 3.72e-01 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 8.77e-02 | 4.41e-01 | 3.72e-01 |
| GOBP MITOTIC DNA REPLICATION | 16 | 2.28e-03 | 4.41e-01 | 4.14e-02 |
| GOBP CHROMOSOME SEPARATION | 72 | 1.10e-10 | 4.40e-01 | 1.78e-08 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 7 | 4.39e-02 | 4.40e-01 | 2.61e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 6 | 6.22e-02 | 4.40e-01 | 3.17e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 12 | 8.48e-03 | 4.39e-01 | 1.04e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 12 | 8.53e-03 | 4.39e-01 | 1.04e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 14 | 4.50e-03 | 4.39e-01 | 6.72e-02 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 9 | 2.28e-02 | 4.38e-01 | 1.85e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 11 | 1.19e-02 | 4.38e-01 | 1.26e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 4.50e-02 | 4.38e-01 | 2.65e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 11 | 1.20e-02 | 4.38e-01 | 1.27e-01 |
| GOCC STEREOCILIUM TIP | 8 | 3.22e-02 | -4.37e-01 | 2.25e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 7 | 4.53e-02 | 4.37e-01 | 2.66e-01 |
| GOMF FRIZZLED BINDING | 13 | 6.43e-03 | -4.37e-01 | 8.53e-02 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 7 | 4.57e-02 | 4.36e-01 | 2.68e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 6 | 6.45e-02 | 4.36e-01 | 3.23e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 4.65e-02 | 4.35e-01 | 2.70e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 9 | 2.44e-02 | -4.33e-01 | 1.92e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 8 | 3.39e-02 | 4.33e-01 | 2.31e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 11 | 1.29e-02 | -4.33e-01 | 1.32e-01 |
| GOBP MACROPINOCYTOSIS | 8 | 3.41e-02 | 4.33e-01 | 2.32e-01 |
| GOCC PINOSOME | 6 | 6.68e-02 | 4.32e-01 | 3.27e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 7 | 4.79e-02 | 4.32e-01 | 2.77e-01 |
| GOCC RETROMER COMPLEX | 12 | 9.62e-03 | 4.32e-01 | 1.11e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 4.80e-02 | 4.32e-01 | 2.77e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 30 | 4.40e-05 | 4.31e-01 | 1.65e-03 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 6.75e-02 | 4.31e-01 | 3.28e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 9.51e-02 | 4.31e-01 | 3.88e-01 |
| GOMF SULFATIDE BINDING | 5 | 9.56e-02 | 4.30e-01 | 3.89e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 16 | 2.89e-03 | -4.30e-01 | 4.89e-02 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 9 | 2.55e-02 | 4.30e-01 | 1.98e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 2.17e-03 | 4.29e-01 | 4.01e-02 |
| GOCC PERICENTRIC HETEROCHROMATIN | 27 | 1.17e-04 | 4.28e-01 | 3.84e-03 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 3.60e-02 | -4.28e-01 | 2.38e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 47 | 3.91e-07 | 4.28e-01 | 2.84e-05 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 1.03e-02 | 4.28e-01 | 1.16e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 9 | 2.64e-02 | 4.28e-01 | 2.01e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 7 | 5.02e-02 | 4.27e-01 | 2.82e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 11 | 1.43e-02 | 4.27e-01 | 1.40e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 14 | 5.71e-03 | -4.27e-01 | 7.92e-02 |
| GOBP PUTRESCINE BIOSYNTHETIC PROCESS | 5 | 9.87e-02 | -4.26e-01 | 3.96e-01 |
| GOBP LYMPHOCYTE ANERGY | 6 | 7.07e-02 | 4.26e-01 | 3.35e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 9.90e-02 | 4.26e-01 | 3.97e-01 |
| GOBP TRANSLESION SYNTHESIS | 23 | 4.14e-04 | 4.25e-01 | 1.11e-02 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 6 | 7.12e-02 | 4.25e-01 | 3.36e-01 |
| GOBP DNA REPLICATION INITIATION | 34 | 1.79e-05 | 4.25e-01 | 7.57e-04 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 1.00e-01 | 4.25e-01 | 3.98e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 5.19e-02 | 4.24e-01 | 2.86e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 6 | 7.19e-02 | 4.24e-01 | 3.37e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 8 | 3.81e-02 | 4.23e-01 | 2.42e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 12 | 1.12e-02 | 4.23e-01 | 1.22e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 5 | 1.02e-01 | -4.23e-01 | 4.01e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 5 | 1.02e-01 | -4.23e-01 | 4.01e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 9 | 2.81e-02 | 4.23e-01 | 2.08e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 5 | 1.02e-01 | 4.22e-01 | 4.01e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 8 | 3.88e-02 | 4.22e-01 | 2.44e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 5 | 1.03e-01 | -4.21e-01 | 4.01e-01 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 1.03e-01 | 4.21e-01 | 4.02e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 6 | 7.40e-02 | 4.21e-01 | 3.42e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 7.40e-02 | 4.21e-01 | 3.42e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 3.93e-02 | 4.21e-01 | 2.46e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 7.42e-02 | 4.21e-01 | 3.42e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 3.94e-02 | 4.21e-01 | 2.46e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 1.04e-01 | 4.20e-01 | 4.02e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 15 | 4.86e-03 | 4.20e-01 | 7.13e-02 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 5.44e-02 | 4.20e-01 | 2.93e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 12 | 1.19e-02 | 4.20e-01 | 1.26e-01 |
| GOBP DNA DEAMINATION | 11 | 1.60e-02 | 4.19e-01 | 1.50e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 6 | 7.55e-02 | 4.19e-01 | 3.44e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 8.91e-03 | 4.19e-01 | 1.07e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 22 | 6.76e-04 | 4.19e-01 | 1.64e-02 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 10 | 2.19e-02 | -4.19e-01 | 1.79e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 9 | 2.97e-02 | 4.19e-01 | 2.16e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 1.05e-01 | 4.18e-01 | 4.05e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 6 | 7.62e-02 | -4.18e-01 | 3.46e-01 |
| GOBP SPINDLE ELONGATION | 12 | 1.22e-02 | 4.18e-01 | 1.28e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 3.00e-02 | 4.18e-01 | 2.17e-01 |
| GOMF MHC PROTEIN BINDING | 31 | 5.75e-05 | 4.18e-01 | 2.10e-03 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 5 | 1.07e-01 | -4.17e-01 | 4.06e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 9 | 3.05e-02 | -4.16e-01 | 2.18e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 5 | 1.07e-01 | -4.16e-01 | 4.07e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 7.76e-02 | 4.16e-01 | 3.48e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.08e-02 | -4.16e-01 | 2.19e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 24 | 4.42e-04 | 4.14e-01 | 1.16e-02 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 9 | 3.15e-02 | 4.14e-01 | 2.21e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 9 | 3.15e-02 | 4.14e-01 | 2.21e-01 |
| GOBP RESPONSE TO INACTIVITY | 5 | 1.09e-01 | 4.14e-01 | 4.11e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 33 | 3.89e-05 | 4.14e-01 | 1.50e-03 |
| GOCC SCAR COMPLEX | 10 | 2.36e-02 | 4.13e-01 | 1.89e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 7.97e-02 | 4.13e-01 | 3.54e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 1.77e-02 | 4.13e-01 | 1.60e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 8 | 4.33e-02 | 4.13e-01 | 2.59e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 9 | 3.23e-02 | 4.12e-01 | 2.25e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 9 | 3.24e-02 | 4.12e-01 | 2.25e-01 |
| GOBP MEIOTIC CYTOKINESIS | 6 | 8.07e-02 | 4.12e-01 | 3.57e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 8 | 4.38e-02 | -4.12e-01 | 2.61e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 10 | 2.43e-02 | 4.11e-01 | 1.92e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 12 | 1.36e-02 | 4.11e-01 | 1.37e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 29 | 1.30e-04 | 4.11e-01 | 4.24e-03 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.02e-02 | 4.10e-01 | 3.10e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 1.12e-01 | 4.10e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 10 | 2.48e-02 | 4.10e-01 | 1.94e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 1.87e-02 | 4.10e-01 | 1.65e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 7 | 6.07e-02 | 4.09e-01 | 3.13e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.50e-02 | -4.09e-01 | 2.65e-01 |
| GOCC SPERM CONNECTING PIECE | 6 | 8.26e-02 | -4.09e-01 | 3.62e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 1.13e-01 | 4.09e-01 | 4.18e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 3.39e-02 | 4.08e-01 | 2.31e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 7 | 6.13e-02 | 4.08e-01 | 3.15e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 3.39e-02 | 4.08e-01 | 2.31e-01 |
| GOBP TRANSFERRIN TRANSPORT | 8 | 4.58e-02 | 4.08e-01 | 2.68e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 4.58e-02 | 4.08e-01 | 2.68e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 5 | 1.14e-01 | 4.08e-01 | 4.19e-01 |
| GOCC SWR1 COMPLEX | 13 | 1.09e-02 | 4.08e-01 | 1.20e-01 |
| GOBP NEGATIVE REGULATION OF ISOTYPE SWITCHING | 5 | 1.15e-01 | -4.08e-01 | 4.19e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.20e-02 | 4.07e-01 | 3.17e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 2.58e-02 | 4.07e-01 | 1.98e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 1.15e-01 | 4.07e-01 | 4.20e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 7 | 6.25e-02 | 4.07e-01 | 3.17e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 3.48e-02 | 4.06e-01 | 2.35e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 5 | 1.16e-01 | 4.06e-01 | 4.21e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 11 | 1.98e-02 | -4.06e-01 | 1.69e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 5 | 1.16e-01 | -4.06e-01 | 4.22e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 10 | 2.64e-02 | 4.05e-01 | 2.01e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 1.14e-02 | 4.05e-01 | 1.23e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 6 | 8.58e-02 | 4.05e-01 | 3.69e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 5 | 1.17e-01 | 4.05e-01 | 4.23e-01 |
| GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY | 5 | 1.17e-01 | 4.05e-01 | 4.23e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 8.60e-02 | 4.05e-01 | 3.69e-01 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 5 | 1.17e-01 | 4.05e-01 | 4.24e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 12 | 1.53e-02 | 4.04e-01 | 1.46e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 3.58e-02 | 4.04e-01 | 2.38e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 9 | 3.59e-02 | -4.04e-01 | 2.38e-01 |
| GOMF QUINONE BINDING | 12 | 1.54e-02 | 4.04e-01 | 1.46e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 36 | 2.83e-05 | 4.03e-01 | 1.13e-03 |
| GOCC GLYCOPROTEIN COMPLEX | 11 | 2.09e-02 | 4.02e-01 | 1.75e-01 |
| GOBP KERATINIZATION | 7 | 6.56e-02 | -4.02e-01 | 3.25e-01 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 7 | 6.56e-02 | 4.02e-01 | 3.25e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 11 | 2.12e-02 | -4.01e-01 | 1.76e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 6.59e-02 | 4.01e-01 | 3.26e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 2.85e-08 | 4.01e-01 | 2.68e-06 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 7 | 6.61e-02 | 4.01e-01 | 3.26e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 8 | 4.96e-02 | -4.01e-01 | 2.80e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 9 | 3.73e-02 | 4.01e-01 | 2.40e-01 |
| GOBP LIPOPHAGY | 7 | 6.64e-02 | 4.01e-01 | 3.27e-01 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 6 | 8.92e-02 | 4.01e-01 | 3.75e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.77e-02 | 4.00e-01 | 2.42e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 6 | 8.98e-02 | -4.00e-01 | 3.75e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 5 | 1.22e-01 | 4.00e-01 | 4.32e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 9 | 3.80e-02 | -3.99e-01 | 2.42e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 7 | 6.73e-02 | 3.99e-01 | 3.27e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 9 | 3.81e-02 | 3.99e-01 | 2.42e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 7 | 6.74e-02 | 3.99e-01 | 3.27e-01 |
| GOBP MISMATCH REPAIR | 26 | 4.29e-04 | 3.99e-01 | 1.15e-02 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 4.35e-04 | 3.99e-01 | 1.15e-02 |
| GOMF CARDIOLIPIN BINDING | 7 | 6.78e-02 | 3.99e-01 | 3.29e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 5.10e-02 | -3.99e-01 | 2.83e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 1.69e-02 | -3.98e-01 | 1.55e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 9 | 3.86e-02 | -3.98e-01 | 2.44e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 7 | 6.81e-02 | 3.98e-01 | 3.29e-01 |
| GOBP R LOOP PROCESSING | 6 | 9.14e-02 | 3.98e-01 | 3.80e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 23 | 9.56e-04 | -3.98e-01 | 2.10e-02 |
| GOBP CHOLINE TRANSPORT | 5 | 1.23e-01 | -3.98e-01 | 4.37e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 5 | 1.23e-01 | -3.98e-01 | 4.37e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 9 | 3.88e-02 | 3.98e-01 | 2.44e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 1.30e-02 | -3.98e-01 | 1.33e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 11 | 2.25e-02 | 3.97e-01 | 1.83e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 12 | 1.72e-02 | 3.97e-01 | 1.58e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 1.52e-06 | 3.97e-01 | 8.94e-05 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 72 | 5.74e-09 | 3.97e-01 | 5.93e-07 |
| GOMF SODIUM ION BINDING | 5 | 1.25e-01 | -3.97e-01 | 4.39e-01 |
| GOBP TRACHEA FORMATION | 6 | 9.26e-02 | 3.97e-01 | 3.82e-01 |
| GOBP TRACHEA MORPHOGENESIS | 6 | 9.26e-02 | 3.97e-01 | 3.82e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 8 | 5.21e-02 | 3.97e-01 | 2.87e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 6 | 9.29e-02 | -3.96e-01 | 3.83e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 1.26e-01 | 3.96e-01 | 4.40e-01 |
| GOBP RESPONSE TO VITAMIN A | 6 | 9.36e-02 | 3.95e-01 | 3.84e-01 |
| GOCC INO80 COMPLEX | 15 | 8.06e-03 | 3.95e-01 | 9.97e-02 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 1.26e-01 | 3.95e-01 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 5.34e-02 | 3.94e-01 | 2.90e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 20 | 2.36e-03 | 3.93e-01 | 4.24e-02 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 6 | 9.67e-02 | -3.92e-01 | 3.91e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 52 | 1.06e-06 | 3.91e-01 | 6.56e-05 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 5 | 1.30e-01 | -3.91e-01 | 4.46e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 6 | 9.71e-02 | 3.91e-01 | 3.92e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 6 | 9.77e-02 | 3.90e-01 | 3.93e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 91 | 1.26e-10 | 3.90e-01 | 2.00e-08 |
| GOMF PHOSPHATIDIC ACID BINDING | 16 | 6.88e-03 | 3.90e-01 | 8.96e-02 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 8 | 5.60e-02 | 3.90e-01 | 2.96e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 45 | 5.97e-06 | 3.90e-01 | 2.89e-04 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 10 | 3.27e-02 | 3.90e-01 | 2.26e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 11 | 2.51e-02 | -3.90e-01 | 1.96e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 17 | 5.38e-03 | 3.90e-01 | 7.61e-02 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 8 | 5.62e-02 | 3.90e-01 | 2.97e-01 |
| GOBP CAMP CATABOLIC PROCESS | 6 | 9.86e-02 | -3.89e-01 | 3.96e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 10 | 3.30e-02 | -3.89e-01 | 2.28e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 5 | 1.32e-01 | -3.89e-01 | 4.47e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 9 | 4.31e-02 | -3.89e-01 | 2.59e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 32 | 1.38e-04 | 3.89e-01 | 4.46e-03 |
| GOMF MHC CLASS IB RECEPTOR ACTIVITY | 7 | 7.45e-02 | 3.89e-01 | 3.42e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 1.32e-01 | -3.89e-01 | 4.48e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 6 | 9.94e-02 | -3.89e-01 | 3.98e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 9.95e-02 | 3.88e-01 | 3.98e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 9.95e-02 | 3.88e-01 | 3.98e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 57 | 4.05e-07 | 3.88e-01 | 2.91e-05 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 9.98e-02 | 3.88e-01 | 3.98e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 6 | 9.98e-02 | 3.88e-01 | 3.98e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 5 | 1.34e-01 | 3.87e-01 | 4.51e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 1.00e-01 | 3.87e-01 | 3.99e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 5 | 1.34e-01 | 3.87e-01 | 4.52e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 6 | 1.01e-01 | 3.87e-01 | 4.00e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 3.44e-02 | 3.86e-01 | 2.33e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 10 | 3.46e-02 | 3.86e-01 | 2.34e-01 |
| GOMF ANKYRIN BINDING | 9 | 4.50e-02 | -3.86e-01 | 2.65e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 5 | 1.35e-01 | -3.86e-01 | 4.53e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 5 | 1.35e-01 | -3.86e-01 | 4.53e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 8 | 5.91e-02 | 3.85e-01 | 3.06e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 1.02e-01 | 3.85e-01 | 4.01e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 7 | 7.76e-02 | -3.85e-01 | 3.48e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 8 | 5.93e-02 | -3.85e-01 | 3.07e-01 |
| GOMF DENEDDYLASE ACTIVITY | 5 | 1.36e-01 | 3.85e-01 | 4.53e-01 |
| GOBP KINETOCHORE ORGANIZATION | 21 | 2.28e-03 | 3.85e-01 | 4.14e-02 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 6.08e-03 | 3.84e-01 | 8.22e-02 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 1.03e-01 | 3.84e-01 | 4.02e-01 |
| GOBP DENDRITIC TRANSPORT | 10 | 3.56e-02 | -3.84e-01 | 2.38e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 6 | 1.04e-01 | 3.83e-01 | 4.03e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 19 | 3.82e-03 | 3.83e-01 | 5.96e-02 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 1.02e-02 | 3.83e-01 | 1.15e-01 |
| GOMF DNA BINDING BENDING | 10 | 3.59e-02 | 3.83e-01 | 2.38e-01 |
| GOCC POLYSOME | 61 | 2.48e-07 | -3.82e-01 | 1.91e-05 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 6 | 1.05e-01 | -3.82e-01 | 4.05e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 6 | 1.05e-01 | 3.82e-01 | 4.05e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 15 | 1.04e-02 | 3.82e-01 | 1.17e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 1.39e-01 | 3.82e-01 | 4.59e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 1.40e-01 | 3.81e-01 | 4.59e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 23 | 1.55e-03 | 3.81e-01 | 3.11e-02 |
| GOBP OXIDATIVE DEMETHYLATION | 7 | 8.10e-02 | -3.81e-01 | 3.57e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 6 | 1.06e-01 | 3.81e-01 | 4.06e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 6 | 1.06e-01 | 3.81e-01 | 4.06e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 13 | 1.75e-02 | 3.81e-01 | 1.58e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 6.24e-02 | 3.81e-01 | 3.17e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 92 | 2.91e-10 | 3.80e-01 | 4.08e-08 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 6 | 1.07e-01 | -3.80e-01 | 4.06e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 6.28e-02 | 3.80e-01 | 3.18e-01 |
| GOCC BORC COMPLEX | 8 | 6.28e-02 | 3.80e-01 | 3.18e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 3.76e-02 | 3.80e-01 | 2.41e-01 |
| GOCC U4 SNRNP | 10 | 3.76e-02 | 3.80e-01 | 2.41e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 10 | 3.78e-02 | 3.79e-01 | 2.42e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 1.08e-01 | 3.79e-01 | 4.08e-01 |
| GOBP CELL PROLIFERATION IN BONE MARROW | 5 | 1.42e-01 | 3.79e-01 | 4.65e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 1.08e-01 | 3.79e-01 | 4.09e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 3.83e-02 | 3.78e-01 | 2.43e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 7 | 8.31e-02 | -3.78e-01 | 3.63e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 12 | 2.33e-02 | 3.78e-01 | 1.87e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 18 | 5.48e-03 | 3.78e-01 | 7.70e-02 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 1.43e-01 | -3.78e-01 | 4.67e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 9 | 4.96e-02 | -3.78e-01 | 2.80e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 50 | 3.86e-06 | 3.78e-01 | 2.02e-04 |
| GOBP EMBRYONIC HEMOPOIESIS | 17 | 7.02e-03 | -3.78e-01 | 9.05e-02 |
| GOBP DNA INTEGRATION | 6 | 1.09e-01 | 3.78e-01 | 4.11e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 21 | 2.77e-03 | 3.77e-01 | 4.73e-02 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 6.51e-02 | 3.77e-01 | 3.25e-01 |
| GOCC TOR COMPLEX | 11 | 3.06e-02 | 3.77e-01 | 2.18e-01 |
| GOBP TAURINE TRANSPORT | 6 | 1.10e-01 | 3.76e-01 | 4.14e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 14 | 1.48e-02 | 3.76e-01 | 1.42e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 1.11e-01 | 3.76e-01 | 4.14e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 12 | 2.43e-02 | -3.75e-01 | 1.92e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 6.60e-02 | 3.75e-01 | 3.26e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 6 | 1.11e-01 | 3.75e-01 | 4.15e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 7 | 8.56e-02 | -3.75e-01 | 3.68e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 7 | 8.56e-02 | -3.75e-01 | 3.68e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 11 | 3.13e-02 | 3.75e-01 | 2.20e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 9 | 5.15e-02 | 3.75e-01 | 2.85e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 6 | 1.12e-01 | 3.75e-01 | 4.16e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 8 | 6.70e-02 | 3.74e-01 | 3.27e-01 |
| GOCC PROTEASOME COMPLEX | 58 | 8.45e-07 | 3.74e-01 | 5.55e-05 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 6 | 1.13e-01 | -3.74e-01 | 4.16e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 6 | 1.13e-01 | -3.74e-01 | 4.16e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 7 | 8.68e-02 | -3.74e-01 | 3.70e-01 |
| GOMF PORIN ACTIVITY | 6 | 1.13e-01 | 3.74e-01 | 4.16e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 10 | 4.09e-02 | 3.73e-01 | 2.51e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY | 5 | 1.49e-01 | 3.73e-01 | 4.77e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 5 | 1.49e-01 | 3.73e-01 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 6 | 1.14e-01 | -3.73e-01 | 4.18e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 7 | 8.75e-02 | 3.73e-01 | 3.71e-01 |
| GOMF OXYGEN BINDING | 10 | 4.11e-02 | 3.73e-01 | 2.51e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 13 | 2.04e-02 | 3.71e-01 | 1.73e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 6.90e-02 | 3.71e-01 | 3.31e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 1.15e-01 | 3.71e-01 | 4.21e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 6 | 1.15e-01 | 3.71e-01 | 4.21e-01 |
| GOMF MYOSIN II BINDING | 7 | 8.91e-02 | 3.71e-01 | 3.74e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 11 | 3.32e-02 | 3.71e-01 | 2.29e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 1.07e-03 | 3.71e-01 | 2.31e-02 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 45 | 1.77e-05 | 3.70e-01 | 7.53e-04 |
| GOMF PROFILIN BINDING | 7 | 9.03e-02 | 3.70e-01 | 3.77e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 10 | 4.31e-02 | 3.69e-01 | 2.59e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 15 | 1.32e-02 | 3.69e-01 | 1.35e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 14 | 1.67e-02 | 3.69e-01 | 1.55e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 7 | 9.06e-02 | -3.69e-01 | 3.78e-01 |
| GOBP SKIN MORPHOGENESIS | 7 | 9.07e-02 | 3.69e-01 | 3.78e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 25 | 1.40e-03 | 3.69e-01 | 2.89e-02 |
| GOBP METANEPHROS MORPHOGENESIS | 8 | 7.07e-02 | 3.69e-01 | 3.35e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 5 | 1.53e-01 | -3.69e-01 | 4.85e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 12 | 2.70e-02 | 3.69e-01 | 2.03e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 13 | 2.13e-02 | 3.69e-01 | 1.77e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 5 | 1.53e-01 | 3.69e-01 | 4.86e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 8 | 7.11e-02 | -3.68e-01 | 3.36e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 19 | 5.44e-03 | 3.68e-01 | 7.66e-02 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 90 | 1.59e-09 | 3.68e-01 | 1.90e-07 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 1.18e-01 | 3.68e-01 | 4.26e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 1.18e-01 | 3.68e-01 | 4.26e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 10 | 4.41e-02 | 3.68e-01 | 2.62e-01 |
| GOMF UBIQUINONE BINDING | 6 | 1.19e-01 | 3.68e-01 | 4.27e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 8 | 7.19e-02 | -3.67e-01 | 3.37e-01 |
| GOBP NEGATIVE T CELL SELECTION | 11 | 3.50e-02 | 3.67e-01 | 2.36e-01 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 5 | 1.55e-01 | 3.67e-01 | 4.89e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 1.13e-06 | 3.67e-01 | 6.77e-05 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 33 | 2.71e-04 | 3.66e-01 | 7.69e-03 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 11 | 3.54e-02 | 3.66e-01 | 2.37e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 1.20e-01 | 3.66e-01 | 4.30e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 8 | 7.32e-02 | 3.66e-01 | 3.40e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 21 | 3.76e-03 | 3.65e-01 | 5.91e-02 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 5 | 1.58e-01 | 3.65e-01 | 4.92e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 7 | 9.50e-02 | 3.64e-01 | 3.87e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 52 | 5.56e-06 | 3.64e-01 | 2.75e-04 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 8 | 7.45e-02 | 3.64e-01 | 3.42e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 4.62e-02 | 3.64e-01 | 2.69e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 8 | 7.47e-02 | 3.64e-01 | 3.43e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 9 | 5.87e-02 | -3.64e-01 | 3.05e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 7 | 9.58e-02 | -3.64e-01 | 3.89e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 3.69e-02 | 3.63e-01 | 2.40e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 13 | 2.33e-02 | 3.63e-01 | 1.88e-01 |
| GOCC GROWTH CONE MEMBRANE | 5 | 1.60e-01 | 3.63e-01 | 4.94e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 10 | 4.68e-02 | 3.63e-01 | 2.72e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 1.60e-01 | 3.63e-01 | 4.94e-01 |
| GOMF EPOXIDE HYDROLASE ACTIVITY | 5 | 1.60e-01 | -3.63e-01 | 4.94e-01 |
| GOBP COMPLEMENT ACTIVATION | 24 | 2.10e-03 | -3.63e-01 | 3.90e-02 |
| GOCC ORGANELLAR RIBOSOME | 89 | 3.51e-09 | 3.62e-01 | 3.87e-07 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 6 | 1.24e-01 | -3.62e-01 | 4.38e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 7.66e-02 | 3.62e-01 | 3.47e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 5 | 1.62e-01 | 3.62e-01 | 4.95e-01 |
| GOCC LATERAL ELEMENT | 11 | 3.79e-02 | 3.61e-01 | 2.42e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 7 | 9.80e-02 | 3.61e-01 | 3.94e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 5 | 1.62e-01 | -3.61e-01 | 4.97e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 12 | 3.04e-02 | 3.61e-01 | 2.18e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 6 | 1.27e-01 | 3.60e-01 | 4.43e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 9 | 6.18e-02 | 3.60e-01 | 3.16e-01 |
| GOCC CALCINEURIN COMPLEX | 5 | 1.64e-01 | 3.59e-01 | 4.99e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 2.49e-02 | 3.59e-01 | 1.95e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 113 | 4.39e-11 | 3.59e-01 | 7.90e-09 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 1.65e-01 | -3.59e-01 | 5.00e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 25 | 1.92e-03 | 3.58e-01 | 3.68e-02 |
| GOCC ENDOCYTIC VESICLE LUMEN | 11 | 3.98e-02 | 3.58e-01 | 2.47e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 14 | 2.04e-02 | -3.58e-01 | 1.73e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 2.04e-02 | 3.58e-01 | 1.73e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 6 | 1.29e-01 | 3.58e-01 | 4.46e-01 |
| GOBP COLLATERAL SPROUTING | 14 | 2.05e-02 | -3.58e-01 | 1.73e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 9 | 6.32e-02 | 3.58e-01 | 3.18e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 9 | 6.32e-02 | 3.58e-01 | 3.18e-01 |
| GOBP DNA LIGATION | 16 | 1.33e-02 | 3.58e-01 | 1.35e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 20 | 5.63e-03 | 3.58e-01 | 7.84e-02 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 7.99e-02 | 3.58e-01 | 3.54e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 11 | 4.02e-02 | -3.57e-01 | 2.49e-01 |
| GOBP REGULATION OF DNA REPLICATION | 106 | 2.21e-10 | 3.57e-01 | 3.38e-08 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 12 | 3.23e-02 | 3.57e-01 | 2.25e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 1.30e-01 | 3.57e-01 | 4.47e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 6 | 1.30e-01 | 3.57e-01 | 4.47e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 13 | 2.61e-02 | -3.56e-01 | 2.00e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 6 | 1.31e-01 | 3.56e-01 | 4.47e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 6 | 1.31e-01 | -3.56e-01 | 4.47e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 6 | 1.31e-01 | -3.56e-01 | 4.47e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 7 | 1.03e-01 | 3.56e-01 | 4.02e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 10 | 5.15e-02 | -3.56e-01 | 2.85e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 8 | 8.16e-02 | 3.56e-01 | 3.60e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 23 | 3.16e-03 | -3.56e-01 | 5.28e-02 |
| GOBP PHOSPHOLIPID EFFLUX | 6 | 1.32e-01 | -3.55e-01 | 4.47e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 9 | 6.49e-02 | -3.55e-01 | 3.24e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 18 | 9.06e-03 | 3.55e-01 | 1.08e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 6 | 1.32e-01 | -3.55e-01 | 4.48e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 15 | 1.72e-02 | -3.55e-01 | 1.58e-01 |
| GOCC B WICH COMPLEX | 7 | 1.04e-01 | 3.55e-01 | 4.03e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 13 | 2.68e-02 | -3.55e-01 | 2.02e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 6.55e-02 | 3.55e-01 | 3.25e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 7 | 1.04e-01 | -3.55e-01 | 4.03e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 2.18e-02 | 3.54e-01 | 1.79e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 1.05e-01 | 3.54e-01 | 4.04e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 7 | 1.05e-01 | -3.54e-01 | 4.05e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 7 | 1.05e-01 | 3.54e-01 | 4.05e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 9 | 6.67e-02 | 3.53e-01 | 3.27e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 35 | 3.05e-04 | 3.53e-01 | 8.54e-03 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 1.35e-01 | 3.52e-01 | 4.53e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 7 | 1.07e-01 | 3.52e-01 | 4.07e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 8.47e-02 | 3.52e-01 | 3.66e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 1.73e-01 | 3.52e-01 | 5.12e-01 |
| GOCC MIB COMPLEX | 13 | 2.80e-02 | 3.52e-01 | 2.08e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 50 | 1.69e-05 | 3.52e-01 | 7.22e-04 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 9 | 6.78e-02 | -3.52e-01 | 3.29e-01 |
| GOBP REGULATION OF CELL MATURATION | 6 | 1.36e-01 | -3.51e-01 | 4.54e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 10 | 5.47e-02 | 3.51e-01 | 2.94e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 16 | 1.51e-02 | -3.51e-01 | 1.45e-01 |
| GOBP MEMBRANE DISASSEMBLY | 10 | 5.49e-02 | 3.51e-01 | 2.94e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 12 | 3.56e-02 | -3.50e-01 | 2.38e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 12 | 3.56e-02 | 3.50e-01 | 2.38e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 1.09e-01 | -3.50e-01 | 4.10e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 1.53e-02 | -3.50e-01 | 1.46e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 4.47e-02 | -3.50e-01 | 2.64e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 1.10e-01 | 3.49e-01 | 4.12e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 1.39e-01 | -3.49e-01 | 4.58e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 1.76e-01 | 3.49e-01 | 5.17e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 1.77e-01 | -3.49e-01 | 5.17e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 16 | 1.58e-02 | -3.49e-01 | 1.48e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 1.11e-01 | 3.48e-01 | 4.14e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 7 | 1.12e-01 | -3.47e-01 | 4.15e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 21 | 5.92e-03 | 3.47e-01 | 8.06e-02 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 6 | 1.41e-01 | 3.47e-01 | 4.63e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 4.90e-03 | 3.47e-01 | 7.16e-02 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 7 | 1.12e-01 | -3.47e-01 | 4.16e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 24 | 3.31e-03 | 3.46e-01 | 5.41e-02 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 9 | 7.23e-02 | 3.46e-01 | 3.38e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 27 | 1.86e-03 | 3.46e-01 | 3.60e-02 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 6 | 1.42e-01 | 3.46e-01 | 4.65e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 1.81e-01 | -3.46e-01 | 5.23e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 12 | 3.82e-02 | -3.46e-01 | 2.42e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 7.27e-02 | -3.46e-01 | 3.39e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 5.85e-02 | 3.46e-01 | 3.04e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 5.85e-02 | 3.46e-01 | 3.04e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 7.85e-06 | 3.45e-01 | 3.62e-04 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 16 | 1.68e-02 | 3.45e-01 | 1.55e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 1.82e-01 | 3.45e-01 | 5.25e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 18 | 1.13e-02 | -3.45e-01 | 1.23e-01 |
| GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX | 5 | 1.82e-01 | -3.45e-01 | 5.25e-01 |
| GOCC LEWY BODY | 7 | 1.14e-01 | -3.45e-01 | 4.19e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 42 | 1.14e-04 | 3.44e-01 | 3.75e-03 |
| GOMF PEPTIDE ANTIGEN BINDING | 32 | 7.77e-04 | 3.43e-01 | 1.81e-02 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 7 | 1.16e-01 | 3.43e-01 | 4.21e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 6 | 1.46e-01 | 3.43e-01 | 4.72e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 37 | 3.06e-04 | 3.43e-01 | 8.56e-03 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 6 | 1.46e-01 | 3.43e-01 | 4.72e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 5 | 1.84e-01 | -3.43e-01 | 5.28e-01 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 16 | 1.76e-02 | 3.43e-01 | 1.59e-01 |
| GOCC METHYLOSOME | 12 | 3.98e-02 | 3.43e-01 | 2.47e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 8 | 9.34e-02 | 3.43e-01 | 3.83e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 13 | 3.25e-02 | 3.42e-01 | 2.26e-01 |
| GOCC REPLICATION FORK | 62 | 3.18e-06 | 3.42e-01 | 1.70e-04 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 1.47e-01 | 3.42e-01 | 4.74e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 6 | 1.47e-01 | 3.42e-01 | 4.75e-01 |
| GOBP HEART TRABECULA FORMATION | 6 | 1.48e-01 | 3.41e-01 | 4.76e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION | 5 | 1.86e-01 | -3.41e-01 | 5.31e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 12 | 4.07e-02 | -3.41e-01 | 2.50e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 17 | 1.49e-02 | -3.41e-01 | 1.43e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 10 | 6.18e-02 | -3.41e-01 | 3.16e-01 |
| GOBP ORGANELLE INHERITANCE | 14 | 2.71e-02 | 3.41e-01 | 2.04e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 6 | 1.48e-01 | -3.41e-01 | 4.77e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 17 | 1.51e-02 | 3.40e-01 | 1.45e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 9 | 7.72e-02 | 3.40e-01 | 3.48e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 5 | 1.88e-01 | 3.40e-01 | 5.33e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 9.60e-02 | 3.40e-01 | 3.90e-01 |
| GOCC GBAF COMPLEX | 13 | 3.39e-02 | 3.40e-01 | 2.31e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 1.20e-01 | 3.40e-01 | 4.29e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 5 | 1.89e-01 | -3.40e-01 | 5.33e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 8 | 9.64e-02 | 3.40e-01 | 3.91e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 11 | 5.12e-02 | 3.40e-01 | 2.84e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 1.50e-01 | 3.39e-01 | 4.81e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 5.16e-02 | 3.39e-01 | 2.85e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 5.16e-02 | 3.39e-01 | 2.85e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 14 | 2.82e-02 | -3.39e-01 | 2.08e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 6 | 1.51e-01 | -3.39e-01 | 4.81e-01 |
| GOMF CHLORIDE ION BINDING | 5 | 1.90e-01 | 3.39e-01 | 5.35e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 6 | 1.51e-01 | -3.38e-01 | 4.81e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 23 | 4.97e-03 | 3.38e-01 | 7.22e-02 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 17 | 1.57e-02 | 3.38e-01 | 1.48e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 5 | 1.90e-01 | -3.38e-01 | 5.36e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 5 | 1.91e-01 | -3.38e-01 | 5.36e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 9 | 7.93e-02 | 3.38e-01 | 3.53e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 6 | 1.52e-01 | 3.38e-01 | 4.82e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 28 | 1.99e-03 | 3.38e-01 | 3.77e-02 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 5.07e-03 | 3.38e-01 | 7.29e-02 |
| GOBP NEURAL CREST FORMATION | 8 | 9.86e-02 | 3.37e-01 | 3.96e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 9.65e-04 | 3.37e-01 | 2.11e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 27 | 2.44e-03 | 3.37e-01 | 4.36e-02 |
| GOMF CYCLASE ACTIVITY | 9 | 8.00e-02 | 3.37e-01 | 3.55e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 12 | 4.34e-02 | 3.37e-01 | 2.60e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 27 | 2.46e-03 | 3.37e-01 | 4.37e-02 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 19 | 1.12e-02 | 3.36e-01 | 1.22e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 8 | 9.96e-02 | -3.36e-01 | 3.98e-01 |
| GOBP KINETOCHORE ASSEMBLY | 17 | 1.65e-02 | 3.36e-01 | 1.53e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 24 | 4.38e-03 | 3.36e-01 | 6.56e-02 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 6 | 1.54e-01 | 3.36e-01 | 4.87e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 5 | 1.94e-01 | 3.36e-01 | 5.39e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 4.87e-13 | -3.36e-01 | 1.34e-10 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 6 | 1.55e-01 | 3.36e-01 | 4.88e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 10 | 6.65e-02 | 3.35e-01 | 3.27e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 7 | 1.25e-01 | -3.35e-01 | 4.39e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 1.01e-01 | 3.35e-01 | 4.00e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 29 | 1.81e-03 | 3.35e-01 | 3.55e-02 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 1.01e-01 | 3.35e-01 | 4.00e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 10 | 6.67e-02 | 3.35e-01 | 3.27e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 15 | 2.48e-02 | 3.35e-01 | 1.94e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 117 | 4.14e-10 | 3.35e-01 | 5.61e-08 |
| GOCC U5 SNRNP | 19 | 1.16e-02 | 3.35e-01 | 1.24e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 1.95e-01 | -3.35e-01 | 5.41e-01 |
| GOBP OXALATE TRANSPORT | 5 | 1.95e-01 | -3.35e-01 | 5.41e-01 |
| GOMF VITAMIN B6 BINDING | 29 | 1.84e-03 | 3.34e-01 | 3.58e-02 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 5 | 1.96e-01 | 3.34e-01 | 5.42e-01 |
| GOMF HISTONE KINASE ACTIVITY | 16 | 2.07e-02 | 3.34e-01 | 1.73e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 21 | 8.07e-03 | 3.34e-01 | 9.98e-02 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 3.05e-02 | 3.34e-01 | 2.18e-01 |
| GOBP SEQUESTERING OF IRON ION | 5 | 1.96e-01 | -3.34e-01 | 5.43e-01 |
| GOBP ATP METABOLIC PROCESS | 118 | 4.08e-10 | 3.33e-01 | 5.61e-08 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 11 | 5.57e-02 | 3.33e-01 | 2.96e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 6 | 1.58e-01 | -3.33e-01 | 4.92e-01 |
| GOMF PROTEASOME BINDING | 15 | 2.56e-02 | 3.33e-01 | 1.98e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 6 | 1.58e-01 | 3.33e-01 | 4.92e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 129 | 7.16e-11 | 3.33e-01 | 1.23e-08 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 28 | 2.32e-03 | 3.33e-01 | 4.20e-02 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 11 | 5.62e-02 | 3.33e-01 | 2.97e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 15 | 2.58e-02 | -3.32e-01 | 1.99e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 1.28e-01 | 3.32e-01 | 4.44e-01 |
| GOMF MRNA 5 UTR BINDING | 22 | 6.97e-03 | -3.32e-01 | 9.02e-02 |
| GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY | 5 | 1.98e-01 | -3.32e-01 | 5.45e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 11 | 5.64e-02 | -3.32e-01 | 2.97e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 1.99e-01 | 3.32e-01 | 5.46e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 8 | 1.04e-01 | -3.32e-01 | 4.03e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 8 | 1.04e-01 | -3.32e-01 | 4.03e-01 |
| GOCC RESPIRASOME | 88 | 7.79e-08 | 3.32e-01 | 6.74e-06 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 8 | 1.05e-01 | -3.31e-01 | 4.03e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 1.29e-01 | -3.31e-01 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 9 | 8.52e-02 | 3.31e-01 | 3.67e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 6.98e-02 | 3.31e-01 | 3.33e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 7 | 1.29e-01 | -3.31e-01 | 4.46e-01 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 6 | 1.60e-01 | -3.31e-01 | 4.95e-01 |
| GOBP RESPONSE TO MERCURY ION | 5 | 2.00e-01 | 3.31e-01 | 5.48e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 6 | 1.61e-01 | -3.31e-01 | 4.95e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 7.03e-02 | 3.31e-01 | 3.34e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 5.77e-02 | 3.31e-01 | 3.02e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 24 | 5.13e-03 | 3.30e-01 | 7.37e-02 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 6 | 1.61e-01 | 3.30e-01 | 4.95e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 1.06e-01 | 3.30e-01 | 4.06e-01 |
| GOCC ENDOLYSOSOME | 21 | 8.98e-03 | 3.29e-01 | 1.07e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 5 | 2.02e-01 | 3.29e-01 | 5.49e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 6 | 1.62e-01 | 3.29e-01 | 4.97e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 21 | 9.04e-03 | 3.29e-01 | 1.08e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 8 | 1.07e-01 | -3.29e-01 | 4.07e-01 |
| GOBP CHROMATIN LOOPING | 11 | 5.90e-02 | 3.29e-01 | 3.06e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 1.63e-01 | 3.29e-01 | 4.98e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.64e-01 | 3.28e-01 | 4.98e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 7.21e-02 | 3.28e-01 | 3.38e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 2.77e-02 | -3.28e-01 | 2.07e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 39 | 4.00e-04 | 3.28e-01 | 1.08e-02 |
| GOBP PINOCYTOSIS | 16 | 2.33e-02 | 3.28e-01 | 1.87e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 8.88e-02 | 3.28e-01 | 3.74e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 9 | 8.91e-02 | -3.27e-01 | 3.74e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 21 | 9.49e-03 | 3.27e-01 | 1.10e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 6 | 1.66e-01 | -3.27e-01 | 5.00e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 9 | 8.97e-02 | -3.27e-01 | 3.75e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 12 | 5.04e-02 | -3.26e-01 | 2.82e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 13 | 4.17e-02 | 3.26e-01 | 2.54e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 5 | 2.07e-01 | 3.26e-01 | 5.55e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 2.07e-01 | 3.26e-01 | 5.55e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 7 | 1.35e-01 | -3.26e-01 | 4.53e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 2.07e-01 | -3.26e-01 | 5.55e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 9 | 9.05e-02 | -3.26e-01 | 3.77e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 15 | 2.89e-02 | -3.26e-01 | 2.12e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 1.40e-02 | 3.26e-01 | 1.39e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 36 | 7.29e-04 | 3.25e-01 | 1.73e-02 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 2.08e-01 | -3.25e-01 | 5.56e-01 |
| GOBP OOCYTE MATURATION | 14 | 3.50e-02 | 3.25e-01 | 2.36e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 2.08e-01 | -3.25e-01 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 11 | 6.22e-02 | 3.25e-01 | 3.17e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 7 | 1.37e-01 | 3.24e-01 | 4.56e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 6 | 1.70e-01 | 3.24e-01 | 5.07e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 1.74e-02 | -3.24e-01 | 1.58e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 2.10e-01 | 3.24e-01 | 5.58e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 2.10e-01 | 3.24e-01 | 5.58e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 2.10e-01 | 3.24e-01 | 5.58e-01 |
| GOBP PROTEIN TRIMERIZATION | 10 | 7.63e-02 | 3.24e-01 | 3.46e-01 |
| GOBP ACTIN NUCLEATION | 44 | 2.06e-04 | 3.23e-01 | 6.20e-03 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 5 | 2.10e-01 | 3.23e-01 | 5.58e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 5 | 2.10e-01 | 3.23e-01 | 5.58e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 14 | 3.62e-02 | 3.23e-01 | 2.38e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 22 | 8.66e-03 | 3.23e-01 | 1.05e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 10 | 7.68e-02 | 3.23e-01 | 3.47e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 1.71e-01 | 3.23e-01 | 5.09e-01 |
| GOBP POSTREPLICATION REPAIR | 32 | 1.60e-03 | 3.22e-01 | 3.18e-02 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 18 | 1.80e-02 | 3.22e-01 | 1.61e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 5.34e-02 | 3.22e-01 | 2.90e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 19 | 1.52e-02 | 3.22e-01 | 1.45e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 8 | 1.16e-01 | 3.21e-01 | 4.21e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 7.86e-02 | 3.21e-01 | 3.51e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 8 | 1.16e-01 | -3.21e-01 | 4.21e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 86 | 2.74e-07 | 3.21e-01 | 2.07e-05 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 101 | 2.63e-08 | 3.21e-01 | 2.50e-06 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 8 | 1.17e-01 | 3.20e-01 | 4.23e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 7 | 1.43e-01 | 3.20e-01 | 4.65e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 1.17e-01 | 3.20e-01 | 4.23e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 6 | 1.75e-01 | -3.20e-01 | 5.15e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 12 | 5.50e-02 | 3.20e-01 | 2.94e-01 |
| GOCC PORE COMPLEX | 17 | 2.25e-02 | 3.20e-01 | 1.83e-01 |
| GOBP SEQUESTERING OF METAL ION | 9 | 9.69e-02 | -3.20e-01 | 3.91e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 1.75e-01 | 3.20e-01 | 5.16e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 6.66e-02 | 3.20e-01 | 3.27e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 1.75e-01 | 3.19e-01 | 5.16e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 8 | 1.18e-01 | -3.19e-01 | 4.25e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 1.18e-01 | 3.19e-01 | 4.26e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 1.77e-01 | -3.19e-01 | 5.17e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 6 | 1.77e-01 | 3.19e-01 | 5.17e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 5 | 2.18e-01 | -3.18e-01 | 5.67e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 5 | 2.18e-01 | 3.18e-01 | 5.67e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 11 | 6.79e-02 | 3.18e-01 | 3.29e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 7 | 1.45e-01 | -3.18e-01 | 4.72e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 5 | 2.19e-01 | 3.18e-01 | 5.69e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 15 | 3.32e-02 | 3.18e-01 | 2.29e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 151 | 1.77e-11 | 3.17e-01 | 3.48e-09 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 8 | 1.20e-01 | -3.17e-01 | 4.29e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 12 | 5.70e-02 | 3.17e-01 | 2.99e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 1.46e-01 | 3.17e-01 | 4.74e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 9 | 1.00e-01 | 3.17e-01 | 3.98e-01 |
| GOBP RENAL FILTRATION | 9 | 1.00e-01 | -3.17e-01 | 3.98e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 10 | 8.32e-02 | 3.16e-01 | 3.63e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 1.80e-01 | 3.16e-01 | 5.22e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 18 | 2.02e-02 | 3.16e-01 | 1.72e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 6 | 1.80e-01 | -3.16e-01 | 5.22e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 170 | 1.26e-12 | 3.16e-01 | 3.37e-10 |
| GOCC INTEGRIN COMPLEX | 15 | 3.41e-02 | 3.16e-01 | 2.32e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 1.81e-01 | 3.16e-01 | 5.23e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 8 | 1.22e-01 | 3.15e-01 | 4.35e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 74 | 2.77e-06 | 3.15e-01 | 1.51e-04 |
| GOBP CELL MIGRATION IN HINDBRAIN | 9 | 1.01e-01 | -3.15e-01 | 4.01e-01 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 108 | 1.57e-08 | 3.15e-01 | 1.52e-06 |
| GOBP DISTAL TUBULE DEVELOPMENT | 5 | 2.22e-01 | 3.15e-01 | 5.72e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 7.55e-03 | 3.15e-01 | 9.55e-02 |
| GOCC POLAR MICROTUBULE | 5 | 2.23e-01 | 3.15e-01 | 5.73e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 24 | 7.72e-03 | 3.14e-01 | 9.72e-02 |
| GOBP VIRAL RNA GENOME REPLICATION | 26 | 5.56e-03 | 3.14e-01 | 7.77e-02 |
| GOBP MITOTIC RECOMBINATION | 23 | 9.11e-03 | 3.14e-01 | 1.08e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 6 | 1.83e-01 | 3.14e-01 | 5.26e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 1.03e-01 | -3.14e-01 | 4.02e-01 |
| GOMF S100 PROTEIN BINDING | 11 | 7.15e-02 | 3.14e-01 | 3.37e-01 |
| GOBP RESPONSE TO MANGANESE ION | 13 | 5.04e-02 | -3.13e-01 | 2.82e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 16 | 3.01e-02 | 3.13e-01 | 2.17e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 9 | 1.04e-01 | 3.13e-01 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 8 | 1.25e-01 | 3.13e-01 | 4.39e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 18 | 2.15e-02 | 3.13e-01 | 1.78e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 8 | 1.26e-01 | 3.12e-01 | 4.40e-01 |
| GOMF TITIN BINDING | 7 | 1.53e-01 | 3.12e-01 | 4.84e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 96 | 1.29e-07 | 3.12e-01 | 1.06e-05 |
| GOCC NUCLEOSOME | 33 | 1.93e-03 | 3.12e-01 | 3.68e-02 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 7 | 1.53e-01 | 3.12e-01 | 4.85e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 1.27e-01 | 3.11e-01 | 4.43e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 12 | 6.21e-02 | 3.11e-01 | 3.17e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 5 | 2.28e-01 | 3.11e-01 | 5.78e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 9 | 1.06e-01 | 3.11e-01 | 4.06e-01 |
| GOBP STARTLE RESPONSE | 11 | 7.41e-02 | -3.11e-01 | 3.42e-01 |
| GOBP AEROBIC RESPIRATION | 171 | 2.48e-12 | 3.11e-01 | 6.04e-10 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 55 | 6.71e-05 | 3.11e-01 | 2.40e-03 |
| GOBP REGULATION OF HYPERSENSITIVITY | 6 | 1.87e-01 | 3.11e-01 | 5.32e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 1.87e-01 | -3.11e-01 | 5.32e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 1.28e-01 | -3.11e-01 | 4.44e-01 |
| GOCC MICOS COMPLEX | 8 | 1.28e-01 | 3.11e-01 | 4.44e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 11 | 7.46e-02 | 3.10e-01 | 3.42e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 128 | 1.41e-09 | 3.10e-01 | 1.74e-07 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 17 | 2.68e-02 | 3.10e-01 | 2.02e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 1.07e-01 | 3.10e-01 | 4.07e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 1.07e-01 | 3.10e-01 | 4.07e-01 |
| GOCC ASTROCYTE PROJECTION | 5 | 2.30e-01 | 3.10e-01 | 5.79e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 9 | 1.07e-01 | 3.10e-01 | 4.07e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 1.89e-01 | -3.10e-01 | 5.34e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 29 | 3.89e-03 | 3.10e-01 | 6.00e-02 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 8 | 1.29e-01 | -3.10e-01 | 4.46e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 5 | 2.30e-01 | 3.10e-01 | 5.80e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 11 | 7.54e-02 | 3.10e-01 | 3.44e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 7 | 1.56e-01 | 3.10e-01 | 4.91e-01 |
| GOCC HETEROCHROMATIN | 62 | 2.52e-05 | 3.10e-01 | 1.02e-03 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 18 | 2.30e-02 | 3.09e-01 | 1.86e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 5 | 2.31e-01 | -3.09e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 8 | 1.30e-01 | -3.09e-01 | 4.46e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 9 | 1.08e-01 | 3.09e-01 | 4.09e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 1.30e-01 | 3.09e-01 | 4.46e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 7 | 1.57e-01 | -3.09e-01 | 4.92e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 7 | 1.57e-01 | -3.09e-01 | 4.92e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 5.84e-06 | -3.09e-01 | 2.84e-04 |
| GOMF ALPHA ACTININ BINDING | 15 | 3.82e-02 | 3.09e-01 | 2.42e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 7 | 1.57e-01 | 3.09e-01 | 4.92e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 11 | 7.61e-02 | 3.09e-01 | 3.46e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 8 | 1.30e-01 | 3.09e-01 | 4.47e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 19 | 1.98e-02 | -3.09e-01 | 1.69e-01 |
| GOBP PEXOPHAGY | 6 | 1.91e-01 | -3.09e-01 | 5.36e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 5 | 2.32e-01 | -3.09e-01 | 5.80e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 9 | 1.09e-01 | 3.08e-01 | 4.11e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 16 | 3.28e-02 | 3.08e-01 | 2.27e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 1.92e-01 | 3.08e-01 | 5.37e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 36 | 1.39e-03 | 3.08e-01 | 2.88e-02 |
| GOCC PRONUCLEUS | 11 | 7.72e-02 | 3.08e-01 | 3.48e-01 |
| GOCC WASH COMPLEX | 9 | 1.10e-01 | 3.08e-01 | 4.13e-01 |
| GOCC SPERM PRINCIPAL PIECE | 18 | 2.39e-02 | -3.08e-01 | 1.90e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 7 | 1.59e-01 | 3.08e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 7 | 1.59e-01 | 3.07e-01 | 4.93e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 6.52e-02 | 3.07e-01 | 3.25e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 20 | 1.74e-02 | -3.07e-01 | 1.58e-01 |
| GOBP FEMALE MEIOSIS I | 7 | 1.59e-01 | 3.07e-01 | 4.93e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 16 | 3.34e-02 | 3.07e-01 | 2.30e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 85 | 1.00e-06 | 3.07e-01 | 6.29e-05 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 8 | 1.33e-01 | -3.07e-01 | 4.50e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 24 | 9.35e-03 | 3.07e-01 | 1.09e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 6 | 1.94e-01 | 3.07e-01 | 5.39e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 8 | 1.33e-01 | -3.07e-01 | 4.50e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 9 | 1.11e-01 | 3.06e-01 | 4.15e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 1.12e-01 | 3.06e-01 | 4.15e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 1.94e-01 | 3.06e-01 | 5.39e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 6 | 1.94e-01 | 3.06e-01 | 5.39e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 9 | 1.12e-01 | -3.06e-01 | 4.16e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 18 | 2.46e-02 | 3.06e-01 | 1.93e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 6 | 1.94e-01 | 3.06e-01 | 5.40e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 9.40e-02 | -3.06e-01 | 3.84e-01 |
| GOCC BRAHMA COMPLEX | 13 | 5.63e-02 | 3.06e-01 | 2.97e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 22 | 1.31e-02 | 3.06e-01 | 1.33e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 2.37e-01 | -3.06e-01 | 5.87e-01 |
| GOBP UREA CYCLE | 6 | 1.95e-01 | -3.06e-01 | 5.41e-01 |
| GOBP UREA METABOLIC PROCESS | 6 | 1.95e-01 | -3.06e-01 | 5.41e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 159 | 3.19e-11 | 3.05e-01 | 5.86e-09 |
| GOCC OXIDOREDUCTASE COMPLEX | 109 | 3.74e-08 | 3.05e-01 | 3.43e-06 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 37 | 1.31e-03 | -3.05e-01 | 2.76e-02 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 40 | 8.47e-04 | 3.05e-01 | 1.92e-02 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 74 | 5.80e-06 | 3.05e-01 | 2.84e-04 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 21 | 1.56e-02 | 3.05e-01 | 1.47e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.38e-01 | 3.05e-01 | 5.87e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 8 | 1.35e-01 | 3.05e-01 | 4.53e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 20 | 1.83e-02 | 3.05e-01 | 1.63e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 6 | 1.96e-01 | 3.05e-01 | 5.42e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 222 | 6.15e-15 | 3.04e-01 | 2.82e-12 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 14 | 4.86e-02 | -3.04e-01 | 2.78e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 14 | 4.86e-02 | -3.04e-01 | 2.78e-01 |
| GOMF DYNEIN COMPLEX BINDING | 18 | 2.55e-02 | 3.04e-01 | 1.98e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 7 | 1.64e-01 | -3.04e-01 | 4.98e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 2.39e-01 | 3.04e-01 | 5.88e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 9.66e-02 | 3.03e-01 | 3.91e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 17 | 3.04e-02 | 3.03e-01 | 2.18e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 8 | 1.38e-01 | -3.03e-01 | 4.57e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 47 | 3.30e-04 | 3.03e-01 | 9.07e-03 |
| GOBP AGGRESOME ASSEMBLY | 5 | 2.41e-01 | -3.03e-01 | 5.90e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 6 | 1.99e-01 | -3.03e-01 | 5.47e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 11 | 8.23e-02 | 3.03e-01 | 3.61e-01 |
| GOBP GENITALIA DEVELOPMENT | 16 | 3.61e-02 | 3.03e-01 | 2.38e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 14 | 5.00e-02 | 3.03e-01 | 2.81e-01 |
| GOCC CYTOCHROME COMPLEX | 30 | 4.14e-03 | 3.03e-01 | 6.30e-02 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 1.99e-01 | 3.03e-01 | 5.47e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 9 | 1.16e-01 | 3.02e-01 | 4.22e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 5 | 2.42e-01 | -3.02e-01 | 5.91e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 9 | 1.17e-01 | 3.02e-01 | 4.23e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 2.43e-01 | -3.02e-01 | 5.91e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 2.01e-01 | -3.02e-01 | 5.49e-01 |
| GOBP RESPONSE TO LEAD ION | 14 | 5.08e-02 | 3.01e-01 | 2.83e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 12 | 7.07e-02 | 3.01e-01 | 3.35e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 6 | 2.01e-01 | 3.01e-01 | 5.49e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 32 | 3.19e-03 | 3.01e-01 | 5.30e-02 |
| GOCC INTEGRATOR COMPLEX | 16 | 3.70e-02 | 3.01e-01 | 2.40e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 14 | 5.11e-02 | -3.01e-01 | 2.83e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 7.10e-02 | 3.01e-01 | 3.36e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 13 | 6.02e-02 | -3.01e-01 | 3.11e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 5 | 2.44e-01 | -3.01e-01 | 5.92e-01 |
| GOMF ANNEALING ACTIVITY | 9 | 1.18e-01 | 3.01e-01 | 4.25e-01 |
| GOMF E BOX BINDING | 21 | 1.70e-02 | -3.01e-01 | 1.56e-01 |
| GOCC U2AF COMPLEX | 5 | 2.44e-01 | -3.01e-01 | 5.92e-01 |
| GOMF KINETOCHORE BINDING | 6 | 2.02e-01 | 3.01e-01 | 5.49e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 2.45e-01 | -3.01e-01 | 5.93e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 95 | 4.39e-07 | 3.00e-01 | 3.11e-05 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 17 | 3.24e-02 | 3.00e-01 | 2.25e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 2.04e-01 | 3.00e-01 | 5.51e-01 |
| GOCC U2 SNRNP | 25 | 9.51e-03 | 3.00e-01 | 1.10e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 9 | 1.20e-01 | 2.99e-01 | 4.29e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 7 | 1.71e-01 | 2.99e-01 | 5.09e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 8 | 1.43e-01 | -2.99e-01 | 4.66e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 20 | 2.06e-02 | -2.99e-01 | 1.73e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 31 | 3.98e-03 | 2.99e-01 | 6.11e-02 |
| GOBP XMP METABOLIC PROCESS | 7 | 1.71e-01 | 2.99e-01 | 5.09e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 35 | 2.23e-03 | 2.99e-01 | 4.08e-02 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 14 | 5.29e-02 | -2.99e-01 | 2.89e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 52 | 1.95e-04 | 2.99e-01 | 5.93e-03 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 2.48e-01 | 2.99e-01 | 5.95e-01 |
| GOMF NAD BINDING | 47 | 4.02e-04 | 2.98e-01 | 1.08e-02 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 43 | 7.12e-04 | 2.98e-01 | 1.72e-02 |
| GOMF MYOSIN V BINDING | 10 | 1.02e-01 | 2.98e-01 | 4.01e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 16 | 3.89e-02 | 2.98e-01 | 2.44e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 13 | 6.27e-02 | -2.98e-01 | 3.18e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 14 | 5.35e-02 | 2.98e-01 | 2.90e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 2.49e-01 | 2.98e-01 | 5.97e-01 |
| GOBP DNA CONFORMATION CHANGE | 86 | 1.92e-06 | 2.97e-01 | 1.10e-04 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 11 | 8.79e-02 | 2.97e-01 | 3.72e-01 |
| GOMF TAU PROTEIN BINDING | 35 | 2.35e-03 | 2.97e-01 | 4.23e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 8 | 1.46e-01 | 2.97e-01 | 4.72e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 16 | 3.97e-02 | -2.97e-01 | 2.47e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 6 | 2.08e-01 | 2.97e-01 | 5.57e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 11 | 8.90e-02 | -2.96e-01 | 3.74e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 8 | 1.47e-01 | -2.96e-01 | 4.75e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 142 | 1.19e-09 | 2.96e-01 | 1.50e-07 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 124 | 1.31e-08 | 2.96e-01 | 1.29e-06 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 16 | 4.06e-02 | 2.96e-01 | 2.50e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 4.95e-07 | 2.96e-01 | 3.47e-05 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 12 | 7.62e-02 | 2.96e-01 | 3.46e-01 |
| GOBP RNA CAPPING | 35 | 2.48e-03 | 2.96e-01 | 4.39e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 72 | 1.46e-05 | 2.96e-01 | 6.40e-04 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 7.63e-02 | 2.96e-01 | 3.46e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 16 | 4.07e-02 | 2.96e-01 | 2.50e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 5.57e-02 | 2.95e-01 | 2.96e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 7 | 1.76e-01 | 2.95e-01 | 5.17e-01 |
| GOBP GDP METABOLIC PROCESS | 11 | 9.00e-02 | -2.95e-01 | 3.76e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 9 | 1.25e-01 | -2.95e-01 | 4.39e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 7 | 1.76e-01 | 2.95e-01 | 5.17e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 10 | 1.06e-01 | 2.95e-01 | 4.06e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 20 | 2.23e-02 | 2.95e-01 | 1.82e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 7 | 1.76e-01 | -2.95e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 2.53e-01 | 2.95e-01 | 6.03e-01 |
| GOBP DNA REPLICATION | 250 | 1.17e-15 | 2.95e-01 | 6.44e-13 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 2.11e-01 | -2.95e-01 | 5.59e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 8 | 1.49e-01 | 2.95e-01 | 4.78e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 18 | 3.05e-02 | 2.95e-01 | 2.18e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 2.54e-01 | 2.94e-01 | 6.03e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 30 | 5.27e-03 | 2.94e-01 | 7.51e-02 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 9 | 1.26e-01 | 2.94e-01 | 4.42e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 10 | 1.08e-01 | 2.94e-01 | 4.08e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 281 | 2.81e-17 | 2.94e-01 | 2.11e-14 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 17 | 3.60e-02 | 2.94e-01 | 2.38e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 7 | 1.78e-01 | 2.94e-01 | 5.20e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 8 | 1.50e-01 | -2.94e-01 | 4.81e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 6.22e-03 | 2.94e-01 | 8.37e-02 |
| GOBP RESPONSE TO MAGNESIUM ION | 11 | 9.19e-02 | -2.94e-01 | 3.80e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 5 | 2.56e-01 | 2.93e-01 | 6.05e-01 |
| GOBP DNA PROTECTION | 5 | 2.56e-01 | 2.93e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 8 | 1.51e-01 | 2.93e-01 | 4.81e-01 |
| GOMF OXYSTEROL BINDING | 8 | 1.51e-01 | -2.93e-01 | 4.81e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 2.56e-01 | -2.93e-01 | 6.05e-01 |
| GOBP PLASMINOGEN ACTIVATION | 13 | 6.74e-02 | 2.93e-01 | 3.27e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 17 | 3.65e-02 | -2.93e-01 | 2.39e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 22 | 1.74e-02 | 2.93e-01 | 1.58e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 7 | 1.80e-01 | -2.93e-01 | 5.22e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 40 | 1.36e-03 | 2.93e-01 | 2.83e-02 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 7 | 1.80e-01 | 2.93e-01 | 5.22e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 1.09e-01 | 2.93e-01 | 4.11e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 5 | 2.57e-01 | -2.93e-01 | 6.06e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 13 | 6.79e-02 | 2.92e-01 | 3.29e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 12 | 7.95e-02 | -2.92e-01 | 3.53e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 2.58e-01 | 2.92e-01 | 6.06e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 6 | 2.15e-01 | -2.92e-01 | 5.64e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 10 | 1.10e-01 | -2.92e-01 | 4.12e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 14 | 5.85e-02 | -2.92e-01 | 3.04e-01 |
| GOCC NPBAF COMPLEX | 14 | 5.86e-02 | 2.92e-01 | 3.05e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 8 | 1.53e-01 | -2.92e-01 | 4.85e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 7 | 1.82e-01 | 2.92e-01 | 5.24e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 6 | 2.17e-01 | 2.91e-01 | 5.65e-01 |
| GOMF EPHRIN RECEPTOR ACTIVITY | 5 | 2.59e-01 | -2.91e-01 | 6.09e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 7 | 1.82e-01 | 2.91e-01 | 5.25e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 7 | 1.82e-01 | 2.91e-01 | 5.25e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 15 | 5.10e-02 | -2.91e-01 | 2.83e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 13 | 6.93e-02 | 2.91e-01 | 3.32e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 9 | 1.32e-01 | 2.90e-01 | 4.48e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 15 | 5.20e-02 | 2.90e-01 | 2.86e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 45 | 7.79e-04 | 2.90e-01 | 1.81e-02 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 1.85e-01 | 2.90e-01 | 5.28e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 17 | 3.90e-02 | -2.89e-01 | 2.44e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 9.69e-02 | 2.89e-01 | 3.91e-01 |
| GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 2.63e-01 | 2.89e-01 | 6.14e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 81 | 7.08e-06 | 2.89e-01 | 3.39e-04 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 22 | 1.90e-02 | 2.89e-01 | 1.67e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 6 | 2.21e-01 | 2.89e-01 | 5.71e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 11 | 9.74e-02 | 2.89e-01 | 3.93e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 5 | 2.64e-01 | 2.89e-01 | 6.14e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 1.34e-01 | 2.89e-01 | 4.51e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.22e-01 | 2.88e-01 | 5.72e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 8 | 1.58e-01 | 2.88e-01 | 4.92e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 46 | 7.27e-04 | 2.88e-01 | 1.73e-02 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.65e-01 | 2.88e-01 | 6.16e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 8 | 1.58e-01 | 2.88e-01 | 4.92e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 35 | 3.22e-03 | 2.88e-01 | 5.31e-02 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 12 | 8.43e-02 | 2.88e-01 | 3.65e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 6 | 2.22e-01 | -2.88e-01 | 5.72e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 9 | 1.35e-01 | -2.88e-01 | 4.53e-01 |
| GOBP SISTER CHROMATID COHESION | 50 | 4.35e-04 | 2.88e-01 | 1.15e-02 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 5 | 2.65e-01 | 2.88e-01 | 6.16e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 4.65e-02 | 2.88e-01 | 2.70e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 7 | 1.88e-01 | 2.87e-01 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 5 | 2.66e-01 | -2.87e-01 | 6.17e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 17 | 4.05e-02 | 2.87e-01 | 2.50e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 8 | 1.60e-01 | 2.87e-01 | 4.94e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 109 | 2.41e-07 | 2.87e-01 | 1.90e-05 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 18 | 3.54e-02 | 2.87e-01 | 2.37e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 22 | 2.00e-02 | 2.86e-01 | 1.71e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 8 | 1.61e-01 | 2.86e-01 | 4.95e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 13 | 7.38e-02 | -2.86e-01 | 3.42e-01 |
| GOBP GLUTAMATE SECRETION | 12 | 8.62e-02 | -2.86e-01 | 3.69e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 7 | 1.90e-01 | -2.86e-01 | 5.36e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 3.58e-02 | 2.86e-01 | 2.38e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 207 | 1.48e-12 | 2.86e-01 | 3.70e-10 |
| GOBP REGULATION OF CHROMATIN BINDING | 10 | 1.18e-01 | 2.86e-01 | 4.25e-01 |
| GOMF ICOSANOID BINDING | 6 | 2.25e-01 | -2.86e-01 | 5.74e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 2.26e-01 | 2.86e-01 | 5.75e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 20 | 2.74e-02 | -2.85e-01 | 2.05e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 13 | 7.52e-02 | 2.85e-01 | 3.44e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 8 | 1.63e-01 | 2.85e-01 | 4.98e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 3.17e-02 | 2.85e-01 | 2.22e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 11 | 1.02e-01 | 2.84e-01 | 4.01e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 13 | 7.58e-02 | -2.84e-01 | 3.45e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 2.28e-01 | 2.84e-01 | 5.77e-01 |
| GOMF OXIDIZED DNA BINDING | 10 | 1.19e-01 | 2.84e-01 | 4.28e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 15 | 5.67e-02 | -2.84e-01 | 2.98e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 5 | 2.71e-01 | 2.84e-01 | 6.20e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 12 | 8.84e-02 | -2.84e-01 | 3.73e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 9 | 1.40e-01 | -2.84e-01 | 4.61e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 7 | 1.93e-01 | -2.84e-01 | 5.39e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 12 | 8.89e-02 | 2.84e-01 | 3.74e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 8 | 1.65e-01 | -2.84e-01 | 5.00e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 8 | 1.65e-01 | 2.84e-01 | 5.00e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 2.72e-01 | 2.84e-01 | 6.22e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 12 | 8.91e-02 | 2.83e-01 | 3.74e-01 |
| GOCC FILOPODIUM | 66 | 6.96e-05 | 2.83e-01 | 2.48e-03 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 30 | 7.32e-03 | 2.83e-01 | 9.32e-02 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 229 | 1.92e-13 | 2.83e-01 | 6.61e-11 |
| GOCC COLLAGEN TRIMER | 18 | 3.79e-02 | -2.83e-01 | 2.42e-01 |
| GOCC CKM COMPLEX | 5 | 2.74e-01 | 2.82e-01 | 6.23e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 31 | 6.52e-03 | 2.82e-01 | 8.61e-02 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 6 | 2.31e-01 | -2.82e-01 | 5.80e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 10 | 1.22e-01 | 2.82e-01 | 4.35e-01 |
| GOCC CELL TRAILING EDGE | 13 | 7.83e-02 | 2.82e-01 | 3.50e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 2.21e-02 | 2.82e-01 | 1.81e-01 |
| GOBP INNERVATION | 11 | 1.06e-01 | -2.82e-01 | 4.05e-01 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 2.75e-01 | -2.82e-01 | 6.25e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 6.82e-02 | -2.82e-01 | 3.29e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 9 | 1.44e-01 | -2.81e-01 | 4.67e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 10 | 1.23e-01 | 2.81e-01 | 4.37e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 1.98e-01 | -2.81e-01 | 5.44e-01 |
| GOBP ACROSOME REACTION | 8 | 1.68e-01 | -2.81e-01 | 5.05e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 18 | 3.91e-02 | 2.81e-01 | 2.45e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 10 | 1.24e-01 | 2.81e-01 | 4.38e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 12 | 9.22e-02 | 2.81e-01 | 3.82e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 5 | 2.78e-01 | 2.80e-01 | 6.27e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 23 | 2.01e-02 | -2.80e-01 | 1.71e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 17 | 4.57e-02 | 2.80e-01 | 2.68e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 11 | 1.08e-01 | 2.80e-01 | 4.09e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 9.32e-02 | 2.80e-01 | 3.83e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 21 | 2.64e-02 | 2.80e-01 | 2.01e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 97 | 2.00e-06 | 2.80e-01 | 1.13e-04 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 6 | 2.36e-01 | -2.79e-01 | 5.86e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 21 | 2.67e-02 | 2.79e-01 | 2.02e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 5 | 2.80e-01 | 2.79e-01 | 6.29e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 5 | 2.80e-01 | 2.79e-01 | 6.29e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 71 | 4.85e-05 | 2.79e-01 | 1.80e-03 |
| GOMF TROPOMYOSIN BINDING | 8 | 1.72e-01 | 2.79e-01 | 5.11e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 12 | 9.47e-02 | -2.79e-01 | 3.87e-01 |
| GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS | 5 | 2.81e-01 | 2.78e-01 | 6.29e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 6 | 2.38e-01 | 2.78e-01 | 5.87e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 2.02e-01 | 2.78e-01 | 5.49e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 16 | 5.40e-02 | -2.78e-01 | 2.92e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 14 | 7.15e-02 | 2.78e-01 | 3.37e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 15 | 6.23e-02 | -2.78e-01 | 3.17e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 10 | 1.28e-01 | -2.78e-01 | 4.44e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 7 | 2.03e-01 | -2.78e-01 | 5.50e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 7 | 2.03e-01 | -2.78e-01 | 5.50e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 5 | 2.83e-01 | 2.78e-01 | 6.31e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 6.29e-02 | -2.77e-01 | 3.18e-01 |
| GOBP MIDBODY ABSCISSION | 15 | 6.29e-02 | 2.77e-01 | 3.18e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 12 | 9.66e-02 | -2.77e-01 | 3.91e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 11 | 1.12e-01 | 2.77e-01 | 4.15e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 8 | 1.75e-01 | -2.77e-01 | 5.16e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 28 | 1.13e-02 | -2.77e-01 | 1.22e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 14 | 7.32e-02 | 2.77e-01 | 3.40e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 25 | 1.67e-02 | 2.77e-01 | 1.55e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 38 | 3.21e-03 | 2.76e-01 | 5.31e-02 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 2.85e-01 | 2.76e-01 | 6.33e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 1.93e-02 | -2.76e-01 | 1.67e-01 |
| GOBP LIPID DROPLET FORMATION | 9 | 1.52e-01 | 2.76e-01 | 4.82e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 6.44e-02 | 2.76e-01 | 3.23e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 17 | 4.90e-02 | 2.76e-01 | 2.79e-01 |
| GOBP AXONEME ASSEMBLY | 35 | 4.76e-03 | -2.76e-01 | 7.02e-02 |
| GOMF POLY A BINDING | 20 | 3.28e-02 | -2.76e-01 | 2.27e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 14 | 7.42e-02 | 2.76e-01 | 3.42e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 1.77e-01 | -2.76e-01 | 5.17e-01 |
| GOBP CRISTAE FORMATION | 17 | 4.93e-02 | 2.75e-01 | 2.80e-01 |
| GOCC CHROMOSOMAL REGION | 346 | 1.76e-18 | 2.75e-01 | 1.61e-15 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 24 | 1.96e-02 | 2.75e-01 | 1.68e-01 |
| GOBP V D J RECOMBINATION | 17 | 4.96e-02 | 2.75e-01 | 2.80e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 7 | 2.08e-01 | -2.75e-01 | 5.56e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 48 | 9.87e-04 | 2.75e-01 | 2.15e-02 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 2.87e-01 | 2.75e-01 | 6.36e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 39 | 3.00e-03 | 2.75e-01 | 5.05e-02 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 3.36e-02 | 2.74e-01 | 2.31e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 64 | 1.48e-04 | 2.74e-01 | 4.70e-03 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 10 | 1.33e-01 | 2.74e-01 | 4.50e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 10 | 1.33e-01 | -2.74e-01 | 4.50e-01 |
| GOBP CILIUM DISASSEMBLY | 5 | 2.88e-01 | 2.74e-01 | 6.36e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 6 | 2.45e-01 | -2.74e-01 | 5.93e-01 |
| GOBP REFLEX | 5 | 2.88e-01 | -2.74e-01 | 6.37e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 10 | 1.33e-01 | -2.74e-01 | 4.50e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 2.09e-01 | -2.74e-01 | 5.57e-01 |
| GOBP KERATINOCYTE MIGRATION | 9 | 1.55e-01 | -2.74e-01 | 4.88e-01 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 2.45e-01 | 2.74e-01 | 5.93e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 2.10e-01 | 2.74e-01 | 5.58e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 1.08e-02 | 2.74e-01 | 1.19e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 5 | 2.89e-01 | 2.74e-01 | 6.38e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 168 | 1.01e-09 | 2.74e-01 | 1.28e-07 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 7.67e-02 | 2.73e-01 | 3.47e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 7 | 2.11e-01 | 2.73e-01 | 5.58e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 7 | 2.11e-01 | 2.73e-01 | 5.58e-01 |
| GOCC SITE OF DNA DAMAGE | 106 | 1.21e-06 | 2.73e-01 | 7.23e-05 |
| GOBP DNA CATABOLIC PROCESS | 21 | 3.03e-02 | 2.73e-01 | 2.18e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 6.74e-02 | 2.73e-01 | 3.27e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 2.91e-01 | -2.73e-01 | 6.38e-01 |
| GOBP REPLICATIVE SENESCENCE | 12 | 1.02e-01 | 2.73e-01 | 4.01e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 22 | 2.68e-02 | 2.73e-01 | 2.02e-01 |
| GOCC NBAF COMPLEX | 14 | 7.73e-02 | 2.73e-01 | 3.48e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 6 | 2.47e-01 | 2.73e-01 | 5.95e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 2.91e-01 | 2.73e-01 | 6.38e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 16 | 5.91e-02 | 2.73e-01 | 3.06e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 7 | 2.12e-01 | 2.73e-01 | 5.60e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 8 | 1.82e-01 | 2.72e-01 | 5.25e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 1.03e-01 | 2.72e-01 | 4.01e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 6 | 2.48e-01 | 2.72e-01 | 5.97e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 2.92e-01 | 2.72e-01 | 6.40e-01 |
| GOMF PEPTIDE HORMONE BINDING | 14 | 7.80e-02 | -2.72e-01 | 3.49e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 8 | 1.83e-01 | 2.72e-01 | 5.26e-01 |
| GOCC CONDENSED CHROMOSOME | 243 | 3.26e-13 | 2.72e-01 | 1.04e-10 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 19 | 4.02e-02 | 2.72e-01 | 2.49e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 7 | 2.13e-01 | -2.72e-01 | 5.62e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 2.49e-01 | 2.72e-01 | 5.97e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 1.58e-01 | 2.72e-01 | 4.92e-01 |
| GOCC RSC TYPE COMPLEX | 14 | 7.84e-02 | 2.72e-01 | 3.50e-01 |
| GOMF G PROTEIN ACTIVITY | 32 | 7.87e-03 | 2.72e-01 | 9.85e-02 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 11 | 1.19e-01 | -2.71e-01 | 4.28e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 5 | 2.94e-01 | -2.71e-01 | 6.40e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 29 | 1.15e-02 | 2.71e-01 | 1.24e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 6 | 2.50e-01 | 2.71e-01 | 5.99e-01 |
| GOBP CELLULAR RESPIRATION | 208 | 1.85e-11 | 2.71e-01 | 3.56e-09 |
| GOMF DNA HELICASE ACTIVITY | 56 | 4.64e-04 | 2.71e-01 | 1.19e-02 |
| GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 5 | 2.95e-01 | 2.70e-01 | 6.40e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 9 | 1.61e-01 | 2.70e-01 | 4.95e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 8 | 1.86e-01 | 2.70e-01 | 5.30e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 2.16e-01 | 2.70e-01 | 5.65e-01 |
| GOBP CHIASMA ASSEMBLY | 5 | 2.96e-01 | -2.70e-01 | 6.41e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 1.21e-01 | 2.70e-01 | 4.32e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX CIRCULATING | 5 | 2.96e-01 | -2.70e-01 | 6.42e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 1.06e-01 | 2.70e-01 | 4.06e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 6 | 2.53e-01 | -2.69e-01 | 6.02e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 24 | 2.23e-02 | 2.69e-01 | 1.82e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 7.09e-02 | 2.69e-01 | 3.35e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 16 | 6.22e-02 | 2.69e-01 | 3.17e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 2.97e-01 | 2.69e-01 | 6.42e-01 |
| GOCC RIBOSOMAL SUBUNIT | 180 | 4.99e-10 | -2.69e-01 | 6.65e-08 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 1.62e-01 | 2.69e-01 | 4.97e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 12 | 1.07e-01 | -2.69e-01 | 4.06e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 4.24e-02 | 2.69e-01 | 2.57e-01 |
| GOMF GROWTH HORMONE RECEPTOR BINDING | 5 | 2.98e-01 | 2.69e-01 | 6.43e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MATURATION | 5 | 2.98e-01 | -2.69e-01 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 11 | 1.23e-01 | 2.69e-01 | 4.36e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 13 | 9.36e-02 | 2.69e-01 | 3.84e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 2.55e-01 | -2.68e-01 | 6.04e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 17 | 5.54e-02 | 2.68e-01 | 2.95e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 4.30e-02 | 2.68e-01 | 2.59e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 161 | 4.63e-09 | 2.68e-01 | 4.91e-07 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 29 | 1.25e-02 | -2.68e-01 | 1.30e-01 |
| GOCC NUCLEAR CHROMOSOME | 189 | 2.29e-10 | 2.68e-01 | 3.44e-08 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 11 | 1.24e-01 | 2.68e-01 | 4.38e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 22 | 2.97e-02 | 2.68e-01 | 2.16e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 10 | 1.42e-01 | -2.68e-01 | 4.65e-01 |
| GOMF LAMIN BINDING | 14 | 8.28e-02 | 2.68e-01 | 3.62e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 3.00e-01 | 2.68e-01 | 6.44e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 13 | 9.50e-02 | 2.68e-01 | 3.87e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 8 | 1.90e-01 | 2.67e-01 | 5.36e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 8 | 1.91e-01 | -2.67e-01 | 5.36e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 11 | 1.25e-01 | -2.67e-01 | 4.39e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 11 | 1.25e-01 | -2.67e-01 | 4.39e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 23 | 2.66e-02 | 2.67e-01 | 2.02e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 23 | 2.67e-02 | 2.67e-01 | 2.02e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 14 | 8.38e-02 | 2.67e-01 | 3.64e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 190 | 2.43e-10 | 2.67e-01 | 3.59e-08 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 3.02e-01 | 2.67e-01 | 6.46e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 82 | 3.00e-05 | 2.67e-01 | 1.18e-03 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 17 | 5.72e-02 | 2.67e-01 | 2.99e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 3.02e-01 | 2.66e-01 | 6.47e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 7 | 2.22e-01 | -2.66e-01 | 5.72e-01 |
| GOBP REGULATION OF RNA BINDING | 8 | 1.92e-01 | -2.66e-01 | 5.37e-01 |
| GOBP FATTY ACID BETA OXIDATION | 61 | 3.29e-04 | 2.66e-01 | 9.06e-03 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 11 | 1.27e-01 | -2.66e-01 | 4.42e-01 |
| GOBP TOXIN TRANSPORT | 5 | 3.04e-01 | 2.66e-01 | 6.47e-01 |
| GOBP DETECTION OF CALCIUM ION | 7 | 2.24e-01 | 2.66e-01 | 5.73e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 5 | 3.04e-01 | -2.65e-01 | 6.47e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 15 | 7.54e-02 | 2.65e-01 | 3.44e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 8 | 1.94e-01 | -2.65e-01 | 5.39e-01 |
| GOCC TORC2 COMPLEX | 9 | 1.68e-01 | 2.65e-01 | 5.05e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 40 | 3.74e-03 | 2.65e-01 | 5.90e-02 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 16 | 6.65e-02 | -2.65e-01 | 3.27e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 14 | 8.61e-02 | 2.65e-01 | 3.69e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 9 | 1.69e-01 | 2.65e-01 | 5.06e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 24 | 2.48e-02 | 2.65e-01 | 1.94e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 10 | 1.47e-01 | -2.65e-01 | 4.75e-01 |
| GOCC MAIN AXON | 33 | 8.53e-03 | -2.65e-01 | 1.04e-01 |
| GOBP REGULATION OF DNA METHYLATION | 13 | 9.86e-02 | 2.65e-01 | 3.96e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 1.13e-01 | 2.65e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 26 | 1.96e-02 | 2.65e-01 | 1.68e-01 |
| GOBP AMINO ACID SALVAGE | 5 | 3.06e-01 | 2.64e-01 | 6.49e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 3.06e-01 | 2.64e-01 | 6.49e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 9 | 1.70e-01 | -2.64e-01 | 5.07e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 11 | 1.29e-01 | -2.64e-01 | 4.46e-01 |
| GOMF C PALMITOYLTRANSFERASE ACTIVITY | 5 | 3.07e-01 | 2.64e-01 | 6.49e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 3.07e-01 | -2.64e-01 | 6.49e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 3.07e-01 | -2.64e-01 | 6.49e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 33 | 8.74e-03 | -2.64e-01 | 1.06e-01 |
| GOMF ACTIVIN BINDING | 8 | 1.97e-01 | -2.64e-01 | 5.43e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 5 | 3.07e-01 | -2.64e-01 | 6.50e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 7 | 2.27e-01 | 2.64e-01 | 5.76e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 33 | 8.85e-03 | 2.63e-01 | 1.07e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 6 | 2.65e-01 | -2.63e-01 | 6.16e-01 |
| GOCC PODOSOME | 21 | 3.72e-02 | 2.63e-01 | 2.40e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 28 | 1.62e-02 | 2.63e-01 | 1.51e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 31 | 1.14e-02 | 2.63e-01 | 1.23e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 11 | 1.32e-01 | 2.62e-01 | 4.48e-01 |
| GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 3.10e-01 | 2.62e-01 | 6.52e-01 |
| GOBP OOCYTE DIFFERENTIATION | 29 | 1.45e-02 | 2.62e-01 | 1.41e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 1.99e-01 | 2.62e-01 | 5.47e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 13 | 1.02e-01 | 2.62e-01 | 4.01e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 13 | 1.02e-01 | 2.62e-01 | 4.01e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 11 | 1.32e-01 | 2.62e-01 | 4.48e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 1.73e-01 | 2.62e-01 | 5.13e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 5 | 3.10e-01 | -2.62e-01 | 6.53e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 2.30e-01 | -2.62e-01 | 5.80e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 6 | 2.67e-01 | 2.62e-01 | 6.17e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 18 | 5.46e-02 | 2.62e-01 | 2.94e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 14 | 9.00e-02 | 2.62e-01 | 3.76e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 7 | 2.31e-01 | 2.62e-01 | 5.80e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 17 | 6.19e-02 | 2.62e-01 | 3.16e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 2.00e-01 | 2.62e-01 | 5.48e-01 |
| GOBP CMP METABOLIC PROCESS | 7 | 2.31e-01 | 2.61e-01 | 5.80e-01 |
| GOCC AXONEMAL MICROTUBULE | 16 | 7.03e-02 | -2.61e-01 | 3.34e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 3.12e-01 | -2.61e-01 | 6.54e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 26 | 2.12e-02 | 2.61e-01 | 1.76e-01 |
| GOCC FEMALE PRONUCLEUS | 9 | 1.75e-01 | 2.61e-01 | 5.16e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 5 | 3.12e-01 | 2.61e-01 | 6.55e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 10 | 1.53e-01 | 2.61e-01 | 4.85e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 18 | 5.54e-02 | 2.61e-01 | 2.95e-01 |
| GOCC IGG IMMUNOGLOBULIN COMPLEX | 6 | 2.69e-01 | -2.61e-01 | 6.19e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 6 | 2.69e-01 | -2.61e-01 | 6.19e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 5 | 3.13e-01 | -2.61e-01 | 6.55e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 1.76e-01 | 2.61e-01 | 5.17e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 89 | 2.25e-05 | 2.60e-01 | 9.33e-04 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 66 | 2.61e-04 | 2.60e-01 | 7.43e-03 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 2.70e-01 | 2.60e-01 | 6.20e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 141 | 1.06e-07 | 2.60e-01 | 8.91e-06 |
| GOMF FOLIC ACID BINDING | 6 | 2.71e-01 | 2.60e-01 | 6.20e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 23 | 3.12e-02 | 2.60e-01 | 2.20e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 17 | 6.39e-02 | 2.60e-01 | 3.21e-01 |
| GOCC PEPTIDASE COMPLEX | 104 | 4.99e-06 | 2.59e-01 | 2.49e-04 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 1.78e-01 | -2.59e-01 | 5.19e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 2.71e-01 | 2.59e-01 | 6.21e-01 |
| GOBP THYMIC T CELL SELECTION | 19 | 5.07e-02 | 2.59e-01 | 2.83e-01 |
| GOBP TONGUE DEVELOPMENT | 7 | 2.36e-01 | -2.59e-01 | 5.85e-01 |
| GOMF SH3 DOMAIN BINDING | 89 | 2.49e-05 | 2.59e-01 | 1.02e-03 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 24 | 2.83e-02 | 2.59e-01 | 2.09e-01 |
| GOCC RIBBON SYNAPSE | 9 | 1.79e-01 | 2.59e-01 | 5.21e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 11 | 1.38e-01 | 2.59e-01 | 4.56e-01 |
| GOMF DNA POLYMERASE BINDING | 21 | 4.04e-02 | 2.58e-01 | 2.49e-01 |
| GOMF LBD DOMAIN BINDING | 5 | 3.17e-01 | 2.58e-01 | 6.58e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 21 | 4.05e-02 | 2.58e-01 | 2.50e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 23 | 3.21e-02 | -2.58e-01 | 2.25e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 37 | 6.59e-03 | 2.58e-01 | 8.67e-02 |
| GOBP DNA BIOSYNTHETIC PROCESS | 153 | 3.78e-08 | 2.58e-01 | 3.43e-06 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 10 | 1.58e-01 | 2.58e-01 | 4.92e-01 |
| GOBP NEUROBLAST DIVISION | 8 | 2.07e-01 | 2.58e-01 | 5.55e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 7.42e-02 | 2.58e-01 | 3.42e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 17 | 6.57e-02 | 2.58e-01 | 3.25e-01 |
| GOCC MICROBODY LUMEN | 38 | 6.01e-03 | 2.58e-01 | 8.16e-02 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 3.19e-01 | 2.58e-01 | 6.59e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 9.36e-03 | 2.58e-01 | 1.09e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 3.19e-01 | -2.58e-01 | 6.59e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 3.19e-01 | -2.58e-01 | 6.59e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 3.19e-01 | 2.57e-01 | 6.59e-01 |
| GOBP SPERM DNA CONDENSATION | 7 | 2.38e-01 | 2.57e-01 | 5.88e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 8 | 2.08e-01 | 2.57e-01 | 5.56e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 7.50e-02 | -2.57e-01 | 3.43e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 5 | 3.20e-01 | -2.57e-01 | 6.60e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 3.70e-02 | 2.57e-01 | 2.40e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 24 | 2.94e-02 | 2.57e-01 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 7 | 2.39e-01 | 2.57e-01 | 5.88e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 16 | 7.54e-02 | 2.57e-01 | 3.44e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 7 | 2.40e-01 | 2.57e-01 | 5.88e-01 |
| GOBP SELF PROTEOLYSIS | 8 | 2.09e-01 | -2.57e-01 | 5.57e-01 |
| GOBP TRNA TRANSPORT | 5 | 3.21e-01 | -2.56e-01 | 6.61e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 20 | 4.74e-02 | 2.56e-01 | 2.75e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 3.21e-01 | -2.56e-01 | 6.62e-01 |
| GOBP GROWTH HORMONE SECRETION | 8 | 2.10e-01 | -2.56e-01 | 5.58e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 2.78e-01 | -2.56e-01 | 6.27e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 6 | 2.78e-01 | 2.56e-01 | 6.27e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 22 | 3.78e-02 | -2.56e-01 | 2.42e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 229 | 2.88e-11 | 2.56e-01 | 5.41e-09 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 11 | 1.42e-01 | 2.56e-01 | 4.65e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 7 | 2.42e-01 | -2.55e-01 | 5.90e-01 |
| GOBP LOCOMOTOR RHYTHM | 9 | 1.85e-01 | -2.55e-01 | 5.28e-01 |
| GOBP SPINDLE LOCALIZATION | 43 | 3.77e-03 | 2.55e-01 | 5.91e-02 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 30 | 1.56e-02 | 2.55e-01 | 1.47e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 10 | 1.62e-01 | 2.55e-01 | 4.97e-01 |
| GOBP BONE CELL DEVELOPMENT | 12 | 1.26e-01 | 2.55e-01 | 4.40e-01 |
| GOBP RECEPTOR CLUSTERING | 31 | 1.40e-02 | 2.55e-01 | 1.39e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 16 | 7.74e-02 | 2.55e-01 | 3.48e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 3.23e-01 | -2.55e-01 | 6.63e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 5 | 3.24e-01 | -2.55e-01 | 6.63e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 6 | 2.80e-01 | 2.55e-01 | 6.29e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 7 | 2.43e-01 | -2.55e-01 | 5.91e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 9 | 1.86e-01 | 2.55e-01 | 5.30e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 8 | 2.12e-01 | 2.55e-01 | 5.61e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 10 | 1.63e-01 | -2.55e-01 | 4.98e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 22 | 3.88e-02 | 2.55e-01 | 2.44e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 55 | 1.10e-03 | 2.54e-01 | 2.36e-02 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 4.90e-02 | 2.54e-01 | 2.79e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 263 | 1.44e-12 | 2.54e-01 | 3.70e-10 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 18 | 6.19e-02 | 2.54e-01 | 3.16e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 8 | 2.13e-01 | 2.54e-01 | 5.62e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 29 | 1.79e-02 | 2.54e-01 | 1.60e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 3.25e-01 | 2.54e-01 | 6.64e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 13 | 1.13e-01 | 2.54e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 10 | 1.65e-01 | 2.54e-01 | 5.00e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 2.45e-01 | -2.54e-01 | 5.93e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 1.88e-01 | 2.54e-01 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 7 | 2.45e-01 | -2.54e-01 | 5.93e-01 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 5 | 3.26e-01 | 2.54e-01 | 6.64e-01 |
| GOCC GRANULAR COMPONENT | 6 | 2.82e-01 | -2.54e-01 | 6.30e-01 |
| GOBP N GLYCAN PROCESSING | 14 | 1.01e-01 | 2.54e-01 | 3.99e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 14 | 1.01e-01 | 2.53e-01 | 3.99e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 38 | 6.89e-03 | 2.53e-01 | 8.96e-02 |
| GOBP REGULATION OF PROTEIN MATURATION | 40 | 5.60e-03 | 2.53e-01 | 7.81e-02 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 8 | 2.15e-01 | 2.53e-01 | 5.64e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 8 | 2.15e-01 | -2.53e-01 | 5.64e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 2.83e-01 | 2.53e-01 | 6.32e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 2.15e-01 | 2.53e-01 | 5.64e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 2.15e-01 | 2.53e-01 | 5.64e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 42 | 4.59e-03 | 2.53e-01 | 6.83e-02 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 8 | 2.16e-01 | -2.53e-01 | 5.65e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 12 | 1.30e-01 | 2.53e-01 | 4.46e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 6 | 2.84e-01 | 2.53e-01 | 6.32e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 10 | 1.67e-01 | -2.53e-01 | 5.02e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 1.30e-01 | 2.53e-01 | 4.46e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 2.16e-01 | 2.53e-01 | 5.65e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 22 | 4.04e-02 | 2.52e-01 | 2.50e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 9 | 1.90e-01 | 2.52e-01 | 5.35e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 99 | 1.47e-05 | 2.52e-01 | 6.40e-04 |
| GOBP FACE MORPHOGENESIS | 16 | 8.07e-02 | -2.52e-01 | 3.57e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 8 | 2.17e-01 | 2.52e-01 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 50 | 2.05e-03 | 2.52e-01 | 3.85e-02 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.29e-01 | -2.52e-01 | 6.67e-01 |
| GOBP PROTEIN NITROSYLATION | 11 | 1.48e-01 | 2.52e-01 | 4.76e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 1.31e-01 | -2.52e-01 | 4.47e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 20 | 5.12e-02 | -2.52e-01 | 2.84e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 14 | 1.03e-01 | -2.52e-01 | 4.02e-01 |
| GOBP HISTONE UBIQUITINATION | 9 | 1.91e-01 | 2.52e-01 | 5.37e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 28 | 2.13e-02 | 2.51e-01 | 1.77e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 33 | 1.25e-02 | 2.51e-01 | 1.29e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 1.54e-02 | 2.51e-01 | 1.46e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 3.31e-01 | -2.51e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 3.31e-01 | -2.51e-01 | 6.67e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 10 | 1.69e-01 | 2.51e-01 | 5.06e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 5 | 3.31e-01 | 2.51e-01 | 6.67e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 9 | 1.92e-01 | 2.51e-01 | 5.37e-01 |
| GOMF U3 SNORNA BINDING | 10 | 1.70e-01 | 2.51e-01 | 5.07e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 39 | 6.75e-03 | -2.51e-01 | 8.85e-02 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 29 | 1.95e-02 | 2.51e-01 | 1.68e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 12 | 1.33e-01 | 2.51e-01 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 31 | 1.58e-02 | -2.51e-01 | 1.48e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 10 | 1.70e-01 | -2.50e-01 | 5.08e-01 |
| GOBP REPLACEMENT OSSIFICATION | 10 | 1.70e-01 | -2.50e-01 | 5.08e-01 |
| GOCC CASPASE COMPLEX | 9 | 1.94e-01 | 2.50e-01 | 5.39e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 15 | 9.34e-02 | 2.50e-01 | 3.83e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 34 | 1.17e-02 | 2.50e-01 | 1.25e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 5 | 3.33e-01 | -2.50e-01 | 6.70e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 13 | 1.19e-01 | 2.50e-01 | 4.27e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 6 | 2.90e-01 | -2.50e-01 | 6.38e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 6.68e-02 | 2.50e-01 | 3.27e-01 |
| GOBP COCHLEA MORPHOGENESIS | 5 | 3.34e-01 | -2.50e-01 | 6.71e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 5 | 3.34e-01 | 2.50e-01 | 6.71e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 6 | 2.90e-01 | -2.49e-01 | 6.38e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 10 | 1.72e-01 | 2.49e-01 | 5.11e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 2.54e-01 | -2.49e-01 | 6.03e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 3.35e-01 | 2.49e-01 | 6.71e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 8 | 2.23e-01 | -2.49e-01 | 5.72e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 7 | 2.54e-01 | 2.49e-01 | 6.03e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 10 | 1.73e-01 | 2.49e-01 | 5.12e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 10 | 1.73e-01 | 2.49e-01 | 5.12e-01 |
| GOBP CYTOKINETIC PROCESS | 36 | 9.78e-03 | 2.49e-01 | 1.12e-01 |
| GOBP GERMINAL CENTER FORMATION | 12 | 1.35e-01 | -2.49e-01 | 4.53e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 12 | 1.35e-01 | 2.49e-01 | 4.53e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 229 | 9.74e-11 | 2.49e-01 | 1.64e-08 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 14 | 1.07e-01 | 2.49e-01 | 4.07e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 12 | 1.36e-01 | 2.49e-01 | 4.53e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 8 | 2.24e-01 | 2.49e-01 | 5.73e-01 |
| GOBP RESPONSE TO UV A | 5 | 3.36e-01 | 2.49e-01 | 6.73e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 6 | 2.92e-01 | -2.48e-01 | 6.40e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 13 | 1.21e-01 | 2.48e-01 | 4.32e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 6.83e-02 | 2.48e-01 | 3.29e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 6.83e-02 | 2.48e-01 | 3.29e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 12 | 1.37e-01 | -2.48e-01 | 4.54e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 35 | 1.11e-02 | 2.48e-01 | 1.22e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 2.93e-01 | 2.48e-01 | 6.40e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 8 | 2.25e-01 | 2.48e-01 | 5.74e-01 |
| GOMF CGMP BINDING | 7 | 2.56e-01 | -2.48e-01 | 6.05e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 12 | 1.37e-01 | -2.48e-01 | 4.56e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 7 | 2.57e-01 | -2.47e-01 | 6.06e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 8 | 2.26e-01 | -2.47e-01 | 5.75e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 29 | 2.13e-02 | 2.47e-01 | 1.77e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 6 | 2.95e-01 | 2.47e-01 | 6.40e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 5 | 3.39e-01 | 2.47e-01 | 6.75e-01 |
| GOBP RRNA TRANSCRIPTION | 31 | 1.74e-02 | 2.47e-01 | 1.58e-01 |
| GOMF PHOSPHATE ION BINDING | 6 | 2.95e-01 | -2.47e-01 | 6.40e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 62 | 7.84e-04 | 2.47e-01 | 1.81e-02 |
| GOBP NERVE DEVELOPMENT | 38 | 8.58e-03 | -2.47e-01 | 1.04e-01 |
| GOBP OSTEOCLAST FUSION | 5 | 3.40e-01 | 2.47e-01 | 6.76e-01 |
| GOBP VASCULAR WOUND HEALING | 10 | 1.77e-01 | -2.46e-01 | 5.17e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 75 | 2.27e-04 | 2.46e-01 | 6.66e-03 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 12 | 1.40e-01 | -2.46e-01 | 4.59e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 35 | 1.17e-02 | 2.46e-01 | 1.25e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 1.57e-01 | 2.46e-01 | 4.92e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 9 | 2.01e-01 | -2.46e-01 | 5.49e-01 |
| GOBP CHROMOSOME ORGANIZATION | 517 | 1.77e-21 | 2.46e-01 | 3.65e-18 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 2.97e-01 | 2.46e-01 | 6.42e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 11 | 1.58e-01 | -2.46e-01 | 4.92e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 8 | 2.29e-01 | 2.46e-01 | 5.78e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 1.41e-01 | 2.46e-01 | 4.61e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 10 | 1.79e-01 | 2.46e-01 | 5.20e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 33 | 1.47e-02 | 2.45e-01 | 1.42e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 7.15e-02 | 2.45e-01 | 3.37e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 13 | 1.26e-01 | 2.45e-01 | 4.40e-01 |
| GOBP HAIR FOLLICLE MATURATION | 7 | 2.61e-01 | 2.45e-01 | 6.12e-01 |
| GOBP STEROID HORMONE SECRETION | 10 | 1.80e-01 | -2.45e-01 | 5.22e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 17 | 8.03e-02 | 2.45e-01 | 3.55e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 7.73e-06 | -2.45e-01 | 3.61e-04 |
| GOBP GLUCOSE CATABOLIC PROCESS | 19 | 6.49e-02 | 2.45e-01 | 3.24e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 28 | 2.52e-02 | 2.45e-01 | 1.96e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 16 | 9.05e-02 | -2.44e-01 | 3.77e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 61 | 9.77e-04 | 2.44e-01 | 2.13e-02 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 1.14e-01 | 2.44e-01 | 4.18e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 3.00e-01 | -2.44e-01 | 6.45e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 8 | 2.32e-01 | -2.44e-01 | 5.80e-01 |
| GOCC BRCA1 A COMPLEX | 8 | 2.32e-01 | 2.44e-01 | 5.80e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 7 | 2.63e-01 | -2.44e-01 | 6.14e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 7 | 2.64e-01 | 2.44e-01 | 6.14e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 11 | 1.61e-01 | 2.44e-01 | 4.95e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 11 | 1.61e-01 | -2.44e-01 | 4.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 48 | 3.48e-03 | 2.44e-01 | 5.59e-02 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 13 | 1.28e-01 | -2.44e-01 | 4.44e-01 |
| GOCC SEPTIN CYTOSKELETON | 11 | 1.61e-01 | 2.44e-01 | 4.95e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 9 | 2.06e-01 | -2.44e-01 | 5.54e-01 |
| GOMF PROTEIN KINASE C ACTIVITY | 14 | 1.15e-01 | 2.44e-01 | 4.19e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 12 | 1.44e-01 | 2.44e-01 | 4.68e-01 |
| GOBP DEPYRIMIDINATION | 8 | 2.33e-01 | 2.44e-01 | 5.82e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 7 | 2.65e-01 | 2.43e-01 | 6.16e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 10 | 1.83e-01 | -2.43e-01 | 5.26e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 8 | 2.34e-01 | 2.43e-01 | 5.83e-01 |
| GOMF LNCRNA BINDING | 11 | 1.63e-01 | 2.43e-01 | 4.98e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 7 | 2.66e-01 | -2.43e-01 | 6.17e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 11 | 1.64e-01 | 2.42e-01 | 4.98e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 43 | 5.96e-03 | 2.42e-01 | 8.11e-02 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 30 | 2.16e-02 | 2.42e-01 | 1.78e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 8.36e-02 | 2.42e-01 | 3.64e-01 |
| GOMF NUCLEOSOME BINDING | 52 | 2.51e-03 | 2.42e-01 | 4.42e-02 |
| GOBP ENDOCARDIUM DEVELOPMENT | 7 | 2.67e-01 | -2.42e-01 | 6.17e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 15 | 1.04e-01 | 2.42e-01 | 4.03e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 6 | 3.04e-01 | 2.42e-01 | 6.47e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 3.48e-01 | 2.42e-01 | 6.82e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 5 | 3.49e-01 | 2.42e-01 | 6.82e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 31 | 1.97e-02 | 2.42e-01 | 1.69e-01 |
| GOCC PREFOLDIN COMPLEX | 7 | 2.68e-01 | 2.42e-01 | 6.18e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 6 | 3.05e-01 | 2.42e-01 | 6.48e-01 |
| GOBP NEURON MATURATION | 22 | 4.97e-02 | -2.42e-01 | 2.80e-01 |
| GOCC NURD COMPLEX | 15 | 1.05e-01 | 2.42e-01 | 4.05e-01 |
| GOBP GLYCINE TRANSPORT | 5 | 3.50e-01 | 2.41e-01 | 6.83e-01 |
| GOBP TELOMERE ORGANIZATION | 150 | 3.47e-07 | 2.41e-01 | 2.56e-05 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 15 | 1.06e-01 | 2.41e-01 | 4.05e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 12 | 1.48e-01 | 2.41e-01 | 4.76e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 3.50e-01 | 2.41e-01 | 6.83e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 43 | 6.24e-03 | 2.41e-01 | 8.37e-02 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 8 | 2.38e-01 | 2.41e-01 | 5.87e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 9 | 2.10e-01 | -2.41e-01 | 5.58e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC SPECIALIZATION MEMBRANE | 5 | 3.51e-01 | -2.41e-01 | 6.83e-01 |
| GOBP RNA 5 END PROCESSING | 21 | 5.59e-02 | 2.41e-01 | 2.96e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 7 | 2.70e-01 | -2.41e-01 | 6.19e-01 |
| GOCC RIBOSOME | 221 | 7.37e-10 | -2.41e-01 | 9.52e-08 |
| GOBP CHROMOSOME SEGREGATION | 369 | 2.44e-15 | 2.41e-01 | 1.26e-12 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 12 | 1.49e-01 | 2.41e-01 | 4.77e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 2.70e-01 | 2.41e-01 | 6.20e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 5 | 3.51e-01 | 2.41e-01 | 6.84e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 9 | 2.11e-01 | -2.41e-01 | 5.59e-01 |
| GOBP RESPONSE TO VITAMIN D | 15 | 1.06e-01 | 2.41e-01 | 4.06e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 7 | 2.70e-01 | 2.41e-01 | 6.20e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 1.03e-02 | 2.41e-01 | 1.15e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 8 | 2.39e-01 | 2.41e-01 | 5.88e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 8 | 2.39e-01 | -2.41e-01 | 5.88e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 15 | 1.07e-01 | -2.40e-01 | 4.07e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 9 | 2.12e-01 | -2.40e-01 | 5.60e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 3.75e-02 | 2.40e-01 | 2.41e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 3.52e-01 | -2.40e-01 | 6.84e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 11 | 1.67e-01 | 2.40e-01 | 5.04e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 5 | 3.52e-01 | -2.40e-01 | 6.84e-01 |
| GOBP ACID SECRETION | 19 | 6.97e-02 | -2.40e-01 | 3.33e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 1.88e-01 | 2.40e-01 | 5.33e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 24 | 4.17e-02 | 2.40e-01 | 2.54e-01 |
| GOMF NADPLUS BINDING | 16 | 9.66e-02 | 2.40e-01 | 3.91e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 12 | 1.50e-01 | 2.40e-01 | 4.81e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 35 | 1.42e-02 | 2.40e-01 | 1.40e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 6 | 3.10e-01 | 2.39e-01 | 6.52e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 44 | 6.02e-03 | 2.39e-01 | 8.17e-02 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 3.54e-01 | 2.39e-01 | 6.86e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 7 | 2.73e-01 | -2.39e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 18 | 7.92e-02 | -2.39e-01 | 3.53e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 23 | 4.74e-02 | 2.39e-01 | 2.75e-01 |
| GOCC B CELL RECEPTOR COMPLEX | 5 | 3.55e-01 | -2.39e-01 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 10 | 1.91e-01 | -2.39e-01 | 5.37e-01 |
| GOCC MITOCHONDRIAL CRISTA | 6 | 3.11e-01 | 2.39e-01 | 6.54e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 9 | 2.15e-01 | 2.39e-01 | 5.64e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 19 | 7.19e-02 | 2.39e-01 | 3.37e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 13 | 1.37e-01 | 2.38e-01 | 4.55e-01 |
| GOCC NUCLEAR PERIPHERY | 128 | 3.28e-06 | 2.38e-01 | 1.74e-04 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 17 | 8.88e-02 | 2.38e-01 | 3.74e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 100 | 3.92e-05 | 2.38e-01 | 1.50e-03 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 2.16e-01 | 2.38e-01 | 5.65e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 5 | 3.57e-01 | -2.38e-01 | 6.87e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 2.44e-01 | 2.38e-01 | 5.92e-01 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 5 | 3.57e-01 | 2.38e-01 | 6.87e-01 |
| GOMF NADPH BINDING | 14 | 1.23e-01 | 2.38e-01 | 4.37e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 14 | 1.23e-01 | 2.38e-01 | 4.37e-01 |
| GOBP TELOMERE MAINTENANCE | 145 | 8.04e-07 | 2.38e-01 | 5.32e-05 |
| GOMF NFAT PROTEIN BINDING | 5 | 3.58e-01 | -2.38e-01 | 6.87e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 16 | 1.00e-01 | -2.38e-01 | 3.98e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 7 | 2.77e-01 | 2.37e-01 | 6.26e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 22 | 5.39e-02 | 2.37e-01 | 2.92e-01 |
| GOMF COA HYDROLASE ACTIVITY | 15 | 1.11e-01 | 2.37e-01 | 4.15e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 43 | 7.10e-03 | 2.37e-01 | 9.11e-02 |
| GOBP PLASMA MEMBRANE TUBULATION | 14 | 1.24e-01 | 2.37e-01 | 4.38e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 8 | 2.45e-01 | -2.37e-01 | 5.93e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 12 | 1.55e-01 | 2.37e-01 | 4.88e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 5 | 3.59e-01 | -2.37e-01 | 6.88e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 3.59e-01 | 2.37e-01 | 6.88e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 2.78e-01 | 2.37e-01 | 6.27e-01 |
| GOBP HYPERSENSITIVITY | 8 | 2.46e-01 | 2.37e-01 | 5.94e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 22 | 5.47e-02 | 2.37e-01 | 2.94e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 9 | 2.19e-01 | -2.37e-01 | 5.69e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 36 | 1.41e-02 | 2.37e-01 | 1.40e-01 |
| GOMF PRERIBOSOME BINDING | 8 | 2.47e-01 | 2.37e-01 | 5.95e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 19 | 7.44e-02 | 2.37e-01 | 3.42e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 11 | 1.75e-01 | 2.36e-01 | 5.15e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 22 | 5.50e-02 | -2.36e-01 | 2.94e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.60e-01 | -2.36e-01 | 6.88e-01 |
| GOMF BH3 DOMAIN BINDING | 6 | 3.16e-01 | -2.36e-01 | 6.58e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 6 | 3.17e-01 | -2.36e-01 | 6.58e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 22 | 5.53e-02 | 2.36e-01 | 2.95e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 3.61e-01 | 2.36e-01 | 6.89e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 10 | 1.97e-01 | -2.36e-01 | 5.43e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 2.80e-01 | -2.36e-01 | 6.29e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 23 | 5.03e-02 | 2.36e-01 | 2.82e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 33 | 1.91e-02 | -2.36e-01 | 1.67e-01 |
| GOBP CENTRIOLE ASSEMBLY | 42 | 8.26e-03 | 2.36e-01 | 1.01e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 5 | 3.62e-01 | -2.36e-01 | 6.90e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 1.97e-01 | 2.36e-01 | 5.43e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 11 | 1.76e-01 | -2.36e-01 | 5.17e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 12 | 1.58e-01 | 2.36e-01 | 4.92e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 9 | 2.22e-01 | -2.35e-01 | 5.72e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 2.49e-01 | 2.35e-01 | 5.97e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 7 | 2.81e-01 | -2.35e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 7 | 2.81e-01 | 2.35e-01 | 6.29e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 1.98e-01 | 2.35e-01 | 5.45e-01 |
| GOMF HYDRO LYASE ACTIVITY | 39 | 1.11e-02 | 2.35e-01 | 1.22e-01 |
| GOCC MITOTIC COHESIN COMPLEX | 6 | 3.19e-01 | 2.35e-01 | 6.59e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 8 | 2.50e-01 | 2.35e-01 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 13 | 1.43e-01 | 2.35e-01 | 4.65e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 86 | 1.69e-04 | 2.35e-01 | 5.31e-03 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 9 | 2.23e-01 | 2.35e-01 | 5.72e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 9 | 2.23e-01 | 2.35e-01 | 5.72e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.20e-01 | -2.35e-01 | 6.60e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 8 | 2.51e-01 | 2.35e-01 | 5.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 5 | 3.64e-01 | -2.35e-01 | 6.93e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 18 | 8.52e-02 | 2.34e-01 | 3.67e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 26 | 3.86e-02 | 2.34e-01 | 2.44e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 3.64e-01 | 2.34e-01 | 6.93e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 9 | 2.23e-01 | 2.34e-01 | 5.73e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 2.24e-01 | 2.34e-01 | 5.73e-01 |
| GOBP ANOIKIS | 25 | 4.27e-02 | 2.34e-01 | 2.58e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 14 | 1.29e-01 | 2.34e-01 | 4.46e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 2.24e-01 | 2.34e-01 | 5.74e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 8 | 2.52e-01 | -2.34e-01 | 6.01e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 38 | 1.26e-02 | 2.34e-01 | 1.30e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 12 | 1.61e-01 | 2.34e-01 | 4.95e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 2.52e-01 | 2.34e-01 | 6.02e-01 |
| GOBP EMBRYONIC CLEAVAGE | 7 | 2.84e-01 | 2.34e-01 | 6.32e-01 |
| GOBP UTP METABOLIC PROCESS | 10 | 2.01e-01 | 2.34e-01 | 5.49e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 16 | 1.06e-01 | -2.34e-01 | 4.06e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 14 | 1.30e-01 | 2.34e-01 | 4.47e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 14 | 1.31e-01 | 2.33e-01 | 4.47e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 27 | 3.59e-02 | 2.33e-01 | 2.38e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 35 | 1.70e-02 | -2.33e-01 | 1.56e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 16 | 1.06e-01 | 2.33e-01 | 4.06e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 3.67e-01 | -2.33e-01 | 6.94e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 20 | 7.14e-02 | -2.33e-01 | 3.37e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 2.02e-01 | -2.33e-01 | 5.49e-01 |
| GOBP PROTEIN DEMETHYLATION | 12 | 1.63e-01 | -2.33e-01 | 4.97e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 18 | 8.75e-02 | 2.33e-01 | 3.71e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 2.54e-01 | 2.33e-01 | 6.03e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 269 | 5.78e-11 | 2.33e-01 | 1.02e-08 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 21 | 6.51e-02 | 2.33e-01 | 3.25e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 7 | 2.87e-01 | 2.33e-01 | 6.36e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 18 | 8.79e-02 | 2.32e-01 | 3.72e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 5 | 3.68e-01 | 2.32e-01 | 6.96e-01 |
| GOBP REGULATION OF T CELL EXTRAVASATION | 5 | 3.69e-01 | -2.32e-01 | 6.96e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 16 | 1.08e-01 | 2.32e-01 | 4.09e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 7 | 2.88e-01 | -2.32e-01 | 6.36e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 27 | 3.71e-02 | 2.32e-01 | 2.40e-01 |
| GOBP NADPH REGENERATION | 19 | 8.03e-02 | 2.32e-01 | 3.55e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 7.28e-02 | 2.32e-01 | 3.40e-01 |
| GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS | 5 | 3.70e-01 | -2.32e-01 | 6.96e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 6 | 3.26e-01 | 2.32e-01 | 6.64e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 12 | 1.65e-01 | -2.31e-01 | 5.00e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 24 | 4.99e-02 | -2.31e-01 | 2.81e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 3.27e-01 | -2.31e-01 | 6.65e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 137 | 3.15e-06 | 2.31e-01 | 1.69e-04 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 2.90e-01 | 2.31e-01 | 6.38e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 7 | 2.90e-01 | 2.31e-01 | 6.38e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 3.71e-01 | 2.31e-01 | 6.98e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 1.22e-01 | -2.31e-01 | 4.33e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 24 | 5.04e-02 | -2.31e-01 | 2.82e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 2.58e-01 | 2.31e-01 | 6.08e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 5 | 3.72e-01 | -2.31e-01 | 6.99e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 9 | 2.31e-01 | -2.31e-01 | 5.80e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 26 | 4.20e-02 | -2.30e-01 | 2.55e-01 |
| GOBP GASTRIC ACID SECRETION | 7 | 2.91e-01 | -2.30e-01 | 6.38e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 127 | 7.55e-06 | 2.30e-01 | 3.57e-04 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 14 | 1.36e-01 | 2.30e-01 | 4.53e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 8.23e-02 | 2.30e-01 | 3.61e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 41 | 1.08e-02 | -2.30e-01 | 1.19e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 57 | 2.65e-03 | 2.30e-01 | 4.61e-02 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 2.08e-01 | -2.30e-01 | 5.56e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 5 | 3.73e-01 | -2.30e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 35 | 1.86e-02 | -2.30e-01 | 1.64e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 55 | 3.20e-03 | 2.30e-01 | 5.30e-02 |
| GOBP ENDOCRINE PROCESS | 31 | 2.68e-02 | -2.30e-01 | 2.02e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 10 | 2.08e-01 | -2.30e-01 | 5.57e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 39 | 1.30e-02 | 2.30e-01 | 1.33e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 14 | 1.37e-01 | -2.30e-01 | 4.55e-01 |
| GOCC DENDRITE MEMBRANE | 10 | 2.09e-01 | -2.30e-01 | 5.57e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 24 | 5.15e-02 | 2.30e-01 | 2.85e-01 |
| GOBP MYELIN MAINTENANCE | 12 | 1.68e-01 | -2.30e-01 | 5.05e-01 |
| GOBP HEAT ACCLIMATION | 6 | 3.30e-01 | -2.30e-01 | 6.67e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 7 | 2.93e-01 | -2.30e-01 | 6.40e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 3.30e-01 | 2.30e-01 | 6.67e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 5 | 3.74e-01 | 2.30e-01 | 7.01e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 26 | 4.28e-02 | 2.30e-01 | 2.58e-01 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.74e-01 | -2.30e-01 | 7.01e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 6 | 3.30e-01 | -2.30e-01 | 6.67e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 7 | 2.93e-01 | -2.29e-01 | 6.40e-01 |
| GOBP AMP METABOLIC PROCESS | 17 | 1.02e-01 | 2.29e-01 | 4.01e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 2.09e-01 | 2.29e-01 | 5.57e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 7 | 2.94e-01 | 2.29e-01 | 6.40e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 8 | 2.62e-01 | 2.29e-01 | 6.12e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 7 | 2.94e-01 | 2.29e-01 | 6.40e-01 |
| GOCC ATPASE COMPLEX | 132 | 5.68e-06 | 2.29e-01 | 2.79e-04 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 20 | 7.63e-02 | 2.29e-01 | 3.46e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 5 | 3.75e-01 | 2.29e-01 | 7.02e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 19 | 8.42e-02 | 2.29e-01 | 3.65e-01 |
| GOBP ATRIOVENTRICULAR NODE DEVELOPMENT | 5 | 3.76e-01 | 2.29e-01 | 7.03e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 2.63e-01 | 2.29e-01 | 6.13e-01 |
| GOBP CHROMOSOME LOCALIZATION | 103 | 6.18e-05 | 2.29e-01 | 2.24e-03 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 5 | 3.76e-01 | -2.29e-01 | 7.03e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 11 | 1.89e-01 | -2.29e-01 | 5.35e-01 |
| GOBP HISTONE DEACETYLATION | 21 | 6.99e-02 | 2.29e-01 | 3.34e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 1.71e-01 | -2.28e-01 | 5.09e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 8 | 2.64e-01 | 2.28e-01 | 6.14e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 58 | 2.66e-03 | 2.28e-01 | 4.61e-02 |
| GOBP NEURONAL ACTION POTENTIAL | 12 | 1.71e-01 | -2.28e-01 | 5.09e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 3.77e-01 | -2.28e-01 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 17 | 1.04e-01 | 2.28e-01 | 4.02e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 8 | 2.64e-01 | -2.28e-01 | 6.15e-01 |
| GOMF HISTONE READER ACTIVITY | 11 | 1.91e-01 | 2.28e-01 | 5.36e-01 |
| GOMF U1 SNRNA BINDING | 8 | 2.65e-01 | 2.28e-01 | 6.16e-01 |
| GOCC KINOCILIUM | 5 | 3.78e-01 | -2.28e-01 | 7.05e-01 |
| GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 5 | 3.78e-01 | 2.28e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 14 | 1.40e-01 | 2.28e-01 | 4.61e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 32 | 2.59e-02 | 2.28e-01 | 1.99e-01 |
| GOBP SULFATION | 8 | 2.65e-01 | -2.28e-01 | 6.16e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 7 | 2.97e-01 | 2.27e-01 | 6.42e-01 |
| GOBP BILE ACID SECRETION | 5 | 3.79e-01 | -2.27e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 2.38e-01 | 2.27e-01 | 5.87e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 2.98e-01 | 2.27e-01 | 6.43e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 38 | 1.54e-02 | 2.27e-01 | 1.46e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 5 | 3.79e-01 | -2.27e-01 | 7.05e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 7 | 2.98e-01 | -2.27e-01 | 6.43e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 17 | 1.05e-01 | 2.27e-01 | 4.05e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 110 | 4.02e-05 | 2.27e-01 | 1.53e-03 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 9 | 2.39e-01 | -2.27e-01 | 5.88e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 6 | 3.37e-01 | -2.27e-01 | 6.73e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 6 | 3.37e-01 | -2.27e-01 | 6.73e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 3.81e-01 | 2.26e-01 | 7.07e-01 |
| GOBP LIPID OXIDATION | 78 | 5.52e-04 | 2.26e-01 | 1.40e-02 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 10 | 2.15e-01 | 2.26e-01 | 5.64e-01 |
| GOMF GLUTATHIONE BINDING | 6 | 3.37e-01 | 2.26e-01 | 6.73e-01 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 1.94e-01 | 2.26e-01 | 5.39e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 59 | 2.67e-03 | 2.26e-01 | 4.61e-02 |
| GOBP PIRNA PROCESSING | 7 | 3.00e-01 | 2.26e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 35 | 2.07e-02 | 2.26e-01 | 1.73e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 25 | 5.04e-02 | 2.26e-01 | 2.82e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 5 | 3.82e-01 | -2.26e-01 | 7.07e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 3.01e-01 | 2.26e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 3.01e-01 | -2.26e-01 | 6.45e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 9 | 2.41e-01 | 2.26e-01 | 5.90e-01 |
| GOCC CLATHRIN COAT | 37 | 1.75e-02 | 2.26e-01 | 1.58e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 14 | 1.44e-01 | 2.26e-01 | 4.67e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 2.69e-01 | -2.26e-01 | 6.19e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 15 | 1.30e-01 | 2.26e-01 | 4.47e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 19 | 8.88e-02 | 2.26e-01 | 3.74e-01 |
| GOCC CALYX OF HELD | 10 | 2.17e-01 | 2.26e-01 | 5.65e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 7 | 3.02e-01 | 2.25e-01 | 6.46e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 1.59e-01 | 2.25e-01 | 4.93e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 12 | 1.77e-01 | 2.25e-01 | 5.17e-01 |
| GOMF SUMO POLYMER BINDING | 5 | 3.83e-01 | 2.25e-01 | 7.08e-01 |
| GOBP TELOMERE CAPPING | 36 | 1.95e-02 | 2.25e-01 | 1.68e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 5 | 3.84e-01 | -2.25e-01 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 3.40e-01 | 2.25e-01 | 6.76e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 29 | 3.61e-02 | 2.25e-01 | 2.38e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 34 | 2.34e-02 | 2.25e-01 | 1.88e-01 |
| GOBP RETICULOPHAGY | 16 | 1.20e-01 | -2.25e-01 | 4.29e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 10 | 2.19e-01 | -2.25e-01 | 5.69e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 8 | 2.71e-01 | -2.25e-01 | 6.21e-01 |
| GOMF NEUROTROPHIN BINDING | 5 | 3.85e-01 | -2.25e-01 | 7.08e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 32 | 2.80e-02 | 2.25e-01 | 2.08e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 20 | 8.23e-02 | 2.24e-01 | 3.61e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 6 | 3.41e-01 | -2.24e-01 | 6.77e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 3.41e-01 | -2.24e-01 | 6.77e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 7 | 3.04e-01 | 2.24e-01 | 6.47e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 1.79e-01 | 2.24e-01 | 5.20e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 2.01e-02 | 2.24e-01 | 1.71e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 42 | 1.21e-02 | 2.24e-01 | 1.27e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 7 | 3.05e-01 | 2.24e-01 | 6.48e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 64 | 1.97e-03 | 2.24e-01 | 3.75e-02 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 21 | 7.61e-02 | 2.24e-01 | 3.46e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 31 | 3.12e-02 | 2.24e-01 | 2.20e-01 |
| GOCC MITOTIC SPINDLE POLE | 33 | 2.63e-02 | 2.24e-01 | 2.01e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 10 | 2.21e-01 | 2.24e-01 | 5.72e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 5 | 3.87e-01 | -2.24e-01 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 21 | 7.63e-02 | -2.23e-01 | 3.46e-01 |
| GOBP AXONAL FASCICULATION | 8 | 2.74e-01 | -2.23e-01 | 6.23e-01 |
| GOBP RESPONSE TO CADMIUM ION | 39 | 1.58e-02 | 2.23e-01 | 1.49e-01 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 5 | 3.87e-01 | 2.23e-01 | 7.10e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 94 | 1.87e-04 | 2.23e-01 | 5.73e-03 |
| GOBP RECOMBINATIONAL REPAIR | 162 | 1.02e-06 | 2.23e-01 | 6.33e-05 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 52 | 5.44e-03 | 2.23e-01 | 7.66e-02 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 2.47e-01 | 2.23e-01 | 5.95e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 467 | 2.25e-16 | 2.23e-01 | 1.33e-13 |
| GOCC FILAMENTOUS ACTIN | 15 | 1.35e-01 | 2.23e-01 | 4.53e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 6 | 3.45e-01 | -2.23e-01 | 6.79e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 7 | 3.08e-01 | 2.23e-01 | 6.50e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 9 | 2.48e-01 | -2.22e-01 | 5.96e-01 |
| GOBP LIPID EXPORT FROM CELL | 22 | 7.10e-02 | -2.22e-01 | 3.36e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 26 | 4.98e-02 | 2.22e-01 | 2.80e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 16 | 1.24e-01 | 2.22e-01 | 4.37e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 25 | 5.44e-02 | 2.22e-01 | 2.93e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 6 | 3.46e-01 | 2.22e-01 | 6.80e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 13 | 1.66e-01 | -2.22e-01 | 5.00e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 8 | 2.77e-01 | -2.22e-01 | 6.26e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 41 | 1.39e-02 | 2.22e-01 | 1.39e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 69 | 1.44e-03 | 2.22e-01 | 2.95e-02 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 29 | 3.87e-02 | 2.22e-01 | 2.44e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 6 | 3.47e-01 | 2.22e-01 | 6.80e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 15 | 1.37e-01 | -2.22e-01 | 4.55e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 8 | 2.77e-01 | -2.22e-01 | 6.27e-01 |
| GOBP REGULATION OF PIGMENTATION | 9 | 2.50e-01 | 2.22e-01 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 39 | 1.67e-02 | 2.22e-01 | 1.55e-01 |
| GOCC HAUS COMPLEX | 8 | 2.78e-01 | 2.22e-01 | 6.27e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 10 | 2.25e-01 | 2.22e-01 | 5.74e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 2.50e-01 | 2.21e-01 | 5.98e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 34 | 2.55e-02 | 2.21e-01 | 1.98e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 16 | 1.26e-01 | 2.21e-01 | 4.40e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 24 | 6.07e-02 | 2.21e-01 | 3.13e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 3.92e-01 | -2.21e-01 | 7.13e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 1.04e-01 | 2.21e-01 | 4.03e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 81 | 5.86e-04 | 2.21e-01 | 1.47e-02 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 13 | 1.67e-01 | -2.21e-01 | 5.04e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 9 | 2.51e-01 | 2.21e-01 | 5.99e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 36 | 2.17e-02 | 2.21e-01 | 1.79e-01 |
| GOMF SIALIC ACID BINDING | 6 | 3.48e-01 | -2.21e-01 | 6.82e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 19 | 9.54e-02 | 2.21e-01 | 3.88e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 7 | 3.12e-01 | -2.21e-01 | 6.54e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 5 | 3.93e-01 | -2.20e-01 | 7.15e-01 |
| GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY | 6 | 3.50e-01 | -2.20e-01 | 6.83e-01 |
| GOMF P53 BINDING | 56 | 4.36e-03 | 2.20e-01 | 6.55e-02 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 3.94e-01 | 2.20e-01 | 7.15e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 7 | 3.13e-01 | 2.20e-01 | 6.55e-01 |
| GOBP CELL KILLING | 127 | 1.87e-05 | 2.20e-01 | 7.88e-04 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 25 | 5.67e-02 | 2.20e-01 | 2.98e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 8 | 2.81e-01 | 2.20e-01 | 6.29e-01 |
| GOBP CELL FATE SPECIFICATION | 34 | 2.64e-02 | 2.20e-01 | 2.01e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 29 | 4.04e-02 | 2.20e-01 | 2.49e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 35 | 2.44e-02 | 2.20e-01 | 1.92e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 1.55e-01 | 2.20e-01 | 4.88e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 2.54e-01 | -2.20e-01 | 6.03e-01 |
| GOCC EARLY PHAGOSOME | 9 | 2.54e-01 | 2.20e-01 | 6.03e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 6 | 3.52e-01 | -2.19e-01 | 6.84e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 3.52e-01 | 2.19e-01 | 6.84e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 9 | 2.55e-01 | -2.19e-01 | 6.04e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 6 | 3.53e-01 | -2.19e-01 | 6.85e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 10 | 2.30e-01 | 2.19e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 16 | 1.30e-01 | 2.19e-01 | 4.46e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 10 | 2.31e-01 | 2.19e-01 | 5.80e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 6 | 3.53e-01 | -2.19e-01 | 6.85e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 3.97e-01 | -2.19e-01 | 7.19e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 3.53e-01 | -2.19e-01 | 6.85e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 14 | 1.57e-01 | -2.19e-01 | 4.91e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 14 | 1.57e-01 | -2.19e-01 | 4.91e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 5 | 3.97e-01 | 2.19e-01 | 7.19e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 14 | 1.57e-01 | 2.19e-01 | 4.92e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 3.97e-01 | 2.19e-01 | 7.19e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 31 | 3.53e-02 | 2.19e-01 | 2.37e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 20 | 9.10e-02 | 2.18e-01 | 3.79e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 27 | 4.98e-02 | 2.18e-01 | 2.81e-01 |
| GOBP RESPONSE TO FOOD | 16 | 1.31e-01 | 2.18e-01 | 4.47e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 3.55e-01 | 2.18e-01 | 6.87e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 72 | 1.39e-03 | 2.18e-01 | 2.88e-02 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 13 | 1.74e-01 | 2.18e-01 | 5.13e-01 |
| GOBP REGULATION OF GASTRULATION | 7 | 3.18e-01 | -2.18e-01 | 6.59e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 7 | 3.18e-01 | -2.18e-01 | 6.59e-01 |
| GOBP ATP TRANSPORT | 14 | 1.58e-01 | 2.18e-01 | 4.92e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 29 | 4.28e-02 | 2.17e-01 | 2.58e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 18 | 1.10e-01 | 2.17e-01 | 4.13e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 31 | 3.62e-02 | 2.17e-01 | 2.38e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 129 | 2.07e-05 | 2.17e-01 | 8.66e-04 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 24 | 6.55e-02 | 2.17e-01 | 3.25e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 7 | 3.20e-01 | -2.17e-01 | 6.60e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 7 | 3.20e-01 | 2.17e-01 | 6.60e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 6 | 3.57e-01 | 2.17e-01 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 248 | 4.35e-09 | 2.17e-01 | 4.67e-07 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 5 | 4.01e-01 | -2.17e-01 | 7.21e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 10 | 2.35e-01 | 2.17e-01 | 5.85e-01 |
| GOBP GLUTAMINE TRANSPORT | 8 | 2.89e-01 | 2.17e-01 | 6.37e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.89e-01 | 2.17e-01 | 6.37e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 20 | 9.38e-02 | 2.17e-01 | 3.84e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 4.02e-01 | 2.16e-01 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 31 | 3.71e-02 | -2.16e-01 | 2.40e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 9 | 2.61e-01 | -2.16e-01 | 6.12e-01 |
| GOBP P BODY ASSEMBLY | 21 | 8.64e-02 | 2.16e-01 | 3.70e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 138 | 1.20e-05 | 2.16e-01 | 5.32e-04 |
| GOBP HISTONE H3 ACETYLATION | 6 | 3.59e-01 | 2.16e-01 | 6.88e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 2.37e-01 | 2.16e-01 | 5.87e-01 |
| GOMF ACTININ BINDING | 19 | 1.03e-01 | 2.16e-01 | 4.02e-01 |
| GOBP DNA REPAIR | 525 | 4.21e-17 | 2.16e-01 | 2.68e-14 |
| GOBP BLOOD VESSEL MATURATION | 5 | 4.04e-01 | -2.16e-01 | 7.23e-01 |
| GOBP HEART FORMATION | 14 | 1.62e-01 | -2.16e-01 | 4.97e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 11 | 2.16e-01 | 2.16e-01 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 12 | 1.96e-01 | 2.15e-01 | 5.43e-01 |
| GOCC DENSE CORE GRANULE | 12 | 1.97e-01 | 2.15e-01 | 5.43e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 13 | 1.79e-01 | 2.15e-01 | 5.21e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 9 | 2.64e-01 | -2.15e-01 | 6.14e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 4.05e-01 | -2.15e-01 | 7.24e-01 |
| GOCC GERM CELL NUCLEUS | 44 | 1.37e-02 | 2.15e-01 | 1.37e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 26 | 5.78e-02 | -2.15e-01 | 3.02e-01 |
| GOCC BRUSH BORDER MEMBRANE | 25 | 6.29e-02 | -2.15e-01 | 3.18e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 57 | 5.02e-03 | 2.15e-01 | 7.25e-02 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 10 | 2.39e-01 | -2.15e-01 | 5.88e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 10 | 2.39e-01 | 2.15e-01 | 5.88e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 97 | 2.60e-04 | 2.15e-01 | 7.43e-03 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 6 | 3.63e-01 | -2.15e-01 | 6.91e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 12 | 1.98e-01 | 2.15e-01 | 5.45e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 1.80e-01 | 2.15e-01 | 5.23e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 5 | 4.06e-01 | -2.15e-01 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 9 | 2.65e-01 | 2.14e-01 | 6.16e-01 |
| GOBP REGULATION OF HAIR CYCLE | 9 | 2.65e-01 | -2.14e-01 | 6.16e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 1.51e-01 | 2.14e-01 | 4.81e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 31 | 3.89e-02 | 2.14e-01 | 2.44e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 24 | 6.92e-02 | 2.14e-01 | 3.32e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 4.07e-01 | 2.14e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 25 | 6.37e-02 | 2.14e-01 | 3.20e-01 |
| GOBP MITOTIC CYTOKINESIS | 75 | 1.35e-03 | 2.14e-01 | 2.82e-02 |
| GOMF ADP BINDING | 31 | 3.90e-02 | 2.14e-01 | 2.45e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 15 | 1.51e-01 | 2.14e-01 | 4.81e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 9 | 2.66e-01 | -2.14e-01 | 6.17e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 21 | 8.97e-02 | 2.14e-01 | 3.75e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 6 | 3.64e-01 | -2.14e-01 | 6.93e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 67 | 2.48e-03 | 2.14e-01 | 4.39e-02 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 16 | 1.39e-01 | 2.14e-01 | 4.58e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 2.42e-01 | 2.14e-01 | 5.90e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 42 | 1.65e-02 | 2.14e-01 | 1.54e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 12 | 2.00e-01 | 2.14e-01 | 5.47e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 15 | 1.52e-01 | 2.14e-01 | 4.82e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 5 | 4.08e-01 | 2.14e-01 | 7.27e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 18 | 1.17e-01 | 2.14e-01 | 4.23e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 5 | 4.08e-01 | 2.14e-01 | 7.27e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 5 | 4.08e-01 | -2.14e-01 | 7.27e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 34 | 3.14e-02 | -2.13e-01 | 2.21e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 9 | 2.68e-01 | 2.13e-01 | 6.19e-01 |
| GOCC COP9 SIGNALOSOME | 17 | 1.28e-01 | 2.13e-01 | 4.44e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 5 | 4.09e-01 | 2.13e-01 | 7.28e-01 |
| GOMF DEAMINASE ACTIVITY | 25 | 6.54e-02 | 2.13e-01 | 3.25e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 21 | 9.12e-02 | -2.13e-01 | 3.79e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 4.10e-01 | -2.13e-01 | 7.28e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 3.67e-01 | 2.13e-01 | 6.94e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 2.44e-01 | 2.13e-01 | 5.92e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 3.30e-01 | 2.12e-01 | 6.67e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 13 | 1.85e-01 | -2.12e-01 | 5.28e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 29 | 4.78e-02 | 2.12e-01 | 2.76e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 3.31e-01 | -2.12e-01 | 6.67e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 5 | 4.11e-01 | -2.12e-01 | 7.29e-01 |
| GOBP POSITIVE REGULATION OF HISTONE DEACETYLATION | 5 | 4.11e-01 | 2.12e-01 | 7.29e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 4.11e-01 | 2.12e-01 | 7.29e-01 |
| GOBP PODOSOME ASSEMBLY | 15 | 1.55e-01 | 2.12e-01 | 4.88e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 10 | 2.46e-01 | 2.12e-01 | 5.93e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 50 | 9.54e-03 | 2.12e-01 | 1.11e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 17 | 1.30e-01 | 2.12e-01 | 4.47e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 9 | 2.71e-01 | -2.12e-01 | 6.20e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 7 | 3.32e-01 | 2.12e-01 | 6.69e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 4.12e-01 | 2.12e-01 | 7.30e-01 |
| GOMF 7SK SNRNA BINDING | 8 | 3.00e-01 | -2.12e-01 | 6.44e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 25 | 6.70e-02 | 2.12e-01 | 3.27e-01 |
| GOBP RIBOSOME ASSEMBLY | 57 | 5.74e-03 | -2.12e-01 | 7.95e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 7 | 3.32e-01 | 2.12e-01 | 6.69e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 28 | 5.27e-02 | 2.12e-01 | 2.88e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 1.56e-01 | 2.12e-01 | 4.91e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 2.72e-01 | -2.12e-01 | 6.22e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 17 | 1.31e-01 | 2.11e-01 | 4.47e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 6 | 3.70e-01 | -2.11e-01 | 6.96e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 10 | 2.47e-01 | -2.11e-01 | 5.95e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 21 | 9.38e-02 | 2.11e-01 | 3.84e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 9 | 2.72e-01 | 2.11e-01 | 6.22e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 19 | 1.11e-01 | 2.11e-01 | 4.14e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 7 | 3.33e-01 | -2.11e-01 | 6.70e-01 |
| GOBP ADP TRANSPORT | 10 | 2.47e-01 | 2.11e-01 | 5.95e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 20 | 1.02e-01 | -2.11e-01 | 4.01e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 213 | 1.17e-07 | 2.11e-01 | 9.70e-06 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 4.14e-01 | 2.11e-01 | 7.30e-01 |
| GOCC LAMELLAR BODY | 5 | 4.14e-01 | -2.11e-01 | 7.30e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 24 | 7.36e-02 | 2.11e-01 | 3.42e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 8 | 3.01e-01 | -2.11e-01 | 6.46e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 5 | 4.14e-01 | 2.11e-01 | 7.30e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 174 | 1.66e-06 | 2.11e-01 | 9.58e-05 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 17 | 1.32e-01 | 2.11e-01 | 4.48e-01 |
| GOBP MUCOCILIARY CLEARANCE | 5 | 4.14e-01 | 2.11e-01 | 7.30e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 29 | 4.94e-02 | 2.11e-01 | 2.80e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 12 | 2.06e-01 | -2.11e-01 | 5.54e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 8 | 3.02e-01 | 2.11e-01 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 6 | 3.71e-01 | 2.11e-01 | 6.98e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 14 | 1.72e-01 | 2.11e-01 | 5.11e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 5 | 4.15e-01 | -2.11e-01 | 7.31e-01 |
| GOCC PSEUDOPODIUM | 11 | 2.27e-01 | 2.11e-01 | 5.76e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 8 | 3.03e-01 | -2.10e-01 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 14 | 1.73e-01 | 2.10e-01 | 5.12e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 3.35e-01 | 2.10e-01 | 6.72e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 62 | 4.23e-03 | 2.10e-01 | 6.37e-02 |
| GOBP PRIMITIVE HEMOPOIESIS | 6 | 3.73e-01 | -2.10e-01 | 7.00e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 4.16e-01 | 2.10e-01 | 7.32e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 81 | 1.09e-03 | 2.10e-01 | 2.34e-02 |
| GOMF GROWTH FACTOR BINDING | 65 | 3.46e-03 | -2.10e-01 | 5.58e-02 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 6 | 3.74e-01 | -2.10e-01 | 7.00e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 31 | 4.33e-02 | 2.10e-01 | 2.59e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 7 | 3.37e-01 | -2.10e-01 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 16 | 1.47e-01 | -2.10e-01 | 4.74e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 29 | 5.10e-02 | 2.09e-01 | 2.83e-01 |
| GOBP MATURATION OF 5 8S RRNA | 36 | 2.97e-02 | 2.09e-01 | 2.16e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 7 | 3.37e-01 | 2.09e-01 | 6.73e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 33 | 3.75e-02 | 2.09e-01 | 2.41e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 12 | 2.09e-01 | 2.09e-01 | 5.57e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 11 | 2.30e-01 | 2.09e-01 | 5.79e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 22 | 8.94e-02 | -2.09e-01 | 3.75e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 22 | 8.96e-02 | -2.09e-01 | 3.75e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 23 | 8.29e-02 | 2.09e-01 | 3.63e-01 |
| GOBP ORGANELLE FISSION | 366 | 8.14e-12 | 2.09e-01 | 1.73e-09 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 8 | 3.06e-01 | 2.09e-01 | 6.49e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 3.39e-01 | -2.09e-01 | 6.75e-01 |
| GOBP MEMBRANE REPOLARIZATION | 14 | 1.77e-01 | 2.09e-01 | 5.17e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 116 | 1.06e-04 | 2.09e-01 | 3.56e-03 |
| GOBP PROTEIN MONOUBIQUITINATION | 40 | 2.25e-02 | 2.09e-01 | 1.83e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 8.37e-02 | 2.08e-01 | 3.64e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 12 | 2.11e-01 | -2.08e-01 | 5.59e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 8 | 3.07e-01 | 2.08e-01 | 6.50e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 23 | 8.37e-02 | 2.08e-01 | 3.64e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 6 | 3.77e-01 | 2.08e-01 | 7.04e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 16 | 1.49e-01 | 2.08e-01 | 4.78e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 24 | 7.75e-02 | 2.08e-01 | 3.48e-01 |
| GOMF DYSTROGLYCAN BINDING | 7 | 3.40e-01 | 2.08e-01 | 6.76e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 14 | 1.77e-01 | 2.08e-01 | 5.18e-01 |
| GOMF CYTOKINE ACTIVITY | 65 | 3.72e-03 | -2.08e-01 | 5.89e-02 |
| GOCC ISWI TYPE COMPLEX | 12 | 2.12e-01 | 2.08e-01 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 60 | 5.36e-03 | 2.08e-01 | 7.58e-02 |
| GOBP I KAPPAB PHOSPHORYLATION | 12 | 2.12e-01 | 2.08e-01 | 5.61e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 5 | 4.21e-01 | 2.08e-01 | 7.35e-01 |
| GOBP GLUTATHIONE TRANSPORT | 5 | 4.21e-01 | 2.08e-01 | 7.35e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.33e-01 | 2.08e-01 | 5.81e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 4.21e-01 | 2.08e-01 | 7.35e-01 |
| GOMF CO SMAD BINDING | 7 | 3.41e-01 | 2.08e-01 | 6.77e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 2.55e-01 | -2.08e-01 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 5 | 4.21e-01 | -2.08e-01 | 7.35e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 23 | 8.47e-02 | 2.08e-01 | 3.66e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 4.21e-02 | 2.08e-01 | 2.55e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 17 | 1.38e-01 | 2.08e-01 | 4.58e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 4.22e-01 | 2.08e-01 | 7.35e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 2.81e-01 | 2.07e-01 | 6.29e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 8 | 3.10e-01 | -2.07e-01 | 6.52e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 3.79e-01 | 2.07e-01 | 7.06e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 10 | 2.57e-01 | 2.07e-01 | 6.05e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 9 | 2.82e-01 | 2.07e-01 | 6.30e-01 |
| GOBP NEURON RECOGNITION | 19 | 1.18e-01 | -2.07e-01 | 4.26e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 3.80e-01 | 2.07e-01 | 7.06e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 129 | 5.02e-05 | 2.07e-01 | 1.85e-03 |
| GOBP MONOCYTE ACTIVATION | 7 | 3.43e-01 | -2.07e-01 | 6.79e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 5 | 4.23e-01 | -2.07e-01 | 7.36e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 7 | 3.43e-01 | 2.07e-01 | 6.79e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 12 | 2.15e-01 | -2.07e-01 | 5.64e-01 |
| GOCC SPECTRIN | 5 | 4.23e-01 | -2.07e-01 | 7.36e-01 |
| GOBP PROTEIN DENEDDYLATION | 10 | 2.58e-01 | 2.07e-01 | 6.07e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 11 | 2.35e-01 | -2.07e-01 | 5.85e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 4.24e-01 | -2.07e-01 | 7.36e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 44 | 1.78e-02 | 2.07e-01 | 1.60e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 4.24e-01 | 2.07e-01 | 7.36e-01 |
| GOCC BLEB | 9 | 2.84e-01 | 2.06e-01 | 6.32e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 72 | 2.49e-03 | 2.06e-01 | 4.40e-02 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.45e-01 | 2.06e-01 | 6.79e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 29 | 5.47e-02 | 2.06e-01 | 2.94e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 13 | 1.98e-01 | -2.06e-01 | 5.45e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 10 | 2.59e-01 | -2.06e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 6 | 3.82e-01 | -2.06e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 29 | 5.48e-02 | 2.06e-01 | 2.94e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 65 | 4.09e-03 | 2.06e-01 | 6.23e-02 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 3.45e-01 | 2.06e-01 | 6.80e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 8 | 3.13e-01 | -2.06e-01 | 6.55e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 25 | 7.48e-02 | 2.06e-01 | 3.43e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 26 | 6.92e-02 | -2.06e-01 | 3.32e-01 |
| GOCC SPECIFIC GRANULE | 111 | 1.82e-04 | 2.06e-01 | 5.64e-03 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 1.68e-01 | 2.06e-01 | 5.04e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 8 | 3.14e-01 | 2.06e-01 | 6.55e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 10 | 2.60e-01 | 2.06e-01 | 6.11e-01 |
| GOCC CATSPER COMPLEX | 6 | 3.83e-01 | -2.06e-01 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 116 | 1.34e-04 | 2.06e-01 | 4.34e-03 |
| GOCC TRAPP COMPLEX | 15 | 1.68e-01 | 2.05e-01 | 5.05e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 30 | 5.15e-02 | 2.05e-01 | 2.85e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 7 | 3.47e-01 | -2.05e-01 | 6.80e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 10 | 2.61e-01 | -2.05e-01 | 6.12e-01 |
| GOMF POLY G BINDING | 8 | 3.15e-01 | 2.05e-01 | 6.56e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 21 | 1.04e-01 | 2.05e-01 | 4.02e-01 |
| GOMF BMP BINDING | 5 | 4.27e-01 | 2.05e-01 | 7.40e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 15 | 1.69e-01 | 2.05e-01 | 5.07e-01 |
| GOBP LONG TERM MEMORY | 20 | 1.13e-01 | -2.05e-01 | 4.16e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 9 | 2.87e-01 | -2.05e-01 | 6.36e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 10 | 2.62e-01 | -2.05e-01 | 6.13e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 6 | 3.85e-01 | -2.05e-01 | 7.09e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.85e-01 | -2.05e-01 | 7.09e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 10 | 2.63e-01 | 2.05e-01 | 6.14e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 24 | 8.30e-02 | -2.04e-01 | 3.63e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 32 | 4.54e-02 | 2.04e-01 | 2.67e-01 |
| GOBP SPINDLE ORGANIZATION | 179 | 2.52e-06 | 2.04e-01 | 1.39e-04 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 11 | 2.41e-01 | -2.04e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 8 | 3.17e-01 | 2.04e-01 | 6.58e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 10 | 2.63e-01 | -2.04e-01 | 6.14e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 7 | 3.50e-01 | 2.04e-01 | 6.83e-01 |
| GOBP TORC1 SIGNALING | 89 | 8.85e-04 | 2.04e-01 | 1.99e-02 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 13 | 2.03e-01 | 2.04e-01 | 5.50e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 14 | 1.86e-01 | -2.04e-01 | 5.31e-01 |
| GOBP POLYAMINE TRANSPORT | 11 | 2.42e-01 | 2.04e-01 | 5.90e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 12 | 2.21e-01 | -2.04e-01 | 5.72e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 72 | 2.81e-03 | 2.04e-01 | 4.80e-02 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 3.87e-01 | -2.04e-01 | 7.10e-01 |
| GOBP VASCULAR TRANSPORT | 44 | 1.95e-02 | 2.04e-01 | 1.68e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 75 | 2.32e-03 | 2.04e-01 | 4.20e-02 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 5 | 4.31e-01 | -2.04e-01 | 7.43e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 10 | 2.66e-01 | 2.03e-01 | 6.16e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 9 | 2.91e-01 | -2.03e-01 | 6.38e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 11 | 2.43e-01 | -2.03e-01 | 5.91e-01 |
| GOBP RESPONSE TO COPPER ION | 18 | 1.36e-01 | 2.03e-01 | 4.53e-01 |
| GOCC NURF COMPLEX | 6 | 3.89e-01 | 2.03e-01 | 7.11e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 3.89e-01 | 2.03e-01 | 7.11e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 11 | 2.44e-01 | -2.03e-01 | 5.92e-01 |
| GOMF BH DOMAIN BINDING | 8 | 3.20e-01 | -2.03e-01 | 6.60e-01 |
| GOBP INNER EAR MORPHOGENESIS | 34 | 4.07e-02 | -2.03e-01 | 2.50e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 45 | 1.86e-02 | 2.03e-01 | 1.65e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 16 | 1.60e-01 | 2.03e-01 | 4.95e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 13 | 2.06e-01 | 2.03e-01 | 5.54e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 51 | 1.24e-02 | 2.03e-01 | 1.29e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 45 | 1.88e-02 | 2.03e-01 | 1.65e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 34 | 4.12e-02 | 2.02e-01 | 2.51e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 9 | 2.93e-01 | -2.02e-01 | 6.40e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 5 | 4.33e-01 | 2.02e-01 | 7.45e-01 |
| GOCC U6 SNRNP | 8 | 3.22e-01 | 2.02e-01 | 6.62e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 30 | 5.54e-02 | 2.02e-01 | 2.95e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 8 | 3.22e-01 | -2.02e-01 | 6.62e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 9 | 2.94e-01 | 2.02e-01 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 50 | 1.35e-02 | 2.02e-01 | 1.37e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 50 | 1.35e-02 | 2.02e-01 | 1.37e-01 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 3.23e-01 | 2.02e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 3.55e-01 | 2.02e-01 | 6.87e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 4.35e-01 | 2.02e-01 | 7.46e-01 |
| GOCC LAMELLIPODIUM | 139 | 4.13e-05 | 2.02e-01 | 1.56e-03 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 119 | 1.48e-04 | 2.02e-01 | 4.70e-03 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 3.24e-01 | -2.02e-01 | 6.63e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 4.35e-01 | -2.02e-01 | 7.46e-01 |
| GOBP UTERUS DEVELOPMENT | 12 | 2.27e-01 | -2.02e-01 | 5.76e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 17 | 1.50e-01 | 2.02e-01 | 4.81e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 7 | 3.56e-01 | -2.01e-01 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 4.36e-01 | 2.01e-01 | 7.46e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 4.36e-01 | -2.01e-01 | 7.46e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 4.36e-01 | 2.01e-01 | 7.46e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 3.69e-02 | 2.01e-01 | 2.40e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 8 | 3.25e-01 | -2.01e-01 | 6.64e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 2.28e-01 | 2.01e-01 | 5.78e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 14 | 1.93e-01 | -2.01e-01 | 5.39e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 20 | 1.20e-01 | 2.01e-01 | 4.29e-01 |
| GOBP EAR MORPHOGENESIS | 42 | 2.44e-02 | -2.01e-01 | 1.92e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 19 | 1.30e-01 | -2.01e-01 | 4.47e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 4.37e-01 | 2.01e-01 | 7.47e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 13 | 2.11e-01 | 2.01e-01 | 5.58e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 12 | 2.29e-01 | 2.01e-01 | 5.78e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 5 | 4.38e-01 | -2.00e-01 | 7.47e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 6 | 3.96e-01 | 2.00e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 6 | 3.96e-01 | -2.00e-01 | 7.18e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 25 | 8.32e-02 | 2.00e-01 | 3.63e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 5 | 4.38e-01 | -2.00e-01 | 7.48e-01 |
| GOCC OUTER DYNEIN ARM | 5 | 4.38e-01 | -2.00e-01 | 7.48e-01 |
| GOBP TORC2 SIGNALING | 15 | 1.80e-01 | 2.00e-01 | 5.22e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 46 | 1.91e-02 | 2.00e-01 | 1.67e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 114 | 2.32e-04 | 2.00e-01 | 6.75e-03 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 7 | 3.60e-01 | -2.00e-01 | 6.88e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 10 | 2.74e-01 | 2.00e-01 | 6.23e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 261 | 3.07e-08 | 2.00e-01 | 2.86e-06 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 12 | 2.31e-01 | -2.00e-01 | 5.80e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 14 | 1.96e-01 | 2.00e-01 | 5.42e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 3.98e-01 | 1.99e-01 | 7.19e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 3.98e-01 | -1.99e-01 | 7.19e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 98 | 6.53e-04 | 1.99e-01 | 1.60e-02 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 15 | 1.81e-01 | 1.99e-01 | 5.24e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 3.01e-01 | -1.99e-01 | 6.45e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 15 | 1.82e-01 | 1.99e-01 | 5.25e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 3.98e-01 | 1.99e-01 | 7.20e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 8 | 3.29e-01 | -1.99e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 11 | 2.53e-01 | 1.99e-01 | 6.02e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 76 | 2.75e-03 | 1.99e-01 | 4.71e-02 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 58 | 8.96e-03 | 1.99e-01 | 1.07e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 23 | 9.94e-02 | 1.99e-01 | 3.98e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 6 | 4.00e-01 | 1.99e-01 | 7.21e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 7 | 3.63e-01 | 1.98e-01 | 6.92e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 3.03e-01 | 1.98e-01 | 6.47e-01 |
| GOCC ENDOSOME LUMEN | 21 | 1.16e-01 | 1.98e-01 | 4.21e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 10 | 2.77e-01 | 1.98e-01 | 6.27e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 14 | 1.99e-01 | -1.98e-01 | 5.47e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 72 | 3.65e-03 | 1.98e-01 | 5.79e-02 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 9 | 3.03e-01 | -1.98e-01 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 70 | 4.16e-03 | 1.98e-01 | 6.31e-02 |
| GOBP REGULATION OF FERTILIZATION | 6 | 4.01e-01 | 1.98e-01 | 7.21e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 19 | 1.35e-01 | 1.98e-01 | 4.53e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 37 | 3.72e-02 | -1.98e-01 | 2.40e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 20 | 1.25e-01 | 1.98e-01 | 4.39e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 7 | 3.64e-01 | 1.98e-01 | 6.93e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 6 | 4.01e-01 | 1.98e-01 | 7.22e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 4.01e-01 | 1.98e-01 | 7.22e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 21 | 1.17e-01 | -1.98e-01 | 4.23e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 42 | 2.66e-02 | 1.98e-01 | 2.02e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 7 | 3.65e-01 | -1.98e-01 | 6.93e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 3.33e-01 | -1.98e-01 | 6.70e-01 |
| GOCC ACTIN FILAMENT | 72 | 3.78e-03 | 1.98e-01 | 5.91e-02 |
| GOBP CARDIOBLAST DIFFERENTIATION | 7 | 3.65e-01 | 1.98e-01 | 6.93e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 3.65e-01 | 1.98e-01 | 6.93e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 10 | 2.79e-01 | 1.98e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 14 | 2.01e-01 | 1.97e-01 | 5.49e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 7 | 3.66e-01 | -1.97e-01 | 6.94e-01 |
| GOBP MEMBRANE INVAGINATION | 45 | 2.21e-02 | 1.97e-01 | 1.81e-01 |
| GOCC MITOCHONDRIAL MATRIX | 424 | 4.17e-12 | 1.97e-01 | 9.58e-10 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 10 | 2.80e-01 | -1.97e-01 | 6.29e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 12 | 2.37e-01 | -1.97e-01 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 7 | 3.67e-01 | 1.97e-01 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 183 | 4.50e-06 | 1.97e-01 | 2.27e-04 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 14 | 2.02e-01 | 1.97e-01 | 5.49e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 5 | 4.46e-01 | -1.97e-01 | 7.53e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 38 | 3.58e-02 | 1.97e-01 | 2.38e-01 |
| GOBP TRNA 5 END PROCESSING | 15 | 1.87e-01 | 1.97e-01 | 5.32e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 3.67e-01 | 1.97e-01 | 6.95e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 9 | 3.07e-01 | -1.97e-01 | 6.49e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 14 | 2.03e-01 | 1.97e-01 | 5.50e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 4.04e-01 | 1.97e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 3.68e-01 | 1.96e-01 | 6.96e-01 |
| GOBP DUMP METABOLIC PROCESS | 6 | 4.05e-01 | 1.96e-01 | 7.24e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 8 | 3.36e-01 | 1.96e-01 | 6.73e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 35 | 4.44e-02 | 1.96e-01 | 2.63e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 7 | 3.68e-01 | 1.96e-01 | 6.96e-01 |
| GOMF ANTIGEN BINDING | 57 | 1.04e-02 | 1.96e-01 | 1.16e-01 |
| GOMF TELOMERIC DNA BINDING | 37 | 3.89e-02 | 1.96e-01 | 2.44e-01 |
| GOBP DIOL METABOLIC PROCESS | 23 | 1.03e-01 | 1.96e-01 | 4.02e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 57 | 1.05e-02 | 1.96e-01 | 1.17e-01 |
| GOBP VIRAL BUDDING | 23 | 1.04e-01 | 1.96e-01 | 4.02e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 3.37e-01 | 1.96e-01 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 6 | 4.06e-01 | -1.96e-01 | 7.25e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 29 | 6.80e-02 | -1.96e-01 | 3.29e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 3.70e-01 | 1.96e-01 | 6.96e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 19 | 1.40e-01 | -1.96e-01 | 4.59e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 41 | 3.02e-02 | 1.96e-01 | 2.17e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 6 | 4.06e-01 | -1.96e-01 | 7.25e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 8 | 3.38e-01 | 1.96e-01 | 6.74e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 10 | 2.84e-01 | -1.96e-01 | 6.32e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 81 | 2.36e-03 | 1.96e-01 | 4.24e-02 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 3.38e-01 | 1.96e-01 | 6.74e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 6 | 4.07e-01 | 1.95e-01 | 7.26e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 3.38e-01 | -1.95e-01 | 6.74e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 34 | 4.87e-02 | 1.95e-01 | 2.78e-01 |
| GOCC CHITOSOME | 11 | 2.62e-01 | 1.95e-01 | 6.13e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 20 | 1.31e-01 | 1.95e-01 | 4.47e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 11 | 2.62e-01 | -1.95e-01 | 6.13e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 2.85e-01 | 1.95e-01 | 6.33e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 2.06e-01 | 1.95e-01 | 5.54e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 55 | 1.23e-02 | -1.95e-01 | 1.29e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 20 | 1.31e-01 | 1.95e-01 | 4.47e-01 |
| GOBP CELL FATE DETERMINATION | 17 | 1.64e-01 | -1.95e-01 | 4.98e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 12 | 2.42e-01 | 1.95e-01 | 5.90e-01 |
| GOMF CYCLIN BINDING | 26 | 8.51e-02 | 1.95e-01 | 3.67e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 9 | 3.11e-01 | -1.95e-01 | 6.53e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 65 | 6.59e-03 | 1.95e-01 | 8.67e-02 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 55 | 1.24e-02 | 1.95e-01 | 1.29e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 41 | 3.10e-02 | 1.95e-01 | 2.20e-01 |
| GOCC THO COMPLEX | 6 | 4.09e-01 | 1.95e-01 | 7.27e-01 |
| GOBP REGULATION OF CENTROMERIC SISTER CHROMATID COHESION | 5 | 4.51e-01 | 1.95e-01 | 7.57e-01 |
| GOCC SARCOPLASMIC RETICULUM | 42 | 2.92e-02 | 1.95e-01 | 2.13e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 12 | 2.43e-01 | -1.95e-01 | 5.91e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 9 | 3.12e-01 | 1.95e-01 | 6.55e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 30 | 6.53e-02 | 1.95e-01 | 3.25e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 2.87e-01 | -1.95e-01 | 6.36e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 9 | 3.12e-01 | 1.94e-01 | 6.55e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 13 | 2.25e-01 | -1.94e-01 | 5.74e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 2.25e-01 | -1.94e-01 | 5.74e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 29 | 7.01e-02 | 1.94e-01 | 3.34e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 14 | 2.08e-01 | 1.94e-01 | 5.57e-01 |
| GOCC MITOTIC SPINDLE | 151 | 3.92e-05 | 1.94e-01 | 1.50e-03 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 143 | 6.31e-05 | 1.94e-01 | 2.28e-03 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 1.15e-01 | 1.94e-01 | 4.20e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 28 | 7.56e-02 | 1.94e-01 | 3.45e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 10 | 2.88e-01 | -1.94e-01 | 6.36e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 3.14e-01 | 1.94e-01 | 6.55e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 7 | 3.74e-01 | -1.94e-01 | 7.01e-01 |
| GOBP PROTEIN TETRAMERIZATION | 64 | 7.37e-03 | 1.94e-01 | 9.36e-02 |
| GOBP INTEGRIN ACTIVATION | 16 | 1.80e-01 | 1.94e-01 | 5.22e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 14 | 2.10e-01 | 1.94e-01 | 5.57e-01 |
| GOBP ERYTHROCYTE MATURATION | 12 | 2.46e-01 | 1.94e-01 | 5.93e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 5 | 4.54e-01 | -1.94e-01 | 7.59e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 2.90e-01 | -1.93e-01 | 6.38e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 17 | 1.68e-01 | 1.93e-01 | 5.04e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 60 | 9.68e-03 | 1.93e-01 | 1.12e-01 |
| GOMF RNA STEM LOOP BINDING | 14 | 2.11e-01 | -1.93e-01 | 5.58e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 30 | 6.72e-02 | 1.93e-01 | 3.27e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 21 | 1.26e-01 | -1.93e-01 | 4.40e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 3.76e-01 | -1.93e-01 | 7.03e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 3.45e-01 | -1.93e-01 | 6.79e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 4.55e-01 | -1.93e-01 | 7.60e-01 |
| GOBP MYOBLAST FUSION | 23 | 1.09e-01 | 1.93e-01 | 4.12e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 37 | 4.24e-02 | 1.93e-01 | 2.57e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 23 | 1.10e-01 | -1.93e-01 | 4.12e-01 |
| GOMF ISOPRENOID BINDING | 9 | 3.17e-01 | 1.93e-01 | 6.58e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 8 | 3.46e-01 | 1.93e-01 | 6.80e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 11 | 2.69e-01 | 1.93e-01 | 6.19e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 6 | 4.14e-01 | -1.93e-01 | 7.30e-01 |
| GOCC PIGMENT GRANULE | 94 | 1.28e-03 | 1.92e-01 | 2.69e-02 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 432 | 9.05e-12 | 1.92e-01 | 1.83e-09 |
| GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.56e-01 | -1.92e-01 | 7.61e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 4.32e-02 | 1.92e-01 | 2.59e-01 |
| GOCC MICROTUBULE END | 25 | 9.64e-02 | 1.92e-01 | 3.91e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 18 | 1.58e-01 | 1.92e-01 | 4.92e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 4.57e-01 | 1.92e-01 | 7.61e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 8 | 3.47e-01 | 1.92e-01 | 6.80e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 4.57e-01 | -1.92e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 7 | 3.79e-01 | -1.92e-01 | 7.05e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 7 | 3.79e-01 | -1.92e-01 | 7.05e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 5 | 4.57e-01 | -1.92e-01 | 7.61e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 29 | 7.39e-02 | 1.92e-01 | 3.42e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 4.58e-01 | 1.92e-01 | 7.61e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 9 | 3.19e-01 | -1.92e-01 | 6.60e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 79 | 3.27e-03 | 1.92e-01 | 5.36e-02 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 11 | 2.71e-01 | 1.92e-01 | 6.21e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 10 | 2.94e-01 | -1.92e-01 | 6.40e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 40 | 3.62e-02 | 1.92e-01 | 2.38e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 29 | 7.44e-02 | 1.91e-01 | 3.42e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 4.59e-01 | -1.91e-01 | 7.62e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 20 | 1.39e-01 | 1.91e-01 | 4.59e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 1.39e-01 | 1.91e-01 | 4.59e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 5 | 4.60e-01 | 1.91e-01 | 7.63e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 24 | 1.06e-01 | -1.91e-01 | 4.06e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 17 | 1.74e-01 | 1.91e-01 | 5.13e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 18 | 1.61e-01 | 1.91e-01 | 4.95e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 13 | 2.34e-01 | 1.91e-01 | 5.83e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 15 | 2.01e-01 | -1.91e-01 | 5.49e-01 |
| GOBP CENTROSOME DUPLICATION | 67 | 7.02e-03 | 1.91e-01 | 9.05e-02 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 23 | 1.14e-01 | 1.91e-01 | 4.18e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 2.34e-01 | 1.91e-01 | 5.83e-01 |
| GOCC LIPID DROPLET | 75 | 4.40e-03 | 1.90e-01 | 6.59e-02 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 27 | 8.71e-02 | 1.90e-01 | 3.71e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 3.51e-01 | -1.90e-01 | 6.84e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 6 | 4.20e-01 | -1.90e-01 | 7.35e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 3.84e-01 | -1.90e-01 | 7.08e-01 |
| GOBP AXIS ELONGATION | 12 | 2.54e-01 | 1.90e-01 | 6.03e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 3.84e-01 | 1.90e-01 | 7.08e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 10 | 2.98e-01 | 1.90e-01 | 6.43e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 3.84e-01 | 1.90e-01 | 7.08e-01 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 3.24e-01 | 1.90e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION | 5 | 4.62e-01 | 1.90e-01 | 7.64e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 40 | 3.79e-02 | 1.90e-01 | 2.42e-01 |
| GOCC AGGRESOME | 28 | 8.25e-02 | -1.90e-01 | 3.62e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 69 | 6.51e-03 | 1.90e-01 | 8.61e-02 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 4.21e-01 | -1.90e-01 | 7.35e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 13 | 2.37e-01 | -1.89e-01 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 56 | 1.43e-02 | 1.89e-01 | 1.40e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 4.22e-01 | -1.89e-01 | 7.35e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 11 | 2.77e-01 | -1.89e-01 | 6.26e-01 |
| GOBP CEREBROSPINAL FLUID CIRCULATION | 6 | 4.22e-01 | -1.89e-01 | 7.35e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 7 | 3.86e-01 | -1.89e-01 | 7.09e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 15 | 2.05e-01 | -1.89e-01 | 5.53e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 19 | 1.54e-01 | 1.89e-01 | 4.86e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 7 | 3.86e-01 | -1.89e-01 | 7.09e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 3.26e-01 | 1.89e-01 | 6.64e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 6 | 4.23e-01 | -1.89e-01 | 7.36e-01 |
| GOBP CELL CELL RECOGNITION | 31 | 6.87e-02 | 1.89e-01 | 3.31e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 3.01e-01 | 1.89e-01 | 6.45e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 25 | 1.02e-01 | 1.89e-01 | 4.01e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 2.38e-01 | 1.89e-01 | 5.88e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 31 | 6.89e-02 | 1.89e-01 | 3.31e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 16 | 1.91e-01 | 1.89e-01 | 5.36e-01 |
| GOBP PHOTOTRANSDUCTION | 14 | 2.21e-01 | -1.89e-01 | 5.72e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 4.65e-01 | -1.89e-01 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 20 | 1.44e-01 | 1.89e-01 | 4.69e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 11 | 2.79e-01 | 1.89e-01 | 6.29e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 9 | 3.28e-01 | -1.88e-01 | 6.66e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 3.03e-01 | 1.88e-01 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 10 | 3.03e-01 | 1.88e-01 | 6.47e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 8 | 3.57e-01 | -1.88e-01 | 6.87e-01 |
| GOBP PROLINE TRANSPORT | 6 | 4.25e-01 | 1.88e-01 | 7.37e-01 |
| GOBP MRNA TRANSCRIPTION | 47 | 2.58e-02 | 1.88e-01 | 1.98e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 2.80e-01 | 1.88e-01 | 6.29e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 2.41e-01 | 1.88e-01 | 5.90e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 3.30e-01 | 1.88e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 8 | 3.59e-01 | 1.87e-01 | 6.88e-01 |
| GOBP RESPONSE TO PROTOZOAN | 20 | 1.47e-01 | 1.87e-01 | 4.75e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 96 | 1.54e-03 | 1.87e-01 | 3.09e-02 |
| GOBP WALKING BEHAVIOR | 20 | 1.47e-01 | 1.87e-01 | 4.75e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 46 | 2.81e-02 | 1.87e-01 | 2.08e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 8 | 3.60e-01 | 1.87e-01 | 6.88e-01 |
| GOBP RESPONSE TO NUTRIENT | 79 | 4.09e-03 | 1.87e-01 | 6.23e-02 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 32 | 6.73e-02 | 1.87e-01 | 3.27e-01 |
| GOCC MICROTUBULE PLUS END | 18 | 1.70e-01 | 1.87e-01 | 5.07e-01 |
| GOBP PREPULSE INHIBITION | 6 | 4.28e-01 | -1.87e-01 | 7.41e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.32e-01 | 1.87e-01 | 6.69e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 23 | 1.21e-01 | -1.87e-01 | 4.32e-01 |
| GOBP BONE GROWTH | 14 | 2.27e-01 | -1.87e-01 | 5.76e-01 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 5 | 4.70e-01 | 1.87e-01 | 7.68e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 5 | 4.70e-01 | 1.87e-01 | 7.68e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 9 | 3.33e-01 | -1.87e-01 | 6.69e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 21 | 1.39e-01 | 1.87e-01 | 4.59e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 19 | 1.59e-01 | -1.87e-01 | 4.93e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 6 | 4.29e-01 | -1.87e-01 | 7.42e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 17 | 1.83e-01 | 1.86e-01 | 5.27e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 5 | 4.71e-01 | 1.86e-01 | 7.68e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 28 | 8.80e-02 | 1.86e-01 | 3.72e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 3.08e-01 | 1.86e-01 | 6.50e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 10 | 3.08e-01 | 1.86e-01 | 6.50e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 17 | 1.84e-01 | -1.86e-01 | 5.27e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 26 | 1.01e-01 | -1.86e-01 | 3.99e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 14 | 2.28e-01 | 1.86e-01 | 5.78e-01 |
| GOMF METAL CLUSTER BINDING | 64 | 1.01e-02 | 1.86e-01 | 1.14e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 31 | 7.32e-02 | 1.86e-01 | 3.40e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 4.30e-01 | -1.86e-01 | 7.43e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 81 | 3.88e-03 | 1.86e-01 | 6.00e-02 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 10 | 3.09e-01 | 1.86e-01 | 6.52e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 47 | 2.78e-02 | 1.86e-01 | 2.07e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 55 | 1.74e-02 | -1.86e-01 | 1.58e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 17 | 1.86e-01 | 1.85e-01 | 5.29e-01 |
| GOBP SPINDLE ASSEMBLY | 120 | 4.62e-04 | 1.85e-01 | 1.19e-02 |
| GOBP RESPONSE TO RAPAMYCIN | 5 | 4.73e-01 | -1.85e-01 | 7.70e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 51 | 2.22e-02 | 1.85e-01 | 1.81e-01 |
| GOBP BASE EXCISION REPAIR | 41 | 4.02e-02 | 1.85e-01 | 2.49e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 15 | 2.14e-01 | 1.85e-01 | 5.64e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 67 | 8.82e-03 | 1.85e-01 | 1.06e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 2.88e-01 | 1.85e-01 | 6.36e-01 |
| GOBP DNA METABOLIC PROCESS | 856 | 9.74e-20 | 1.85e-01 | 1.15e-16 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 22 | 1.33e-01 | 1.85e-01 | 4.50e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 8 | 3.65e-01 | -1.85e-01 | 6.93e-01 |
| GOCC MALE GERM CELL NUCLEUS | 37 | 5.16e-02 | 1.85e-01 | 2.85e-01 |
| GOCC KINESIN COMPLEX | 34 | 6.25e-02 | 1.85e-01 | 3.17e-01 |
| GOMF RRNA BINDING | 62 | 1.20e-02 | -1.85e-01 | 1.27e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 154 | 7.99e-05 | 1.85e-01 | 2.82e-03 |
| GOMF STEROL TRANSFER ACTIVITY | 13 | 2.50e-01 | -1.84e-01 | 5.98e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 2.90e-01 | 1.84e-01 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 48 | 2.73e-02 | 1.84e-01 | 2.04e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 27 | 9.76e-02 | 1.84e-01 | 3.93e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 1.11e-01 | -1.84e-01 | 4.14e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 7 | 3.99e-01 | 1.84e-01 | 7.20e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 116 | 6.22e-04 | 1.84e-01 | 1.54e-02 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 24 | 1.18e-01 | 1.84e-01 | 4.26e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 70 | 7.80e-03 | 1.84e-01 | 9.81e-02 |
| GOMF OLIGOSACCHARIDE BINDING | 5 | 4.76e-01 | -1.84e-01 | 7.73e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 15 | 2.17e-01 | 1.84e-01 | 5.66e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 48 | 2.75e-02 | 1.84e-01 | 2.06e-01 |
| GOBP FEAR RESPONSE | 17 | 1.89e-01 | -1.84e-01 | 5.35e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 37 | 5.30e-02 | 1.84e-01 | 2.89e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 13 | 2.51e-01 | -1.84e-01 | 6.00e-01 |
| GOCC DENDRITE TERMINUS | 10 | 3.14e-01 | -1.84e-01 | 6.56e-01 |
| GOBP REGULATION OF DNA REPAIR | 195 | 1.01e-05 | 1.84e-01 | 4.56e-04 |
| GOBP MEIOTIC CELL CYCLE | 179 | 2.32e-05 | 1.84e-01 | 9.58e-04 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 19 | 1.66e-01 | -1.84e-01 | 5.00e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 3.68e-01 | -1.84e-01 | 6.96e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 3.15e-01 | -1.83e-01 | 6.57e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 8 | 3.69e-01 | -1.83e-01 | 6.96e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 19 | 1.67e-01 | -1.83e-01 | 5.02e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 26 | 1.06e-01 | -1.83e-01 | 4.06e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 4.01e-01 | 1.83e-01 | 7.22e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 6 | 4.37e-01 | -1.83e-01 | 7.47e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 4.37e-01 | 1.83e-01 | 7.47e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 10 | 3.16e-01 | 1.83e-01 | 6.58e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 10 | 3.16e-01 | -1.83e-01 | 6.58e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 4.02e-01 | 1.83e-01 | 7.22e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 11 | 2.94e-01 | 1.83e-01 | 6.40e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 3.70e-01 | 1.83e-01 | 6.97e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 5 | 4.79e-01 | -1.83e-01 | 7.74e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 47 | 3.02e-02 | 1.83e-01 | 2.17e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 31 | 7.83e-02 | 1.83e-01 | 3.50e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 300 | 5.81e-08 | 1.83e-01 | 5.11e-06 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 23 | 1.29e-01 | 1.83e-01 | 4.46e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 20 | 1.57e-01 | 1.83e-01 | 4.92e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 22 | 1.38e-01 | -1.83e-01 | 4.58e-01 |
| GOBP MALE MEIOSIS I | 14 | 2.37e-01 | 1.83e-01 | 5.87e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 1.58e-01 | -1.83e-01 | 4.92e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 35 | 6.18e-02 | 1.83e-01 | 3.16e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 14 | 2.37e-01 | -1.83e-01 | 5.87e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 52 | 2.29e-02 | 1.83e-01 | 1.85e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 2.21e-01 | 1.82e-01 | 5.72e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 16 | 2.07e-01 | 1.82e-01 | 5.55e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 4.80e-01 | 1.82e-01 | 7.75e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 20 | 1.58e-01 | 1.82e-01 | 4.92e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 27 | 1.01e-01 | -1.82e-01 | 4.01e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 25 | 1.15e-01 | -1.82e-01 | 4.20e-01 |
| GOBP REGULATION OF VESICLE SIZE | 18 | 1.81e-01 | 1.82e-01 | 5.24e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 273 | 2.46e-07 | 1.82e-01 | 1.91e-05 |
| GOBP MICROGLIAL CELL MIGRATION | 5 | 4.81e-01 | -1.82e-01 | 7.76e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 28 | 9.59e-02 | 1.82e-01 | 3.90e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.73e-01 | -1.82e-01 | 7.00e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 38 | 5.29e-02 | 1.82e-01 | 2.89e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 2.97e-01 | 1.81e-01 | 6.42e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 9 | 3.46e-01 | -1.81e-01 | 6.80e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 18 | 1.83e-01 | -1.81e-01 | 5.26e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 37 | 5.63e-02 | 1.81e-01 | 2.97e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 39 | 5.03e-02 | 1.81e-01 | 2.82e-01 |
| GOMF ALPHA TUBULIN BINDING | 33 | 7.20e-02 | -1.81e-01 | 3.37e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 6 | 4.43e-01 | 1.81e-01 | 7.51e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 56 | 1.92e-02 | -1.81e-01 | 1.67e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 60 | 1.55e-02 | 1.81e-01 | 1.47e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 6 | 4.43e-01 | 1.81e-01 | 7.52e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 9 | 3.48e-01 | -1.81e-01 | 6.81e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 30 | 8.68e-02 | 1.81e-01 | 3.70e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 122 | 5.83e-04 | 1.81e-01 | 1.47e-02 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 7 | 4.08e-01 | 1.81e-01 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 50 | 2.74e-02 | 1.80e-01 | 2.05e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 23 | 1.34e-01 | 1.80e-01 | 4.52e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 10 | 3.23e-01 | -1.80e-01 | 6.63e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 7 | 4.09e-01 | -1.80e-01 | 7.27e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 8 | 3.77e-01 | 1.80e-01 | 7.05e-01 |
| GOBP HORMONE CATABOLIC PROCESS | 6 | 4.45e-01 | 1.80e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 31 | 8.28e-02 | 1.80e-01 | 3.62e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 9 | 3.50e-01 | -1.80e-01 | 6.83e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 382 | 1.90e-09 | 1.80e-01 | 2.18e-07 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 94 | 2.62e-03 | 1.80e-01 | 4.56e-02 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 1.75e-01 | 1.80e-01 | 5.16e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 42 | 4.39e-02 | 1.80e-01 | 2.61e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 12 | 2.81e-01 | -1.80e-01 | 6.29e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 12 | 2.81e-01 | 1.80e-01 | 6.29e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 40 | 4.95e-02 | 1.80e-01 | 2.80e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 15 | 2.29e-01 | 1.80e-01 | 5.78e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 62 | 1.46e-02 | 1.80e-01 | 1.41e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 7 | 4.11e-01 | -1.79e-01 | 7.29e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 4.47e-01 | 1.79e-01 | 7.54e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 18 | 1.88e-01 | -1.79e-01 | 5.33e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 46 | 3.54e-02 | 1.79e-01 | 2.37e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 9 | 3.51e-01 | 1.79e-01 | 6.84e-01 |
| GOBP DNA RECOMBINATION | 274 | 3.56e-07 | 1.79e-01 | 2.60e-05 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 8 | 3.80e-01 | 1.79e-01 | 7.06e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 16 | 2.14e-01 | 1.79e-01 | 5.64e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 4.88e-01 | -1.79e-01 | 7.79e-01 |
| GOBP SNRNA PROCESSING | 26 | 1.14e-01 | 1.79e-01 | 4.18e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 280 | 2.75e-07 | 1.79e-01 | 2.07e-05 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 17 | 2.01e-01 | 1.79e-01 | 5.49e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 10 | 3.27e-01 | -1.79e-01 | 6.66e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 4.89e-01 | 1.79e-01 | 7.80e-01 |
| GOBP GLUCOCORTICOID SECRETION | 8 | 3.81e-01 | -1.79e-01 | 7.07e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 7 | 4.13e-01 | 1.79e-01 | 7.30e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 20 | 1.67e-01 | 1.79e-01 | 5.02e-01 |
| GOBP RENAL ABSORPTION | 12 | 2.84e-01 | 1.79e-01 | 6.32e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 3.82e-01 | 1.79e-01 | 7.07e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 17 | 2.03e-01 | 1.78e-01 | 5.50e-01 |
| GOCC PROTEIN LIPID COMPLEX | 15 | 2.32e-01 | 1.78e-01 | 5.80e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 2.17e-01 | -1.78e-01 | 5.65e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 29 | 9.65e-02 | -1.78e-01 | 3.91e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 50 | 2.92e-02 | 1.78e-01 | 2.13e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 5 | 4.90e-01 | 1.78e-01 | 7.81e-01 |
| GOBP ICOSANOID SECRETION | 16 | 2.17e-01 | -1.78e-01 | 5.65e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 19 | 1.79e-01 | 1.78e-01 | 5.20e-01 |
| GOMF FILAMIN BINDING | 7 | 4.15e-01 | -1.78e-01 | 7.31e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 124 | 6.29e-04 | 1.78e-01 | 1.55e-02 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 23 | 1.40e-01 | -1.78e-01 | 4.59e-01 |
| GOMF PRE MIRNA BINDING | 8 | 3.83e-01 | 1.78e-01 | 7.08e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 668 | 7.83e-15 | 1.78e-01 | 3.41e-12 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 32 | 8.19e-02 | 1.78e-01 | 3.60e-01 |
| GOCC SUPER ELONGATION COMPLEX | 6 | 4.51e-01 | -1.78e-01 | 7.57e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 4.91e-01 | 1.78e-01 | 7.82e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 32 | 8.22e-02 | 1.78e-01 | 3.61e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 16 | 2.19e-01 | -1.78e-01 | 5.69e-01 |
| GOBP RETINA HOMEOSTASIS | 36 | 6.55e-02 | -1.77e-01 | 3.25e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 9 | 3.57e-01 | 1.77e-01 | 6.87e-01 |
| GOBP PROTEIN OXIDATION | 7 | 4.16e-01 | -1.77e-01 | 7.32e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 4.17e-01 | -1.77e-01 | 7.32e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 627 | 5.65e-14 | 1.77e-01 | 2.13e-11 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 4.17e-01 | 1.77e-01 | 7.32e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 9 | 3.57e-01 | 1.77e-01 | 6.87e-01 |
| GOBP EXPLORATION BEHAVIOR | 12 | 2.88e-01 | -1.77e-01 | 6.36e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 4.93e-01 | -1.77e-01 | 7.82e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 40 | 5.27e-02 | 1.77e-01 | 2.88e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 14 | 2.51e-01 | -1.77e-01 | 6.00e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 15 | 2.35e-01 | -1.77e-01 | 5.85e-01 |
| GOCC PRP19 COMPLEX | 12 | 2.89e-01 | 1.77e-01 | 6.37e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 24 | 1.34e-01 | 1.77e-01 | 4.51e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 9 | 3.58e-01 | 1.77e-01 | 6.88e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 34 | 7.45e-02 | 1.77e-01 | 3.42e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 10 | 3.33e-01 | -1.77e-01 | 6.70e-01 |
| GOBP PROSTAGLANDIN SECRETION | 9 | 3.59e-01 | -1.76e-01 | 6.88e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 15 | 2.37e-01 | 1.76e-01 | 5.87e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 4.19e-01 | -1.76e-01 | 7.34e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 82 | 5.82e-03 | 1.76e-01 | 8.00e-02 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 23 | 1.43e-01 | -1.76e-01 | 4.67e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 9 | 3.60e-01 | -1.76e-01 | 6.88e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 27 | 1.13e-01 | -1.76e-01 | 4.16e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 4.55e-01 | 1.76e-01 | 7.60e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 8 | 3.88e-01 | -1.76e-01 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 20 | 1.73e-01 | -1.76e-01 | 5.12e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 12 | 2.91e-01 | 1.76e-01 | 6.38e-01 |
| GOCC MANCHETTE | 12 | 2.91e-01 | -1.76e-01 | 6.38e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 10 | 3.35e-01 | 1.76e-01 | 6.72e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 6 | 4.55e-01 | 1.76e-01 | 7.60e-01 |
| GOBP CGMP MEDIATED SIGNALING | 8 | 3.89e-01 | -1.76e-01 | 7.11e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 6 | 4.56e-01 | -1.76e-01 | 7.60e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 4.21e-01 | -1.76e-01 | 7.35e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 20 | 1.74e-01 | 1.76e-01 | 5.14e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 68 | 1.23e-02 | 1.76e-01 | 1.29e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 40 | 5.47e-02 | 1.76e-01 | 2.94e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 19 | 1.85e-01 | 1.76e-01 | 5.29e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 5 | 4.97e-01 | -1.76e-01 | 7.85e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 4.97e-01 | 1.76e-01 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 83 | 5.75e-03 | 1.76e-01 | 7.95e-02 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 10 | 3.37e-01 | 1.75e-01 | 6.73e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 9 | 3.62e-01 | 1.75e-01 | 6.91e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 8 | 3.90e-01 | 1.75e-01 | 7.12e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 8 | 3.91e-01 | -1.75e-01 | 7.12e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 4.57e-01 | -1.75e-01 | 7.61e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 33 | 8.17e-02 | 1.75e-01 | 3.60e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 3.63e-01 | -1.75e-01 | 6.91e-01 |
| GOBP RELAXATION OF MUSCLE | 19 | 1.86e-01 | -1.75e-01 | 5.31e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 1.15e-01 | 1.75e-01 | 4.21e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 22 | 1.55e-01 | 1.75e-01 | 4.89e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 3.91e-01 | -1.75e-01 | 7.13e-01 |
| GOBP BLEB ASSEMBLY | 6 | 4.58e-01 | 1.75e-01 | 7.61e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 14 | 2.57e-01 | 1.75e-01 | 6.06e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 10 | 3.38e-01 | -1.75e-01 | 6.74e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 12 | 2.94e-01 | 1.75e-01 | 6.40e-01 |
| GOBP VIRAL GENOME REPLICATION | 110 | 1.56e-03 | 1.75e-01 | 3.12e-02 |
| GOBP MITOCHONDRION DISTRIBUTION | 13 | 2.75e-01 | -1.75e-01 | 6.25e-01 |
| GOBP FIBROBLAST MIGRATION | 40 | 5.60e-02 | 1.75e-01 | 2.96e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 59 | 2.04e-02 | 1.75e-01 | 1.73e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.64e-01 | 1.75e-01 | 6.93e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 4.59e-01 | 1.75e-01 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 32 | 8.78e-02 | -1.74e-01 | 3.72e-01 |
| GOBP AORTA MORPHOGENESIS | 13 | 2.76e-01 | -1.74e-01 | 6.26e-01 |
| GOBP RESPONSE TO AMINE | 25 | 1.31e-01 | 1.74e-01 | 4.47e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 52 | 2.97e-02 | -1.74e-01 | 2.16e-01 |
| GOBP RESPONSE TO FORSKOLIN | 6 | 4.60e-01 | -1.74e-01 | 7.63e-01 |
| GOCC CENTRIOLE | 125 | 7.79e-04 | 1.74e-01 | 1.81e-02 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 4.25e-01 | 1.74e-01 | 7.37e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 3.17e-01 | 1.74e-01 | 6.58e-01 |
| GOCC FILOPODIUM TIP | 13 | 2.77e-01 | 1.74e-01 | 6.26e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 12 | 2.96e-01 | 1.74e-01 | 6.41e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 60 | 1.97e-02 | 1.74e-01 | 1.69e-01 |
| GOMF LRR DOMAIN BINDING | 15 | 2.43e-01 | 1.74e-01 | 5.91e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 6 | 4.60e-01 | -1.74e-01 | 7.63e-01 |
| GOBP VASODILATION | 18 | 2.01e-01 | -1.74e-01 | 5.49e-01 |
| GOCC BLOOD MICROPARTICLE | 48 | 3.71e-02 | 1.74e-01 | 2.40e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 833 | 3.28e-17 | -1.74e-01 | 2.26e-14 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 7 | 4.26e-01 | 1.74e-01 | 7.38e-01 |
| GOCC VESICLE TETHERING COMPLEX | 52 | 3.02e-02 | 1.74e-01 | 2.17e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 4.61e-01 | 1.74e-01 | 7.64e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 1.58e-01 | 1.74e-01 | 4.92e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 6 | 4.61e-01 | -1.74e-01 | 7.64e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 22 | 1.59e-01 | 1.74e-01 | 4.92e-01 |
| GOBP CATECHOLAMINE UPTAKE | 6 | 4.61e-01 | 1.74e-01 | 7.64e-01 |
| GOMF SNORNA BINDING | 32 | 8.93e-02 | 1.74e-01 | 3.75e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 61 | 1.91e-02 | 1.74e-01 | 1.67e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 6 | 4.62e-01 | 1.73e-01 | 7.64e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 18 | 2.03e-01 | -1.73e-01 | 5.50e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 25 | 1.34e-01 | -1.73e-01 | 4.51e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 21 | 1.69e-01 | -1.73e-01 | 5.06e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 47 | 4.03e-02 | 1.73e-01 | 2.49e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 1.92e-01 | 1.73e-01 | 5.37e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 2.04e-01 | 1.73e-01 | 5.51e-01 |
| GOBP URATE METABOLIC PROCESS | 5 | 5.03e-01 | -1.73e-01 | 7.90e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 16 | 2.31e-01 | 1.73e-01 | 5.80e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 16 | 2.31e-01 | 1.73e-01 | 5.80e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 4.64e-01 | 1.73e-01 | 7.64e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 52 | 3.13e-02 | 1.73e-01 | 2.20e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 23 | 1.52e-01 | 1.73e-01 | 4.82e-01 |
| GOBP CYTOPLASM ORGANIZATION | 9 | 3.70e-01 | -1.73e-01 | 6.96e-01 |
| GOCC MICROBODY MEMBRANE | 56 | 2.56e-02 | 1.73e-01 | 1.98e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 35 | 7.76e-02 | -1.72e-01 | 3.48e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 1.62e-01 | 1.72e-01 | 4.95e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 7 | 4.30e-01 | 1.72e-01 | 7.43e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 21 | 1.72e-01 | -1.72e-01 | 5.10e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 41 | 5.64e-02 | 1.72e-01 | 2.97e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 20 | 1.83e-01 | 1.72e-01 | 5.26e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 110 | 1.85e-03 | 1.72e-01 | 3.58e-02 |
| GOBP RESPONSE TO ATP | 16 | 2.34e-01 | -1.72e-01 | 5.83e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 26 | 1.29e-01 | -1.72e-01 | 4.46e-01 |
| GOMF MISMATCHED DNA BINDING | 13 | 2.83e-01 | 1.72e-01 | 6.32e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 7 | 4.31e-01 | 1.72e-01 | 7.43e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 8 | 4.00e-01 | 1.72e-01 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 379 | 1.08e-08 | 1.72e-01 | 1.08e-06 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 12 | 3.03e-01 | -1.72e-01 | 6.47e-01 |
| GOBP DAMP METABOLIC PROCESS | 5 | 5.06e-01 | 1.72e-01 | 7.91e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.67e-01 | -1.72e-01 | 7.66e-01 |
| GOBP DETECTION OF VIRUS | 5 | 5.06e-01 | -1.72e-01 | 7.91e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 17 | 2.21e-01 | 1.72e-01 | 5.71e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 6 | 4.67e-01 | -1.72e-01 | 7.66e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 9 | 3.73e-01 | -1.72e-01 | 7.00e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 20 | 1.85e-01 | -1.71e-01 | 5.28e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 14 | 2.67e-01 | 1.71e-01 | 6.18e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 7 | 4.33e-01 | 1.71e-01 | 7.45e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 7 | 4.33e-01 | -1.71e-01 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 17 | 2.22e-01 | 1.71e-01 | 5.72e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 11 | 3.26e-01 | 1.71e-01 | 6.64e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 14 | 2.68e-01 | -1.71e-01 | 6.19e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 5.08e-01 | -1.71e-01 | 7.91e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 1.35e-02 | -1.71e-01 | 1.37e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 31 | 9.97e-02 | 1.71e-01 | 3.98e-01 |
| GOBP PANCREATIC JUICE SECRETION | 5 | 5.08e-01 | 1.71e-01 | 7.91e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 14 | 2.69e-01 | 1.71e-01 | 6.19e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 25 | 1.40e-01 | 1.71e-01 | 4.59e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 25 | 1.40e-01 | 1.71e-01 | 4.59e-01 |
| GOBP SPERM EGG RECOGNITION | 16 | 2.37e-01 | 1.71e-01 | 5.87e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 19 | 1.98e-01 | 1.71e-01 | 5.45e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 8 | 4.03e-01 | 1.71e-01 | 7.23e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 2.69e-01 | -1.71e-01 | 6.19e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 29 | 1.12e-01 | 1.71e-01 | 4.16e-01 |
| GOCC DENDRITE CYTOPLASM | 20 | 1.87e-01 | -1.71e-01 | 5.32e-01 |
| GOMF ACTIN MONOMER BINDING | 20 | 1.87e-01 | 1.70e-01 | 5.32e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 17 | 2.24e-01 | 1.70e-01 | 5.73e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 66 | 1.67e-02 | 1.70e-01 | 1.55e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 6 | 4.70e-01 | 1.70e-01 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 6 | 4.70e-01 | 1.70e-01 | 7.68e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 11 | 3.28e-01 | -1.70e-01 | 6.66e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 24 | 1.49e-01 | -1.70e-01 | 4.78e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 37 | 7.33e-02 | 1.70e-01 | 3.41e-01 |
| GOBP REGULATION OF CELL KILLING | 77 | 9.90e-03 | 1.70e-01 | 1.13e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 47 | 4.37e-02 | 1.70e-01 | 2.60e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 8 | 4.05e-01 | 1.70e-01 | 7.24e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 5.10e-01 | 1.70e-01 | 7.92e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 47 | 4.38e-02 | 1.70e-01 | 2.61e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 8 | 4.06e-01 | 1.70e-01 | 7.25e-01 |
| GOMF TETRAPYRROLE BINDING | 54 | 3.10e-02 | 1.70e-01 | 2.20e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 4.71e-01 | 1.70e-01 | 7.69e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 11 | 3.30e-01 | -1.70e-01 | 6.67e-01 |
| GOBP CHORION DEVELOPMENT | 6 | 4.72e-01 | 1.70e-01 | 7.70e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 10 | 3.53e-01 | 1.70e-01 | 6.85e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 12 | 3.10e-01 | 1.69e-01 | 6.52e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 11 | 3.31e-01 | -1.69e-01 | 6.67e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 30 | 1.09e-01 | 1.69e-01 | 4.10e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 19 | 2.02e-01 | -1.69e-01 | 5.49e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 28 | 1.21e-01 | 1.69e-01 | 4.32e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 33 | 9.29e-02 | 1.69e-01 | 3.83e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 38 | 7.15e-02 | -1.69e-01 | 3.37e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 4.74e-01 | 1.69e-01 | 7.71e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 11 | 3.32e-01 | 1.69e-01 | 6.69e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 16 | 2.43e-01 | 1.69e-01 | 5.91e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 65 | 1.88e-02 | 1.69e-01 | 1.65e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 22 | 1.71e-01 | 1.69e-01 | 5.09e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 4.40e-01 | 1.68e-01 | 7.49e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 10 | 3.57e-01 | -1.68e-01 | 6.87e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 24 | 1.53e-01 | -1.68e-01 | 4.86e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 27 | 1.30e-01 | 1.68e-01 | 4.47e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 20 | 1.93e-01 | 1.68e-01 | 5.38e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 21 | 1.82e-01 | 1.68e-01 | 5.25e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 10 | 3.57e-01 | -1.68e-01 | 6.87e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 3.61e-02 | 1.68e-01 | 2.38e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 5.15e-01 | 1.68e-01 | 7.96e-01 |
| GOBP VIRAL TRANSLATION | 20 | 1.93e-01 | -1.68e-01 | 5.39e-01 |
| GOCC MICROTUBULE MINUS END | 6 | 4.76e-01 | 1.68e-01 | 7.73e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 121 | 1.44e-03 | 1.68e-01 | 2.95e-02 |
| GOCC RNA POLYMERASE II HOLOENZYME | 69 | 1.59e-02 | 1.68e-01 | 1.49e-01 |
| GOMF PHOSPHOLIPASE BINDING | 16 | 2.45e-01 | -1.68e-01 | 5.93e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 1.18e-01 | 1.68e-01 | 4.25e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 12 | 3.14e-01 | 1.68e-01 | 6.56e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 3.66e-02 | 1.68e-01 | 2.39e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 23 | 1.64e-01 | 1.68e-01 | 4.99e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 13 | 2.95e-01 | 1.68e-01 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 79 | 1.01e-02 | 1.68e-01 | 1.14e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 22 | 1.74e-01 | 1.68e-01 | 5.13e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 3.36e-01 | -1.68e-01 | 6.73e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 18 | 2.19e-01 | 1.67e-01 | 5.69e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 9 | 3.85e-01 | -1.67e-01 | 7.08e-01 |
| GOCC CONTRACTILE RING | 9 | 3.85e-01 | 1.67e-01 | 7.08e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 39 | 7.08e-02 | 1.67e-01 | 3.35e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 25 | 1.48e-01 | 1.67e-01 | 4.76e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 10 | 3.60e-01 | -1.67e-01 | 6.88e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 8 | 4.13e-01 | 1.67e-01 | 7.30e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 14 | 2.79e-01 | 1.67e-01 | 6.29e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 41 | 6.45e-02 | 1.67e-01 | 3.23e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 29 | 1.20e-01 | 1.67e-01 | 4.29e-01 |
| GOBP LATE NUCLEOPHAGY | 8 | 4.14e-01 | -1.67e-01 | 7.30e-01 |
| GOBP FIBROBLAST ACTIVATION | 11 | 3.38e-01 | 1.67e-01 | 6.74e-01 |
| GOMF ALCOHOL BINDING | 52 | 3.75e-02 | 1.67e-01 | 2.41e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 5 | 5.18e-01 | -1.67e-01 | 7.97e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 2.80e-01 | -1.67e-01 | 6.29e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 20 | 1.97e-01 | 1.67e-01 | 5.43e-01 |
| GOBP BLASTODERM SEGMENTATION | 6 | 4.80e-01 | 1.67e-01 | 7.74e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 6 | 4.80e-01 | 1.67e-01 | 7.74e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 53 | 3.59e-02 | 1.67e-01 | 2.38e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 26 | 1.42e-01 | 1.66e-01 | 4.65e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 25 | 1.50e-01 | -1.66e-01 | 4.81e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 28 | 1.28e-01 | 1.66e-01 | 4.44e-01 |
| GOBP POSITIVE T CELL SELECTION | 33 | 9.87e-02 | 1.66e-01 | 3.96e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 7 | 4.47e-01 | -1.66e-01 | 7.54e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 9 | 3.88e-01 | 1.66e-01 | 7.11e-01 |
| GOMF LIGASE ACTIVITY | 123 | 1.49e-03 | 1.66e-01 | 3.03e-02 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 6 | 4.81e-01 | 1.66e-01 | 7.76e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 78 | 1.13e-02 | 1.66e-01 | 1.23e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 8 | 4.16e-01 | 1.66e-01 | 7.32e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 456 | 1.55e-09 | 1.66e-01 | 1.88e-07 |
| GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 5.21e-01 | -1.66e-01 | 8.00e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 6 | 4.82e-01 | -1.66e-01 | 7.76e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 91 | 6.34e-03 | 1.66e-01 | 8.46e-02 |
| GOBP CALCIUM ION HOMEOSTASIS | 173 | 1.75e-04 | 1.66e-01 | 5.47e-03 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 59 | 2.79e-02 | -1.66e-01 | 2.07e-01 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 9 | 3.90e-01 | -1.66e-01 | 7.12e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 4.18e-01 | 1.66e-01 | 7.33e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 18 | 2.24e-01 | 1.65e-01 | 5.74e-01 |
| GOBP NK T CELL ACTIVATION | 11 | 3.42e-01 | 1.65e-01 | 6.78e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 7 | 4.48e-01 | 1.65e-01 | 7.55e-01 |
| GOBP SPERM CAPACITATION | 10 | 3.65e-01 | -1.65e-01 | 6.93e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 5.22e-01 | 1.65e-01 | 8.01e-01 |
| GOMF NADP BINDING | 39 | 7.44e-02 | 1.65e-01 | 3.42e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 3.66e-01 | 1.65e-01 | 6.94e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 11 | 3.43e-01 | 1.65e-01 | 6.79e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 7 | 4.49e-01 | 1.65e-01 | 7.55e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 21 | 1.90e-01 | -1.65e-01 | 5.36e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 10 | 3.66e-01 | -1.65e-01 | 6.94e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 4.19e-01 | 1.65e-01 | 7.34e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 3.22e-01 | 1.65e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 5 | 5.23e-01 | 1.65e-01 | 8.01e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 17 | 2.39e-01 | 1.65e-01 | 5.88e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 13 | 3.04e-01 | -1.65e-01 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 58 | 3.01e-02 | 1.65e-01 | 2.17e-01 |
| GOBP CELL DIVISION | 508 | 2.76e-10 | 1.65e-01 | 3.93e-08 |
| GOCC CONTRACTILE FIBER | 127 | 1.38e-03 | 1.65e-01 | 2.87e-02 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 3.45e-01 | 1.65e-01 | 6.79e-01 |
| GOBP DNA MODIFICATION | 83 | 9.66e-03 | 1.65e-01 | 1.12e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 245 | 9.84e-06 | 1.64e-01 | 4.47e-04 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 4.85e-01 | 1.64e-01 | 7.78e-01 |
| GOBP RIBOSOME DISASSEMBLY | 13 | 3.05e-01 | 1.64e-01 | 6.47e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 12 | 3.24e-01 | -1.64e-01 | 6.63e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 4.86e-01 | 1.64e-01 | 7.78e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 20 | 2.04e-01 | 1.64e-01 | 5.51e-01 |
| GOBP MYOBLAST PROLIFERATION | 12 | 3.25e-01 | -1.64e-01 | 6.64e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 275 | 3.06e-06 | 1.64e-01 | 1.65e-04 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 11 | 3.46e-01 | 1.64e-01 | 6.80e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 6 | 4.86e-01 | 1.64e-01 | 7.79e-01 |
| GOBP NUCLEAR MIGRATION | 20 | 2.04e-01 | 1.64e-01 | 5.51e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 7 | 4.53e-01 | 1.64e-01 | 7.58e-01 |
| GOCC NUCLEOID | 43 | 6.30e-02 | 1.64e-01 | 3.18e-01 |
| GOBP STRIATUM DEVELOPMENT | 14 | 2.88e-01 | -1.64e-01 | 6.36e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 14 | 2.88e-01 | -1.64e-01 | 6.36e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 62 | 2.58e-02 | -1.64e-01 | 1.98e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 19 | 2.16e-01 | -1.64e-01 | 5.65e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 39 | 7.68e-02 | 1.64e-01 | 3.47e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 32 | 1.09e-01 | -1.64e-01 | 4.11e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 12 | 3.26e-01 | 1.64e-01 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 5 | 5.26e-01 | -1.64e-01 | 8.03e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 4.23e-01 | -1.64e-01 | 7.36e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 37 | 8.54e-02 | 1.64e-01 | 3.68e-01 |
| GOCC A BAND | 18 | 2.30e-01 | 1.63e-01 | 5.79e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 225 | 2.52e-05 | 1.63e-01 | 1.02e-03 |
| GOMF DAMAGED DNA BINDING | 65 | 2.28e-02 | 1.63e-01 | 1.85e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 28 | 1.35e-01 | -1.63e-01 | 4.52e-01 |
| GOBP GTP METABOLIC PROCESS | 20 | 2.07e-01 | 1.63e-01 | 5.55e-01 |
| GOCC PRC1 COMPLEX | 13 | 3.09e-01 | -1.63e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 19 | 2.19e-01 | 1.63e-01 | 5.68e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 107 | 3.64e-03 | 1.63e-01 | 5.79e-02 |
| GOCC TRANSPORTER COMPLEX | 201 | 7.21e-05 | 1.63e-01 | 2.56e-03 |
| GOBP ERBB SIGNALING PATHWAY | 83 | 1.05e-02 | 1.63e-01 | 1.17e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 86 | 9.20e-03 | -1.63e-01 | 1.08e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 6 | 4.90e-01 | 1.63e-01 | 7.81e-01 |
| GOBP PROTEIN ACETYLATION | 87 | 8.81e-03 | 1.63e-01 | 1.06e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 3.50e-01 | 1.63e-01 | 6.83e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 1.23e-01 | 1.63e-01 | 4.37e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 5.29e-01 | 1.63e-01 | 8.04e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 29 | 1.30e-01 | -1.63e-01 | 4.46e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 461 | 2.77e-09 | 1.63e-01 | 3.10e-07 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 89 | 8.15e-03 | 1.62e-01 | 1.00e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 30 | 1.24e-01 | 1.62e-01 | 4.37e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 50 | 4.71e-02 | 1.62e-01 | 2.73e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 13 | 3.11e-01 | 1.62e-01 | 6.53e-01 |
| GOBP LIVER REGENERATION | 16 | 2.61e-01 | 1.62e-01 | 6.12e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 4.91e-01 | -1.62e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 28 | 1.37e-01 | 1.62e-01 | 4.56e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 6 | 4.91e-01 | 1.62e-01 | 7.82e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 17 | 2.47e-01 | -1.62e-01 | 5.95e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 84 | 1.02e-02 | 1.62e-01 | 1.15e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 2.09e-01 | 1.62e-01 | 5.57e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 18 | 2.34e-01 | 1.62e-01 | 5.83e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 8 | 4.27e-01 | -1.62e-01 | 7.41e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 36 | 9.29e-02 | 1.62e-01 | 3.83e-01 |
| GOBP GERM CELL PROLIFERATION | 7 | 4.58e-01 | 1.62e-01 | 7.62e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 5.31e-01 | -1.62e-01 | 8.05e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 147 | 7.23e-04 | 1.62e-01 | 1.73e-02 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 36 | 9.33e-02 | -1.62e-01 | 3.83e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 40 | 7.71e-02 | 1.62e-01 | 3.48e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 125 | 1.84e-03 | 1.62e-01 | 3.58e-02 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 9 | 4.02e-01 | 1.61e-01 | 7.22e-01 |
| GOBP ORGAN INDUCTION | 6 | 4.94e-01 | -1.61e-01 | 7.83e-01 |
| GOBP RETINAL METABOLIC PROCESS | 8 | 4.29e-01 | 1.61e-01 | 7.43e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 9 | 4.02e-01 | 1.61e-01 | 7.22e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 2.37e-01 | 1.61e-01 | 5.87e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 10 | 3.78e-01 | -1.61e-01 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 8 | 4.30e-01 | -1.61e-01 | 7.43e-01 |
| GOBP HISTONE MODIFICATION | 108 | 3.88e-03 | 1.61e-01 | 6.00e-02 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 5.33e-01 | -1.61e-01 | 8.06e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 3.56e-01 | -1.61e-01 | 6.87e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 8 | 4.31e-01 | 1.61e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 10 | 3.78e-01 | -1.61e-01 | 7.05e-01 |
| GOBP MEMBRANE FISSION | 40 | 7.86e-02 | 1.61e-01 | 3.51e-01 |
| GOBP CARDIAC CONDUCTION | 38 | 8.65e-02 | 1.61e-01 | 3.70e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 7 | 4.62e-01 | 1.61e-01 | 7.64e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 29 | 1.34e-01 | -1.61e-01 | 4.52e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 32 | 1.16e-01 | 1.61e-01 | 4.21e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 24 | 1.73e-01 | -1.61e-01 | 5.12e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 37 | 9.12e-02 | 1.61e-01 | 3.79e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 6 | 4.96e-01 | 1.60e-01 | 7.85e-01 |
| GOBP HYPOTONIC RESPONSE | 6 | 4.96e-01 | 1.60e-01 | 7.85e-01 |
| GOBP BONE MORPHOGENESIS | 38 | 8.73e-02 | -1.60e-01 | 3.71e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 3.57e-01 | 1.60e-01 | 6.87e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 23 | 1.84e-01 | -1.60e-01 | 5.27e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 13 | 3.17e-01 | -1.60e-01 | 6.58e-01 |
| GOBP SNRNA MODIFICATION | 7 | 4.63e-01 | 1.60e-01 | 7.64e-01 |
| GOBP MITOTIC CELL CYCLE | 731 | 2.87e-13 | 1.60e-01 | 9.51e-11 |
| GOBP INCLUSION BODY ASSEMBLY | 18 | 2.40e-01 | -1.60e-01 | 5.88e-01 |
| GOBP CHOLESTEROL IMPORT | 6 | 4.97e-01 | -1.60e-01 | 7.86e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 10 | 3.81e-01 | 1.60e-01 | 7.07e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 8 | 4.34e-01 | 1.60e-01 | 7.45e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 57 | 3.69e-02 | 1.60e-01 | 2.40e-01 |
| GOBP G0 TO G1 TRANSITION | 31 | 1.24e-01 | 1.60e-01 | 4.37e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 8 | 4.34e-01 | -1.60e-01 | 7.45e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 6 | 4.98e-01 | 1.60e-01 | 7.86e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 4.64e-01 | 1.60e-01 | 7.65e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 4.98e-01 | -1.60e-01 | 7.86e-01 |
| GOBP CGMP METABOLIC PROCESS | 5 | 5.36e-01 | -1.60e-01 | 8.09e-01 |
| GOCC RNA POLYMERASE COMPLEX | 96 | 6.90e-03 | 1.60e-01 | 8.96e-02 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 11 | 3.59e-01 | 1.60e-01 | 6.88e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 51 | 4.86e-02 | 1.60e-01 | 2.78e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 27 | 1.51e-01 | -1.60e-01 | 4.81e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 113 | 3.41e-03 | 1.60e-01 | 5.53e-02 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 16 | 2.69e-01 | 1.60e-01 | 6.19e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 5.37e-01 | 1.60e-01 | 8.09e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 2.06e-01 | -1.59e-01 | 5.54e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 145 | 9.47e-04 | 1.59e-01 | 2.08e-02 |
| GOBP INTESTINAL ABSORPTION | 17 | 2.56e-01 | -1.59e-01 | 6.05e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 7 | 4.66e-01 | -1.59e-01 | 7.65e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 3.83e-01 | 1.59e-01 | 7.08e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 56 | 3.95e-02 | -1.59e-01 | 2.46e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 41 | 7.80e-02 | 1.59e-01 | 3.49e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 9 | 4.08e-01 | 1.59e-01 | 7.27e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 5 | 5.38e-01 | -1.59e-01 | 8.09e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 127 | 2.00e-03 | 1.59e-01 | 3.78e-02 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 16 | 2.71e-01 | -1.59e-01 | 6.20e-01 |
| GOCC HOST CELLULAR COMPONENT | 7 | 4.66e-01 | 1.59e-01 | 7.66e-01 |
| GOCC TRAMP COMPLEX | 5 | 5.38e-01 | 1.59e-01 | 8.09e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 54 | 4.36e-02 | -1.59e-01 | 2.60e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 15 | 2.88e-01 | 1.59e-01 | 6.36e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 88 | 1.02e-02 | 1.59e-01 | 1.15e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 15 | 2.88e-01 | 1.58e-01 | 6.36e-01 |
| GOBP DNA DEALKYLATION | 32 | 1.21e-01 | 1.58e-01 | 4.32e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 7 | 4.68e-01 | -1.58e-01 | 7.67e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 46 | 6.34e-02 | -1.58e-01 | 3.19e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 7 | 4.68e-01 | 1.58e-01 | 7.67e-01 |
| GOCC CLATHRIN VESICLE COAT | 25 | 1.71e-01 | 1.58e-01 | 5.09e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 38 | 9.17e-02 | 1.58e-01 | 3.80e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 3.87e-01 | 1.58e-01 | 7.09e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 19 | 2.34e-01 | 1.58e-01 | 5.83e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 66 | 2.67e-02 | -1.58e-01 | 2.02e-01 |
| GOBP HISTAMINE SECRETION | 9 | 4.12e-01 | 1.58e-01 | 7.30e-01 |
| GOBP HISTAMINE TRANSPORT | 9 | 4.12e-01 | 1.58e-01 | 7.30e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 2.47e-01 | 1.58e-01 | 5.95e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 11 | 3.65e-01 | 1.58e-01 | 6.93e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 59 | 3.62e-02 | 1.58e-01 | 2.38e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 50 | 5.39e-02 | -1.58e-01 | 2.92e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 8 | 4.40e-01 | 1.58e-01 | 7.49e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 3.65e-01 | 1.58e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 31 | 1.29e-01 | -1.58e-01 | 4.46e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 2.34e-01 | 1.58e-01 | 5.83e-01 |
| GOCC ACTOMYOSIN | 46 | 6.46e-02 | 1.58e-01 | 3.23e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 8 | 4.40e-01 | -1.58e-01 | 7.49e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 12 | 3.45e-01 | 1.57e-01 | 6.80e-01 |
| GOBP DETOXIFICATION | 78 | 1.64e-02 | 1.57e-01 | 1.52e-01 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 5.42e-01 | -1.57e-01 | 8.13e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 32 | 1.24e-01 | -1.57e-01 | 4.37e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 11 | 3.67e-01 | -1.57e-01 | 6.94e-01 |
| GOBP RESPONSE TO UV B | 13 | 3.26e-01 | 1.57e-01 | 6.65e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 49 | 5.73e-02 | -1.57e-01 | 3.00e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 46 | 6.54e-02 | -1.57e-01 | 3.25e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 4.15e-01 | 1.57e-01 | 7.31e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 14 | 3.09e-01 | 1.57e-01 | 6.52e-01 |
| GOCC SPINDLE POLE | 151 | 8.94e-04 | 1.57e-01 | 2.00e-02 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 9 | 4.15e-01 | 1.57e-01 | 7.31e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 8 | 4.42e-01 | -1.57e-01 | 7.51e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 15 | 2.93e-01 | -1.57e-01 | 6.40e-01 |
| GOBP BRADYKININ CATABOLIC PROCESS | 6 | 5.06e-01 | 1.57e-01 | 7.91e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 3.28e-01 | -1.57e-01 | 6.66e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 8 | 4.43e-01 | 1.57e-01 | 7.51e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 24 | 1.84e-01 | -1.57e-01 | 5.28e-01 |
| GOBP SYNAPSE PRUNING | 5 | 5.44e-01 | 1.57e-01 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 11 | 3.69e-01 | -1.57e-01 | 6.96e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.16e-01 | -1.57e-01 | 7.32e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 46 | 6.64e-02 | 1.57e-01 | 3.27e-01 |
| GOCC CELL CORTEX REGION | 19 | 2.38e-01 | 1.56e-01 | 5.87e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 9 | 4.17e-01 | -1.56e-01 | 7.32e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 6 | 5.08e-01 | 1.56e-01 | 7.91e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 16 | 2.80e-01 | 1.56e-01 | 6.29e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 18 | 2.52e-01 | 1.56e-01 | 6.01e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 65 | 2.98e-02 | 1.56e-01 | 2.16e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 6 | 5.09e-01 | -1.56e-01 | 7.91e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.09e-01 | -1.56e-01 | 7.91e-01 |
| GOBP RESPONSE TO ALKALOID | 55 | 4.57e-02 | 1.56e-01 | 2.68e-01 |
| GOBP OTOLITH DEVELOPMENT | 5 | 5.46e-01 | -1.56e-01 | 8.16e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 4.76e-01 | 1.56e-01 | 7.72e-01 |
| GOMF DNA TRANSLOCASE ACTIVITY | 5 | 5.47e-01 | 1.56e-01 | 8.16e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 7 | 4.76e-01 | 1.56e-01 | 7.72e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 353 | 5.78e-07 | 1.56e-01 | 4.02e-05 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 16 | 2.81e-01 | 1.56e-01 | 6.29e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 42 | 8.17e-02 | -1.55e-01 | 3.60e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 5 | 5.48e-01 | 1.55e-01 | 8.17e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 13 | 3.33e-01 | -1.55e-01 | 6.69e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 1.41e-01 | 1.55e-01 | 4.63e-01 |
| GOBP DNA DAMAGE RESPONSE | 768 | 4.43e-13 | 1.55e-01 | 1.26e-10 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 27 | 1.63e-01 | 1.55e-01 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 35 | 1.13e-01 | 1.55e-01 | 4.16e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 3.15e-01 | -1.55e-01 | 6.57e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 11 | 3.73e-01 | -1.55e-01 | 7.00e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 15 | 2.99e-01 | -1.55e-01 | 6.44e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 17 | 2.69e-01 | -1.55e-01 | 6.19e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 14 | 3.16e-01 | 1.55e-01 | 6.57e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 4.48e-01 | 1.55e-01 | 7.54e-01 |
| GOBP LACTATE METABOLIC PROCESS | 14 | 3.16e-01 | 1.55e-01 | 6.58e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 123 | 3.10e-03 | 1.55e-01 | 5.18e-02 |
| GOBP PLATELET MORPHOGENESIS | 18 | 2.56e-01 | 1.55e-01 | 6.05e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 54 | 4.95e-02 | 1.55e-01 | 2.80e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 16 | 2.84e-01 | 1.55e-01 | 6.32e-01 |
| GOCC I BAND | 73 | 2.25e-02 | 1.55e-01 | 1.83e-01 |
| GOBP STEROID CATABOLIC PROCESS | 6 | 5.12e-01 | 1.55e-01 | 7.94e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 15 | 3.00e-01 | 1.55e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 43 | 7.98e-02 | 1.55e-01 | 3.54e-01 |
| GOBP MICROVILLUS ASSEMBLY | 16 | 2.85e-01 | 1.54e-01 | 6.33e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 24 | 1.91e-01 | -1.54e-01 | 5.36e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 35 | 1.14e-01 | 1.54e-01 | 4.19e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 10 | 3.98e-01 | 1.54e-01 | 7.19e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 55 | 4.81e-02 | 1.54e-01 | 2.77e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 30 | 1.44e-01 | 1.54e-01 | 4.68e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 28 | 1.58e-01 | 1.54e-01 | 4.92e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 5 | 5.51e-01 | -1.54e-01 | 8.19e-01 |
| GOBP UV PROTECTION | 9 | 4.24e-01 | 1.54e-01 | 7.36e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 2.86e-01 | 1.54e-01 | 6.35e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 23 | 2.01e-01 | 1.54e-01 | 5.49e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 48 | 6.52e-02 | 1.54e-01 | 3.25e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 10 | 3.99e-01 | 1.54e-01 | 7.21e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 40 | 9.24e-02 | 1.54e-01 | 3.82e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 218 | 9.50e-05 | -1.54e-01 | 3.26e-03 |
| GOMF SULFOTRANSFERASE ACTIVITY | 17 | 2.72e-01 | -1.54e-01 | 6.22e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 2.02e-01 | 1.54e-01 | 5.49e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 47 | 6.84e-02 | 1.54e-01 | 3.30e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 200 | 1.86e-04 | 1.54e-01 | 5.73e-03 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 358 | 6.68e-07 | 1.54e-01 | 4.57e-05 |
| GOBP CYTOKINESIS | 149 | 1.25e-03 | 1.53e-01 | 2.64e-02 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 15 | 3.04e-01 | 1.53e-01 | 6.47e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 19 | 2.47e-01 | -1.53e-01 | 5.95e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 561 | 7.15e-10 | 1.53e-01 | 9.38e-08 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 15 | 3.04e-01 | -1.53e-01 | 6.47e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 5 | 5.53e-01 | -1.53e-01 | 8.21e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 3.39e-01 | 1.53e-01 | 6.75e-01 |
| GOCC ESCRT I COMPLEX | 10 | 4.02e-01 | 1.53e-01 | 7.22e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 28 | 1.61e-01 | 1.53e-01 | 4.95e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 38 | 1.03e-01 | 1.53e-01 | 4.01e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 31 | 1.40e-01 | -1.53e-01 | 4.61e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 28 | 1.61e-01 | -1.53e-01 | 4.95e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 19 | 2.49e-01 | 1.53e-01 | 5.97e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 6 | 5.17e-01 | -1.53e-01 | 7.97e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 6 | 5.17e-01 | -1.53e-01 | 7.97e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 20 | 2.38e-01 | 1.53e-01 | 5.87e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 2.26e-01 | 1.53e-01 | 5.76e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 7 | 4.85e-01 | 1.52e-01 | 7.78e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 22 | 2.16e-01 | -1.52e-01 | 5.65e-01 |
| GOBP ASTROCYTE ACTIVATION | 15 | 3.07e-01 | -1.52e-01 | 6.49e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 20 | 2.38e-01 | 1.52e-01 | 5.88e-01 |
| GOBP NEGATIVE REGULATION OF NEURON MIGRATION | 5 | 5.55e-01 | -1.52e-01 | 8.22e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 92 | 1.17e-02 | 1.52e-01 | 1.25e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 62 | 3.83e-02 | 1.52e-01 | 2.42e-01 |
| GOBP REGULATION OF DNA BINDING | 61 | 3.99e-02 | 1.52e-01 | 2.48e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 8 | 4.56e-01 | -1.52e-01 | 7.61e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 6 | 5.19e-01 | -1.52e-01 | 7.98e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 87 | 1.43e-02 | 1.52e-01 | 1.40e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 23 | 2.07e-01 | 1.52e-01 | 5.55e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 23 | 2.08e-01 | 1.52e-01 | 5.56e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 68 | 3.05e-02 | 1.52e-01 | 2.18e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 109 | 6.23e-03 | 1.52e-01 | 8.37e-02 |
| GOBP BODY MORPHOGENESIS | 28 | 1.65e-01 | -1.52e-01 | 4.99e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 5 | 5.57e-01 | 1.52e-01 | 8.22e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 11 | 3.84e-01 | 1.52e-01 | 7.08e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 25 | 1.90e-01 | 1.52e-01 | 5.35e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 8 | 4.58e-01 | 1.52e-01 | 7.61e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 8 | 4.58e-01 | 1.51e-01 | 7.62e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 34 | 1.27e-01 | -1.51e-01 | 4.42e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 7 | 4.88e-01 | 1.51e-01 | 7.80e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 63 | 3.80e-02 | 1.51e-01 | 2.42e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 29 | 1.59e-01 | 1.51e-01 | 4.93e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 25 | 1.91e-01 | 1.51e-01 | 5.36e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 13 | 3.46e-01 | 1.51e-01 | 6.80e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 21 | 2.31e-01 | 1.51e-01 | 5.80e-01 |
| GOCC SPINDLE MICROTUBULE | 71 | 2.79e-02 | 1.51e-01 | 2.07e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 17 | 2.82e-01 | -1.51e-01 | 6.30e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 17 | 2.82e-01 | -1.51e-01 | 6.30e-01 |
| GOBP ACTIN FILAMENT SEVERING | 14 | 3.29e-01 | 1.51e-01 | 6.67e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 149 | 1.52e-03 | 1.51e-01 | 3.08e-02 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 11 | 3.87e-01 | 1.51e-01 | 7.09e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 4.60e-01 | -1.51e-01 | 7.63e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 10 | 4.09e-01 | -1.51e-01 | 7.28e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 4.61e-01 | 1.51e-01 | 7.63e-01 |
| GOCC CLATHRIN COATED VESICLE | 143 | 1.92e-03 | 1.51e-01 | 3.68e-02 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 4.61e-01 | 1.51e-01 | 7.64e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 45 | 8.09e-02 | 1.50e-01 | 3.57e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 5 | 5.61e-01 | 1.50e-01 | 8.25e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 5 | 5.61e-01 | 1.50e-01 | 8.25e-01 |
| GOBP PROTEIN POLYMERIZATION | 205 | 2.16e-04 | 1.50e-01 | 6.40e-03 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 33 | 1.36e-01 | 1.50e-01 | 4.53e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 9 | 4.35e-01 | -1.50e-01 | 7.46e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 8 | 4.62e-01 | -1.50e-01 | 7.64e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 16 | 2.99e-01 | 1.50e-01 | 6.44e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 58 | 4.82e-02 | 1.50e-01 | 2.77e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 6 | 5.25e-01 | 1.50e-01 | 8.02e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 5.25e-01 | 1.50e-01 | 8.02e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 49 | 6.96e-02 | 1.50e-01 | 3.33e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 3.89e-01 | 1.50e-01 | 7.11e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 5.25e-01 | 1.50e-01 | 8.02e-01 |
| GOBP RESPONSE TO LITHIUM ION | 7 | 4.93e-01 | 1.50e-01 | 7.82e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 51 | 6.46e-02 | 1.50e-01 | 3.23e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 22 | 2.24e-01 | 1.50e-01 | 5.74e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 5 | 5.62e-01 | 1.50e-01 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 9 | 4.37e-01 | 1.50e-01 | 7.47e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 444 | 7.82e-08 | 1.50e-01 | 6.74e-06 |
| GOCC NUCLEAR LAMINA | 11 | 3.91e-01 | 1.49e-01 | 7.12e-01 |
| GOBP RESPONSE TO VITAMIN | 38 | 1.11e-01 | 1.49e-01 | 4.15e-01 |
| GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY | 5 | 5.63e-01 | 1.49e-01 | 8.25e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 19 | 2.60e-01 | -1.49e-01 | 6.10e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 20 | 2.48e-01 | 1.49e-01 | 5.95e-01 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 9 | 4.38e-01 | 1.49e-01 | 7.48e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 9 | 4.38e-01 | -1.49e-01 | 7.48e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 136 | 2.72e-03 | 1.49e-01 | 4.68e-02 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 26 | 1.88e-01 | 1.49e-01 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 17 | 2.87e-01 | 1.49e-01 | 6.36e-01 |
| GOBP OVULATION | 7 | 4.95e-01 | -1.49e-01 | 7.84e-01 |
| GOBP MICROTUBULE NUCLEATION | 44 | 8.75e-02 | 1.49e-01 | 3.71e-01 |
| GOBP PHOTOPERIODISM | 21 | 2.37e-01 | -1.49e-01 | 5.87e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 19 | 2.61e-01 | 1.49e-01 | 6.12e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 30 | 1.58e-01 | 1.49e-01 | 4.92e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 2.88e-01 | 1.49e-01 | 6.36e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 5 | 5.65e-01 | 1.49e-01 | 8.27e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 28 | 1.73e-01 | 1.49e-01 | 5.12e-01 |
| GOCC CELL POLE | 5 | 5.65e-01 | 1.49e-01 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 11 | 3.93e-01 | 1.49e-01 | 7.15e-01 |
| GOCC MITOCHONDRION | 1354 | 2.16e-19 | 1.49e-01 | 2.23e-16 |
| GOBP COPULATION | 6 | 5.28e-01 | -1.49e-01 | 8.04e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 5 | 5.65e-01 | -1.49e-01 | 8.27e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 5.65e-01 | -1.49e-01 | 8.27e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 96 | 1.21e-02 | 1.48e-01 | 1.27e-01 |
| GOBP CELL CYCLE PROCESS | 1006 | 4.04e-15 | 1.48e-01 | 1.96e-12 |
| GOBP TOR SIGNALING | 138 | 2.67e-03 | 1.48e-01 | 4.61e-02 |
| GOCC CHLORIDE CHANNEL COMPLEX | 13 | 3.55e-01 | 1.48e-01 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 91 | 1.46e-02 | 1.48e-01 | 1.41e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 9 | 4.41e-01 | 1.48e-01 | 7.50e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 7 | 4.97e-01 | -1.48e-01 | 7.86e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 104 | 9.12e-03 | 1.48e-01 | 1.08e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 21 | 2.40e-01 | -1.48e-01 | 5.88e-01 |
| GOBP MATING BEHAVIOR | 13 | 3.55e-01 | 1.48e-01 | 6.87e-01 |
| GOBP RESPONSE TO X RAY | 24 | 2.09e-01 | 1.48e-01 | 5.57e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 3.05e-01 | 1.48e-01 | 6.48e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 140 | 2.53e-03 | 1.48e-01 | 4.43e-02 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 2.40e-01 | 1.48e-01 | 5.89e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 25 | 2.01e-01 | 1.48e-01 | 5.49e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 13 | 3.56e-01 | 1.48e-01 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 8 | 4.69e-01 | 1.48e-01 | 7.68e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.43e-01 | 1.48e-01 | 7.51e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 5.31e-01 | 1.48e-01 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 11 | 3.97e-01 | -1.48e-01 | 7.19e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 4.99e-01 | 1.48e-01 | 7.87e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 100 | 1.09e-02 | 1.48e-01 | 1.20e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 25 | 2.02e-01 | 1.48e-01 | 5.49e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 13 | 3.57e-01 | 1.47e-01 | 6.87e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 5 | 5.68e-01 | 1.47e-01 | 8.29e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 5.68e-01 | 1.47e-01 | 8.29e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 67 | 3.73e-02 | 1.47e-01 | 2.40e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 10 | 4.20e-01 | 1.47e-01 | 7.35e-01 |
| GOBP PARTURITION | 5 | 5.69e-01 | -1.47e-01 | 8.29e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 13 | 3.59e-01 | 1.47e-01 | 6.88e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 2.55e-01 | 1.47e-01 | 6.05e-01 |
| GOCC CATALYTIC COMPLEX | 1477 | 2.20e-20 | 1.47e-01 | 3.63e-17 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 23 | 2.23e-01 | 1.47e-01 | 5.73e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 5.01e-01 | 1.47e-01 | 7.88e-01 |
| GOCC MYOSIN II COMPLEX | 10 | 4.22e-01 | 1.47e-01 | 7.35e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 4.72e-01 | 1.47e-01 | 7.70e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 35 | 1.33e-01 | 1.47e-01 | 4.50e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 20 | 2.56e-01 | 1.47e-01 | 6.05e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 6 | 5.34e-01 | 1.47e-01 | 8.07e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 57 | 5.58e-02 | 1.47e-01 | 2.96e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 5 | 5.71e-01 | 1.47e-01 | 8.29e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 69 | 3.55e-02 | 1.46e-01 | 2.38e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 26 | 1.96e-01 | -1.46e-01 | 5.43e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 5 | 5.71e-01 | -1.46e-01 | 8.29e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 3.80e-01 | 1.46e-01 | 7.06e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 11 | 4.00e-01 | -1.46e-01 | 7.21e-01 |
| GOMF GTPASE BINDING | 252 | 6.61e-05 | 1.46e-01 | 2.38e-03 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 174 | 8.87e-04 | 1.46e-01 | 1.99e-02 |
| GOBP PROTEIN C LINKED GLYCOSYLATION | 5 | 5.71e-01 | -1.46e-01 | 8.29e-01 |
| GOCC DESMOSOME | 11 | 4.01e-01 | -1.46e-01 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 10 | 4.23e-01 | 1.46e-01 | 7.36e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 19 | 2.70e-01 | -1.46e-01 | 6.20e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 38 | 1.19e-01 | 1.46e-01 | 4.28e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 5.04e-01 | -1.46e-01 | 7.90e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 5.04e-01 | -1.46e-01 | 7.90e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 3.82e-01 | 1.46e-01 | 7.07e-01 |
| GOCC GID COMPLEX | 5 | 5.72e-01 | -1.46e-01 | 8.29e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 3.45e-01 | 1.46e-01 | 6.79e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 8 | 4.75e-01 | -1.46e-01 | 7.72e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 42 | 1.02e-01 | -1.46e-01 | 4.01e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 98 | 1.27e-02 | 1.46e-01 | 1.31e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 95 | 1.42e-02 | 1.46e-01 | 1.40e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 793 | 5.11e-12 | 1.46e-01 | 1.14e-09 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 11 | 4.03e-01 | -1.46e-01 | 7.22e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 5.37e-01 | 1.46e-01 | 8.09e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 44 | 9.48e-02 | 1.46e-01 | 3.87e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 8 | 4.76e-01 | -1.46e-01 | 7.72e-01 |
| GOBP MEMBRANE DOCKING | 71 | 3.41e-02 | 1.46e-01 | 2.32e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 30 | 1.68e-01 | 1.46e-01 | 5.04e-01 |
| GOBP NODAL SIGNALING PATHWAY | 8 | 4.76e-01 | -1.45e-01 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 26 | 1.99e-01 | 1.45e-01 | 5.47e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 13 | 3.64e-01 | -1.45e-01 | 6.93e-01 |
| GOCC ESCRT COMPLEX | 25 | 2.08e-01 | 1.45e-01 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 8 | 4.76e-01 | -1.45e-01 | 7.73e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 18 | 2.86e-01 | 1.45e-01 | 6.35e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 5.38e-01 | -1.45e-01 | 8.09e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 6 | 5.38e-01 | 1.45e-01 | 8.09e-01 |
| GOCC PHAGOCYTIC CUP | 23 | 2.28e-01 | 1.45e-01 | 5.78e-01 |
| GOBP REGULATION OF HEART RATE | 37 | 1.27e-01 | 1.45e-01 | 4.43e-01 |
| GOBP MESODERM MORPHOGENESIS | 31 | 1.62e-01 | 1.45e-01 | 4.97e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 12 | 3.84e-01 | -1.45e-01 | 7.08e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 9 | 4.51e-01 | -1.45e-01 | 7.57e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 115 | 7.30e-03 | 1.45e-01 | 9.31e-02 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 5.74e-01 | 1.45e-01 | 8.30e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 22 | 2.39e-01 | 1.45e-01 | 5.88e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 47 | 8.58e-02 | 1.45e-01 | 3.69e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 65 | 4.36e-02 | 1.45e-01 | 2.60e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 11 | 4.06e-01 | 1.45e-01 | 7.25e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 792 | 7.06e-12 | 1.45e-01 | 1.54e-09 |
| GOMF SYNTAXIN 1 BINDING | 11 | 4.06e-01 | -1.45e-01 | 7.25e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 43 | 1.01e-01 | -1.45e-01 | 4.00e-01 |
| GOMF PH DOMAIN BINDING | 8 | 4.79e-01 | 1.45e-01 | 7.74e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 13 | 3.67e-01 | 1.45e-01 | 6.94e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 9 | 4.52e-01 | -1.45e-01 | 7.58e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 7 | 5.08e-01 | -1.45e-01 | 7.91e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 16 | 3.17e-01 | -1.45e-01 | 6.58e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 26 | 2.02e-01 | 1.45e-01 | 5.49e-01 |
| GOMF PROTEIN KINASE B BINDING | 9 | 4.53e-01 | -1.44e-01 | 7.59e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 25 | 2.12e-01 | -1.44e-01 | 5.60e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 16 | 3.18e-01 | 1.44e-01 | 6.58e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 6 | 5.41e-01 | 1.44e-01 | 8.11e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 21 | 2.53e-01 | 1.44e-01 | 6.02e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 39 | 1.19e-01 | -1.44e-01 | 4.28e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 6 | 5.41e-01 | 1.44e-01 | 8.11e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 15 | 3.34e-01 | -1.44e-01 | 6.71e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 11 | 4.08e-01 | -1.44e-01 | 7.27e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 5.77e-01 | -1.44e-01 | 8.32e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 4.81e-01 | 1.44e-01 | 7.75e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 38 | 1.25e-01 | 1.44e-01 | 4.39e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 10 | 4.31e-01 | -1.44e-01 | 7.43e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 31 | 1.66e-01 | 1.44e-01 | 5.00e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 15 | 3.35e-01 | -1.44e-01 | 6.71e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 15 | 3.35e-01 | 1.44e-01 | 6.71e-01 |
| GOCC CCR4 NOT COMPLEX | 13 | 3.69e-01 | -1.44e-01 | 6.96e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 91 | 1.79e-02 | 1.44e-01 | 1.60e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 26 | 2.05e-01 | 1.44e-01 | 5.52e-01 |
| GOBP MICROTUBULE ANCHORING | 20 | 2.66e-01 | 1.44e-01 | 6.17e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 907 | 4.34e-13 | 1.44e-01 | 1.26e-10 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 10 | 4.32e-01 | 1.44e-01 | 7.44e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 10 | 4.32e-01 | 1.44e-01 | 7.44e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 16 | 3.20e-01 | -1.44e-01 | 6.60e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 9 | 4.56e-01 | 1.44e-01 | 7.61e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 43 | 1.04e-01 | 1.43e-01 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 4.11e-01 | -1.43e-01 | 7.29e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 3.53e-01 | -1.43e-01 | 6.85e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 12 | 3.90e-01 | -1.43e-01 | 7.12e-01 |
| GOCC ENVELOPE | 1039 | 1.46e-14 | 1.43e-01 | 6.03e-12 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 21 | 2.56e-01 | 1.43e-01 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 8 | 4.83e-01 | -1.43e-01 | 7.77e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 16 | 3.22e-01 | 1.43e-01 | 6.62e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 5.44e-01 | -1.43e-01 | 8.14e-01 |
| GOBP TRANSPOSITION | 19 | 2.81e-01 | 1.43e-01 | 6.29e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 20 | 2.69e-01 | -1.43e-01 | 6.19e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 74 | 3.38e-02 | 1.43e-01 | 2.31e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 11 | 4.12e-01 | 1.43e-01 | 7.30e-01 |
| GOBP RESPONSE TO FATTY ACID | 27 | 2.00e-01 | 1.43e-01 | 5.47e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 22 | 2.47e-01 | -1.43e-01 | 5.95e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 28 | 1.92e-01 | 1.43e-01 | 5.37e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 4.85e-01 | 1.43e-01 | 7.78e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 11 | 4.13e-01 | -1.43e-01 | 7.30e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 26 | 2.09e-01 | 1.43e-01 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 10 | 4.36e-01 | -1.42e-01 | 7.46e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 49 | 8.48e-02 | 1.42e-01 | 3.66e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 4.14e-01 | 1.42e-01 | 7.30e-01 |
| GOBP RESPONSE TO CAFFEINE | 12 | 3.93e-01 | 1.42e-01 | 7.15e-01 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 5 | 5.82e-01 | 1.42e-01 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 16 | 3.25e-01 | -1.42e-01 | 6.64e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 22 | 2.49e-01 | -1.42e-01 | 5.97e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 15 | 3.41e-01 | 1.42e-01 | 6.77e-01 |
| GOBP CELL CYCLE | 1382 | 3.75e-18 | 1.42e-01 | 3.10e-15 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 27 | 2.01e-01 | 1.42e-01 | 5.49e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 7 | 5.15e-01 | 1.42e-01 | 7.96e-01 |
| GOBP TOLL SIGNALING PATHWAY | 8 | 4.87e-01 | -1.42e-01 | 7.79e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 30 | 1.78e-01 | 1.42e-01 | 5.20e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 67 | 4.47e-02 | 1.42e-01 | 2.64e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 19 | 2.84e-01 | -1.42e-01 | 6.32e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.15e-01 | 1.42e-01 | 7.31e-01 |
| GOCC EUCHROMATIN | 40 | 1.21e-01 | 1.42e-01 | 4.31e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 27 | 2.02e-01 | 1.42e-01 | 5.49e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 16 | 3.26e-01 | -1.42e-01 | 6.64e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 7 | 5.16e-01 | 1.42e-01 | 7.97e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 7 | 5.16e-01 | 1.42e-01 | 7.97e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 75 | 3.40e-02 | 1.42e-01 | 2.31e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 37 | 1.36e-01 | -1.42e-01 | 4.53e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 5 | 5.83e-01 | 1.42e-01 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 5.83e-01 | -1.42e-01 | 8.36e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 25 | 2.21e-01 | 1.42e-01 | 5.71e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 132 | 5.05e-03 | 1.42e-01 | 7.28e-02 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 25 | 2.21e-01 | 1.42e-01 | 5.71e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 87 | 2.27e-02 | 1.41e-01 | 1.84e-01 |
| GOBP CAMP MEDIATED SIGNALING | 22 | 2.51e-01 | -1.41e-01 | 5.99e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 14 | 3.59e-01 | -1.41e-01 | 6.88e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 12 | 3.97e-01 | -1.41e-01 | 7.19e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 20 | 2.74e-01 | 1.41e-01 | 6.23e-01 |
| GOBP ENTRY INTO HOST | 101 | 1.42e-02 | 1.41e-01 | 1.40e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 26 | 2.12e-01 | 1.41e-01 | 5.61e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 415 | 9.03e-07 | 1.41e-01 | 5.76e-05 |
| GOBP THYMUS DEVELOPMENT | 34 | 1.54e-01 | 1.41e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 16 | 3.28e-01 | 1.41e-01 | 6.66e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 38 | 1.32e-01 | -1.41e-01 | 4.48e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 9 | 4.64e-01 | 1.41e-01 | 7.65e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 172 | 1.45e-03 | -1.41e-01 | 2.96e-02 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 43 | 1.10e-01 | 1.41e-01 | 4.12e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 161 | 2.07e-03 | 1.41e-01 | 3.85e-02 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 23 | 2.42e-01 | 1.41e-01 | 5.90e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 3.79e-01 | 1.41e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 10 | 4.40e-01 | -1.41e-01 | 7.49e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 16 | 3.30e-01 | 1.41e-01 | 6.67e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 5 | 5.86e-01 | -1.41e-01 | 8.38e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 24 | 2.33e-01 | -1.41e-01 | 5.82e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 42 | 1.15e-01 | -1.41e-01 | 4.21e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 8 | 4.91e-01 | -1.41e-01 | 7.82e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 5.86e-01 | 1.41e-01 | 8.38e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 28 | 1.98e-01 | -1.40e-01 | 5.45e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 54 | 7.43e-02 | 1.40e-01 | 3.42e-01 |
| GOBP FAT PAD DEVELOPMENT | 6 | 5.51e-01 | -1.40e-01 | 8.20e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 7 | 5.20e-01 | -1.40e-01 | 7.99e-01 |
| GOMF LYASE ACTIVITY | 131 | 5.66e-03 | 1.40e-01 | 7.87e-02 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 64 | 5.26e-02 | 1.40e-01 | 2.88e-01 |
| GOBP VIRAL LIFE CYCLE | 237 | 2.11e-04 | 1.40e-01 | 6.31e-03 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 9 | 4.67e-01 | 1.40e-01 | 7.66e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 5.87e-01 | 1.40e-01 | 8.39e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 10 | 4.43e-01 | -1.40e-01 | 7.51e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 713 | 2.75e-10 | -1.40e-01 | 3.93e-08 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 6 | 5.52e-01 | -1.40e-01 | 8.21e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 5.88e-01 | 1.40e-01 | 8.39e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 23 | 2.45e-01 | 1.40e-01 | 5.93e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 373 | 3.84e-06 | 1.40e-01 | 2.02e-04 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 10 | 4.44e-01 | 1.40e-01 | 7.52e-01 |
| GOBP AMINO ACID ACTIVATION | 25 | 2.27e-01 | 1.40e-01 | 5.76e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 4.22e-01 | -1.40e-01 | 7.36e-01 |
| GOBP GLYCOLYTIC PROCESS | 65 | 5.16e-02 | 1.40e-01 | 2.85e-01 |
| GOBP RESPONSE TO SELENIUM ION | 5 | 5.89e-01 | -1.40e-01 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 27 | 2.09e-01 | -1.40e-01 | 5.57e-01 |
| GOBP PROTEIN REFOLDING | 20 | 2.80e-01 | -1.40e-01 | 6.29e-01 |
| GOMF COMPLEMENT BINDING | 8 | 4.94e-01 | 1.40e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 9 | 4.69e-01 | 1.40e-01 | 7.67e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 88 | 2.38e-02 | 1.40e-01 | 1.90e-01 |
| GOCC SPINDLE | 357 | 6.61e-06 | 1.39e-01 | 3.18e-04 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 17 | 3.20e-01 | 1.39e-01 | 6.60e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 10 | 4.45e-01 | -1.39e-01 | 7.53e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 79 | 3.24e-02 | 1.39e-01 | 2.25e-01 |
| GOMF ACYL COA BINDING | 15 | 3.50e-01 | 1.39e-01 | 6.83e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 18 | 3.07e-01 | -1.39e-01 | 6.49e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 8 | 4.95e-01 | -1.39e-01 | 7.84e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 5.24e-01 | 1.39e-01 | 8.02e-01 |
| GOBP RESPONSE TO ESTROGEN | 37 | 1.43e-01 | 1.39e-01 | 4.67e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 29 | 1.95e-01 | -1.39e-01 | 5.41e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 89 | 2.37e-02 | -1.39e-01 | 1.89e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 65 | 5.30e-02 | -1.39e-01 | 2.89e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 15 | 3.52e-01 | 1.39e-01 | 6.84e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 11 | 4.26e-01 | 1.39e-01 | 7.38e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 13 | 3.87e-01 | 1.39e-01 | 7.09e-01 |
| GOMF MAGNESIUM ION BINDING | 169 | 1.91e-03 | 1.39e-01 | 3.68e-02 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 45 | 1.08e-01 | 1.39e-01 | 4.08e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 35 | 1.56e-01 | 1.39e-01 | 4.91e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 31 | 1.82e-01 | -1.39e-01 | 5.25e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 4.98e-01 | -1.38e-01 | 7.86e-01 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 5.92e-01 | -1.38e-01 | 8.41e-01 |
| GOBP MICROVILLUS ORGANIZATION | 19 | 2.97e-01 | 1.38e-01 | 6.42e-01 |
| GOCC 90S PRERIBOSOME | 25 | 2.32e-01 | 1.38e-01 | 5.80e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 13 | 3.89e-01 | 1.38e-01 | 7.11e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 12 | 4.08e-01 | 1.38e-01 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 5 | 5.93e-01 | 1.38e-01 | 8.42e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 15 | 3.55e-01 | 1.38e-01 | 6.87e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 24 | 2.43e-01 | -1.38e-01 | 5.91e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 34 | 1.65e-01 | -1.38e-01 | 4.99e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 15 | 3.56e-01 | 1.38e-01 | 6.87e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 19 | 2.99e-01 | 1.38e-01 | 6.44e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 5.59e-01 | -1.38e-01 | 8.25e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 57 | 7.27e-02 | 1.38e-01 | 3.39e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 39 | 1.37e-01 | 1.38e-01 | 4.56e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 26 | 2.25e-01 | 1.38e-01 | 5.74e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 5.60e-01 | 1.37e-01 | 8.25e-01 |
| GOBP DNA METHYLATION | 39 | 1.38e-01 | 1.37e-01 | 4.56e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 5.01e-01 | 1.37e-01 | 7.88e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 15 | 3.57e-01 | 1.37e-01 | 6.87e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 45 | 1.11e-01 | 1.37e-01 | 4.15e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 6 | 5.60e-01 | 1.37e-01 | 8.25e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 39 | 1.38e-01 | -1.37e-01 | 4.58e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 4.52e-01 | 1.37e-01 | 7.58e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 27 | 2.18e-01 | 1.37e-01 | 5.67e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 28 | 2.09e-01 | 1.37e-01 | 5.57e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 25 | 2.36e-01 | -1.37e-01 | 5.85e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 62 | 6.24e-02 | 1.37e-01 | 3.17e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 11 | 4.32e-01 | -1.37e-01 | 7.44e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 4.32e-01 | 1.37e-01 | 7.44e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 17 | 3.29e-01 | 1.37e-01 | 6.67e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 130 | 7.17e-03 | 1.37e-01 | 9.19e-02 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 36 | 1.56e-01 | -1.37e-01 | 4.90e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 16 | 3.44e-01 | 1.37e-01 | 6.79e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 5.04e-01 | -1.37e-01 | 7.90e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 21 | 2.79e-01 | 1.37e-01 | 6.28e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 1.75e-01 | 1.37e-01 | 5.15e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 24 | 2.47e-01 | 1.37e-01 | 5.95e-01 |
| GOCC STEREOCILIUM BUNDLE | 30 | 1.96e-01 | -1.36e-01 | 5.42e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 12 | 4.13e-01 | 1.36e-01 | 7.30e-01 |
| GOCC LATE ENDOSOME | 244 | 2.55e-04 | 1.36e-01 | 7.33e-03 |
| GOBP REGULATION OF P38MAPK CASCADE | 30 | 1.97e-01 | -1.36e-01 | 5.43e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 9 | 4.79e-01 | 1.36e-01 | 7.74e-01 |
| GOMF ACTIN FILAMENT BINDING | 130 | 7.41e-03 | 1.36e-01 | 9.40e-02 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 391 | 4.34e-06 | 1.36e-01 | 2.21e-04 |
| GOMF NOTCH BINDING | 14 | 3.78e-01 | 1.36e-01 | 7.05e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 20 | 2.92e-01 | 1.36e-01 | 6.40e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 5.05e-01 | -1.36e-01 | 7.91e-01 |
| GOCC CIA COMPLEX | 5 | 5.98e-01 | 1.36e-01 | 8.44e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 4.35e-01 | 1.36e-01 | 7.46e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 19 | 3.05e-01 | 1.36e-01 | 6.48e-01 |
| GOBP MACROMOLECULE DEACYLATION | 61 | 6.65e-02 | 1.36e-01 | 3.27e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 4.15e-01 | -1.36e-01 | 7.31e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 42 | 1.28e-01 | -1.36e-01 | 4.44e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 18 | 3.19e-01 | -1.36e-01 | 6.59e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 3.06e-01 | 1.36e-01 | 6.49e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 23 | 2.60e-01 | 1.36e-01 | 6.10e-01 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 5.65e-01 | 1.36e-01 | 8.28e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 6 | 5.66e-01 | -1.35e-01 | 8.28e-01 |
| GOCC NUCLEAR PORE | 88 | 2.83e-02 | 1.35e-01 | 2.09e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 9 | 4.82e-01 | -1.35e-01 | 7.76e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 18 | 3.20e-01 | 1.35e-01 | 6.60e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 14 | 3.81e-01 | 1.35e-01 | 7.07e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 185 | 1.55e-03 | 1.35e-01 | 3.11e-02 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 11 | 4.38e-01 | 1.35e-01 | 7.47e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 20 | 2.95e-01 | 1.35e-01 | 6.40e-01 |
| GOMF SYMPORTER ACTIVITY | 61 | 6.82e-02 | 1.35e-01 | 3.29e-01 |
| GOMF SUMO BINDING | 16 | 3.50e-01 | 1.35e-01 | 6.83e-01 |
| GOMF TAT PROTEIN BINDING | 10 | 4.60e-01 | 1.35e-01 | 7.63e-01 |
| GOBP MANNOSYLATION | 19 | 3.08e-01 | 1.35e-01 | 6.51e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 19 | 3.08e-01 | 1.35e-01 | 6.51e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 5 | 6.01e-01 | -1.35e-01 | 8.46e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 22 | 2.73e-01 | -1.35e-01 | 6.22e-01 |
| GOBP RESPONSE TO DSRNA | 33 | 1.80e-01 | -1.35e-01 | 5.22e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 3.51e-01 | 1.35e-01 | 6.83e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 4.84e-01 | -1.35e-01 | 7.77e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 6 | 5.68e-01 | -1.35e-01 | 8.29e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 16 | 3.51e-01 | 1.35e-01 | 6.84e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 41 | 1.36e-01 | 1.35e-01 | 4.53e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 6 | 5.68e-01 | -1.35e-01 | 8.29e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 126 | 9.22e-03 | 1.35e-01 | 1.09e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 24 | 2.54e-01 | -1.34e-01 | 6.03e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 115 | 1.29e-02 | 1.34e-01 | 1.32e-01 |
| GOCC CORTICAL CYTOSKELETON | 62 | 6.73e-02 | 1.34e-01 | 3.27e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 51 | 9.70e-02 | 1.34e-01 | 3.91e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 3.24e-01 | 1.34e-01 | 6.63e-01 |
| GOMF HYALURONIC ACID BINDING | 11 | 4.41e-01 | -1.34e-01 | 7.49e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 13 | 4.02e-01 | 1.34e-01 | 7.22e-01 |
| GOBP REGULATION OF BINDING | 186 | 1.63e-03 | 1.34e-01 | 3.23e-02 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 11 | 4.41e-01 | 1.34e-01 | 7.50e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 13 | 4.02e-01 | 1.34e-01 | 7.22e-01 |
| GOBP DIGESTION | 41 | 1.38e-01 | -1.34e-01 | 4.56e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 41 | 1.38e-01 | -1.34e-01 | 4.56e-01 |
| GOBP IMP METABOLIC PROCESS | 13 | 4.03e-01 | 1.34e-01 | 7.22e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 23 | 2.66e-01 | -1.34e-01 | 6.17e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 20 | 3.00e-01 | -1.34e-01 | 6.44e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 12 | 4.22e-01 | -1.34e-01 | 7.35e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 295 | 8.10e-05 | 1.34e-01 | 2.85e-03 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 3.26e-01 | -1.34e-01 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 19 | 3.13e-01 | 1.34e-01 | 6.55e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 55 | 8.63e-02 | -1.34e-01 | 3.70e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 14 | 3.86e-01 | 1.34e-01 | 7.09e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 50 | 1.02e-01 | 1.34e-01 | 4.01e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 39 | 1.49e-01 | 1.34e-01 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 33 | 1.84e-01 | 1.34e-01 | 5.27e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 12 | 4.23e-01 | 1.34e-01 | 7.36e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 7 | 5.40e-01 | -1.34e-01 | 8.11e-01 |
| GOMF NF KAPPAB BINDING | 29 | 2.13e-01 | 1.34e-01 | 5.62e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 14 | 3.87e-01 | 1.34e-01 | 7.09e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 6 | 5.71e-01 | 1.34e-01 | 8.29e-01 |
| GOBP RESPONSE TO PH | 16 | 3.56e-01 | 1.33e-01 | 6.87e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 11 | 4.44e-01 | -1.33e-01 | 7.52e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 3.88e-01 | 1.33e-01 | 7.10e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 50 | 1.03e-01 | 1.33e-01 | 4.02e-01 |
| GOMF LEUCINE BINDING | 6 | 5.72e-01 | -1.33e-01 | 8.29e-01 |
| GOBP VISUAL BEHAVIOR | 27 | 2.31e-01 | -1.33e-01 | 5.80e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 7 | 5.42e-01 | -1.33e-01 | 8.12e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 19 | 3.15e-01 | 1.33e-01 | 6.57e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 73 | 4.94e-02 | 1.33e-01 | 2.80e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 29 | 2.15e-01 | 1.33e-01 | 5.64e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 25 | 2.49e-01 | -1.33e-01 | 5.98e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 55 | 8.81e-02 | 1.33e-01 | 3.72e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 69 | 5.63e-02 | 1.33e-01 | 2.97e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1173 | 4.32e-14 | 1.33e-01 | 1.70e-11 |
| GOBP VESICLE DOCKING | 46 | 1.19e-01 | 1.33e-01 | 4.27e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 270 | 1.79e-04 | 1.33e-01 | 5.57e-03 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 30 | 2.08e-01 | -1.33e-01 | 5.57e-01 |
| GOBP TRNA METABOLIC PROCESS | 170 | 2.88e-03 | 1.33e-01 | 4.89e-02 |
| GOMF TOLL LIKE RECEPTOR BINDING | 11 | 4.46e-01 | -1.33e-01 | 7.53e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1085 | 3.51e-13 | 1.33e-01 | 1.08e-10 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 11 | 4.46e-01 | 1.33e-01 | 7.53e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 20 | 3.04e-01 | 1.33e-01 | 6.47e-01 |
| GOBP HEAD MORPHOGENESIS | 20 | 3.04e-01 | -1.33e-01 | 6.47e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 31 | 2.01e-01 | 1.33e-01 | 5.49e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 6 | 5.74e-01 | -1.33e-01 | 8.30e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 16 | 3.58e-01 | 1.33e-01 | 6.88e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 2.93e-01 | 1.33e-01 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 74 | 4.88e-02 | 1.33e-01 | 2.78e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 22 | 2.82e-01 | -1.33e-01 | 6.30e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 5 | 6.08e-01 | 1.32e-01 | 8.50e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 162 | 3.72e-03 | 1.32e-01 | 5.89e-02 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 9 | 4.92e-01 | -1.32e-01 | 7.82e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 2.94e-01 | 1.32e-01 | 6.40e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 41 | 1.43e-01 | 1.32e-01 | 4.66e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 48 | 1.13e-01 | 1.32e-01 | 4.16e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 10 | 4.69e-01 | 1.32e-01 | 7.67e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 142 | 6.61e-03 | 1.32e-01 | 8.68e-02 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 116 | 1.41e-02 | -1.32e-01 | 1.40e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 59 | 7.95e-02 | 1.32e-01 | 3.53e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 38 | 1.59e-01 | 1.32e-01 | 4.93e-01 |
| GOMF FERRIC IRON BINDING | 5 | 6.09e-01 | 1.32e-01 | 8.50e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 17 | 3.46e-01 | -1.32e-01 | 6.80e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 478 | 9.08e-07 | 1.32e-01 | 5.76e-05 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 37 | 1.65e-01 | 1.32e-01 | 5.00e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 151 | 5.23e-03 | 1.32e-01 | 7.47e-02 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 484 | 8.04e-07 | 1.32e-01 | 5.32e-05 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 5.46e-01 | 1.32e-01 | 8.16e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 11 | 4.49e-01 | 1.32e-01 | 7.55e-01 |
| GOBP CALCIUM ION TRANSPORT | 218 | 8.32e-04 | 1.32e-01 | 1.89e-02 |
| GOBP REGENERATION | 99 | 2.37e-02 | 1.32e-01 | 1.89e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 40 | 1.50e-01 | 1.32e-01 | 4.80e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 9 | 4.94e-01 | -1.32e-01 | 7.84e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 42 | 1.40e-01 | 1.32e-01 | 4.61e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 26 | 2.46e-01 | 1.32e-01 | 5.94e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 48 | 1.15e-01 | 1.31e-01 | 4.21e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 4.95e-01 | -1.31e-01 | 7.84e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 450 | 2.04e-06 | 1.31e-01 | 1.14e-04 |
| GOBP NUCLEUS LOCALIZATION | 26 | 2.46e-01 | 1.31e-01 | 5.94e-01 |
| GOBP PODOCYTE CELL MIGRATION | 5 | 6.11e-01 | -1.31e-01 | 8.50e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 9 | 4.95e-01 | -1.31e-01 | 7.84e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 21 | 2.98e-01 | 1.31e-01 | 6.43e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 164 | 3.81e-03 | 1.31e-01 | 5.96e-02 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 6.12e-01 | 1.31e-01 | 8.51e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 296 | 1.11e-04 | 1.31e-01 | 3.66e-03 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 10 | 4.73e-01 | 1.31e-01 | 7.70e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 78 | 4.56e-02 | 1.31e-01 | 2.68e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 50 | 1.09e-01 | 1.31e-01 | 4.11e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 8 | 5.21e-01 | 1.31e-01 | 8.00e-01 |
| GOCC SWI SNF COMPLEX | 28 | 2.30e-01 | 1.31e-01 | 5.80e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 111 | 1.73e-02 | 1.31e-01 | 1.58e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 22 | 2.88e-01 | 1.31e-01 | 6.36e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 6.12e-01 | 1.31e-01 | 8.51e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 8 | 5.21e-01 | -1.31e-01 | 8.00e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 5.79e-01 | -1.31e-01 | 8.33e-01 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 5.79e-01 | 1.31e-01 | 8.33e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 6 | 5.79e-01 | -1.31e-01 | 8.33e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 14 | 3.97e-01 | 1.31e-01 | 7.19e-01 |
| GOBP NADP METABOLIC PROCESS | 32 | 2.00e-01 | 1.31e-01 | 5.49e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 3.97e-01 | 1.31e-01 | 7.19e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 11 | 4.53e-01 | -1.31e-01 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 298 | 1.10e-04 | 1.31e-01 | 3.64e-03 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 26 | 2.49e-01 | 1.31e-01 | 5.97e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 19 | 3.24e-01 | 1.31e-01 | 6.63e-01 |
| GOBP CERAMIDE TRANSPORT | 10 | 4.74e-01 | -1.31e-01 | 7.71e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 27 | 2.40e-01 | -1.31e-01 | 5.88e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 5.79e-01 | 1.31e-01 | 8.33e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 97 | 2.64e-02 | 1.31e-01 | 2.01e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 15 | 3.81e-01 | -1.31e-01 | 7.07e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 11 | 4.53e-01 | 1.31e-01 | 7.59e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 490 | 8.82e-07 | 1.31e-01 | 5.70e-05 |
| GOCC GABA ERGIC SYNAPSE | 25 | 2.59e-01 | -1.30e-01 | 6.09e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 4.34e-01 | 1.30e-01 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 6 | 5.80e-01 | 1.30e-01 | 8.34e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 14 | 3.98e-01 | 1.30e-01 | 7.20e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 5.80e-01 | -1.30e-01 | 8.34e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 13 | 4.16e-01 | 1.30e-01 | 7.32e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 3.38e-02 | 1.30e-01 | 2.31e-01 |
| GOMF 5S RRNA BINDING | 9 | 4.99e-01 | -1.30e-01 | 7.87e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 20 | 3.14e-01 | -1.30e-01 | 6.55e-01 |
| GOCC EARLY ENDOSOME | 302 | 1.06e-04 | 1.30e-01 | 3.56e-03 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 8 | 5.24e-01 | 1.30e-01 | 8.02e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 8 | 5.24e-01 | 1.30e-01 | 8.02e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 5.81e-01 | -1.30e-01 | 8.35e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 25 | 2.61e-01 | 1.30e-01 | 6.11e-01 |
| GOBP T CELL EXTRAVASATION | 11 | 4.55e-01 | -1.30e-01 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 22 | 2.92e-01 | 1.30e-01 | 6.39e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 81 | 4.35e-02 | 1.30e-01 | 2.60e-01 |
| GOCC SPERM PLASMA MEMBRANE | 5 | 6.15e-01 | -1.30e-01 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 8 | 5.25e-01 | 1.30e-01 | 8.02e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 18 | 3.40e-01 | 1.30e-01 | 6.76e-01 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 5 | 6.15e-01 | -1.30e-01 | 8.52e-01 |
| GOBP RESPONSE TO BMP | 72 | 5.71e-02 | -1.30e-01 | 2.99e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 6.16e-01 | 1.30e-01 | 8.52e-01 |
| GOBP EXOCYTIC PROCESS | 54 | 9.98e-02 | 1.30e-01 | 3.98e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 17 | 3.55e-01 | -1.30e-01 | 6.87e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 21 | 3.04e-01 | 1.30e-01 | 6.47e-01 |
| GOCC XY BODY | 12 | 4.37e-01 | 1.29e-01 | 7.47e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 34 | 1.92e-01 | 1.29e-01 | 5.37e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 12 | 4.38e-01 | 1.29e-01 | 7.48e-01 |
| GOMF CHOLESTEROL BINDING | 36 | 1.80e-01 | 1.29e-01 | 5.22e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 18 | 3.43e-01 | 1.29e-01 | 6.78e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 10 | 4.79e-01 | 1.29e-01 | 7.74e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 23 | 2.84e-01 | 1.29e-01 | 6.32e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 8 | 5.27e-01 | -1.29e-01 | 8.03e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 9 | 5.03e-01 | -1.29e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 729 | 4.23e-09 | 1.29e-01 | 4.60e-07 |
| GOCC AMPHISOME | 12 | 4.39e-01 | -1.29e-01 | 7.48e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 18 | 3.44e-01 | 1.29e-01 | 6.79e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 10 | 4.80e-01 | -1.29e-01 | 7.75e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 94 | 3.11e-02 | 1.29e-01 | 2.20e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 37 | 1.75e-01 | -1.29e-01 | 5.16e-01 |
| GOBP RESPONSE TO ESTRADIOL | 57 | 9.28e-02 | 1.29e-01 | 3.83e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 68 | 6.69e-02 | 1.29e-01 | 3.27e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 34 | 1.95e-01 | 1.29e-01 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 17 | 3.59e-01 | 1.28e-01 | 6.88e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 28 | 2.40e-01 | -1.28e-01 | 5.88e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 17 | 3.59e-01 | -1.28e-01 | 6.88e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 254 | 4.44e-04 | 1.28e-01 | 1.16e-02 |
| GOCC COMPACT MYELIN | 8 | 5.30e-01 | -1.28e-01 | 8.04e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 6.19e-01 | -1.28e-01 | 8.55e-01 |
| GOCC AZUROPHIL GRANULE | 122 | 1.45e-02 | 1.28e-01 | 1.41e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 40 | 1.61e-01 | 1.28e-01 | 4.95e-01 |
| GOBP ALANINE TRANSPORT | 11 | 4.61e-01 | 1.28e-01 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 28 | 2.41e-01 | 1.28e-01 | 5.89e-01 |
| GOBP RETINA LAYER FORMATION | 11 | 4.62e-01 | -1.28e-01 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 7 | 5.57e-01 | 1.28e-01 | 8.22e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 12 | 4.42e-01 | 1.28e-01 | 7.51e-01 |
| GOMF HELICASE ACTIVITY | 141 | 8.78e-03 | 1.28e-01 | 1.06e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 8 | 5.31e-01 | 1.28e-01 | 8.05e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 71 | 6.25e-02 | 1.28e-01 | 3.17e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 11 | 4.63e-01 | 1.28e-01 | 7.64e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 140 | 9.10e-03 | 1.28e-01 | 1.08e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 90 | 3.62e-02 | 1.28e-01 | 2.38e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 58 | 9.23e-02 | -1.28e-01 | 3.82e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 30 | 2.26e-01 | 1.28e-01 | 5.75e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 20 | 3.22e-01 | 1.28e-01 | 6.62e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 5.07e-01 | 1.28e-01 | 7.91e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 68 | 6.86e-02 | 1.28e-01 | 3.30e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 13 | 4.25e-01 | -1.28e-01 | 7.37e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 8 | 5.31e-01 | 1.28e-01 | 8.05e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 11 | 4.63e-01 | 1.28e-01 | 7.64e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 82 | 4.59e-02 | 1.28e-01 | 2.68e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 9 | 5.07e-01 | -1.28e-01 | 7.91e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 59 | 9.01e-02 | 1.28e-01 | 3.76e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 12 | 4.44e-01 | 1.28e-01 | 7.52e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 8 | 5.32e-01 | -1.28e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 24 | 2.80e-01 | -1.27e-01 | 6.29e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 318 | 9.99e-05 | 1.27e-01 | 3.41e-03 |
| GOMF CASPASE BINDING | 7 | 5.60e-01 | -1.27e-01 | 8.25e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 471 | 2.54e-06 | 1.27e-01 | 1.39e-04 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 11 | 4.65e-01 | -1.27e-01 | 7.65e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 5.89e-01 | 1.27e-01 | 8.39e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 8 | 5.33e-01 | 1.27e-01 | 8.06e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 5 | 6.22e-01 | -1.27e-01 | 8.56e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 81 | 4.80e-02 | 1.27e-01 | 2.77e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 15 | 3.94e-01 | -1.27e-01 | 7.15e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 59 | 9.14e-02 | 1.27e-01 | 3.80e-01 |
| GOMF INSULIN RECEPTOR BINDING | 14 | 4.10e-01 | -1.27e-01 | 7.29e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 35 | 1.93e-01 | 1.27e-01 | 5.39e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 11 | 4.66e-01 | -1.27e-01 | 7.65e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 49 | 1.24e-01 | 1.27e-01 | 4.38e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 6 | 5.90e-01 | 1.27e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 17 | 3.65e-01 | -1.27e-01 | 6.93e-01 |
| GOBP RESPONSE TO REDOX STATE | 11 | 4.66e-01 | 1.27e-01 | 7.65e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 22 | 3.03e-01 | 1.27e-01 | 6.47e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 10 | 4.87e-01 | 1.27e-01 | 7.79e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 87 | 4.10e-02 | 1.27e-01 | 2.51e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 58 | 9.49e-02 | 1.27e-01 | 3.87e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 511 | 1.08e-06 | 1.27e-01 | 6.62e-05 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 6 | 5.90e-01 | 1.27e-01 | 8.39e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 211 | 1.54e-03 | 1.27e-01 | 3.09e-02 |
| GOCC MALE PRONUCLEUS | 7 | 5.61e-01 | 1.27e-01 | 8.25e-01 |
| GOBP AMP SALVAGE | 5 | 6.23e-01 | 1.27e-01 | 8.57e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 30 | 2.29e-01 | -1.27e-01 | 5.79e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 22 | 3.04e-01 | -1.27e-01 | 6.47e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 23 | 2.94e-01 | 1.27e-01 | 6.40e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 39 | 1.72e-01 | 1.26e-01 | 5.11e-01 |
| GOBP URETER DEVELOPMENT | 5 | 6.24e-01 | 1.26e-01 | 8.58e-01 |
| GOCC CORNIFIED ENVELOPE | 11 | 4.68e-01 | 1.26e-01 | 7.67e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 7 | 5.63e-01 | -1.26e-01 | 8.25e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 18 | 3.54e-01 | -1.26e-01 | 6.86e-01 |
| GOMF 7S RNA BINDING | 7 | 5.63e-01 | 1.26e-01 | 8.25e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 4.90e-01 | 1.26e-01 | 7.81e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 4.69e-01 | 1.26e-01 | 7.67e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 35 | 1.97e-01 | 1.26e-01 | 5.43e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 9 | 5.12e-01 | 1.26e-01 | 7.94e-01 |
| GOBP FATTY ACID ELONGATION | 10 | 4.90e-01 | 1.26e-01 | 7.81e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 15 | 3.98e-01 | -1.26e-01 | 7.19e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 53 | 1.13e-01 | 1.26e-01 | 4.16e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 17 | 3.68e-01 | 1.26e-01 | 6.96e-01 |
| GOBP MEMBRANE FUSION | 115 | 1.97e-02 | 1.26e-01 | 1.69e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 37 | 1.85e-01 | 1.26e-01 | 5.28e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 184 | 3.28e-03 | 1.26e-01 | 5.36e-02 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 11 | 4.69e-01 | 1.26e-01 | 7.68e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 6 | 5.93e-01 | 1.26e-01 | 8.42e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 15 | 3.99e-01 | 1.26e-01 | 7.20e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 47 | 1.36e-01 | 1.26e-01 | 4.53e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 6.26e-01 | -1.26e-01 | 8.59e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 5 | 6.26e-01 | -1.26e-01 | 8.59e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 5.94e-01 | 1.26e-01 | 8.42e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 236 | 9.13e-04 | 1.26e-01 | 2.03e-02 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 6 | 5.94e-01 | 1.26e-01 | 8.42e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 89 | 4.09e-02 | 1.26e-01 | 2.51e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 50 | 1.25e-01 | 1.25e-01 | 4.39e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 24 | 2.88e-01 | 1.25e-01 | 6.36e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 172 | 4.64e-03 | 1.25e-01 | 6.86e-02 |
| GOBP AXON GUIDANCE | 94 | 3.59e-02 | -1.25e-01 | 2.38e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 14 | 4.18e-01 | 1.25e-01 | 7.33e-01 |
| GOBP MACROAUTOPHAGY | 298 | 2.16e-04 | 1.25e-01 | 6.40e-03 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 11 | 4.73e-01 | 1.25e-01 | 7.70e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 9 | 5.16e-01 | 1.25e-01 | 7.97e-01 |
| GOBP MUSCLE ATROPHY | 5 | 6.28e-01 | -1.25e-01 | 8.60e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 526 | 1.12e-06 | 1.25e-01 | 6.77e-05 |
| GOBP MONOCYTE EXTRAVASATION | 9 | 5.17e-01 | 1.25e-01 | 7.97e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 28 | 2.53e-01 | 1.25e-01 | 6.02e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 37 | 1.89e-01 | 1.25e-01 | 5.34e-01 |
| GOBP RESPONSE TO DOPAMINE | 30 | 2.37e-01 | -1.25e-01 | 5.87e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 9 | 5.17e-01 | 1.25e-01 | 7.97e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 78 | 5.71e-02 | 1.25e-01 | 2.99e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 23 | 3.01e-01 | -1.25e-01 | 6.45e-01 |
| GOCC DENDRITIC GROWTH CONE | 7 | 5.68e-01 | -1.25e-01 | 8.29e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 12 | 4.55e-01 | 1.25e-01 | 7.60e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 19 | 3.47e-01 | -1.25e-01 | 6.81e-01 |
| GOCC CHROMOSOME | 1288 | 1.64e-13 | 1.25e-01 | 5.90e-11 |
| GOBP SYNAPTIC VESICLE MATURATION | 19 | 3.48e-01 | 1.25e-01 | 6.81e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 17 | 3.74e-01 | 1.24e-01 | 7.01e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 12 | 4.55e-01 | 1.24e-01 | 7.60e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 5 | 6.30e-01 | 1.24e-01 | 8.61e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 69 | 7.42e-02 | 1.24e-01 | 3.42e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 5.18e-01 | -1.24e-01 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 18 | 3.61e-01 | 1.24e-01 | 6.89e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 7 | 5.69e-01 | 1.24e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 26 | 2.73e-01 | 1.24e-01 | 6.22e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 9 | 5.19e-01 | -1.24e-01 | 7.98e-01 |
| GOMF VITAMIN BINDING | 77 | 5.97e-02 | 1.24e-01 | 3.09e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 38 | 1.85e-01 | -1.24e-01 | 5.29e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 138 | 1.19e-02 | 1.24e-01 | 1.27e-01 |
| GOCC CILIARY TRANSITION ZONE | 50 | 1.29e-01 | -1.24e-01 | 4.46e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 26 | 2.74e-01 | -1.24e-01 | 6.23e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 32 | 2.25e-01 | 1.24e-01 | 5.74e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 772 | 6.59e-09 | 1.24e-01 | 6.64e-07 |
| GOCC VESICLE LUMEN | 222 | 1.50e-03 | 1.24e-01 | 3.05e-02 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 9 | 5.20e-01 | 1.24e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 70 | 7.32e-02 | -1.24e-01 | 3.40e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 5.99e-01 | 1.24e-01 | 8.45e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 46 | 1.46e-01 | 1.24e-01 | 4.74e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 120 | 1.93e-02 | 1.24e-01 | 1.68e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 22 | 3.15e-01 | 1.24e-01 | 6.57e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 25 | 2.84e-01 | -1.24e-01 | 6.32e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 7 | 5.71e-01 | -1.24e-01 | 8.29e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 11 | 4.77e-01 | 1.24e-01 | 7.73e-01 |
| GOMF CORECEPTOR ACTIVITY | 27 | 2.66e-01 | -1.24e-01 | 6.17e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 5.45e-01 | -1.24e-01 | 8.15e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 96 | 3.68e-02 | 1.23e-01 | 2.40e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 6.33e-01 | 1.23e-01 | 8.62e-01 |
| GOBP PHAGOSOME MATURATION | 23 | 3.06e-01 | 1.23e-01 | 6.49e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 30 | 2.43e-01 | -1.23e-01 | 5.91e-01 |
| GOMF DEACETYLASE ACTIVITY | 32 | 2.28e-01 | 1.23e-01 | 5.77e-01 |
| GOBP RESPONSE TO ETHER | 10 | 5.00e-01 | -1.23e-01 | 7.87e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 48 | 1.40e-01 | 1.23e-01 | 4.61e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 4.42e-01 | 1.23e-01 | 7.51e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 21 | 3.29e-01 | 1.23e-01 | 6.67e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 8 | 5.47e-01 | -1.23e-01 | 8.16e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 8 | 5.47e-01 | -1.23e-01 | 8.16e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 21 | 3.29e-01 | 1.23e-01 | 6.67e-01 |
| GOBP RRNA METHYLATION | 21 | 3.29e-01 | 1.23e-01 | 6.67e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 33 | 2.22e-01 | 1.23e-01 | 5.72e-01 |
| GOBP PROTEIN MATURATION | 377 | 4.52e-05 | 1.23e-01 | 1.69e-03 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 5 | 6.34e-01 | -1.23e-01 | 8.62e-01 |
| GOCC VACUOLAR MEMBRANE | 397 | 2.95e-05 | 1.23e-01 | 1.17e-03 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 6.02e-01 | 1.23e-01 | 8.46e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 22 | 3.19e-01 | 1.23e-01 | 6.60e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 85 | 5.08e-02 | 1.23e-01 | 2.83e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 7 | 5.74e-01 | 1.23e-01 | 8.30e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 34 | 2.16e-01 | 1.23e-01 | 5.65e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 60 | 1.01e-01 | 1.23e-01 | 4.00e-01 |
| GOBP RESPONSE TO STEROL | 24 | 2.99e-01 | 1.23e-01 | 6.44e-01 |
| GOCC COATED VESICLE MEMBRANE | 150 | 9.74e-03 | 1.23e-01 | 1.12e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 28 | 2.62e-01 | -1.22e-01 | 6.13e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 6 | 6.04e-01 | 1.22e-01 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 330 | 1.43e-04 | 1.22e-01 | 4.60e-03 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 4.63e-01 | 1.22e-01 | 7.64e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 40 | 1.81e-01 | 1.22e-01 | 5.24e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 15 | 4.13e-01 | 1.22e-01 | 7.30e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 45 | 1.56e-01 | 1.22e-01 | 4.91e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 47 | 1.48e-01 | 1.22e-01 | 4.76e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 5.04e-01 | 1.22e-01 | 7.90e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 29 | 2.55e-01 | 1.22e-01 | 6.05e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 13 | 4.46e-01 | -1.22e-01 | 7.53e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 21 | 3.33e-01 | -1.22e-01 | 6.70e-01 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 6.37e-01 | 1.22e-01 | 8.63e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 12 | 4.65e-01 | -1.22e-01 | 7.65e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 4.65e-01 | 1.22e-01 | 7.65e-01 |
| GOCC VACUOLE | 640 | 1.88e-07 | 1.22e-01 | 1.51e-05 |
| GOMF DOUBLE STRANDED RNA BINDING | 66 | 8.75e-02 | 1.22e-01 | 3.71e-01 |
| GOBP KETONE CATABOLIC PROCESS | 9 | 5.27e-01 | 1.22e-01 | 8.03e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 678 | 8.60e-08 | 1.22e-01 | 7.33e-06 |
| GOMF VINCULIN BINDING | 10 | 5.05e-01 | 1.22e-01 | 7.91e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 32 | 2.34e-01 | -1.22e-01 | 5.83e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 10 | 5.05e-01 | -1.22e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 6 | 6.06e-01 | -1.22e-01 | 8.49e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 5 | 6.38e-01 | 1.22e-01 | 8.63e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 77 | 6.54e-02 | -1.22e-01 | 3.25e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 85 | 5.30e-02 | 1.22e-01 | 2.89e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 190 | 3.95e-03 | 1.22e-01 | 6.09e-02 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 7 | 5.78e-01 | -1.22e-01 | 8.32e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 145 | 1.18e-02 | 1.21e-01 | 1.25e-01 |
| GOMF PHOSPHATIDYLSERINE FLIPPASE ACTIVITY | 5 | 6.38e-01 | 1.21e-01 | 8.63e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 15 | 4.16e-01 | 1.21e-01 | 7.32e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 33 | 2.28e-01 | 1.21e-01 | 5.78e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 8 | 5.53e-01 | 1.21e-01 | 8.21e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 705 | 5.65e-08 | 1.21e-01 | 5.03e-06 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 34 | 2.22e-01 | 1.21e-01 | 5.72e-01 |
| GOBP VIRAL PROCESS | 336 | 1.46e-04 | 1.21e-01 | 4.66e-03 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 8 | 5.53e-01 | 1.21e-01 | 8.21e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 9 | 5.30e-01 | 1.21e-01 | 8.05e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 8 | 5.54e-01 | -1.21e-01 | 8.21e-01 |
| GOBP TRNA PROCESSING | 126 | 1.93e-02 | 1.21e-01 | 1.68e-01 |
| GOMF CYCLOSPORIN A BINDING | 16 | 4.03e-01 | 1.21e-01 | 7.22e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 19 | 3.62e-01 | -1.21e-01 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 61 | 1.03e-01 | 1.21e-01 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 27 | 2.78e-01 | 1.21e-01 | 6.27e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 11 | 4.89e-01 | 1.21e-01 | 7.80e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 65 | 9.34e-02 | 1.20e-01 | 3.83e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 28 | 2.70e-01 | -1.20e-01 | 6.20e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 145 | 1.25e-02 | 1.20e-01 | 1.30e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 127 | 1.94e-02 | 1.20e-01 | 1.68e-01 |
| GOMF CHROMATIN BINDING | 442 | 1.63e-05 | 1.20e-01 | 7.01e-04 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 6.10e-01 | -1.20e-01 | 8.50e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 381 | 6.16e-05 | 1.20e-01 | 2.24e-03 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 8 | 5.56e-01 | 1.20e-01 | 8.22e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 328 | 1.97e-04 | 1.20e-01 | 5.97e-03 |
| GOCC CALCIUM CHANNEL COMPLEX | 40 | 1.89e-01 | 1.20e-01 | 5.34e-01 |
| GOCC ADHERENS JUNCTION | 111 | 2.91e-02 | 1.20e-01 | 2.13e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 6 | 6.11e-01 | 1.20e-01 | 8.50e-01 |
| GOBP CELLULAR RESPONSE TO UV | 71 | 8.06e-02 | 1.20e-01 | 3.57e-01 |
| GOBP ADP METABOLIC PROCESS | 7 | 5.83e-01 | 1.20e-01 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 10 | 5.11e-01 | 1.20e-01 | 7.94e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 102 | 3.68e-02 | 1.20e-01 | 2.40e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 600 | 6.61e-07 | 1.20e-01 | 4.56e-05 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 128 | 1.94e-02 | 1.20e-01 | 1.68e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 6 | 6.11e-01 | 1.20e-01 | 8.51e-01 |
| GOBP HEART PROCESS | 104 | 3.50e-02 | 1.20e-01 | 2.36e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 6.43e-01 | -1.20e-01 | 8.65e-01 |
| GOCC SAGA TYPE COMPLEX | 36 | 2.14e-01 | 1.20e-01 | 5.64e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 17 | 3.93e-01 | 1.20e-01 | 7.15e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 23 | 3.21e-01 | -1.20e-01 | 6.61e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 7 | 5.84e-01 | -1.20e-01 | 8.36e-01 |
| GOBP PROTEIN PROCESSING | 141 | 1.44e-02 | 1.20e-01 | 1.41e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 116 | 2.64e-02 | -1.20e-01 | 2.01e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 20 | 3.55e-01 | 1.20e-01 | 6.87e-01 |
| GOCC ACTIN CYTOSKELETON | 306 | 3.45e-04 | 1.19e-01 | 9.44e-03 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 12 | 4.74e-01 | 1.19e-01 | 7.71e-01 |
| GOCC BLOC 1 COMPLEX | 9 | 5.35e-01 | 1.19e-01 | 8.08e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 9 | 5.35e-01 | 1.19e-01 | 8.08e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 19 | 3.68e-01 | -1.19e-01 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 4.40e-01 | 1.19e-01 | 7.49e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 4.57e-01 | -1.19e-01 | 7.61e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 324 | 2.39e-04 | 1.19e-01 | 6.94e-03 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 15 | 4.24e-01 | -1.19e-01 | 7.36e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 87 | 5.49e-02 | 1.19e-01 | 2.94e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 6.13e-01 | -1.19e-01 | 8.51e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 60 | 1.11e-01 | 1.19e-01 | 4.14e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 24 | 3.13e-01 | 1.19e-01 | 6.55e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 43 | 1.77e-01 | 1.19e-01 | 5.17e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 122 | 2.34e-02 | 1.19e-01 | 1.88e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 21 | 3.45e-01 | 1.19e-01 | 6.80e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 7 | 5.86e-01 | -1.19e-01 | 8.38e-01 |
| GOBP T CELL MIGRATION | 54 | 1.31e-01 | 1.19e-01 | 4.47e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 8 | 5.60e-01 | -1.19e-01 | 8.25e-01 |
| GOMF HEPARIN BINDING | 54 | 1.31e-01 | -1.19e-01 | 4.47e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 12 | 4.76e-01 | 1.19e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 6.14e-01 | 1.19e-01 | 8.52e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 128 | 2.07e-02 | 1.19e-01 | 1.73e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 38 | 2.06e-01 | 1.19e-01 | 5.54e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 9 | 5.38e-01 | 1.19e-01 | 8.09e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 11 | 4.96e-01 | 1.19e-01 | 7.85e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 5 | 6.46e-01 | -1.19e-01 | 8.66e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 10 | 5.16e-01 | 1.19e-01 | 7.97e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 4.43e-01 | 1.18e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 46 | 1.65e-01 | -1.18e-01 | 5.00e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 75 | 7.68e-02 | 1.18e-01 | 3.47e-01 |
| GOCC COPII VESICLE COAT | 16 | 4.13e-01 | -1.18e-01 | 7.30e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 18 | 3.85e-01 | 1.18e-01 | 7.09e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 10 | 5.18e-01 | -1.18e-01 | 7.97e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 12 | 4.79e-01 | 1.18e-01 | 7.74e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 12 | 4.79e-01 | -1.18e-01 | 7.74e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 15 | 4.29e-01 | -1.18e-01 | 7.42e-01 |
| GOBP XENOPHAGY | 14 | 4.44e-01 | 1.18e-01 | 7.52e-01 |
| GOMF EXONUCLEASE ACTIVITY | 75 | 7.76e-02 | 1.18e-01 | 3.48e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 56 | 1.27e-01 | 1.18e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 41 | 1.92e-01 | 1.18e-01 | 5.37e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 5.89e-01 | 1.18e-01 | 8.39e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 21 | 3.50e-01 | -1.18e-01 | 6.83e-01 |
| GOBP EXCRETION | 7 | 5.89e-01 | -1.18e-01 | 8.39e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 7 | 5.90e-01 | -1.18e-01 | 8.39e-01 |
| GOCC SARCOPLASM | 55 | 1.31e-01 | 1.18e-01 | 4.47e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 199 | 4.34e-03 | 1.18e-01 | 6.52e-02 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 7 | 5.90e-01 | -1.18e-01 | 8.39e-01 |
| GOBP PROTEIN DESTABILIZATION | 45 | 1.73e-01 | 1.18e-01 | 5.12e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 6.49e-01 | -1.18e-01 | 8.68e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 15 | 4.31e-01 | 1.18e-01 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 7 | 5.90e-01 | -1.17e-01 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 5.42e-01 | 1.17e-01 | 8.13e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 46 | 1.69e-01 | 1.17e-01 | 5.06e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 5.91e-01 | 1.17e-01 | 8.40e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 7 | 5.91e-01 | 1.17e-01 | 8.40e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 5.21e-01 | 1.17e-01 | 8.00e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 168 | 8.98e-03 | 1.17e-01 | 1.07e-01 |
| GOBP LYMPHANGIOGENESIS | 6 | 6.19e-01 | -1.17e-01 | 8.55e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 12 | 4.83e-01 | 1.17e-01 | 7.76e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 53 | 1.41e-01 | 1.17e-01 | 4.62e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 99 | 4.46e-02 | -1.17e-01 | 2.64e-01 |
| GOMF CHROMATIN DNA BINDING | 79 | 7.27e-02 | 1.17e-01 | 3.39e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 69 | 9.34e-02 | 1.17e-01 | 3.83e-01 |
| GOBP MATURATION OF LSU RRNA | 28 | 2.85e-01 | -1.17e-01 | 6.33e-01 |
| GOCC COATED VESICLE | 232 | 2.25e-03 | 1.17e-01 | 4.12e-02 |
| GOBP MEMBRANE ORGANIZATION | 593 | 1.46e-06 | 1.17e-01 | 8.60e-05 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 6.51e-01 | 1.17e-01 | 8.70e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 5 | 6.52e-01 | -1.17e-01 | 8.70e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 50 | 1.54e-01 | -1.17e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 198 | 4.81e-03 | 1.17e-01 | 7.08e-02 |
| GOMF ACID THIOL LIGASE ACTIVITY | 21 | 3.56e-01 | 1.17e-01 | 6.87e-01 |
| GOMF POTASSIUM ION BINDING | 6 | 6.21e-01 | 1.16e-01 | 8.56e-01 |
| GOBP AGGREPHAGY | 8 | 5.69e-01 | 1.16e-01 | 8.29e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 15 | 4.35e-01 | -1.16e-01 | 7.46e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 6 | 6.22e-01 | -1.16e-01 | 8.56e-01 |
| GOBP FAT CELL DIFFERENTIATION | 138 | 1.85e-02 | -1.16e-01 | 1.64e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 53 | 1.43e-01 | 1.16e-01 | 4.67e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 34 | 2.41e-01 | 1.16e-01 | 5.89e-01 |
| GOCC RIPOPTOSOME | 6 | 6.22e-01 | -1.16e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 5 | 6.53e-01 | -1.16e-01 | 8.70e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 8 | 5.70e-01 | 1.16e-01 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 52 | 1.48e-01 | 1.16e-01 | 4.76e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 31 | 2.64e-01 | 1.16e-01 | 6.14e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 8 | 5.70e-01 | 1.16e-01 | 8.29e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 8 | 5.70e-01 | -1.16e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 7 | 5.95e-01 | -1.16e-01 | 8.42e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 14 | 4.53e-01 | -1.16e-01 | 7.58e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 14 | 4.53e-01 | 1.16e-01 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 20 | 3.70e-01 | 1.16e-01 | 6.96e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 75 | 8.31e-02 | 1.16e-01 | 3.63e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.23e-01 | 1.16e-01 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 333 | 2.99e-04 | 1.16e-01 | 8.41e-03 |
| GOBP FIBROBLAST PROLIFERATION | 71 | 9.18e-02 | 1.16e-01 | 3.80e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 8 | 5.71e-01 | -1.16e-01 | 8.29e-01 |
| GOBP OOGENESIS | 48 | 1.66e-01 | 1.16e-01 | 5.00e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 8 | 5.71e-01 | 1.16e-01 | 8.29e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 278 | 9.36e-04 | 1.16e-01 | 2.07e-02 |
| GOMF SCAFFOLD PROTEIN BINDING | 40 | 2.06e-01 | 1.16e-01 | 5.54e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 20 | 3.71e-01 | -1.16e-01 | 6.97e-01 |
| GOBP BLASTOCYST GROWTH | 19 | 3.83e-01 | -1.16e-01 | 7.08e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 2.73e-01 | 1.16e-01 | 6.22e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 30 | 2.73e-01 | -1.16e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 10 | 5.27e-01 | 1.16e-01 | 8.03e-01 |
| GOBP RESPONSE TO ZINC ION | 26 | 3.08e-01 | 1.16e-01 | 6.50e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 9 | 5.48e-01 | 1.16e-01 | 8.17e-01 |
| GOBP REGULATION OF CELL CYCLE | 835 | 2.03e-08 | 1.16e-01 | 1.95e-06 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 46 | 1.75e-01 | 1.16e-01 | 5.16e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 20 | 3.71e-01 | -1.16e-01 | 6.98e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 8 | 5.71e-01 | 1.16e-01 | 8.29e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 28 | 2.90e-01 | 1.16e-01 | 6.38e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 60 | 1.22e-01 | 1.16e-01 | 4.34e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 242 | 2.04e-03 | 1.15e-01 | 3.84e-02 |
| GOBP CYTOSKELETON ORGANIZATION | 955 | 2.50e-09 | 1.15e-01 | 2.83e-07 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 26 | 3.09e-01 | 1.15e-01 | 6.51e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 5 | 6.55e-01 | 1.15e-01 | 8.72e-01 |
| GOCC PHAGOCYTIC VESICLE | 118 | 3.07e-02 | 1.15e-01 | 2.18e-01 |
| GOBP MELANIN METABOLIC PROCESS | 15 | 4.39e-01 | 1.15e-01 | 7.49e-01 |
| GOCC SEX CHROMOSOME | 25 | 3.18e-01 | 1.15e-01 | 6.59e-01 |
| GOBP TRABECULA FORMATION | 9 | 5.49e-01 | 1.15e-01 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 5 | 6.55e-01 | -1.15e-01 | 8.72e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 11 | 5.08e-01 | 1.15e-01 | 7.91e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 5.98e-01 | 1.15e-01 | 8.44e-01 |
| GOBP CELLULAR PIGMENTATION | 51 | 1.55e-01 | 1.15e-01 | 4.88e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 8.70e-02 | -1.15e-01 | 3.71e-01 |
| GOMF POLY PURINE TRACT BINDING | 26 | 3.10e-01 | -1.15e-01 | 6.52e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 23 | 3.40e-01 | 1.15e-01 | 6.76e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 101 | 4.60e-02 | -1.15e-01 | 2.69e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 602 | 1.74e-06 | 1.15e-01 | 9.99e-05 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 13 | 4.73e-01 | -1.15e-01 | 7.70e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 75 | 8.54e-02 | -1.15e-01 | 3.68e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 38 | 2.20e-01 | 1.15e-01 | 5.71e-01 |
| GOMF WW DOMAIN BINDING | 14 | 4.57e-01 | -1.15e-01 | 7.61e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 5.99e-01 | -1.15e-01 | 8.44e-01 |
| GOBP VIRION ASSEMBLY | 30 | 2.76e-01 | 1.15e-01 | 6.26e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 24 | 3.30e-01 | 1.15e-01 | 6.67e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 285 | 8.97e-04 | 1.15e-01 | 2.00e-02 |
| GOBP REGULATION OF STEROL TRANSPORT | 33 | 2.54e-01 | 1.15e-01 | 6.03e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 356 | 2.17e-04 | -1.15e-01 | 6.40e-03 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 5 | 6.57e-01 | -1.15e-01 | 8.73e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 50 | 1.61e-01 | -1.15e-01 | 4.95e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 49 | 1.66e-01 | 1.14e-01 | 5.01e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 57 | 1.35e-01 | 1.14e-01 | 4.53e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 26 | 3.13e-01 | 1.14e-01 | 6.55e-01 |
| GOMF HORMONE RECEPTOR BINDING | 10 | 5.31e-01 | 1.14e-01 | 8.05e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 17 | 4.15e-01 | -1.14e-01 | 7.31e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 5.53e-01 | 1.14e-01 | 8.21e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 48 | 1.71e-01 | 1.14e-01 | 5.09e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 13 | 4.76e-01 | 1.14e-01 | 7.73e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 8 | 5.76e-01 | -1.14e-01 | 8.31e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 55 | 1.44e-01 | -1.14e-01 | 4.67e-01 |
| GOMF CENTROMERIC DNA BINDING | 6 | 6.29e-01 | 1.14e-01 | 8.60e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 22 | 3.55e-01 | 1.14e-01 | 6.87e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 6.01e-01 | 1.14e-01 | 8.46e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 26 | 3.15e-01 | 1.14e-01 | 6.56e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 5.33e-01 | 1.14e-01 | 8.06e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 13 | 4.77e-01 | 1.14e-01 | 7.73e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 13 | 4.77e-01 | -1.14e-01 | 7.73e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 16 | 4.31e-01 | 1.14e-01 | 7.43e-01 |
| GOBP PRENYLATION | 10 | 5.33e-01 | -1.14e-01 | 8.06e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 214 | 4.23e-03 | 1.14e-01 | 6.37e-02 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 48 | 1.73e-01 | 1.14e-01 | 5.12e-01 |
| GOCC BLOC COMPLEX | 14 | 4.61e-01 | 1.14e-01 | 7.64e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 37 | 2.32e-01 | 1.14e-01 | 5.80e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 65 | 1.14e-01 | 1.14e-01 | 4.18e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 35 | 2.45e-01 | 1.14e-01 | 5.93e-01 |
| GOBP PROTEIN DEACETYLATION | 51 | 1.61e-01 | 1.14e-01 | 4.95e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 19 | 3.92e-01 | 1.14e-01 | 7.13e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 375 | 1.74e-04 | 1.13e-01 | 5.44e-03 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 45 | 1.88e-01 | -1.13e-01 | 5.33e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 5 | 6.60e-01 | 1.13e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 25 | 3.26e-01 | 1.13e-01 | 6.64e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 24 | 3.37e-01 | 1.13e-01 | 6.73e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 21 | 3.69e-01 | 1.13e-01 | 6.96e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 10 | 5.35e-01 | 1.13e-01 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 42 | 2.04e-01 | 1.13e-01 | 5.52e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 14 | 4.63e-01 | 1.13e-01 | 7.64e-01 |
| GOBP ANIMAL ORGAN MATURATION | 15 | 4.48e-01 | -1.13e-01 | 7.54e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 6.05e-01 | 1.13e-01 | 8.48e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 175 | 1.01e-02 | 1.13e-01 | 1.14e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 13 | 4.81e-01 | 1.13e-01 | 7.75e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 19 | 3.94e-01 | 1.13e-01 | 7.16e-01 |
| GOBP MUCUS SECRETION | 9 | 5.57e-01 | 1.13e-01 | 8.23e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 39 | 2.23e-01 | -1.13e-01 | 5.72e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 261 | 1.75e-03 | -1.13e-01 | 3.45e-02 |
| GOBP NEURAL RETINA DEVELOPMENT | 32 | 2.69e-01 | -1.13e-01 | 6.19e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 109 | 4.20e-02 | 1.13e-01 | 2.55e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 9 | 5.58e-01 | -1.13e-01 | 8.23e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 28 | 3.01e-01 | 1.13e-01 | 6.46e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 62 | 1.25e-01 | 1.13e-01 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 123 | 3.10e-02 | 1.13e-01 | 2.20e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 11 | 5.17e-01 | -1.13e-01 | 7.97e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 290 | 1.00e-03 | 1.13e-01 | 2.18e-02 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 307 | 7.31e-04 | 1.13e-01 | 1.73e-02 |
| GOCC ENDOSOME | 749 | 2.15e-07 | 1.12e-01 | 1.71e-05 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 41 | 2.13e-01 | -1.12e-01 | 5.62e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 10 | 5.38e-01 | 1.12e-01 | 8.09e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 6.63e-01 | 1.12e-01 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 10 | 5.38e-01 | 1.12e-01 | 8.09e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 10 | 5.38e-01 | 1.12e-01 | 8.09e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 12 | 5.01e-01 | -1.12e-01 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 28 | 3.04e-01 | -1.12e-01 | 6.47e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 5 | 6.64e-01 | -1.12e-01 | 8.76e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1209 | 1.06e-10 | 1.12e-01 | 1.75e-08 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 78 | 8.70e-02 | 1.12e-01 | 3.71e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 29 | 2.96e-01 | 1.12e-01 | 6.41e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 20 | 3.86e-01 | 1.12e-01 | 7.09e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 34 | 2.58e-01 | 1.12e-01 | 6.08e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 26 | 3.23e-01 | -1.12e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 6 | 6.35e-01 | 1.12e-01 | 8.63e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 37 | 2.39e-01 | 1.12e-01 | 5.88e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 159 | 1.51e-02 | 1.12e-01 | 1.45e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 10 | 5.40e-01 | -1.12e-01 | 8.11e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 76 | 9.21e-02 | 1.12e-01 | 3.81e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 3.87e-01 | 1.12e-01 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 3.43e-01 | -1.12e-01 | 6.79e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 11 | 5.21e-01 | -1.12e-01 | 8.00e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 21 | 3.75e-01 | 1.12e-01 | 7.02e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 144 | 2.08e-02 | 1.12e-01 | 1.74e-01 |
| GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE | 6 | 6.36e-01 | 1.12e-01 | 8.63e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 240 | 2.98e-03 | 1.12e-01 | 5.03e-02 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 12 | 5.03e-01 | -1.12e-01 | 7.90e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 73 | 9.95e-02 | 1.12e-01 | 3.98e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 188 | 8.51e-03 | 1.12e-01 | 1.04e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 16 | 4.40e-01 | 1.12e-01 | 7.49e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 6 | 6.36e-01 | -1.12e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 12 | 5.04e-01 | 1.12e-01 | 7.90e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.36e-01 | 1.11e-01 | 8.63e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 32 | 2.75e-01 | -1.11e-01 | 6.25e-01 |
| GOBP PROTEIN FOLDING | 174 | 1.14e-02 | 1.11e-01 | 1.23e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 38 | 2.35e-01 | 1.11e-01 | 5.85e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 7 | 6.10e-01 | -1.11e-01 | 8.50e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 14 | 4.71e-01 | -1.11e-01 | 7.69e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 76 | 9.39e-02 | -1.11e-01 | 3.84e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 25 | 3.36e-01 | -1.11e-01 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 16 | 4.41e-01 | -1.11e-01 | 7.50e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 6 | 6.37e-01 | -1.11e-01 | 8.63e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 6 | 6.37e-01 | -1.11e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 5.87e-01 | -1.11e-01 | 8.38e-01 |
| GOMF SPHINGOLIPID BINDING | 20 | 3.90e-01 | -1.11e-01 | 7.12e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 38 | 2.37e-01 | -1.11e-01 | 5.87e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 114 | 4.11e-02 | 1.11e-01 | 2.51e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 6.38e-01 | -1.11e-01 | 8.63e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 6.68e-01 | -1.11e-01 | 8.78e-01 |
| GOMF U2 SNRNA BINDING | 6 | 6.38e-01 | 1.11e-01 | 8.63e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 465 | 4.76e-05 | 1.11e-01 | 1.77e-03 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 164 | 1.46e-02 | 1.11e-01 | 1.41e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 46 | 1.94e-01 | -1.11e-01 | 5.39e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 181 | 1.04e-02 | 1.11e-01 | 1.16e-01 |
| GOMF HSP70 PROTEIN BINDING | 42 | 2.15e-01 | -1.11e-01 | 5.64e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 16 | 4.43e-01 | 1.11e-01 | 7.52e-01 |
| GOCC ATAC COMPLEX | 13 | 4.90e-01 | 1.11e-01 | 7.81e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 3.38e-01 | 1.11e-01 | 6.74e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 11 | 5.25e-01 | 1.11e-01 | 8.02e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 53 | 1.64e-01 | -1.11e-01 | 4.99e-01 |
| GOBP TELOMERE LOCALIZATION | 7 | 6.13e-01 | -1.10e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 17 | 4.31e-01 | -1.10e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 6.69e-01 | 1.10e-01 | 8.79e-01 |
| GOBP BLASTOCYST FORMATION | 33 | 2.73e-01 | 1.10e-01 | 6.22e-01 |
| GOBP HISTONE METHYLATION | 34 | 2.66e-01 | 1.10e-01 | 6.17e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 7 | 6.13e-01 | -1.10e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 38 | 2.40e-01 | -1.10e-01 | 5.88e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 6 | 6.40e-01 | -1.10e-01 | 8.64e-01 |
| GOBP BONE MARROW DEVELOPMENT | 7 | 6.14e-01 | 1.10e-01 | 8.52e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 40 | 2.28e-01 | -1.10e-01 | 5.78e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 21 | 3.82e-01 | -1.10e-01 | 7.08e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 19 | 4.06e-01 | 1.10e-01 | 7.25e-01 |
| GOCC MEMBRANE COAT | 81 | 8.74e-02 | 1.10e-01 | 3.71e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 6.41e-01 | -1.10e-01 | 8.65e-01 |
| GOBP TRNA METHYLATION | 41 | 2.23e-01 | 1.10e-01 | 5.73e-01 |
| GOBP CELLULAR RESPONSE TO PH | 10 | 5.47e-01 | 1.10e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 11 | 5.28e-01 | 1.10e-01 | 8.04e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 29 | 3.06e-01 | 1.10e-01 | 6.49e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 6 | 6.41e-01 | -1.10e-01 | 8.65e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 95 | 6.46e-02 | 1.10e-01 | 3.23e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 183 | 1.06e-02 | 1.10e-01 | 1.18e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 5 | 6.71e-01 | -1.10e-01 | 8.80e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 6.71e-01 | -1.10e-01 | 8.80e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 15 | 4.62e-01 | -1.10e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 33 | 2.76e-01 | 1.10e-01 | 6.25e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 77 | 9.66e-02 | 1.10e-01 | 3.91e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 51 | 1.76e-01 | 1.10e-01 | 5.17e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 17 | 4.34e-01 | 1.10e-01 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 119 | 3.93e-02 | -1.10e-01 | 2.46e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1448 | 8.65e-12 | 1.09e-01 | 1.79e-09 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 64 | 1.30e-01 | 1.09e-01 | 4.47e-01 |
| GOBP CHROMATIN REMODELING | 485 | 4.13e-05 | 1.09e-01 | 1.56e-03 |
| GOMF TELOMERASE RNA BINDING | 21 | 3.86e-01 | 1.09e-01 | 7.09e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 7 | 6.17e-01 | -1.09e-01 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 34 | 2.70e-01 | 1.09e-01 | 6.20e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 40 | 2.32e-01 | 1.09e-01 | 5.80e-01 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 6.72e-01 | 1.09e-01 | 8.81e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 12 | 5.12e-01 | 1.09e-01 | 7.94e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 83 | 8.58e-02 | 1.09e-01 | 3.69e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 6.73e-01 | 1.09e-01 | 8.81e-01 |
| GOMF MRNA 3 UTR BINDING | 83 | 8.59e-02 | -1.09e-01 | 3.69e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 17 | 4.36e-01 | -1.09e-01 | 7.46e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 44 | 2.11e-01 | 1.09e-01 | 5.58e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 12 | 5.13e-01 | -1.09e-01 | 7.94e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 8 | 5.93e-01 | -1.09e-01 | 8.42e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 23 | 3.65e-01 | 1.09e-01 | 6.93e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 9 | 5.71e-01 | 1.09e-01 | 8.29e-01 |
| GOMF DIACYLGLYCEROL BINDING | 7 | 6.17e-01 | 1.09e-01 | 8.53e-01 |
| GOBP IMPORT INTO NUCLEUS | 133 | 3.02e-02 | 1.09e-01 | 2.17e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 39 | 2.39e-01 | 1.09e-01 | 5.88e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.17e-01 | 1.09e-01 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 6.73e-01 | 1.09e-01 | 8.81e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 5.13e-01 | 1.09e-01 | 7.94e-01 |
| GOMF GDP BINDING | 55 | 1.63e-01 | 1.09e-01 | 4.97e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 17 | 4.37e-01 | 1.09e-01 | 7.47e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 26 | 3.37e-01 | -1.09e-01 | 6.73e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 73 | 1.08e-01 | 1.09e-01 | 4.09e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 15 | 4.66e-01 | 1.09e-01 | 7.65e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 7 | 6.18e-01 | 1.09e-01 | 8.54e-01 |
| GOBP REGULATION OF CYTOKINESIS | 72 | 1.11e-01 | 1.09e-01 | 4.14e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 5.94e-01 | 1.09e-01 | 8.42e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 2.87e-01 | 1.09e-01 | 6.36e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 75 | 1.04e-01 | -1.09e-01 | 4.02e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 103 | 5.70e-02 | 1.09e-01 | 2.99e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 33 | 2.81e-01 | 1.09e-01 | 6.29e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 6.19e-01 | 1.09e-01 | 8.55e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 9 | 5.73e-01 | -1.09e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 45 | 2.08e-01 | 1.08e-01 | 5.57e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 46 | 2.04e-01 | 1.08e-01 | 5.51e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 15 | 4.68e-01 | 1.08e-01 | 7.67e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 37 | 2.54e-01 | -1.08e-01 | 6.03e-01 |
| GOBP TRANSLATIONAL INITIATION | 112 | 4.81e-02 | -1.08e-01 | 2.77e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 5.53e-01 | 1.08e-01 | 8.21e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 5.16e-01 | 1.08e-01 | 7.97e-01 |
| GOBP LIPID MODIFICATION | 132 | 3.21e-02 | 1.08e-01 | 2.25e-01 |
| GOBP RESPONSE TO INSULIN | 181 | 1.23e-02 | 1.08e-01 | 1.28e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 76 | 1.03e-01 | -1.08e-01 | 4.02e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 88 | 7.98e-02 | -1.08e-01 | 3.54e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 13 | 5.00e-01 | -1.08e-01 | 7.87e-01 |
| GOBP RESPONSE TO PAIN | 16 | 4.54e-01 | -1.08e-01 | 7.59e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 10 | 5.54e-01 | -1.08e-01 | 8.21e-01 |
| GOBP ENERGY HOMEOSTASIS | 42 | 2.26e-01 | -1.08e-01 | 5.75e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 197 | 9.13e-03 | 1.08e-01 | 1.08e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1041 | 6.47e-09 | -1.08e-01 | 6.61e-07 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 9 | 5.75e-01 | -1.08e-01 | 8.31e-01 |
| GOBP RESPONSE TO UV | 121 | 4.07e-02 | 1.08e-01 | 2.50e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 7 | 6.21e-01 | -1.08e-01 | 8.56e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 121 | 4.10e-02 | 1.08e-01 | 2.51e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 10 | 5.55e-01 | 1.08e-01 | 8.22e-01 |
| GOCC CELL CORTEX | 197 | 9.42e-03 | 1.08e-01 | 1.10e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 11 | 5.37e-01 | -1.08e-01 | 8.09e-01 |
| GOBP MONOAMINE TRANSPORT | 28 | 3.25e-01 | 1.07e-01 | 6.64e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 232 | 4.95e-03 | 1.07e-01 | 7.21e-02 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 28 | 3.25e-01 | 1.07e-01 | 6.64e-01 |
| GOCC CELL BODY MEMBRANE | 8 | 5.99e-01 | 1.07e-01 | 8.45e-01 |
| GOBP RNA SURVEILLANCE | 17 | 4.43e-01 | -1.07e-01 | 7.52e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 336 | 7.62e-04 | 1.07e-01 | 1.79e-02 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 26 | 3.44e-01 | 1.07e-01 | 6.79e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 168 | 1.67e-02 | 1.07e-01 | 1.55e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 18 | 4.31e-01 | 1.07e-01 | 7.44e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 9 | 5.78e-01 | -1.07e-01 | 8.32e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 137 | 3.07e-02 | 1.07e-01 | 2.18e-01 |
| GOMF SUMO LIGASE ACTIVITY | 12 | 5.21e-01 | -1.07e-01 | 8.00e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 21 | 3.96e-01 | -1.07e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 25 | 3.54e-01 | 1.07e-01 | 6.86e-01 |
| GOCC CENTROSOME | 541 | 2.36e-05 | 1.07e-01 | 9.70e-04 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 5 | 6.79e-01 | 1.07e-01 | 8.84e-01 |
| GOMF CADHERIN BINDING | 258 | 3.20e-03 | 1.07e-01 | 5.30e-02 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 254 | 3.44e-03 | 1.07e-01 | 5.57e-02 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 96 | 7.05e-02 | 1.07e-01 | 3.35e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 77 | 1.05e-01 | 1.07e-01 | 4.05e-01 |
| GOBP PROTEIN SUMOYLATION | 58 | 1.60e-01 | 1.07e-01 | 4.94e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 72 | 1.17e-01 | 1.07e-01 | 4.24e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 21 | 3.97e-01 | -1.07e-01 | 7.19e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 76 | 1.08e-01 | 1.07e-01 | 4.09e-01 |
| GOBP METHYLATION | 231 | 5.34e-03 | 1.07e-01 | 7.57e-02 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 38 | 2.55e-01 | -1.07e-01 | 6.05e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 186 | 1.23e-02 | 1.07e-01 | 1.29e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 2.68e-01 | 1.07e-01 | 6.19e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 3.98e-01 | 1.07e-01 | 7.19e-01 |
| GOBP RNA METHYLATION | 84 | 9.17e-02 | 1.07e-01 | 3.80e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 366 | 4.95e-04 | 1.07e-01 | 1.26e-02 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 5 | 6.80e-01 | 1.07e-01 | 8.85e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 74 | 1.14e-01 | -1.07e-01 | 4.18e-01 |
| GOCC VACUOLAR LUMEN | 116 | 4.79e-02 | 1.06e-01 | 2.77e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 27 | 3.38e-01 | -1.06e-01 | 6.74e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 20 | 4.10e-01 | -1.06e-01 | 7.29e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 7 | 6.26e-01 | 1.06e-01 | 8.59e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 6 | 6.52e-01 | 1.06e-01 | 8.70e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 19 | 4.23e-01 | 1.06e-01 | 7.36e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 43 | 2.29e-01 | 1.06e-01 | 5.78e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 16 | 4.63e-01 | 1.06e-01 | 7.64e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 31 | 3.07e-01 | 1.06e-01 | 6.49e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 75 | 1.13e-01 | 1.06e-01 | 4.16e-01 |
| GOBP VESICLE TETHERING | 32 | 3.00e-01 | 1.06e-01 | 6.44e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 19 | 4.24e-01 | -1.06e-01 | 7.36e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 8 | 6.04e-01 | -1.06e-01 | 8.47e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 23 | 3.79e-01 | 1.06e-01 | 7.05e-01 |
| GOBP TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE | 5 | 6.82e-01 | -1.06e-01 | 8.86e-01 |
| GOBP ABSCISSION | 5 | 6.82e-01 | 1.06e-01 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 6.54e-01 | -1.06e-01 | 8.71e-01 |
| GOBP ZINC ION TRANSPORT | 20 | 4.13e-01 | 1.06e-01 | 7.30e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 6.82e-01 | -1.06e-01 | 8.87e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 6 | 6.54e-01 | 1.06e-01 | 8.71e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 5 | 6.83e-01 | -1.06e-01 | 8.87e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 28 | 3.34e-01 | -1.06e-01 | 6.71e-01 |
| GOCC SECRETORY GRANULE | 549 | 2.74e-05 | 1.05e-01 | 1.10e-03 |
| GOBP RESPONSE TO TESTOSTERONE | 27 | 3.43e-01 | 1.05e-01 | 6.79e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 24 | 3.71e-01 | -1.05e-01 | 6.98e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 44 | 2.27e-01 | -1.05e-01 | 5.76e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 58 | 1.65e-01 | 1.05e-01 | 5.00e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 10 | 5.64e-01 | 1.05e-01 | 8.27e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 12 | 5.28e-01 | -1.05e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 6.84e-01 | 1.05e-01 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 27 | 3.44e-01 | 1.05e-01 | 6.79e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 547 | 2.97e-05 | 1.05e-01 | 1.17e-03 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 673 | 4.05e-06 | 1.05e-01 | 2.09e-04 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 204 | 9.82e-03 | 1.05e-01 | 1.12e-01 |
| GOBP ORGANELLE LOCALIZATION | 471 | 1.03e-04 | 1.05e-01 | 3.49e-03 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 31 | 3.11e-01 | 1.05e-01 | 6.54e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 13 | 5.12e-01 | -1.05e-01 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 13 | 5.12e-01 | 1.05e-01 | 7.94e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 101 | 6.87e-02 | 1.05e-01 | 3.31e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 44 | 2.29e-01 | -1.05e-01 | 5.78e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 6.57e-01 | -1.05e-01 | 8.73e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 63 | 1.51e-01 | -1.05e-01 | 4.81e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 7 | 6.31e-01 | 1.05e-01 | 8.61e-01 |
| GOCC PML BODY | 98 | 7.37e-02 | 1.05e-01 | 3.42e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 41 | 2.46e-01 | -1.05e-01 | 5.94e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 15 | 4.83e-01 | 1.05e-01 | 7.77e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 5.30e-01 | -1.05e-01 | 8.05e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1212 | 1.69e-09 | 1.05e-01 | 1.97e-07 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 6.86e-01 | 1.05e-01 | 8.89e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1219 | 1.60e-09 | 1.04e-01 | 1.90e-07 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 476 | 1.05e-04 | 1.04e-01 | 3.54e-03 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 11 | 5.49e-01 | -1.04e-01 | 8.17e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 14 | 4.99e-01 | 1.04e-01 | 7.87e-01 |
| GOCC NADPH OXIDASE COMPLEX | 9 | 5.88e-01 | 1.04e-01 | 8.39e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 12 | 5.31e-01 | -1.04e-01 | 8.05e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 14 | 5.00e-01 | 1.04e-01 | 7.87e-01 |
| GOCC MRNA EDITING COMPLEX | 13 | 5.15e-01 | 1.04e-01 | 7.96e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 6.87e-01 | -1.04e-01 | 8.89e-01 |
| GOBP THYROID HORMONE GENERATION | 9 | 5.89e-01 | 1.04e-01 | 8.39e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 5 | 6.87e-01 | -1.04e-01 | 8.89e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 5.89e-01 | 1.04e-01 | 8.39e-01 |
| GOMF PHOSPHATASE BINDING | 147 | 2.98e-02 | 1.04e-01 | 2.16e-01 |
| GOMF HISTONE BINDING | 216 | 8.64e-03 | 1.04e-01 | 1.05e-01 |
| GOCC TRANSFERASE COMPLEX | 749 | 1.64e-06 | 1.04e-01 | 9.58e-05 |
| GOBP PLATELET AGGREGATION | 45 | 2.28e-01 | 1.04e-01 | 5.77e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 73 | 1.25e-01 | 1.04e-01 | 4.39e-01 |
| GOCC ENDOCYTIC VESICLE | 232 | 6.56e-03 | 1.04e-01 | 8.65e-02 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 8 | 6.11e-01 | 1.04e-01 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 19 | 4.33e-01 | -1.04e-01 | 7.45e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 28 | 3.42e-01 | 1.04e-01 | 6.77e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 10 | 5.70e-01 | -1.04e-01 | 8.29e-01 |
| GOBP IRON IMPORT INTO CELL | 7 | 6.35e-01 | -1.04e-01 | 8.63e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 9 | 5.90e-01 | 1.04e-01 | 8.39e-01 |
| GOMF TRANSPORTER ACTIVITY | 635 | 1.01e-05 | 1.04e-01 | 4.56e-04 |
| GOBP REGULATION OF IMMUNE RESPONSE | 653 | 7.76e-06 | 1.04e-01 | 3.61e-04 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 22 | 4.01e-01 | 1.04e-01 | 7.21e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 55 | 1.85e-01 | 1.03e-01 | 5.28e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 31 | 3.19e-01 | 1.03e-01 | 6.60e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 359 | 8.18e-04 | 1.03e-01 | 1.86e-02 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 208 | 1.04e-02 | -1.03e-01 | 1.17e-01 |
| GOCC EXOCYST | 11 | 5.53e-01 | 1.03e-01 | 8.21e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 191 | 1.41e-02 | 1.03e-01 | 1.40e-01 |
| GOCC MSL COMPLEX | 5 | 6.89e-01 | 1.03e-01 | 8.91e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 30 | 3.28e-01 | -1.03e-01 | 6.66e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 50 | 2.07e-01 | 1.03e-01 | 5.56e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 33 | 3.05e-01 | -1.03e-01 | 6.48e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 6.62e-01 | 1.03e-01 | 8.75e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 13 | 5.20e-01 | 1.03e-01 | 7.99e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 344 | 1.08e-03 | 1.03e-01 | 2.32e-02 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 62 | 1.61e-01 | 1.03e-01 | 4.95e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 69 | 1.39e-01 | 1.03e-01 | 4.59e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 19 | 4.37e-01 | -1.03e-01 | 7.47e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 65 | 1.52e-01 | 1.03e-01 | 4.82e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 118 | 5.39e-02 | 1.03e-01 | 2.92e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 71 | 1.34e-01 | 1.03e-01 | 4.52e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 102 | 7.30e-02 | 1.03e-01 | 3.40e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 31 | 3.22e-01 | 1.03e-01 | 6.62e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 78 | 1.17e-01 | 1.03e-01 | 4.23e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 6.63e-01 | 1.03e-01 | 8.76e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 181 | 1.74e-02 | 1.03e-01 | 1.58e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 47 | 2.24e-01 | -1.03e-01 | 5.73e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 7 | 6.38e-01 | -1.03e-01 | 8.63e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 85 | 1.02e-01 | 1.03e-01 | 4.01e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 24 | 3.84e-01 | -1.03e-01 | 7.08e-01 |
| GOBP GENOMIC IMPRINTING | 11 | 5.56e-01 | 1.03e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 12 | 5.38e-01 | -1.03e-01 | 8.09e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 32 | 3.16e-01 | 1.02e-01 | 6.58e-01 |
| GOBP ORGANELLE FUSION | 125 | 4.83e-02 | 1.02e-01 | 2.77e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 9 | 5.95e-01 | -1.02e-01 | 8.42e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 132 | 4.25e-02 | 1.02e-01 | 2.57e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 74 | 1.28e-01 | 1.02e-01 | 4.44e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 129 | 4.51e-02 | 1.02e-01 | 2.65e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 6.92e-01 | 1.02e-01 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 15 | 4.93e-01 | 1.02e-01 | 7.82e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 27 | 3.58e-01 | -1.02e-01 | 6.87e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 7 | 6.39e-01 | -1.02e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 22 | 4.07e-01 | 1.02e-01 | 7.26e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 12 | 5.40e-01 | -1.02e-01 | 8.11e-01 |
| GOBP DECIDUALIZATION | 13 | 5.24e-01 | 1.02e-01 | 8.02e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 7 | 6.40e-01 | -1.02e-01 | 8.64e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 86 | 1.02e-01 | 1.02e-01 | 4.01e-01 |
| GOBP NEURON CELL CELL ADHESION | 6 | 6.65e-01 | -1.02e-01 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 26 | 3.69e-01 | 1.02e-01 | 6.96e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 40 | 2.65e-01 | 1.02e-01 | 6.16e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 6.18e-01 | -1.02e-01 | 8.54e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 11 | 5.59e-01 | -1.02e-01 | 8.24e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 8 | 6.18e-01 | -1.02e-01 | 8.54e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 10 | 5.78e-01 | -1.02e-01 | 8.32e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 10 | 5.78e-01 | 1.02e-01 | 8.32e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 8 | 6.19e-01 | -1.02e-01 | 8.55e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 31 | 3.28e-01 | 1.02e-01 | 6.66e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 58 | 1.81e-01 | -1.02e-01 | 5.24e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 25 | 3.80e-01 | 1.02e-01 | 7.06e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 13 | 5.26e-01 | 1.02e-01 | 8.03e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 74 | 1.32e-01 | 1.01e-01 | 4.47e-01 |
| GOBP CALCIUM ION IMPORT | 21 | 4.21e-01 | 1.01e-01 | 7.35e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 378 | 7.64e-04 | 1.01e-01 | 1.79e-02 |
| GOBP DEPHOSPHORYLATION | 232 | 8.03e-03 | 1.01e-01 | 9.97e-02 |
| GOBP COCHLEA DEVELOPMENT | 15 | 4.97e-01 | 1.01e-01 | 7.85e-01 |
| GOCC WNT SIGNALOSOME | 7 | 6.43e-01 | 1.01e-01 | 8.65e-01 |
| GOBP MAINTENANCE OF LOCATION | 234 | 7.82e-03 | 1.01e-01 | 9.82e-02 |
| GOBP SECONDARY METABOLIC PROCESS | 26 | 3.72e-01 | 1.01e-01 | 6.98e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 6 | 6.68e-01 | 1.01e-01 | 8.78e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 854 | 7.04e-07 | 1.01e-01 | 4.77e-05 |
| GOBP PROTEIN HYDROXYLATION | 19 | 4.45e-01 | -1.01e-01 | 7.53e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 95 | 8.90e-02 | -1.01e-01 | 3.74e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 9 | 6.00e-01 | -1.01e-01 | 8.45e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 16 | 4.84e-01 | 1.01e-01 | 7.77e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 6.21e-01 | 1.01e-01 | 8.56e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 14 | 5.13e-01 | -1.01e-01 | 7.94e-01 |
| GOBP MUSCLE CELL MIGRATION | 49 | 2.22e-01 | -1.01e-01 | 5.72e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 11 | 5.62e-01 | 1.01e-01 | 8.25e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1515 | 1.37e-10 | 1.01e-01 | 2.14e-08 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 6.21e-01 | 1.01e-01 | 8.56e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 60 | 1.77e-01 | 1.01e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 44 | 2.47e-01 | 1.01e-01 | 5.95e-01 |
| GOBP L GLUTAMATE IMPORT | 22 | 4.13e-01 | -1.01e-01 | 7.30e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 42 | 2.58e-01 | 1.01e-01 | 6.08e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 64 | 1.63e-01 | -1.01e-01 | 4.98e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 148 | 3.49e-02 | 1.01e-01 | 2.35e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 586 | 3.64e-05 | 1.01e-01 | 1.41e-03 |
| GOBP RRNA BASE METHYLATION | 8 | 6.23e-01 | 1.00e-01 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 108 | 7.17e-02 | 1.00e-01 | 3.37e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 6.46e-01 | -1.00e-01 | 8.66e-01 |
| GOCC FLEMMING BODY | 30 | 3.41e-01 | 1.00e-01 | 6.77e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 84 | 1.12e-01 | 1.00e-01 | 4.16e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 424 | 4.27e-04 | 1.00e-01 | 1.14e-02 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 6.46e-01 | 1.00e-01 | 8.66e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1251 | 4.77e-09 | -1.00e-01 | 5.00e-07 |
| GOBP RESPONSE TO HYPEROXIA | 12 | 5.48e-01 | 1.00e-01 | 8.17e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 5.02e-01 | 1.00e-01 | 7.89e-01 |
| GOBP SLEEP | 9 | 6.03e-01 | 1.00e-01 | 8.47e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 10 | 5.84e-01 | 1.00e-01 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 492 | 1.60e-04 | 1.00e-01 | 5.04e-03 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 5.49e-01 | 1.00e-01 | 8.17e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 6.99e-01 | -1.00e-01 | 8.96e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 6 | 6.71e-01 | -1.00e-01 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 37 | 2.93e-01 | -1.00e-01 | 6.40e-01 |
| GOBP ENDOCYTOSIS | 449 | 3.09e-04 | 9.99e-02 | 8.60e-03 |
| GOMF ENZYME REGULATOR ACTIVITY | 868 | 7.94e-07 | 9.99e-02 | 5.32e-05 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 58 | 1.89e-01 | -9.99e-02 | 5.33e-01 |
| GOBP QUINONE METABOLIC PROCESS | 30 | 3.44e-01 | 9.99e-02 | 6.79e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 19 | 4.52e-01 | 9.98e-02 | 7.58e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 15 | 5.04e-01 | 9.97e-02 | 7.90e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 17 | 4.77e-01 | 9.97e-02 | 7.73e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 11 | 5.67e-01 | -9.96e-02 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 31 | 3.37e-01 | -9.96e-02 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 5.68e-01 | 9.96e-02 | 8.29e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 11 | 5.68e-01 | -9.96e-02 | 8.29e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 41 | 2.70e-01 | 9.95e-02 | 6.20e-01 |
| GOMF POLYSACCHARIDE BINDING | 10 | 5.86e-01 | -9.95e-02 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 17 | 4.78e-01 | -9.95e-02 | 7.74e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 7.00e-01 | -9.94e-02 | 8.97e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 8 | 6.26e-01 | 9.94e-02 | 8.59e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 33 | 3.23e-01 | -9.94e-02 | 6.63e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 9 | 6.06e-01 | -9.94e-02 | 8.49e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 33 | 3.24e-01 | -9.93e-02 | 6.63e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 11 | 5.68e-01 | 9.93e-02 | 8.29e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 7 | 6.49e-01 | 9.93e-02 | 8.68e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 23 | 4.10e-01 | 9.93e-02 | 7.28e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 15 | 5.06e-01 | 9.93e-02 | 7.91e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 30 | 3.47e-01 | 9.93e-02 | 6.80e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 117 | 6.41e-02 | -9.93e-02 | 3.22e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 176 | 2.36e-02 | 9.92e-02 | 1.89e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 11 | 5.69e-01 | -9.91e-02 | 8.29e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 6.74e-01 | -9.91e-02 | 8.82e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 71 | 1.49e-01 | 9.90e-02 | 4.79e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 2.13e-01 | 9.90e-02 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 6.50e-01 | -9.90e-02 | 8.69e-01 |
| GOMF ACTIN BINDING | 279 | 4.60e-03 | 9.90e-02 | 6.83e-02 |
| GOCC NUCLEAR OUTER MEMBRANE | 20 | 4.44e-01 | 9.89e-02 | 7.52e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 5.53e-01 | 9.89e-02 | 8.21e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 6.08e-01 | 9.88e-02 | 8.50e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1038 | 1.16e-07 | 9.88e-02 | 9.70e-06 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 7 | 6.51e-01 | -9.87e-02 | 8.70e-01 |
| GOCC CILIARY TIP | 34 | 3.20e-01 | -9.87e-02 | 6.60e-01 |
| GOBP LYMPHOCYTE MIGRATION | 73 | 1.46e-01 | 9.86e-02 | 4.72e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 41 | 2.75e-01 | 9.86e-02 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 6.52e-01 | 9.85e-02 | 8.70e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 7 | 6.52e-01 | 9.85e-02 | 8.70e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 166 | 2.90e-02 | 9.84e-02 | 2.13e-01 |
| GOBP SIRNA PROCESSING | 8 | 6.30e-01 | -9.84e-02 | 8.61e-01 |
| GOBP RESPONSE TO LEPTIN | 12 | 5.55e-01 | -9.83e-02 | 8.22e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 78 | 1.34e-01 | 9.83e-02 | 4.51e-01 |
| GOMF DEATH DOMAIN BINDING | 11 | 5.73e-01 | -9.82e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 8 | 6.31e-01 | 9.82e-02 | 8.61e-01 |
| GOBP LIPID CATABOLIC PROCESS | 197 | 1.79e-02 | 9.81e-02 | 1.60e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 26 | 3.87e-01 | 9.81e-02 | 7.09e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 66 | 1.69e-01 | -9.81e-02 | 5.05e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 738 | 7.21e-06 | 9.80e-02 | 3.43e-04 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 22 | 4.26e-01 | 9.80e-02 | 7.39e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 784 | 3.94e-06 | 9.80e-02 | 2.05e-04 |
| GOCC GAP JUNCTION | 5 | 7.05e-01 | 9.79e-02 | 9.00e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 6.11e-01 | -9.79e-02 | 8.50e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 23 | 4.17e-01 | -9.79e-02 | 7.32e-01 |
| GOCC VESICLE MEMBRANE | 836 | 2.04e-06 | 9.78e-02 | 1.14e-04 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 45 | 2.56e-01 | 9.78e-02 | 6.05e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 6.78e-01 | 9.78e-02 | 8.84e-01 |
| GOBP DENDRITE EXTENSION | 18 | 4.73e-01 | -9.78e-02 | 7.70e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 128 | 5.65e-02 | -9.78e-02 | 2.97e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 13 | 5.42e-01 | -9.78e-02 | 8.12e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 8 | 6.32e-01 | 9.78e-02 | 8.62e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 6.12e-01 | 9.77e-02 | 8.51e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 52 | 2.23e-01 | 9.77e-02 | 5.73e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 6 | 6.79e-01 | 9.77e-02 | 8.84e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 50 | 2.32e-01 | 9.77e-02 | 5.81e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 90 | 1.10e-01 | 9.77e-02 | 4.12e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 41 | 2.80e-01 | -9.76e-02 | 6.29e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 81 | 1.30e-01 | 9.75e-02 | 4.46e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 95 | 1.01e-01 | -9.75e-02 | 4.00e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 5.28e-01 | -9.75e-02 | 8.04e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 14 | 5.28e-01 | 9.74e-02 | 8.04e-01 |
| GOMF MAP KINASE ACTIVITY | 12 | 5.59e-01 | 9.74e-02 | 8.25e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 26 | 3.90e-01 | -9.74e-02 | 7.12e-01 |
| GOBP REGULATION OF APPETITE | 8 | 6.34e-01 | -9.73e-02 | 8.62e-01 |
| GOMF COLLAGEN BINDING | 30 | 3.56e-01 | -9.73e-02 | 6.87e-01 |
| GOMF LAMININ BINDING | 11 | 5.76e-01 | 9.73e-02 | 8.31e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 8 | 6.34e-01 | -9.73e-02 | 8.62e-01 |
| GOBP RESPONSE TO ACIDIC PH | 10 | 5.95e-01 | 9.72e-02 | 8.42e-01 |
| GOMF ISOMERASE ACTIVITY | 128 | 5.80e-02 | 9.72e-02 | 3.03e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 116 | 7.11e-02 | 9.72e-02 | 3.36e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 107 | 8.29e-02 | 9.72e-02 | 3.63e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 26 | 3.91e-01 | 9.72e-02 | 7.13e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 13 | 5.44e-01 | 9.71e-02 | 8.14e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 7 | 6.57e-01 | -9.70e-02 | 8.73e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 6.57e-01 | -9.70e-02 | 8.73e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 118 | 6.92e-02 | 9.70e-02 | 3.32e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 6 | 6.81e-01 | 9.70e-02 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 19 | 4.65e-01 | -9.69e-02 | 7.65e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 53 | 2.23e-01 | 9.69e-02 | 5.72e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 39 | 2.95e-01 | 9.69e-02 | 6.40e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 10 | 5.96e-01 | -9.69e-02 | 8.43e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 8 | 6.35e-01 | -9.68e-02 | 8.63e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 12 | 5.61e-01 | 9.68e-02 | 8.25e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 5 | 7.08e-01 | 9.68e-02 | 9.01e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 6.15e-01 | -9.68e-02 | 8.52e-01 |
| GOBP UBIQUITIN RECYCLING | 12 | 5.62e-01 | 9.68e-02 | 8.25e-01 |
| GOCC ZYMOGEN GRANULE | 8 | 6.36e-01 | 9.68e-02 | 8.63e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 21 | 4.43e-01 | 9.67e-02 | 7.51e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 62 | 1.88e-01 | -9.67e-02 | 5.33e-01 |
| GOCC RUFFLE | 142 | 4.71e-02 | 9.67e-02 | 2.73e-01 |
| GOCC CELL LEADING EDGE | 292 | 4.65e-03 | 9.67e-02 | 6.86e-02 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 7 | 6.58e-01 | -9.67e-02 | 8.73e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 7 | 6.58e-01 | 9.66e-02 | 8.73e-01 |
| GOMF GTPASE ACTIVITY | 228 | 1.23e-02 | 9.66e-02 | 1.28e-01 |
| GOCC TERTIARY GRANULE LUMEN | 35 | 3.23e-01 | 9.66e-02 | 6.63e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 23 | 4.23e-01 | -9.65e-02 | 7.36e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 135 | 5.33e-02 | 9.65e-02 | 2.90e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 5.18e-01 | -9.65e-02 | 7.97e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 5 | 7.09e-01 | 9.65e-02 | 9.01e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 26 | 3.95e-01 | 9.64e-02 | 7.17e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 36 | 3.17e-01 | 9.64e-02 | 6.58e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 97 | 1.02e-01 | 9.63e-02 | 4.01e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 122 | 6.66e-02 | 9.63e-02 | 3.27e-01 |
| GOBP REGULATION OF WOUND HEALING | 56 | 2.13e-01 | -9.63e-02 | 5.62e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 5 | 7.09e-01 | 9.63e-02 | 9.01e-01 |
| GOBP ARTERY MORPHOGENESIS | 27 | 3.87e-01 | -9.63e-02 | 7.09e-01 |
| GOCC INTERCELLULAR BRIDGE | 59 | 2.01e-01 | 9.63e-02 | 5.49e-01 |
| GOMF INTEGRIN BINDING | 69 | 1.67e-01 | 9.63e-02 | 5.03e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 42 | 2.81e-01 | 9.63e-02 | 6.29e-01 |
| GOBP PROTEIN PALMITOYLATION | 25 | 4.05e-01 | -9.62e-02 | 7.24e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 27 | 3.87e-01 | -9.62e-02 | 7.10e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 7.10e-01 | -9.62e-02 | 9.01e-01 |
| GOMF FERROUS IRON BINDING | 19 | 4.68e-01 | -9.62e-02 | 7.67e-01 |
| GOBP RESPONSE TO LECTIN | 20 | 4.57e-01 | 9.61e-02 | 7.61e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 37 | 3.12e-01 | 9.61e-02 | 6.54e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 17 | 4.93e-01 | -9.60e-02 | 7.83e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 12 | 5.65e-01 | -9.60e-02 | 8.27e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 5 | 7.10e-01 | 9.59e-02 | 9.02e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 22 | 4.37e-01 | 9.59e-02 | 7.47e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 48 | 2.51e-01 | 9.58e-02 | 5.99e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 6.00e-01 | 9.58e-02 | 8.45e-01 |
| GOCC GLIAL CELL PROJECTION | 18 | 4.82e-01 | 9.58e-02 | 7.76e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 40 | 2.95e-01 | -9.58e-02 | 6.40e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 6.61e-01 | 9.57e-02 | 8.75e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 490 | 3.15e-04 | 9.57e-02 | 8.74e-03 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 5 | 7.11e-01 | 9.56e-02 | 9.02e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 6.20e-01 | -9.56e-02 | 8.55e-01 |
| GOBP PROTEASOME ASSEMBLY | 12 | 5.67e-01 | 9.56e-02 | 8.29e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 44 | 2.73e-01 | -9.56e-02 | 6.22e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 8 | 6.40e-01 | -9.55e-02 | 8.64e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 5.08e-01 | 9.55e-02 | 7.91e-01 |
| GOBP RESPONSE TO IRON ION | 20 | 4.60e-01 | -9.55e-02 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 53 | 2.30e-01 | 9.54e-02 | 5.79e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 98 | 1.03e-01 | 9.54e-02 | 4.02e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 55 | 2.21e-01 | 9.54e-02 | 5.72e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 84 | 1.31e-01 | 9.54e-02 | 4.47e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 6.02e-01 | 9.54e-02 | 8.46e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 41 | 2.91e-01 | 9.53e-02 | 6.38e-01 |
| GOBP REGULATION OF ANOIKIS | 16 | 5.09e-01 | 9.53e-02 | 7.92e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 18 | 4.84e-01 | 9.53e-02 | 7.77e-01 |
| GOMF NUCLEASE ACTIVITY | 172 | 3.15e-02 | 9.53e-02 | 2.21e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 7 | 6.62e-01 | -9.53e-02 | 8.76e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 5.52e-01 | -9.53e-02 | 8.21e-01 |
| GOCC ENDOSOME MEMBRANE | 428 | 7.80e-04 | 9.53e-02 | 1.81e-02 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 17 | 4.97e-01 | -9.52e-02 | 7.85e-01 |
| GOBP RRNA MODIFICATION | 30 | 3.67e-01 | 9.51e-02 | 6.95e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 24 | 4.20e-01 | -9.51e-02 | 7.35e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 239 | 1.17e-02 | 9.50e-02 | 1.25e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 6.42e-01 | 9.49e-02 | 8.65e-01 |
| GOBP O GLYCAN PROCESSING | 28 | 3.85e-01 | 9.49e-02 | 7.08e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 18 | 4.86e-01 | 9.49e-02 | 7.78e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 33 | 3.46e-01 | 9.48e-02 | 6.80e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 15 | 5.25e-01 | -9.48e-02 | 8.02e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 5 | 7.14e-01 | -9.48e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 7 | 6.64e-01 | 9.48e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 28 | 3.86e-01 | 9.47e-02 | 7.09e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 5 | 7.14e-01 | 9.47e-02 | 9.02e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 6 | 6.88e-01 | 9.46e-02 | 8.90e-01 |
| GOBP PROTEIN ACYLATION | 121 | 7.27e-02 | 9.46e-02 | 3.39e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 94 | 1.14e-01 | 9.46e-02 | 4.18e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 122 | 7.18e-02 | 9.46e-02 | 3.37e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 36 | 3.27e-01 | 9.45e-02 | 6.65e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 119 | 7.58e-02 | 9.44e-02 | 3.45e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 93 | 1.16e-01 | 9.43e-02 | 4.22e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 13 | 5.56e-01 | 9.43e-02 | 8.22e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 8 | 6.44e-01 | -9.43e-02 | 8.66e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 428 | 8.96e-04 | 9.42e-02 | 2.00e-02 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 45 | 2.76e-01 | 9.40e-02 | 6.25e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 94 | 1.16e-01 | 9.40e-02 | 4.21e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 5.43e-01 | 9.40e-02 | 8.13e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 57 | 2.21e-01 | 9.39e-02 | 5.71e-01 |
| GOBP SARCOMERE ORGANIZATION | 17 | 5.03e-01 | 9.38e-02 | 7.90e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 16 | 5.16e-01 | -9.38e-02 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 140 | 5.60e-02 | -9.37e-02 | 2.96e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 13 | 5.59e-01 | -9.37e-02 | 8.24e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 7.17e-01 | -9.37e-02 | 9.04e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 15 | 5.30e-01 | -9.37e-02 | 8.05e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 322 | 4.03e-03 | 9.36e-02 | 6.17e-02 |
| GOBP FOCAL ADHESION ASSEMBLY | 55 | 2.30e-01 | 9.36e-02 | 5.80e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 67 | 1.86e-01 | 9.36e-02 | 5.29e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 34 | 3.45e-01 | -9.36e-02 | 6.80e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 6.08e-01 | 9.36e-02 | 8.50e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 75 | 1.62e-01 | -9.36e-02 | 4.95e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 347 | 2.87e-03 | 9.36e-02 | 4.89e-02 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 5 | 7.17e-01 | 9.36e-02 | 9.04e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 62 | 2.03e-01 | -9.36e-02 | 5.50e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 442 | 8.04e-04 | -9.36e-02 | 1.85e-02 |
| GOBP SYNCYTIUM FORMATION | 32 | 3.60e-01 | 9.35e-02 | 6.88e-01 |
| GOBP CELL SUBSTRATE ADHESION | 191 | 2.63e-02 | 9.35e-02 | 2.01e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 7 | 6.69e-01 | -9.34e-02 | 8.78e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 9 | 6.28e-01 | -9.34e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 7 | 6.69e-01 | -9.34e-02 | 8.78e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 5 | 7.18e-01 | 9.33e-02 | 9.04e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 163 | 4.02e-02 | 9.33e-02 | 2.49e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 115 | 8.44e-02 | 9.33e-02 | 3.66e-01 |
| GOBP CELL MATRIX ADHESION | 130 | 6.67e-02 | 9.33e-02 | 3.27e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 10 | 6.10e-01 | -9.32e-02 | 8.50e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 157 | 4.42e-02 | -9.32e-02 | 2.62e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 10 | 6.10e-01 | -9.32e-02 | 8.50e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 202 | 2.28e-02 | 9.32e-02 | 1.85e-01 |
| GOCC TERTIARY GRANULE | 116 | 8.36e-02 | 9.32e-02 | 3.64e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 181 | 3.11e-02 | 9.31e-02 | 2.20e-01 |
| GOCC MIDBODY | 182 | 3.07e-02 | 9.31e-02 | 2.18e-01 |
| GOMF ORGANIC ACID BINDING | 92 | 1.23e-01 | 9.31e-02 | 4.37e-01 |
| GOCC PLASMA MEMBRANE RAFT | 58 | 2.21e-01 | 9.31e-02 | 5.71e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 108 | 9.53e-02 | -9.31e-02 | 3.88e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 300 | 5.77e-03 | 9.30e-02 | 7.96e-02 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 5 | 7.19e-01 | -9.30e-02 | 9.05e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 37 | 3.28e-01 | 9.29e-02 | 6.66e-01 |
| GOBP SPERM MOTILITY | 50 | 2.56e-01 | -9.29e-02 | 6.05e-01 |
| GOBP DIAPEDESIS | 6 | 6.93e-01 | 9.29e-02 | 8.93e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 6.11e-01 | 9.29e-02 | 8.50e-01 |
| GOCC SPINDLE POLE CENTROSOME | 11 | 5.94e-01 | 9.29e-02 | 8.42e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 35 | 3.42e-01 | 9.29e-02 | 6.77e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 57 | 2.25e-01 | 9.29e-02 | 5.74e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 109 | 9.46e-02 | -9.28e-02 | 3.87e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 11 | 5.94e-01 | -9.28e-02 | 8.42e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 35 | 3.43e-01 | 9.27e-02 | 6.78e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 17 | 5.08e-01 | 9.27e-02 | 7.91e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 51 | 2.53e-01 | 9.27e-02 | 6.02e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 8 | 6.50e-01 | -9.27e-02 | 8.69e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 142 | 5.74e-02 | 9.25e-02 | 3.00e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 6.50e-01 | -9.25e-02 | 8.69e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 147 | 5.34e-02 | -9.25e-02 | 2.90e-01 |
| GOBP TUBE FORMATION | 81 | 1.51e-01 | -9.25e-02 | 4.81e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 108 | 9.73e-02 | 9.25e-02 | 3.92e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 10 | 6.13e-01 | 9.25e-02 | 8.51e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 30 | 3.81e-01 | -9.24e-02 | 7.07e-01 |
| GOMF MICROTUBULE BINDING | 200 | 2.47e-02 | 9.24e-02 | 1.94e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 44 | 2.89e-01 | -9.24e-02 | 6.38e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 44 | 2.90e-01 | 9.23e-02 | 6.38e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 17 | 5.10e-01 | 9.23e-02 | 7.92e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 15 | 5.36e-01 | 9.23e-02 | 8.09e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 477 | 6.04e-04 | 9.23e-02 | 1.50e-02 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 5 | 7.21e-01 | 9.23e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 55 | 2.37e-01 | 9.22e-02 | 5.87e-01 |
| GOCC PCG PROTEIN COMPLEX | 31 | 3.75e-01 | -9.21e-02 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 86 | 1.40e-01 | -9.21e-02 | 4.61e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 4.65e-01 | 9.21e-02 | 7.65e-01 |
| GOBP HEMOSTASIS | 124 | 7.71e-02 | 9.21e-02 | 3.48e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 48 | 2.70e-01 | 9.20e-02 | 6.20e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.97e-01 | 9.20e-02 | 8.44e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 5 | 7.22e-01 | -9.20e-02 | 9.06e-01 |
| GOCC SECRETORY VESICLE | 636 | 8.65e-05 | 9.20e-02 | 3.02e-03 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 17 | 5.11e-01 | 9.20e-02 | 7.94e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 6 | 6.97e-01 | 9.19e-02 | 8.95e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1300 | 4.73e-08 | 9.19e-02 | 4.25e-06 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 682 | 5.08e-05 | 9.19e-02 | 1.87e-03 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 6.74e-01 | 9.19e-02 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 7.22e-01 | -9.19e-02 | 9.06e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 45 | 2.87e-01 | 9.19e-02 | 6.36e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 10 | 6.15e-01 | -9.18e-02 | 8.52e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 453 | 8.73e-04 | 9.18e-02 | 1.97e-02 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 40 | 3.15e-01 | -9.18e-02 | 6.57e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 18 | 5.01e-01 | 9.16e-02 | 7.88e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 9 | 6.34e-01 | 9.16e-02 | 8.62e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 11 | 5.99e-01 | -9.15e-02 | 8.45e-01 |
| GOMF UBIQUITIN BINDING | 98 | 1.18e-01 | 9.15e-02 | 4.25e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 43 | 3.00e-01 | 9.15e-02 | 6.44e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 5.68e-01 | 9.14e-02 | 8.29e-01 |
| GOBP LYSOSOMAL TRANSPORT | 113 | 9.40e-02 | 9.13e-02 | 3.84e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 7 | 6.76e-01 | 9.13e-02 | 8.83e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 643 | 9.02e-05 | 9.13e-02 | 3.12e-03 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 6 | 6.99e-01 | 9.13e-02 | 8.96e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 21 | 4.69e-01 | -9.13e-02 | 7.68e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 6.99e-01 | -9.12e-02 | 8.96e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 2.80e-01 | 9.12e-02 | 6.29e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 80 | 1.59e-01 | 9.12e-02 | 4.93e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 141 | 6.23e-02 | -9.11e-02 | 3.17e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 5 | 7.25e-01 | -9.10e-02 | 9.07e-01 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 5 | 7.25e-01 | -9.09e-02 | 9.07e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 13 | 5.70e-01 | 9.09e-02 | 8.29e-01 |
| GOCC SPINDLE MIDZONE | 29 | 3.97e-01 | -9.09e-02 | 7.19e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 7.00e-01 | -9.09e-02 | 8.96e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 42 | 3.09e-01 | 9.09e-02 | 6.51e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 23 | 4.51e-01 | -9.08e-02 | 7.57e-01 |
| GOBP PHAGOCYTOSIS | 154 | 5.25e-02 | 9.07e-02 | 2.88e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 5.57e-01 | 9.07e-02 | 8.22e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 18 | 5.06e-01 | -9.07e-02 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 264 | 1.15e-02 | 9.07e-02 | 1.24e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 6.20e-01 | 9.06e-02 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 7 | 6.78e-01 | -9.06e-02 | 8.84e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 23 | 4.52e-01 | -9.06e-02 | 7.58e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 18 | 5.06e-01 | 9.06e-02 | 7.91e-01 |
| GOBP T CELL SELECTION | 43 | 3.05e-01 | 9.06e-02 | 6.47e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1066 | 8.77e-07 | 9.05e-02 | 5.70e-05 |
| GOBP REGULATION OF XENOPHAGY | 9 | 6.38e-01 | 9.05e-02 | 8.63e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 164 | 4.61e-02 | 9.05e-02 | 2.69e-01 |
| GOBP PML BODY ORGANIZATION | 6 | 7.01e-01 | -9.04e-02 | 8.97e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 11 | 6.04e-01 | -9.04e-02 | 8.47e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 18 | 5.07e-01 | -9.04e-02 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 23 | 4.53e-01 | 9.03e-02 | 7.59e-01 |
| GOBP FLUID TRANSPORT | 13 | 5.73e-01 | 9.03e-02 | 8.30e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 6.79e-01 | 9.03e-02 | 8.84e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 258 | 1.28e-02 | 9.03e-02 | 1.32e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 18 | 5.07e-01 | 9.03e-02 | 7.91e-01 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 7.27e-01 | -9.02e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 24 | 4.45e-01 | -9.02e-02 | 7.52e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 249 | 1.46e-02 | 9.01e-02 | 1.41e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 12 | 5.89e-01 | 9.01e-02 | 8.39e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 13 | 5.74e-01 | 9.01e-02 | 8.30e-01 |
| GOBP RNA MODIFICATION | 163 | 4.77e-02 | 9.01e-02 | 2.76e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 7.02e-01 | -9.01e-02 | 8.98e-01 |
| GOBP ENDOSOMAL TRANSPORT | 208 | 2.56e-02 | 9.01e-02 | 1.98e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 252 | 1.45e-02 | 8.98e-02 | 1.41e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 24 | 4.47e-01 | -8.97e-02 | 7.54e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 60 | 2.30e-01 | 8.97e-02 | 5.79e-01 |
| GOBP MITOCHONDRIAL FISSION | 34 | 3.66e-01 | 8.96e-02 | 6.94e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 14 | 5.62e-01 | 8.96e-02 | 8.25e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 58 | 2.38e-01 | 8.96e-02 | 5.88e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 27 | 4.20e-01 | 8.96e-02 | 7.35e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 8 | 6.61e-01 | -8.96e-02 | 8.75e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 127 | 8.21e-02 | 8.95e-02 | 3.61e-01 |
| GOCC PROTEIN DNA COMPLEX | 835 | 1.42e-05 | 8.95e-02 | 6.24e-04 |
| GOBP PRESYNAPSE ORGANIZATION | 21 | 4.78e-01 | -8.95e-02 | 7.74e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 38 | 3.40e-01 | 8.95e-02 | 6.76e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 9 | 6.42e-01 | -8.95e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 9 | 6.42e-01 | 8.94e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 57 | 2.43e-01 | 8.94e-02 | 5.91e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 62 | 2.24e-01 | 8.94e-02 | 5.73e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 36 | 3.53e-01 | 8.94e-02 | 6.85e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 18 | 5.12e-01 | -8.94e-02 | 7.94e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 9 | 6.43e-01 | -8.94e-02 | 8.65e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 372 | 3.26e-03 | 8.93e-02 | 5.36e-02 |
| GOBP SNORNA LOCALIZATION | 6 | 7.05e-01 | 8.91e-02 | 9.00e-01 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 5 | 7.30e-01 | 8.91e-02 | 9.09e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 9 | 6.44e-01 | -8.91e-02 | 8.66e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 55 | 2.53e-01 | 8.91e-02 | 6.03e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 23 | 4.60e-01 | 8.91e-02 | 7.63e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 166 | 4.82e-02 | 8.91e-02 | 2.77e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 8 | 6.63e-01 | -8.91e-02 | 8.76e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 5 | 7.30e-01 | -8.91e-02 | 9.09e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 18 | 5.13e-01 | -8.91e-02 | 7.94e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 17 | 5.25e-01 | 8.90e-02 | 8.02e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 157 | 5.47e-02 | 8.90e-02 | 2.94e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 20 | 4.91e-01 | -8.90e-02 | 7.82e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 7 | 6.84e-01 | 8.89e-02 | 8.88e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 9 | 6.44e-01 | -8.89e-02 | 8.66e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 5.26e-01 | 8.89e-02 | 8.03e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 58 | 2.42e-01 | -8.88e-02 | 5.90e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 373 | 3.38e-03 | 8.88e-02 | 5.48e-02 |
| GOBP REGULATION OF BEHAVIOR | 30 | 4.00e-01 | -8.88e-02 | 7.21e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 25 | 4.42e-01 | 8.88e-02 | 7.51e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 54 | 2.59e-01 | 8.88e-02 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 30 | 4.00e-01 | -8.88e-02 | 7.21e-01 |
| GOMF CUPROUS ION BINDING | 6 | 7.06e-01 | -8.88e-02 | 9.00e-01 |
| GOBP NEURON PROJECTION REGENERATION | 30 | 4.00e-01 | 8.88e-02 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 5 | 7.31e-01 | -8.88e-02 | 9.10e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 9 | 6.45e-01 | 8.88e-02 | 8.66e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 259 | 1.43e-02 | 8.87e-02 | 1.40e-01 |
| GOBP BONE MATURATION | 13 | 5.80e-01 | -8.87e-02 | 8.34e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 6 | 7.07e-01 | -8.87e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 7.31e-01 | 8.87e-02 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 7.31e-01 | -8.87e-02 | 9.10e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 12 | 5.95e-01 | 8.86e-02 | 8.42e-01 |
| GOBP FAT CELL PROLIFERATION | 9 | 6.45e-01 | 8.86e-02 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 18 | 5.16e-01 | 8.85e-02 | 7.97e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 209 | 2.79e-02 | 8.85e-02 | 2.07e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 39 | 3.39e-01 | -8.85e-02 | 6.75e-01 |
| GOCC PHOSPHATASE COMPLEX | 47 | 2.94e-01 | 8.85e-02 | 6.40e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 101 | 1.25e-01 | 8.84e-02 | 4.40e-01 |
| GOMF GAMMA TUBULIN BINDING | 29 | 4.11e-01 | -8.83e-02 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 33 | 3.80e-01 | 8.83e-02 | 7.06e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 31 | 3.96e-01 | -8.82e-02 | 7.18e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 18 | 5.18e-01 | -8.81e-02 | 7.97e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 155 | 5.89e-02 | 8.81e-02 | 3.06e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 12 | 5.97e-01 | 8.81e-02 | 8.44e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 62 | 2.31e-01 | 8.80e-02 | 5.80e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 8 | 6.67e-01 | -8.80e-02 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 14 | 5.69e-01 | 8.80e-02 | 8.29e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 683 | 1.04e-04 | 8.80e-02 | 3.52e-03 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 66 | 2.17e-01 | 8.80e-02 | 5.65e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 25 | 4.47e-01 | 8.79e-02 | 7.54e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 182 | 4.12e-02 | 8.79e-02 | 2.51e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 5 | 7.34e-01 | -8.79e-02 | 9.10e-01 |
| GOBP THALAMUS DEVELOPMENT | 5 | 7.34e-01 | 8.79e-02 | 9.10e-01 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 5 | 7.34e-01 | 8.79e-02 | 9.10e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 92 | 1.46e-01 | 8.78e-02 | 4.73e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 135 | 7.89e-02 | 8.78e-02 | 3.52e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 7.34e-01 | 8.77e-02 | 9.10e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 16 | 5.44e-01 | -8.77e-02 | 8.14e-01 |
| GOCC SIN3 TYPE COMPLEX | 22 | 4.77e-01 | 8.76e-02 | 7.73e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 7 | 6.88e-01 | -8.76e-02 | 8.90e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.88e-01 | 8.76e-02 | 8.90e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 6.49e-01 | 8.76e-02 | 8.68e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 12 | 6.00e-01 | -8.75e-02 | 8.45e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 47 | 2.99e-01 | -8.75e-02 | 6.44e-01 |
| GOBP IMPORT INTO CELL | 539 | 5.62e-04 | 8.75e-02 | 1.42e-02 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 7 | 6.89e-01 | -8.75e-02 | 8.90e-01 |
| GOBP MALE SEX DIFFERENTIATION | 88 | 1.57e-01 | 8.74e-02 | 4.92e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 29 | 4.16e-01 | 8.73e-02 | 7.32e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 6.16e-01 | 8.73e-02 | 8.53e-01 |
| GOBP GROOMING BEHAVIOR | 5 | 7.35e-01 | 8.73e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 17 | 5.34e-01 | 8.72e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 9 | 6.51e-01 | -8.72e-02 | 8.69e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 7.36e-01 | -8.72e-02 | 9.11e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 280 | 1.24e-02 | 8.72e-02 | 1.29e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 6 | 7.12e-01 | 8.71e-02 | 9.02e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 378 | 3.83e-03 | 8.71e-02 | 5.97e-02 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.90e-01 | -8.70e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 10 | 6.34e-01 | 8.70e-02 | 8.62e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 39 | 3.48e-01 | 8.70e-02 | 6.81e-01 |
| GOBP CYTOSOLIC TRANSPORT | 160 | 5.82e-02 | 8.70e-02 | 3.04e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 78 | 1.85e-01 | -8.69e-02 | 5.29e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 36 | 3.67e-01 | 8.69e-02 | 6.95e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 52 | 2.79e-01 | 8.69e-02 | 6.29e-01 |
| GOBP NUCLEOSIDE SALVAGE | 10 | 6.35e-01 | -8.68e-02 | 8.63e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 14 | 5.74e-01 | 8.68e-02 | 8.30e-01 |
| GOBP RECEPTOR INTERNALIZATION | 77 | 1.89e-01 | 8.67e-02 | 5.34e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 10 | 6.35e-01 | 8.67e-02 | 8.63e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 25 | 4.54e-01 | -8.66e-02 | 7.59e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 7.14e-01 | 8.66e-02 | 9.02e-01 |
| GOBP SPLEEN DEVELOPMENT | 27 | 4.36e-01 | -8.66e-02 | 7.47e-01 |
| GOBP FEMALE GAMETE GENERATION | 79 | 1.84e-01 | 8.66e-02 | 5.28e-01 |
| GOCC ENDONUCLEASE COMPLEX | 35 | 3.76e-01 | 8.65e-02 | 7.03e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 62 | 2.39e-01 | 8.65e-02 | 5.88e-01 |
| GOBP PLASMA MEMBRANE FUSION | 5 | 7.38e-01 | -8.65e-02 | 9.11e-01 |
| GOBP PEROXISOME ORGANIZATION | 32 | 3.98e-01 | 8.64e-02 | 7.19e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 14 | 5.76e-01 | -8.64e-02 | 8.31e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 7.14e-01 | 8.64e-02 | 9.02e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 17 | 5.38e-01 | -8.64e-02 | 8.09e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 55 | 2.68e-01 | 8.64e-02 | 6.19e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.38e-01 | 8.63e-02 | 9.12e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 19 | 5.15e-01 | 8.63e-02 | 7.96e-01 |
| GOMF AMIDE BINDING | 228 | 2.54e-02 | 8.62e-02 | 1.97e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 78 | 1.89e-01 | 8.62e-02 | 5.33e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 6.73e-01 | -8.62e-02 | 8.81e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 39 | 3.52e-01 | -8.62e-02 | 6.84e-01 |
| GOBP INNATE IMMUNE RESPONSE | 620 | 2.85e-04 | 8.61e-02 | 8.07e-03 |
| GOMF ENZYME INHIBITOR ACTIVITY | 199 | 3.68e-02 | 8.61e-02 | 2.40e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 5 | 7.39e-01 | -8.60e-02 | 9.12e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 17 | 5.39e-01 | 8.60e-02 | 8.10e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 167 | 5.57e-02 | 8.60e-02 | 2.96e-01 |
| GOCC CHROMATOID BODY | 6 | 7.15e-01 | -8.60e-02 | 9.03e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 146 | 7.36e-02 | 8.60e-02 | 3.42e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 237 | 2.31e-02 | 8.60e-02 | 1.86e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 558 | 5.86e-04 | 8.58e-02 | 1.47e-02 |
| GOBP HORMONE METABOLIC PROCESS | 94 | 1.51e-01 | -8.58e-02 | 4.81e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 51 | 2.90e-01 | -8.58e-02 | 6.38e-01 |
| GOBP CATECHOLAMINE SECRETION | 16 | 5.53e-01 | 8.57e-02 | 8.21e-01 |
| GOBP RNA LOCALIZATION | 178 | 4.92e-02 | 8.57e-02 | 2.79e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 13 | 5.93e-01 | -8.56e-02 | 8.42e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 75 | 2.01e-01 | -8.56e-02 | 5.49e-01 |
| GOBP VIRAL TRANSCRIPTION | 47 | 3.11e-01 | 8.55e-02 | 6.53e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 40 | 3.50e-01 | -8.55e-02 | 6.83e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 5 | 7.41e-01 | -8.55e-02 | 9.12e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 99 | 1.42e-01 | 8.55e-02 | 4.65e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 6.08e-01 | -8.55e-02 | 8.50e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 45 | 3.21e-01 | 8.55e-02 | 6.62e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 116 | 1.13e-01 | 8.54e-02 | 4.16e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 117 | 1.11e-01 | 8.54e-02 | 4.15e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 6 | 7.17e-01 | -8.53e-02 | 9.04e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 28 | 4.35e-01 | -8.53e-02 | 7.46e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 47 | 3.12e-01 | -8.53e-02 | 6.55e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 10 | 6.41e-01 | 8.52e-02 | 8.65e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 6.58e-01 | 8.52e-02 | 8.73e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 9 | 6.58e-01 | -8.52e-02 | 8.73e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 32 | 4.04e-01 | -8.52e-02 | 7.24e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 7 | 6.96e-01 | -8.52e-02 | 8.95e-01 |
| GOCC GOLGI CISTERNA | 82 | 1.83e-01 | 8.51e-02 | 5.26e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 21 | 5.00e-01 | -8.51e-02 | 7.87e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 322 | 8.95e-03 | 8.51e-02 | 1.07e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 21 | 5.00e-01 | -8.51e-02 | 7.87e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 7 | 6.97e-01 | 8.51e-02 | 8.95e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 7.42e-01 | -8.51e-02 | 9.12e-01 |
| GOBP DOPAMINE TRANSPORT | 16 | 5.56e-01 | 8.51e-02 | 8.22e-01 |
| GOBP NUCLEUS ORGANIZATION | 121 | 1.07e-01 | 8.51e-02 | 4.06e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 5.69e-01 | -8.51e-02 | 8.29e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 5 | 7.42e-01 | 8.51e-02 | 9.12e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 12 | 6.10e-01 | 8.50e-02 | 8.50e-01 |
| GOBP AMELOGENESIS | 10 | 6.42e-01 | -8.50e-02 | 8.65e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 6 | 7.19e-01 | -8.50e-02 | 9.05e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 15 | 5.69e-01 | 8.49e-02 | 8.29e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 70 | 2.20e-01 | -8.49e-02 | 5.70e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 12 | 6.11e-01 | 8.49e-02 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 7 | 6.97e-01 | -8.49e-02 | 8.95e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 5 | 7.43e-01 | 8.48e-02 | 9.12e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 723 | 1.20e-04 | 8.48e-02 | 3.92e-03 |
| GOBP MACROMOLECULE METHYLATION | 179 | 5.10e-02 | 8.48e-02 | 2.83e-01 |
| GOCC CILIARY PLASM | 77 | 1.99e-01 | -8.47e-02 | 5.47e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 22 | 4.92e-01 | -8.47e-02 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 89 | 1.68e-01 | 8.46e-02 | 5.05e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 11 | 6.27e-01 | 8.46e-02 | 8.60e-01 |
| GOCC SAGA COMPLEX | 23 | 4.83e-01 | 8.45e-02 | 7.77e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 11 | 6.28e-01 | -8.45e-02 | 8.60e-01 |
| GOCC PAR POLARITY COMPLEX | 6 | 7.20e-01 | -8.45e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 17 | 5.47e-01 | 8.44e-02 | 8.16e-01 |
| GOCC MYOFILAMENT | 10 | 6.44e-01 | 8.44e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 6 | 7.21e-01 | -8.43e-02 | 9.05e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 6.99e-01 | -8.43e-02 | 8.96e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 168 | 6.01e-02 | -8.43e-02 | 3.10e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 264 | 1.89e-02 | 8.42e-02 | 1.66e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 10 | 6.45e-01 | -8.42e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 20 | 5.14e-01 | 8.42e-02 | 7.96e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 6 | 7.21e-01 | 8.42e-02 | 9.05e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 238 | 2.57e-02 | 8.42e-02 | 1.98e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 23 | 4.85e-01 | 8.42e-02 | 7.78e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 88 | 1.73e-01 | -8.42e-02 | 5.12e-01 |
| GOBP RESPONSE TO COLD | 29 | 4.33e-01 | -8.41e-02 | 7.45e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 61 | 2.56e-01 | 8.41e-02 | 6.05e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 114 | 1.21e-01 | 8.41e-02 | 4.32e-01 |
| GOBP REGULATION OF COAGULATION | 29 | 4.33e-01 | -8.41e-02 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 61 | 2.56e-01 | 8.41e-02 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 22 | 4.95e-01 | -8.41e-02 | 7.84e-01 |
| GOMF L ASCORBIC ACID BINDING | 15 | 5.73e-01 | -8.40e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 73 | 2.15e-01 | -8.40e-02 | 5.64e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 8 | 6.81e-01 | -8.40e-02 | 8.86e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 7 | 7.01e-01 | 8.39e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 524 | 1.10e-03 | 8.39e-02 | 2.35e-02 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 51 | 3.01e-01 | 8.38e-02 | 6.45e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 69 | 2.29e-01 | 8.38e-02 | 5.78e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 6 | 7.22e-01 | -8.38e-02 | 9.06e-01 |
| GOBP STEROL TRANSPORT | 76 | 2.07e-01 | 8.38e-02 | 5.56e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 40 | 3.59e-01 | 8.38e-02 | 6.88e-01 |
| GOBP AXONAL TRANSPORT | 53 | 2.92e-01 | -8.37e-02 | 6.40e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 85 | 1.83e-01 | -8.36e-02 | 5.26e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 240 | 2.62e-02 | 8.36e-02 | 2.01e-01 |
| GOBP EAR DEVELOPMENT | 84 | 1.86e-01 | -8.36e-02 | 5.30e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 7.23e-01 | 8.35e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 231 | 2.93e-02 | 8.35e-02 | 2.14e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 9 | 6.65e-01 | 8.35e-02 | 8.77e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 77 | 2.06e-01 | 8.35e-02 | 5.54e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 10 | 6.48e-01 | 8.35e-02 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 108 | 1.35e-01 | 8.35e-02 | 4.52e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 5 | 7.47e-01 | -8.34e-02 | 9.15e-01 |
| GOCC CELL DIVISION SITE | 58 | 2.72e-01 | 8.34e-02 | 6.22e-01 |
| GOBP AORTA DEVELOPMENT | 27 | 4.54e-01 | 8.34e-02 | 7.59e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 19 | 5.30e-01 | 8.33e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 10 | 6.48e-01 | 8.33e-02 | 8.68e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 13 | 6.03e-01 | 8.33e-02 | 8.47e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 142 | 8.73e-02 | -8.33e-02 | 3.71e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 56 | 2.82e-01 | -8.33e-02 | 6.29e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 29 | 4.38e-01 | 8.32e-02 | 7.48e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 7 | 7.03e-01 | -8.32e-02 | 8.99e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 30 | 4.31e-01 | -8.31e-02 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 9 | 6.66e-01 | -8.31e-02 | 8.77e-01 |
| GOBP MICROTUBULE BASED PROCESS | 644 | 3.64e-04 | 8.31e-02 | 9.91e-03 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 8 | 6.84e-01 | 8.31e-02 | 8.88e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 41 | 3.58e-01 | -8.30e-02 | 6.87e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 5 | 7.48e-01 | -8.30e-02 | 9.15e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 6.66e-01 | 8.30e-02 | 8.77e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 260 | 2.17e-02 | 8.30e-02 | 1.79e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 148 | 8.22e-02 | 8.30e-02 | 3.61e-01 |
| GOBP LEUCINE TRANSPORT | 7 | 7.04e-01 | 8.29e-02 | 8.99e-01 |
| GOCC NODE OF RANVIER | 8 | 6.85e-01 | 8.29e-02 | 8.88e-01 |
| GOBP T CELL PROLIFERATION | 154 | 7.68e-02 | 8.28e-02 | 3.47e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 5 | 7.49e-01 | 8.28e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 25 | 4.74e-01 | 8.28e-02 | 7.71e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 26 | 4.65e-01 | 8.28e-02 | 7.65e-01 |
| GOBP ER OVERLOAD RESPONSE | 10 | 6.50e-01 | 8.28e-02 | 8.69e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 503 | 1.61e-03 | 8.27e-02 | 3.19e-02 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 46 | 3.32e-01 | -8.27e-02 | 6.69e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 27 | 4.57e-01 | 8.27e-02 | 7.61e-01 |
| GOCC U1 SNRNP | 19 | 5.33e-01 | 8.27e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 11 | 6.35e-01 | -8.26e-02 | 8.63e-01 |
| GOBP CELLULAR HOMEOSTASIS | 481 | 2.06e-03 | 8.26e-02 | 3.85e-02 |
| GOCC BASAL PART OF CELL | 152 | 7.95e-02 | 8.26e-02 | 3.53e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 58 | 2.77e-01 | 8.26e-02 | 6.27e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 38 | 3.79e-01 | 8.25e-02 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 133 | 1.01e-01 | 8.25e-02 | 4.00e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 6.86e-01 | 8.25e-02 | 8.89e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 13 | 6.07e-01 | 8.25e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 32 | 4.20e-01 | -8.25e-02 | 7.35e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 23 | 4.94e-01 | -8.24e-02 | 7.84e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 72 | 2.27e-01 | -8.24e-02 | 5.76e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 6.21e-01 | -8.24e-02 | 8.56e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 28 | 4.51e-01 | 8.23e-02 | 7.57e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 15 | 5.81e-01 | 8.23e-02 | 8.35e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 7.50e-01 | 8.23e-02 | 9.15e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 39 | 3.75e-01 | 8.22e-02 | 7.01e-01 |
| GOBP IRON ION TRANSPORT | 33 | 4.14e-01 | -8.22e-02 | 7.30e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 8 | 6.88e-01 | -8.21e-02 | 8.90e-01 |
| GOMF AMINO ACID BINDING | 20 | 5.25e-01 | 8.21e-02 | 8.02e-01 |
| GOBP ICOSANOID TRANSPORT | 22 | 5.06e-01 | -8.20e-02 | 7.91e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 83 | 1.97e-01 | 8.20e-02 | 5.43e-01 |
| GOBP PLATELET DEGRANULATION | 6 | 7.28e-01 | -8.20e-02 | 9.09e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 15 | 5.83e-01 | 8.20e-02 | 8.36e-01 |
| GOMF C C CHEMOKINE BINDING | 15 | 5.83e-01 | -8.19e-02 | 8.36e-01 |
| GOCC INTERCALATED DISC | 25 | 4.79e-01 | -8.19e-02 | 7.74e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 28 | 4.54e-01 | -8.19e-02 | 7.59e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 806 | 9.37e-05 | 8.19e-02 | 3.23e-03 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 13 | 6.10e-01 | -8.18e-02 | 8.50e-01 |
| GOBP REGULATION OF AUTOPHAGY | 297 | 1.57e-02 | 8.18e-02 | 1.48e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 25 | 4.79e-01 | -8.18e-02 | 7.74e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 6.89e-01 | -8.18e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 16 | 5.71e-01 | -8.18e-02 | 8.29e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 7 | 7.08e-01 | -8.17e-02 | 9.01e-01 |
| GOBP L SERINE TRANSPORT | 7 | 7.08e-01 | 8.17e-02 | 9.01e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.08e-01 | 8.17e-02 | 9.01e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 479 | 2.35e-03 | 8.17e-02 | 4.23e-02 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 101 | 1.57e-01 | 8.16e-02 | 4.92e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 44 | 3.50e-01 | -8.15e-02 | 6.83e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 24 | 4.90e-01 | -8.15e-02 | 7.81e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 7.52e-01 | 8.15e-02 | 9.17e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 18 | 5.50e-01 | 8.14e-02 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 66 | 2.53e-01 | 8.14e-02 | 6.02e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 22 | 5.09e-01 | -8.14e-02 | 7.91e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 6.25e-01 | 8.14e-02 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 15 | 5.85e-01 | 8.14e-02 | 8.38e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 35 | 4.05e-01 | -8.14e-02 | 7.24e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 29 | 4.49e-01 | 8.13e-02 | 7.55e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 62 | 2.69e-01 | 8.13e-02 | 6.19e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 25 | 4.82e-01 | 8.13e-02 | 7.76e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 156 | 8.05e-02 | 8.13e-02 | 3.56e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 15 | 5.86e-01 | -8.12e-02 | 8.38e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 5 | 7.53e-01 | 8.12e-02 | 9.17e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 6.91e-01 | -8.12e-02 | 8.92e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 54 | 3.02e-01 | 8.12e-02 | 6.47e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 23 | 5.00e-01 | -8.12e-02 | 7.88e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 72 | 2.34e-01 | 8.12e-02 | 5.83e-01 |
| GOBP REGULATION OF BONE REMODELING | 26 | 4.74e-01 | -8.12e-02 | 7.71e-01 |
| GOCC TIGHT JUNCTION | 67 | 2.51e-01 | -8.12e-02 | 6.00e-01 |
| GOBP ACUTE PHASE RESPONSE | 17 | 5.63e-01 | 8.11e-02 | 8.25e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 26 | 4.74e-01 | 8.11e-02 | 7.71e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 247 | 2.87e-02 | 8.11e-02 | 2.11e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 129 | 1.13e-01 | 8.11e-02 | 4.16e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 5 | 7.54e-01 | 8.10e-02 | 9.17e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 625 | 6.16e-04 | -8.10e-02 | 1.53e-02 |
| GOBP CHEMOKINE PRODUCTION | 57 | 2.91e-01 | -8.08e-02 | 6.39e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 43 | 3.60e-01 | 8.08e-02 | 6.88e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 22 | 5.12e-01 | -8.08e-02 | 7.94e-01 |
| GOBP RESPONSE TO VIRUS | 318 | 1.37e-02 | 8.08e-02 | 1.37e-01 |
| GOMF CLATHRIN BINDING | 46 | 3.44e-01 | 8.07e-02 | 6.79e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 19 | 5.43e-01 | 8.07e-02 | 8.13e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 31 | 4.37e-01 | 8.07e-02 | 7.47e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 9 | 6.75e-01 | 8.07e-02 | 8.82e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 13 | 6.15e-01 | -8.06e-02 | 8.52e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 7.55e-01 | -8.06e-02 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 5 | 7.55e-01 | -8.06e-02 | 9.17e-01 |
| GOMF RNA CAP BINDING | 19 | 5.43e-01 | 8.05e-02 | 8.14e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 25 | 4.86e-01 | 8.05e-02 | 7.78e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 29 | 4.53e-01 | 8.05e-02 | 7.59e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 7 | 7.12e-01 | 8.05e-02 | 9.02e-01 |
| GOBP THYMOCYTE MIGRATION | 7 | 7.12e-01 | 8.04e-02 | 9.02e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 72 | 2.39e-01 | 8.04e-02 | 5.88e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 17 | 5.66e-01 | -8.04e-02 | 8.29e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 7.13e-01 | 8.03e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 30 | 4.47e-01 | 8.03e-02 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 5 | 7.56e-01 | 8.03e-02 | 9.17e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 7.56e-01 | 8.02e-02 | 9.17e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 63 | 2.71e-01 | 8.02e-02 | 6.20e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 14 | 6.03e-01 | 8.02e-02 | 8.47e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 7.34e-01 | -8.02e-02 | 9.10e-01 |
| GOBP WOUND HEALING | 227 | 3.81e-02 | 8.01e-02 | 2.42e-01 |
| GOBP DETECTION OF STIMULUS | 92 | 1.85e-01 | -8.01e-02 | 5.28e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 55 | 3.04e-01 | 8.01e-02 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 30 | 4.48e-01 | -8.01e-02 | 7.54e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 270 | 2.41e-02 | 8.01e-02 | 1.91e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 62 | 2.76e-01 | -8.00e-02 | 6.26e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 139 | 1.04e-01 | 8.00e-02 | 4.03e-01 |
| GOMF DEMETHYLASE ACTIVITY | 34 | 4.20e-01 | -8.00e-02 | 7.35e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 78 | 2.23e-01 | 7.99e-02 | 5.72e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 6.62e-01 | 7.99e-02 | 8.75e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 59 | 2.89e-01 | 7.99e-02 | 6.37e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 7.14e-01 | 7.99e-02 | 9.02e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 23 | 5.08e-01 | -7.98e-02 | 7.91e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 65 | 2.66e-01 | -7.98e-02 | 6.17e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 12 | 6.32e-01 | -7.98e-02 | 8.62e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 23 | 5.08e-01 | 7.98e-02 | 7.91e-01 |
| GOMF IRON ION BINDING | 65 | 2.66e-01 | 7.98e-02 | 6.17e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 61 | 2.81e-01 | 7.98e-02 | 6.29e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 108 | 1.53e-01 | 7.98e-02 | 4.84e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 9 | 6.79e-01 | -7.97e-02 | 8.84e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 8 | 6.96e-01 | 7.97e-02 | 8.95e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1303 | 2.18e-06 | 7.96e-02 | 1.21e-04 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 6.63e-01 | -7.96e-02 | 8.76e-01 |
| GOMF REGULATORY RNA BINDING | 41 | 3.78e-01 | -7.96e-02 | 7.05e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 58 | 2.95e-01 | 7.96e-02 | 6.40e-01 |
| GOCC NON MOTILE CILIUM | 77 | 2.28e-01 | -7.95e-02 | 5.78e-01 |
| GOBP ECTODERM DEVELOPMENT | 13 | 6.20e-01 | 7.95e-02 | 8.55e-01 |
| GOBP MYELIN ASSEMBLY | 12 | 6.34e-01 | -7.95e-02 | 8.62e-01 |
| GOBP NUCLEOBASE TRANSPORT | 6 | 7.36e-01 | 7.94e-02 | 9.11e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 17 | 5.71e-01 | 7.93e-02 | 8.29e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 644 | 6.63e-04 | 7.93e-02 | 1.62e-02 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 6 | 7.37e-01 | 7.93e-02 | 9.11e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 35 | 4.17e-01 | 7.93e-02 | 7.32e-01 |
| GOCC SMN COMPLEX | 10 | 6.64e-01 | 7.93e-02 | 8.76e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 14 | 6.08e-01 | -7.93e-02 | 8.50e-01 |
| GOMF ALKALI METAL ION BINDING | 10 | 6.64e-01 | -7.92e-02 | 8.77e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 356 | 1.06e-02 | 7.92e-02 | 1.18e-01 |
| GOBP VESICLE LOCALIZATION | 166 | 7.90e-02 | 7.92e-02 | 3.52e-01 |
| GOMF GATED CHANNEL ACTIVITY | 91 | 1.92e-01 | 7.92e-02 | 5.38e-01 |
| GOBP LEUKOCYTE AGGREGATION | 10 | 6.65e-01 | -7.90e-02 | 8.77e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 13 | 6.22e-01 | 7.90e-02 | 8.56e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 55 | 3.11e-01 | 7.90e-02 | 6.54e-01 |
| GOBP EXOCYTOSIS | 221 | 4.36e-02 | 7.90e-02 | 2.60e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 116 | 1.42e-01 | -7.90e-02 | 4.65e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 62 | 2.83e-01 | 7.90e-02 | 6.31e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 131 | 1.19e-01 | -7.89e-02 | 4.28e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 52 | 3.26e-01 | 7.89e-02 | 6.64e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 6 | 7.38e-01 | -7.89e-02 | 9.11e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 63 | 2.79e-01 | -7.89e-02 | 6.29e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 189 | 6.23e-02 | 7.88e-02 | 3.17e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 14 | 6.10e-01 | 7.88e-02 | 8.50e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 74 | 2.42e-01 | 7.88e-02 | 5.90e-01 |
| GOBP EGG ACTIVATION | 5 | 7.60e-01 | 7.88e-02 | 9.18e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 105 | 1.64e-01 | 7.88e-02 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 28 | 4.71e-01 | -7.87e-02 | 7.69e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 7 | 7.18e-01 | 7.87e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 37 | 4.08e-01 | -7.87e-02 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 92 | 1.93e-01 | 7.87e-02 | 5.38e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 125 | 1.30e-01 | 7.87e-02 | 4.46e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 40 | 3.90e-01 | 7.86e-02 | 7.12e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 6.67e-01 | 7.86e-02 | 8.78e-01 |
| GOBP VALINE METABOLIC PROCESS | 6 | 7.39e-01 | -7.86e-02 | 9.12e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 21 | 5.33e-01 | 7.85e-02 | 8.06e-01 |
| GOMF MYOSIN BINDING | 40 | 3.91e-01 | 7.84e-02 | 7.13e-01 |
| GOCC MICROBODY | 114 | 1.49e-01 | 7.84e-02 | 4.78e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 12 | 6.38e-01 | 7.84e-02 | 8.63e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 16 | 5.88e-01 | 7.83e-02 | 8.39e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 18 | 5.65e-01 | -7.83e-02 | 8.27e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 6 | 7.40e-01 | -7.83e-02 | 9.12e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 37 | 4.10e-01 | 7.83e-02 | 7.28e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 29 | 4.66e-01 | 7.83e-02 | 7.65e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 7 | 7.20e-01 | 7.83e-02 | 9.05e-01 |
| GOCC CLEAVAGE FURROW | 44 | 3.69e-01 | 7.83e-02 | 6.96e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 494 | 3.09e-03 | 7.83e-02 | 5.18e-02 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 7 | 7.20e-01 | -7.83e-02 | 9.05e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 12 | 6.39e-01 | 7.82e-02 | 8.63e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 8 | 7.02e-01 | 7.82e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 11 | 6.53e-01 | -7.82e-02 | 8.71e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 248 | 3.47e-02 | 7.82e-02 | 2.34e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 49 | 3.44e-01 | 7.81e-02 | 6.79e-01 |
| GOCC KERATIN FILAMENT | 6 | 7.40e-01 | 7.81e-02 | 9.12e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 43 | 3.76e-01 | 7.81e-02 | 7.03e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 6.26e-01 | 7.81e-02 | 8.59e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 11 | 6.54e-01 | 7.80e-02 | 8.71e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 51 | 3.36e-01 | 7.79e-02 | 6.73e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1023 | 3.32e-05 | 7.79e-02 | 1.30e-03 |
| GOBP HEME TRANSPORT | 5 | 7.63e-01 | 7.78e-02 | 9.19e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 5 | 7.63e-01 | 7.78e-02 | 9.19e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.63e-01 | 7.78e-02 | 9.19e-01 |
| GOBP CILIUM MOVEMENT | 76 | 2.41e-01 | -7.78e-02 | 5.90e-01 |
| GOBP B CELL HOMEOSTASIS | 30 | 4.61e-01 | 7.78e-02 | 7.64e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 18 | 5.68e-01 | 7.78e-02 | 8.29e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 22 | 5.28e-01 | 7.77e-02 | 8.04e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 21 | 5.38e-01 | 7.77e-02 | 8.09e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 263 | 3.07e-02 | 7.77e-02 | 2.18e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 25 | 5.02e-01 | -7.77e-02 | 7.89e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 61 | 2.95e-01 | 7.76e-02 | 6.40e-01 |
| GOBP SOMITOGENESIS | 29 | 4.70e-01 | 7.76e-02 | 7.68e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 84 | 2.20e-01 | -7.76e-02 | 5.70e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 5 | 7.64e-01 | -7.75e-02 | 9.19e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 21 | 5.39e-01 | 7.75e-02 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 66 | 2.77e-01 | 7.75e-02 | 6.26e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 4.86e-01 | 7.74e-02 | 7.79e-01 |
| GOBP RNA STABILIZATION | 56 | 3.17e-01 | -7.74e-02 | 6.58e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 13 | 6.29e-01 | -7.74e-02 | 8.60e-01 |
| GOCC T TUBULE | 24 | 5.12e-01 | -7.73e-02 | 7.94e-01 |
| GOBP INTRACILIARY TRANSPORT | 37 | 4.16e-01 | -7.73e-02 | 7.32e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 201 | 5.96e-02 | 7.73e-02 | 3.09e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 10 | 6.72e-01 | 7.73e-02 | 8.81e-01 |
| GOMF MANNOSE BINDING | 9 | 6.88e-01 | 7.72e-02 | 8.90e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 55 | 3.23e-01 | 7.71e-02 | 6.62e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 532 | 2.52e-03 | 7.71e-02 | 4.43e-02 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 89 | 2.09e-01 | 7.71e-02 | 5.57e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 10 | 6.73e-01 | 7.70e-02 | 8.81e-01 |
| GOBP BICARBONATE TRANSPORT | 19 | 5.61e-01 | 7.70e-02 | 8.25e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 12 | 6.44e-01 | -7.70e-02 | 8.66e-01 |
| GOBP MACROPHAGE MIGRATION | 37 | 4.18e-01 | 7.70e-02 | 7.33e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 30 | 4.66e-01 | -7.69e-02 | 7.65e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 15 | 6.06e-01 | -7.69e-02 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 13 | 6.31e-01 | -7.69e-02 | 8.62e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 38 | 4.13e-01 | -7.69e-02 | 7.30e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 20 | 5.52e-01 | 7.68e-02 | 8.21e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 87 | 2.16e-01 | -7.68e-02 | 5.65e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 93 | 2.01e-01 | -7.67e-02 | 5.49e-01 |
| GOCC AXON CYTOPLASM | 51 | 3.44e-01 | -7.67e-02 | 6.79e-01 |
| GOCC SYNAPTIC CLEFT | 6 | 7.45e-01 | 7.67e-02 | 9.14e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 57 | 3.17e-01 | 7.67e-02 | 6.58e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 22 | 5.34e-01 | 7.67e-02 | 8.06e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 5 | 7.67e-01 | -7.66e-02 | 9.21e-01 |
| GOBP MUSCLE CONTRACTION | 150 | 1.06e-01 | 7.66e-02 | 4.06e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 199 | 6.33e-02 | 7.66e-02 | 3.19e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 12 | 6.46e-01 | 7.65e-02 | 8.66e-01 |
| GOBP NEURAL TUBE FORMATION | 69 | 2.72e-01 | -7.65e-02 | 6.22e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 7.67e-01 | 7.65e-02 | 9.21e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 152 | 1.04e-01 | 7.65e-02 | 4.03e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 7 | 7.26e-01 | -7.64e-02 | 9.08e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 5.54e-01 | 7.64e-02 | 8.21e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 18 | 5.75e-01 | -7.64e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 28 | 4.85e-01 | -7.64e-02 | 7.77e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 16 | 5.97e-01 | 7.63e-02 | 8.44e-01 |
| GOCC NUCLEAR ENVELOPE | 393 | 9.87e-03 | 7.63e-02 | 1.13e-01 |
| GOBP VACUOLAR TRANSPORT | 146 | 1.13e-01 | 7.62e-02 | 4.16e-01 |
| GOMF NUCLEOSIDE BINDING | 7 | 7.27e-01 | 7.62e-02 | 9.08e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 191 | 7.02e-02 | -7.62e-02 | 3.34e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 120 | 1.51e-01 | 7.61e-02 | 4.81e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 165 | 9.28e-02 | 7.60e-02 | 3.83e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 6 | 7.47e-01 | 7.60e-02 | 9.15e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 6.49e-01 | 7.60e-02 | 8.68e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 7 | 7.28e-01 | 7.60e-02 | 9.09e-01 |
| GOCC MICROTUBULE | 325 | 1.91e-02 | 7.59e-02 | 1.67e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 7.28e-01 | -7.59e-02 | 9.09e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 175 | 8.40e-02 | 7.59e-02 | 3.65e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 8 | 7.10e-01 | -7.59e-02 | 9.02e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 7.48e-01 | -7.58e-02 | 9.15e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 126 | 1.42e-01 | 7.58e-02 | 4.65e-01 |
| GOBP INORGANIC ANION TRANSPORT | 72 | 2.66e-01 | 7.58e-02 | 6.17e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 5.78e-01 | -7.58e-02 | 8.32e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 5 | 7.69e-01 | -7.57e-02 | 9.21e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 114 | 1.64e-01 | -7.56e-02 | 4.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 124 | 1.47e-01 | 7.56e-02 | 4.75e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 11 | 6.64e-01 | -7.56e-02 | 8.77e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 17 | 5.90e-01 | -7.56e-02 | 8.39e-01 |
| GOBP EOSINOPHIL ACTIVATION | 7 | 7.29e-01 | -7.55e-02 | 9.09e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 7 | 7.29e-01 | 7.55e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 15 | 6.13e-01 | 7.54e-02 | 8.51e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 19 | 5.69e-01 | 7.54e-02 | 8.29e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 10 | 6.80e-01 | -7.54e-02 | 8.85e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 5 | 7.70e-01 | 7.54e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 20 | 5.60e-01 | 7.53e-02 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 8 | 7.12e-01 | 7.53e-02 | 9.02e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 7 | 7.30e-01 | 7.53e-02 | 9.09e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 44 | 3.88e-01 | 7.52e-02 | 7.11e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 71 | 2.74e-01 | 7.52e-02 | 6.23e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 52 | 3.49e-01 | 7.52e-02 | 6.82e-01 |
| GOBP MANGANESE ION TRANSPORT | 8 | 7.13e-01 | -7.52e-02 | 9.02e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 69 | 2.81e-01 | -7.51e-02 | 6.29e-01 |
| GOMF PEPTIDE BINDING | 174 | 8.82e-02 | 7.51e-02 | 3.73e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 92 | 2.14e-01 | 7.51e-02 | 5.63e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 28 | 4.92e-01 | 7.51e-02 | 7.82e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 12 | 6.53e-01 | 7.51e-02 | 8.70e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 115 | 1.65e-01 | 7.50e-02 | 5.00e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 3.46e-01 | 7.49e-02 | 6.80e-01 |
| GOCC MYOSIN FILAMENT | 8 | 7.14e-01 | -7.49e-02 | 9.02e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 13 | 6.40e-01 | 7.49e-02 | 8.64e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 12 | 6.53e-01 | -7.49e-02 | 8.71e-01 |
| GOMF VIRION BINDING | 5 | 7.72e-01 | 7.48e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 109 | 1.78e-01 | 7.47e-02 | 5.20e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 7.72e-01 | -7.47e-02 | 9.22e-01 |
| GOBP NUCLEAR TRANSPORT | 280 | 3.23e-02 | 7.46e-02 | 2.25e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 29 | 4.87e-01 | -7.46e-02 | 7.79e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 27 | 5.03e-01 | 7.45e-02 | 7.90e-01 |
| GOBP B CELL DIFFERENTIATION | 105 | 1.88e-01 | 7.45e-02 | 5.33e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 47 | 3.78e-01 | 7.44e-02 | 7.05e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 135 | 1.36e-01 | 7.44e-02 | 4.54e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 9 | 6.99e-01 | -7.44e-02 | 8.96e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 152 | 1.14e-01 | 7.43e-02 | 4.19e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 24 | 5.29e-01 | -7.43e-02 | 8.04e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 17 | 5.96e-01 | 7.43e-02 | 8.43e-01 |
| GOBP CELLULAR SENESCENCE | 83 | 2.43e-01 | 7.43e-02 | 5.91e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 7.53e-01 | 7.43e-02 | 9.17e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 40 | 4.17e-01 | 7.43e-02 | 7.32e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 64 | 3.05e-01 | 7.43e-02 | 6.47e-01 |
| GOBP VASCULOGENESIS | 37 | 4.35e-01 | -7.42e-02 | 7.46e-01 |
| GOBP COPPER ION HOMEOSTASIS | 16 | 6.07e-01 | -7.42e-02 | 8.50e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 16 | 6.07e-01 | -7.42e-02 | 8.50e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 14 | 6.31e-01 | -7.42e-02 | 8.61e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 45 | 3.90e-01 | 7.42e-02 | 7.12e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 82 | 2.46e-01 | -7.41e-02 | 5.94e-01 |
| GOBP RESPONSE TO HEAT | 70 | 2.84e-01 | 7.41e-02 | 6.32e-01 |
| GOCC MYOSIN COMPLEX | 26 | 5.13e-01 | 7.41e-02 | 7.94e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 116 | 1.69e-01 | 7.41e-02 | 5.05e-01 |
| GOCC APICAL DENDRITE | 12 | 6.57e-01 | -7.41e-02 | 8.73e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 56 | 3.38e-01 | 7.41e-02 | 6.74e-01 |
| GOBP RESPONSE TO VITAMIN E | 5 | 7.74e-01 | 7.41e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 41 | 4.12e-01 | -7.41e-02 | 7.30e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 24 | 5.31e-01 | 7.39e-02 | 8.05e-01 |
| GOBP VACUOLE ORGANIZATION | 195 | 7.59e-02 | 7.39e-02 | 3.45e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 7 | 7.35e-01 | -7.39e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 18 | 5.88e-01 | 7.39e-02 | 8.39e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 5 | 7.75e-01 | 7.39e-02 | 9.23e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 5 | 7.75e-01 | -7.38e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 52 | 3.58e-01 | -7.38e-02 | 6.87e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 6 | 7.54e-01 | 7.38e-02 | 9.17e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 755 | 6.46e-04 | 7.37e-02 | 1.58e-02 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 14 | 6.33e-01 | 7.37e-02 | 8.62e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 10 | 6.87e-01 | 7.37e-02 | 8.89e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 16 | 6.10e-01 | 7.36e-02 | 8.50e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 193 | 7.85e-02 | 7.36e-02 | 3.51e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 150 | 1.21e-01 | 7.36e-02 | 4.31e-01 |
| GOBP MELANOSOME ASSEMBLY | 18 | 5.89e-01 | 7.35e-02 | 8.39e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 11 | 6.73e-01 | -7.35e-02 | 8.81e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.55e-01 | 7.35e-02 | 9.17e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 47 | 3.84e-01 | 7.35e-02 | 7.08e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 68 | 2.95e-01 | -7.35e-02 | 6.40e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 25 | 5.26e-01 | 7.34e-02 | 8.03e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 19 | 5.80e-01 | -7.33e-02 | 8.34e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 7.56e-01 | -7.33e-02 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 34 | 4.60e-01 | 7.33e-02 | 7.63e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 122 | 1.63e-01 | 7.33e-02 | 4.98e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 7.77e-01 | 7.33e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 7.77e-01 | 7.33e-02 | 9.23e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 18 | 5.91e-01 | -7.32e-02 | 8.40e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 20 | 5.71e-01 | 7.32e-02 | 8.29e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 53 | 3.57e-01 | 7.32e-02 | 6.87e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 7.77e-01 | -7.32e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 65 | 3.08e-01 | 7.32e-02 | 6.51e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 33 | 4.68e-01 | 7.31e-02 | 7.67e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 13 | 6.48e-01 | -7.31e-02 | 8.68e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 6 | 7.57e-01 | -7.31e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 12 | 6.61e-01 | 7.31e-02 | 8.75e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 48 | 3.82e-01 | -7.30e-02 | 7.07e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 6 | 7.57e-01 | -7.30e-02 | 9.17e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 64 | 3.13e-01 | -7.30e-02 | 6.55e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 36 | 4.49e-01 | 7.30e-02 | 7.55e-01 |
| GOBP T CELL HOMEOSTASIS | 39 | 4.31e-01 | 7.29e-02 | 7.43e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 372 | 1.63e-02 | 7.29e-02 | 1.52e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 42 | 4.14e-01 | 7.29e-02 | 7.30e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 16 | 6.14e-01 | 7.29e-02 | 8.52e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 39 | 4.31e-01 | 7.29e-02 | 7.44e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 7.78e-01 | 7.29e-02 | 9.24e-01 |
| GOMF TELOMERASE ACTIVITY | 5 | 7.78e-01 | 7.29e-02 | 9.24e-01 |
| GOMF U6 SNRNA BINDING | 14 | 6.37e-01 | 7.29e-02 | 8.63e-01 |
| GOMF ATPASE BINDING | 62 | 3.22e-01 | 7.28e-02 | 6.62e-01 |
| GOMF FATTY ACID BINDING | 23 | 5.46e-01 | -7.28e-02 | 8.15e-01 |
| GOBP SECRETION BY TISSUE | 18 | 5.93e-01 | 7.28e-02 | 8.42e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 9 | 7.05e-01 | -7.28e-02 | 9.00e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 32 | 4.76e-01 | 7.28e-02 | 7.73e-01 |
| GOMF LIPID BINDING | 497 | 5.82e-03 | 7.28e-02 | 8.00e-02 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 5.83e-01 | 7.28e-02 | 8.36e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 263 | 4.31e-02 | 7.27e-02 | 2.59e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 216 | 6.64e-02 | 7.27e-02 | 3.27e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 57 | 3.43e-01 | -7.26e-02 | 6.79e-01 |
| GOMF PHOSPHOLIPID BINDING | 313 | 2.78e-02 | 7.26e-02 | 2.07e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 67 | 3.04e-01 | 7.26e-02 | 6.47e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 637 | 1.94e-03 | 7.26e-02 | 3.69e-02 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 7 | 7.39e-01 | 7.26e-02 | 9.12e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 7 | 7.39e-01 | 7.26e-02 | 9.12e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 31 | 4.85e-01 | -7.26e-02 | 7.77e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 84 | 2.51e-01 | 7.26e-02 | 5.99e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 76 | 2.75e-01 | -7.25e-02 | 6.24e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 7.58e-01 | -7.25e-02 | 9.18e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 12 | 6.64e-01 | -7.25e-02 | 8.76e-01 |
| GOBP DUMP CATABOLIC PROCESS | 5 | 7.79e-01 | 7.24e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 7.79e-01 | 7.24e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 5 | 7.79e-01 | 7.24e-02 | 9.24e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 9 | 7.07e-01 | 7.24e-02 | 9.00e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 110 | 1.91e-01 | 7.24e-02 | 5.36e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 5.85e-01 | 7.23e-02 | 8.38e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 6 | 7.59e-01 | 7.23e-02 | 9.18e-01 |
| GOBP TOLERANCE INDUCTION | 23 | 5.49e-01 | 7.23e-02 | 8.17e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 7.41e-01 | 7.23e-02 | 9.12e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 7 | 7.41e-01 | 7.23e-02 | 9.12e-01 |
| GOCC PROTEIN KINASE COMPLEX | 123 | 1.67e-01 | 7.22e-02 | 5.04e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 6 | 7.60e-01 | 7.22e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 26 | 5.24e-01 | 7.22e-02 | 8.02e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 6.79e-01 | 7.22e-02 | 8.84e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 125 | 1.65e-01 | -7.21e-02 | 4.99e-01 |
| GOBP VESICLE COATING | 36 | 4.54e-01 | 7.21e-02 | 7.59e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 45 | 4.04e-01 | 7.20e-02 | 7.23e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 15 | 6.30e-01 | 7.20e-02 | 8.61e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 14 | 6.41e-01 | -7.19e-02 | 8.65e-01 |
| GOBP RESPONSE TO WATER | 7 | 7.42e-01 | -7.19e-02 | 9.12e-01 |
| GOCC INCLUSION BODY | 56 | 3.53e-01 | -7.19e-02 | 6.85e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 15 | 6.30e-01 | -7.18e-02 | 8.61e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 10 | 6.94e-01 | -7.18e-02 | 8.94e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 20 | 5.79e-01 | 7.18e-02 | 8.33e-01 |
| GOCC P BODY | 85 | 2.54e-01 | 7.17e-02 | 6.03e-01 |
| GOCC CELL CELL JUNCTION | 272 | 4.26e-02 | 7.17e-02 | 2.57e-01 |
| GOBP SEGMENTATION | 41 | 4.27e-01 | 7.17e-02 | 7.41e-01 |
| GOBP ENDODERM FORMATION | 25 | 5.35e-01 | 7.16e-02 | 8.08e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 16 | 6.20e-01 | -7.16e-02 | 8.55e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 53 | 3.68e-01 | 7.16e-02 | 6.95e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 58 | 3.46e-01 | 7.15e-02 | 6.80e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 7.43e-01 | 7.15e-02 | 9.13e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 118 | 1.81e-01 | -7.14e-02 | 5.23e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 62 | 3.31e-01 | 7.14e-02 | 6.68e-01 |
| GOCC GOLGI STACK | 107 | 2.03e-01 | 7.14e-02 | 5.50e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 18 | 6.00e-01 | -7.14e-02 | 8.45e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 6.11e-01 | 7.14e-02 | 8.50e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 18 | 6.01e-01 | -7.12e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 7.83e-01 | 7.12e-02 | 9.25e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 33 | 4.80e-01 | -7.12e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 18 | 6.01e-01 | 7.11e-02 | 8.46e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 14 | 6.45e-01 | 7.11e-02 | 8.66e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 227 | 6.61e-02 | 7.10e-02 | 3.26e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 6.13e-01 | -7.10e-02 | 8.51e-01 |
| GOBP COPII COATED VESICLE BUDDING | 41 | 4.33e-01 | 7.09e-02 | 7.44e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 6 | 7.64e-01 | 7.09e-02 | 9.19e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 13 | 6.58e-01 | 7.08e-02 | 8.73e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 7.84e-01 | 7.08e-02 | 9.25e-01 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 7.84e-01 | 7.08e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 20 | 5.84e-01 | 7.08e-02 | 8.36e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 62 | 3.36e-01 | 7.07e-02 | 6.73e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 7.14e-01 | 7.07e-02 | 9.02e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 9 | 7.14e-01 | -7.07e-02 | 9.02e-01 |
| GOBP RESPONSE TO ALCOHOL | 148 | 1.39e-01 | 7.06e-02 | 4.59e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 223 | 7.01e-02 | 7.06e-02 | 3.34e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 521 | 6.21e-03 | 7.06e-02 | 8.37e-02 |
| GOBP INTERFERON ALPHA PRODUCTION | 21 | 5.76e-01 | 7.05e-02 | 8.31e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 60 | 3.45e-01 | 7.05e-02 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 47 | 4.04e-01 | 7.05e-02 | 7.23e-01 |
| GOBP P38MAPK CASCADE | 39 | 4.47e-01 | -7.04e-02 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 36 | 4.65e-01 | -7.04e-02 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 14 | 6.48e-01 | -7.04e-02 | 8.68e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 135 | 1.59e-01 | -7.03e-02 | 4.93e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 17 | 6.16e-01 | 7.03e-02 | 8.52e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 8 | 7.31e-01 | -7.03e-02 | 9.10e-01 |
| GOCC PLATELET DENSE GRANULE | 13 | 6.61e-01 | 7.03e-02 | 8.75e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 12 | 6.74e-01 | 7.02e-02 | 8.81e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 20 | 5.87e-01 | -7.02e-02 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 8 | 7.31e-01 | -7.02e-02 | 9.10e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 85 | 2.64e-01 | 7.01e-02 | 6.15e-01 |
| GOCC COPI COATED VESICLE | 25 | 5.44e-01 | -7.01e-02 | 8.14e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 7.86e-01 | 7.01e-02 | 9.26e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 33 | 4.86e-01 | 7.01e-02 | 7.78e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 16 | 6.27e-01 | 7.01e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 27 | 5.29e-01 | 7.01e-02 | 8.04e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1024 | 1.87e-04 | 7.01e-02 | 5.73e-03 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 10 | 7.01e-01 | 7.00e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 50 | 3.92e-01 | 7.00e-02 | 7.14e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 66 | 3.26e-01 | 6.99e-02 | 6.64e-01 |
| GOBP REGULATION OF GTP BINDING | 8 | 7.32e-01 | 6.99e-02 | 9.10e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 20 | 5.88e-01 | -6.99e-02 | 8.39e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 7 | 7.49e-01 | -6.99e-02 | 9.15e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 22 | 5.70e-01 | 6.99e-02 | 8.29e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 86 | 2.63e-01 | -6.99e-02 | 6.14e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 13 | 6.63e-01 | -6.99e-02 | 8.76e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 22 | 5.71e-01 | 6.98e-02 | 8.29e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 9 | 7.17e-01 | 6.98e-02 | 9.04e-01 |
| GOBP REGULATED EXOCYTOSIS | 136 | 1.61e-01 | 6.98e-02 | 4.95e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 69 | 3.17e-01 | -6.98e-02 | 6.58e-01 |
| GOCC AUTOPHAGOSOME | 99 | 2.31e-01 | 6.97e-02 | 5.80e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 245 | 6.14e-02 | 6.96e-02 | 3.15e-01 |
| GOMF SYNTAXIN BINDING | 45 | 4.19e-01 | 6.96e-02 | 7.35e-01 |
| GOBP PEROXISOME FISSION | 7 | 7.50e-01 | 6.96e-02 | 9.15e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 21 | 5.81e-01 | 6.95e-02 | 8.35e-01 |
| GOBP NEPHRIC DUCT DEVELOPMENT | 6 | 7.68e-01 | -6.95e-02 | 9.21e-01 |
| GOCC CLATHRIN COATED PIT | 53 | 3.82e-01 | 6.95e-02 | 7.07e-01 |
| GOCC SYMMETRIC SYNAPSE | 5 | 7.88e-01 | -6.94e-02 | 9.28e-01 |
| GOCC EXCITATORY SYNAPSE | 23 | 5.65e-01 | -6.93e-02 | 8.27e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 395 | 1.88e-02 | 6.92e-02 | 1.65e-01 |
| GOBP SODIUM ION TRANSPORT | 95 | 2.44e-01 | 6.92e-02 | 5.92e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 105 | 2.21e-01 | 6.92e-02 | 5.72e-01 |
| GOCC COSTAMERE | 10 | 7.05e-01 | 6.92e-02 | 9.00e-01 |
| GOMF SNRNP BINDING | 9 | 7.20e-01 | -6.91e-02 | 9.05e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 77 | 2.95e-01 | -6.91e-02 | 6.40e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 16 | 6.32e-01 | 6.91e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 262 | 5.51e-02 | 6.91e-02 | 2.94e-01 |
| GOCC SPERM HEAD | 6 | 7.70e-01 | -6.91e-02 | 9.22e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 66 | 3.32e-01 | -6.91e-02 | 6.69e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 78 | 2.92e-01 | -6.91e-02 | 6.40e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 5 | 7.89e-01 | 6.91e-02 | 9.28e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 22 | 5.75e-01 | -6.90e-02 | 8.31e-01 |
| GOCC PHAGOLYSOSOME | 5 | 7.89e-01 | -6.90e-02 | 9.28e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 168 | 1.24e-01 | 6.90e-02 | 4.38e-01 |
| GOBP PROTEOLYSIS | 1114 | 1.34e-04 | 6.89e-02 | 4.34e-03 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 6 | 7.70e-01 | 6.89e-02 | 9.22e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 13 | 6.68e-01 | -6.88e-02 | 8.78e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 515 | 8.01e-03 | 6.88e-02 | 9.97e-02 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 56 | 3.74e-01 | 6.88e-02 | 7.01e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 60 | 3.57e-01 | -6.88e-02 | 6.87e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 34 | 4.88e-01 | 6.87e-02 | 7.80e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 5.78e-01 | 6.86e-02 | 8.32e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 11 | 6.94e-01 | 6.86e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 108 | 2.19e-01 | 6.85e-02 | 5.69e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 423 | 1.62e-02 | 6.85e-02 | 1.51e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 886 | 6.32e-04 | 6.85e-02 | 1.56e-02 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 30 | 5.16e-01 | 6.85e-02 | 7.97e-01 |
| GOCC FLOTILLIN COMPLEX | 7 | 7.54e-01 | -6.85e-02 | 9.17e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 47 | 4.17e-01 | 6.85e-02 | 7.32e-01 |
| GOBP VESICLE ORGANIZATION | 280 | 4.96e-02 | 6.85e-02 | 2.80e-01 |
| GOMF PHOSPHATASE ACTIVITY | 192 | 1.03e-01 | 6.84e-02 | 4.02e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 33 | 4.97e-01 | 6.84e-02 | 7.85e-01 |
| GOBP B CELL PROLIFERATION | 61 | 3.56e-01 | -6.84e-02 | 6.87e-01 |
| GOBP FORELIMB MORPHOGENESIS | 19 | 6.06e-01 | -6.83e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 5 | 7.91e-01 | -6.83e-02 | 9.29e-01 |
| GOBP PIGMENT ACCUMULATION | 10 | 7.09e-01 | -6.83e-02 | 9.01e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 7.09e-01 | -6.83e-02 | 9.01e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 15 | 6.47e-01 | -6.82e-02 | 8.67e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 11 | 6.95e-01 | -6.82e-02 | 8.95e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 23 | 5.71e-01 | 6.82e-02 | 8.29e-01 |
| GOBP SULFATE TRANSPORT | 8 | 7.38e-01 | -6.82e-02 | 9.12e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 10 | 7.09e-01 | 6.82e-02 | 9.01e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 183 | 1.13e-01 | 6.82e-02 | 4.16e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 14 | 6.59e-01 | 6.82e-02 | 8.74e-01 |
| GOCC PRERIBOSOME | 103 | 2.33e-01 | -6.81e-02 | 5.81e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 122 | 1.95e-01 | 6.81e-02 | 5.41e-01 |
| GOBP ARGININE METABOLIC PROCESS | 11 | 6.96e-01 | 6.81e-02 | 8.95e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 52 | 3.96e-01 | 6.80e-02 | 7.19e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 10 | 7.10e-01 | 6.80e-02 | 9.01e-01 |
| GOBP TISSUE REGENERATION | 38 | 4.68e-01 | 6.80e-02 | 7.67e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 6.38e-01 | 6.80e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 13 | 6.71e-01 | -6.80e-02 | 8.80e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 7.92e-01 | 6.80e-02 | 9.30e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1071 | 2.17e-04 | 6.79e-02 | 6.40e-03 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 844 | 9.29e-04 | 6.79e-02 | 2.05e-02 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 175 | 1.22e-01 | -6.79e-02 | 4.34e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 8 | 7.40e-01 | 6.79e-02 | 9.12e-01 |
| GOBP CELL CELL SIGNALING BY WNT | 261 | 6.01e-02 | -6.79e-02 | 3.10e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 69 | 3.31e-01 | 6.78e-02 | 6.67e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 8 | 7.40e-01 | 6.78e-02 | 9.12e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 8 | 7.40e-01 | -6.77e-02 | 9.12e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 135 | 1.75e-01 | 6.77e-02 | 5.16e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 23 | 5.75e-01 | -6.77e-02 | 8.30e-01 |
| GOBP REGULATION OF VESICLE FUSION | 11 | 6.98e-01 | 6.76e-02 | 8.96e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 9 | 7.25e-01 | 6.76e-02 | 9.08e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 7.25e-01 | 6.76e-02 | 9.08e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 602 | 5.01e-03 | 6.75e-02 | 7.24e-02 |
| GOBP SECRETORY GRANULE LOCALIZATION | 8 | 7.41e-01 | -6.75e-02 | 9.12e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 512 | 9.50e-03 | 6.74e-02 | 1.10e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 208 | 9.47e-02 | 6.74e-02 | 3.87e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 260 | 6.28e-02 | 6.73e-02 | 3.18e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 33 | 5.04e-01 | 6.72e-02 | 7.90e-01 |
| GOMF FAD BINDING | 26 | 5.53e-01 | 6.72e-02 | 8.21e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 7.95e-01 | 6.72e-02 | 9.31e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 34 | 4.98e-01 | -6.72e-02 | 7.86e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 7 | 7.58e-01 | -6.72e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 15 | 6.53e-01 | -6.71e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 11 | 7.00e-01 | 6.71e-02 | 8.96e-01 |
| GOBP VACUOLAR ACIDIFICATION | 31 | 5.18e-01 | 6.71e-02 | 7.97e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 13 | 6.76e-01 | 6.70e-02 | 8.83e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 75 | 3.16e-01 | -6.70e-02 | 6.58e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 99 | 2.50e-01 | -6.70e-02 | 5.98e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 81 | 2.98e-01 | -6.70e-02 | 6.43e-01 |
| GOCC GOLGI MEMBRANE | 495 | 1.13e-02 | 6.70e-02 | 1.23e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 36 | 4.87e-01 | 6.69e-02 | 7.79e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 32 | 5.13e-01 | -6.69e-02 | 7.94e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 7.59e-01 | -6.68e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 15 | 6.54e-01 | 6.68e-02 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 11 | 7.02e-01 | 6.67e-02 | 8.98e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 173 | 1.31e-01 | 6.67e-02 | 4.47e-01 |
| GOBP RESPONSE TO ETHANOL | 66 | 3.49e-01 | 6.67e-02 | 6.83e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 8 | 7.44e-01 | 6.67e-02 | 9.13e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 26 | 5.57e-01 | -6.66e-02 | 8.22e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 7.30e-01 | 6.65e-02 | 9.09e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 6.78e-01 | -6.65e-02 | 8.84e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 109 | 2.31e-01 | 6.65e-02 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 345 | 3.48e-02 | 6.65e-02 | 2.35e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 208 | 9.95e-02 | 6.65e-02 | 3.98e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 372 | 2.86e-02 | 6.64e-02 | 2.10e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 18 | 6.26e-01 | 6.64e-02 | 8.59e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 7 | 7.61e-01 | 6.64e-02 | 9.18e-01 |
| GOBP SYNAPSE MATURATION | 15 | 6.56e-01 | 6.63e-02 | 8.73e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 23 | 5.82e-01 | 6.63e-02 | 8.35e-01 |
| GOBP RESPONSE TO GLUCAGON | 9 | 7.30e-01 | -6.63e-02 | 9.09e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 29 | 5.37e-01 | 6.63e-02 | 8.09e-01 |
| GOCC GOLGI APPARATUS | 1110 | 2.50e-04 | 6.62e-02 | 7.20e-03 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 6 | 7.79e-01 | -6.61e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 113 | 2.26e-01 | 6.61e-02 | 5.74e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 7 | 7.63e-01 | 6.59e-02 | 9.19e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 38 | 4.82e-01 | -6.59e-02 | 7.76e-01 |
| GOBP AMINE CATABOLIC PROCESS | 8 | 7.47e-01 | -6.58e-02 | 9.15e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 13 | 6.81e-01 | 6.58e-02 | 8.86e-01 |
| GOMF RDNA BINDING | 9 | 7.32e-01 | 6.58e-02 | 9.10e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 5 | 7.99e-01 | -6.58e-02 | 9.32e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 245 | 7.74e-02 | 6.57e-02 | 3.48e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 11 | 7.06e-01 | -6.57e-02 | 9.00e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 209 | 1.03e-01 | -6.57e-02 | 4.01e-01 |
| GOMF PRE MRNA BINDING | 31 | 5.27e-01 | 6.57e-02 | 8.03e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 7.99e-01 | 6.57e-02 | 9.32e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 692 | 3.59e-03 | 6.56e-02 | 5.74e-02 |
| GOBP REGULATION OF CELL DIVISION | 120 | 2.16e-01 | 6.56e-02 | 5.64e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 63 | 3.69e-01 | 6.55e-02 | 6.96e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 6 | 7.81e-01 | -6.55e-02 | 9.24e-01 |
| GOBP EMBRYO IMPLANTATION | 26 | 5.64e-01 | -6.55e-02 | 8.26e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 6 | 7.81e-01 | -6.54e-02 | 9.24e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 6 | 7.81e-01 | -6.54e-02 | 9.24e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 23 | 5.87e-01 | -6.54e-02 | 8.38e-01 |
| GOBP FEEDING BEHAVIOR | 32 | 5.22e-01 | -6.54e-02 | 8.01e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 87 | 2.92e-01 | 6.54e-02 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 50 | 4.24e-01 | 6.53e-02 | 7.37e-01 |
| GOBP STRESS FIBER ASSEMBLY | 77 | 3.23e-01 | 6.52e-02 | 6.63e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 5.37e-01 | 6.52e-02 | 8.09e-01 |
| GOBP RESPONSE TO HORMONE | 505 | 1.28e-02 | 6.51e-02 | 1.32e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 12 | 6.96e-01 | 6.51e-02 | 8.95e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 13 | 6.85e-01 | -6.51e-02 | 8.88e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 34 | 5.12e-01 | 6.51e-02 | 7.94e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 14 | 6.73e-01 | -6.51e-02 | 8.81e-01 |
| GOBP HEART VALVE DEVELOPMENT | 35 | 5.06e-01 | -6.51e-02 | 7.91e-01 |
| GOBP MIRNA METABOLIC PROCESS | 71 | 3.44e-01 | -6.50e-02 | 6.79e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 7.83e-01 | -6.50e-02 | 9.25e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 31 | 5.32e-01 | 6.49e-02 | 8.05e-01 |
| GOBP CDP CHOLINE PATHWAY | 5 | 8.02e-01 | -6.49e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 29 | 5.46e-01 | -6.49e-02 | 8.15e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 21 | 6.07e-01 | 6.48e-02 | 8.50e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 6.86e-01 | 6.47e-02 | 8.89e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 6.98e-01 | 6.47e-02 | 8.96e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 11 | 7.10e-01 | 6.47e-02 | 9.02e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 216 | 1.03e-01 | 6.47e-02 | 4.01e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 27 | 5.61e-01 | 6.46e-02 | 8.25e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 151 | 1.72e-01 | 6.46e-02 | 5.10e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 57 | 3.99e-01 | 6.46e-02 | 7.21e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 18 | 6.36e-01 | 6.45e-02 | 8.63e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 189 | 1.27e-01 | 6.45e-02 | 4.43e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 33 | 5.22e-01 | 6.45e-02 | 8.01e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 32 | 5.28e-01 | 6.44e-02 | 8.04e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 15 | 6.66e-01 | 6.44e-02 | 8.77e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 24 | 5.85e-01 | -6.44e-02 | 8.37e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 28 | 5.55e-01 | 6.44e-02 | 8.22e-01 |
| GOBP RESPONSE TO NICOTINE | 22 | 6.01e-01 | -6.44e-02 | 8.46e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 708 | 3.85e-03 | -6.44e-02 | 5.98e-02 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 29 | 5.49e-01 | -6.44e-02 | 8.17e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 7 | 7.68e-01 | 6.43e-02 | 9.21e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 18 | 6.37e-01 | 6.43e-02 | 8.63e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 45 | 4.56e-01 | -6.43e-02 | 7.60e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 18 | 6.37e-01 | -6.43e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 8 | 7.53e-01 | 6.43e-02 | 9.17e-01 |
| GOBP TRNA MODIFICATION | 90 | 2.93e-01 | 6.42e-02 | 6.40e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 63 | 3.79e-01 | -6.42e-02 | 7.05e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 29 | 5.50e-01 | -6.42e-02 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 8 | 7.53e-01 | -6.42e-02 | 9.17e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 239 | 8.89e-02 | -6.41e-02 | 3.74e-01 |
| GOBP MAST CELL ACTIVATION | 52 | 4.24e-01 | -6.41e-02 | 7.37e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 18 | 6.38e-01 | -6.41e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 8.04e-01 | -6.41e-02 | 9.34e-01 |
| GOMF INSULIN BINDING | 5 | 8.04e-01 | -6.41e-02 | 9.34e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 7.13e-01 | 6.41e-02 | 9.02e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 6 | 7.86e-01 | 6.40e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 17 | 6.48e-01 | -6.40e-02 | 8.68e-01 |
| GOBP HORMONE TRANSPORT | 151 | 1.76e-01 | -6.40e-02 | 5.17e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 7 | 7.70e-01 | 6.39e-02 | 9.22e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 90 | 2.95e-01 | 6.39e-02 | 6.40e-01 |
| GOBP NAD METABOLIC PROCESS | 26 | 5.73e-01 | -6.39e-02 | 8.30e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 78 | 3.30e-01 | -6.39e-02 | 6.67e-01 |
| GOBP G1 TO G0 TRANSITION | 14 | 6.79e-01 | -6.38e-02 | 8.85e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 280 | 6.72e-02 | 6.38e-02 | 3.27e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 21 | 6.13e-01 | -6.38e-02 | 8.51e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 326 | 4.89e-02 | 6.38e-02 | 2.78e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 6.05e-01 | -6.38e-02 | 8.48e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 48 | 4.45e-01 | -6.37e-02 | 7.53e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 99 | 2.74e-01 | -6.37e-02 | 6.23e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 75 | 3.41e-01 | -6.37e-02 | 6.77e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 143 | 1.90e-01 | 6.36e-02 | 5.36e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 338 | 4.57e-02 | 6.35e-02 | 2.68e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 114 | 2.42e-01 | 6.35e-02 | 5.90e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 9 | 7.42e-01 | -6.35e-02 | 9.12e-01 |
| GOMF GLUCOSE BINDING | 7 | 7.71e-01 | 6.35e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 325 | 5.03e-02 | 6.35e-02 | 2.82e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 267 | 7.55e-02 | 6.34e-02 | 3.44e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 7.16e-01 | -6.34e-02 | 9.03e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 9 | 7.42e-01 | 6.34e-02 | 9.12e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1154 | 3.60e-04 | 6.34e-02 | 9.82e-03 |
| GOCC MULTIVESICULAR BODY | 40 | 4.88e-01 | -6.34e-02 | 7.80e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 18 | 6.42e-01 | 6.33e-02 | 8.65e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 148 | 1.84e-01 | 6.33e-02 | 5.28e-01 |
| GOCC AXONAL GROWTH CONE | 19 | 6.33e-01 | -6.33e-02 | 8.62e-01 |
| GOBP AMINE METABOLIC PROCESS | 54 | 4.21e-01 | -6.33e-02 | 7.35e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 130 | 2.14e-01 | -6.33e-02 | 5.63e-01 |
| GOCC MMXD COMPLEX | 5 | 8.07e-01 | 6.32e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 10 | 7.29e-01 | 6.32e-02 | 9.09e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 29 | 5.56e-01 | -6.32e-02 | 8.22e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 31 | 5.43e-01 | -6.31e-02 | 8.13e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 44 | 4.69e-01 | -6.31e-02 | 7.68e-01 |
| GOBP REGULATION OF RNA SPLICING | 153 | 1.79e-01 | -6.31e-02 | 5.20e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 7.73e-01 | -6.31e-02 | 9.22e-01 |
| GOBP HEART GROWTH | 47 | 4.55e-01 | -6.31e-02 | 7.60e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 8 | 7.57e-01 | -6.31e-02 | 9.18e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 8 | 7.58e-01 | 6.30e-02 | 9.18e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1036 | 7.28e-04 | 6.30e-02 | 1.73e-02 |
| GOBP LIPID PHOSPHORYLATION | 8 | 7.58e-01 | -6.30e-02 | 9.18e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 8 | 7.58e-01 | -6.30e-02 | 9.18e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 11 | 7.18e-01 | 6.29e-02 | 9.04e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 25 | 5.86e-01 | 6.29e-02 | 8.38e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 93 | 2.95e-01 | 6.29e-02 | 6.40e-01 |
| GOBP LIPID HOMEOSTASIS | 84 | 3.20e-01 | 6.29e-02 | 6.60e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 88 | 3.09e-01 | -6.28e-02 | 6.51e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 46 | 4.61e-01 | 6.28e-02 | 7.64e-01 |
| GOCC MKS COMPLEX | 11 | 7.18e-01 | -6.28e-02 | 9.05e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 23 | 6.02e-01 | 6.28e-02 | 8.46e-01 |
| GOBP RETINOL METABOLIC PROCESS | 18 | 6.45e-01 | 6.28e-02 | 8.66e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 5 | 8.08e-01 | 6.28e-02 | 9.37e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 14 | 6.84e-01 | -6.28e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 7.31e-01 | -6.27e-02 | 9.10e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 8 | 7.59e-01 | 6.27e-02 | 9.18e-01 |
| GOBP EPIBOLY | 26 | 5.80e-01 | 6.27e-02 | 8.34e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 8 | 7.59e-01 | -6.27e-02 | 9.18e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 33 | 5.34e-01 | -6.27e-02 | 8.06e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 30 | 5.53e-01 | 6.26e-02 | 8.21e-01 |
| GOMF BETA TUBULIN BINDING | 33 | 5.34e-01 | 6.26e-02 | 8.06e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 71 | 3.62e-01 | 6.26e-02 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 129 | 2.20e-01 | 6.26e-02 | 5.71e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 28 | 5.67e-01 | -6.26e-02 | 8.29e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 91 | 3.03e-01 | 6.26e-02 | 6.47e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 178 | 1.51e-01 | 6.25e-02 | 4.81e-01 |
| GOMF LIPID KINASE ACTIVITY | 34 | 5.28e-01 | 6.25e-02 | 8.04e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 47 | 4.59e-01 | -6.25e-02 | 7.62e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 8.09e-01 | 6.25e-02 | 9.37e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 35 | 5.23e-01 | 6.25e-02 | 8.01e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 52 | 4.36e-01 | 6.25e-02 | 7.46e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 12 | 7.08e-01 | -6.24e-02 | 9.01e-01 |
| GOBP NUCLEAR EXPORT | 150 | 1.88e-01 | 6.24e-02 | 5.33e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 7.33e-01 | 6.24e-02 | 9.10e-01 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 8.09e-01 | -6.23e-02 | 9.37e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 139 | 2.06e-01 | 6.23e-02 | 5.54e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 11 | 7.21e-01 | -6.23e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 33 | 5.36e-01 | -6.23e-02 | 8.08e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 7.61e-01 | 6.22e-02 | 9.18e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 38 | 5.07e-01 | -6.22e-02 | 7.91e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 290 | 6.99e-02 | -6.21e-02 | 3.34e-01 |
| GOCC MLL3 4 COMPLEX | 12 | 7.10e-01 | 6.21e-02 | 9.01e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 7.76e-01 | 6.21e-02 | 9.23e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 5 | 8.10e-01 | -6.20e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 16 | 6.68e-01 | -6.20e-02 | 8.78e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 106 | 2.71e-01 | 6.20e-02 | 6.20e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 6 | 7.93e-01 | 6.20e-02 | 9.30e-01 |
| GOMF HSP90 PROTEIN BINDING | 33 | 5.38e-01 | 6.19e-02 | 8.09e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 131 | 2.22e-01 | 6.19e-02 | 5.72e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 7 | 7.77e-01 | 6.18e-02 | 9.23e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 168 | 1.68e-01 | 6.18e-02 | 5.05e-01 |
| GOCC EMC COMPLEX | 10 | 7.35e-01 | 6.18e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 6 | 7.94e-01 | -6.17e-02 | 9.30e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 77 | 3.50e-01 | -6.17e-02 | 6.83e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 363 | 4.48e-02 | 6.16e-02 | 2.64e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 7.94e-01 | 6.16e-02 | 9.30e-01 |
| GOBP INTERFERON BETA PRODUCTION | 51 | 4.47e-01 | 6.16e-02 | 7.54e-01 |
| GOBP AMINO ACID TRANSPORT | 77 | 3.51e-01 | -6.15e-02 | 6.84e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 8 | 7.63e-01 | -6.15e-02 | 9.19e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 50 | 4.52e-01 | -6.15e-02 | 7.58e-01 |
| GOBP RRNA CATABOLIC PROCESS | 19 | 6.43e-01 | 6.14e-02 | 8.66e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 10 | 7.37e-01 | 6.14e-02 | 9.11e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 14 | 6.91e-01 | -6.14e-02 | 8.92e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 7.79e-01 | 6.13e-02 | 9.24e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 722 | 5.49e-03 | -6.13e-02 | 7.71e-02 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 204 | 1.32e-01 | 6.13e-02 | 4.49e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 42 | 4.92e-01 | -6.13e-02 | 7.82e-01 |
| GOBP GMP METABOLIC PROCESS | 25 | 5.97e-01 | 6.11e-02 | 8.44e-01 |
| GOMF SIRNA BINDING | 9 | 7.51e-01 | 6.10e-02 | 9.16e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 47 | 4.69e-01 | 6.10e-02 | 7.68e-01 |
| GOBP ENAMEL MINERALIZATION | 7 | 7.80e-01 | 6.10e-02 | 9.24e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1066 | 9.29e-04 | 6.10e-02 | 2.05e-02 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 134 | 2.24e-01 | 6.09e-02 | 5.74e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 76 | 3.59e-01 | -6.09e-02 | 6.88e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 11 | 7.27e-01 | -6.09e-02 | 9.08e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 10 | 7.39e-01 | -6.09e-02 | 9.12e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 100 | 2.94e-01 | -6.08e-02 | 6.40e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 16 | 6.74e-01 | -6.08e-02 | 8.81e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 6 | 7.97e-01 | 6.08e-02 | 9.31e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 38 | 5.17e-01 | -6.07e-02 | 7.97e-01 |
| GOBP ENDOCYTIC RECYCLING | 69 | 3.84e-01 | 6.07e-02 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 115 | 2.62e-01 | 6.07e-02 | 6.13e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 47 | 4.72e-01 | 6.07e-02 | 7.70e-01 |
| GOBP ORGANELLE ASSEMBLY | 737 | 5.55e-03 | 6.06e-02 | 7.77e-02 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 20 | 6.39e-01 | -6.06e-02 | 8.63e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 21 | 6.31e-01 | -6.06e-02 | 8.61e-01 |
| GOMF PDZ DOMAIN BINDING | 48 | 4.68e-01 | 6.06e-02 | 7.67e-01 |
| GOBP BLOOD VESSEL REMODELING | 22 | 6.23e-01 | -6.06e-02 | 8.57e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 43 | 4.92e-01 | 6.06e-02 | 7.82e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 71 | 3.78e-01 | 6.05e-02 | 7.05e-01 |
| GOBP MRNA TRANSPORT | 112 | 2.70e-01 | 6.05e-02 | 6.19e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 26 | 5.94e-01 | 6.04e-02 | 8.42e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 125 | 2.44e-01 | -6.04e-02 | 5.92e-01 |
| GOMF TUBULIN BINDING | 280 | 8.33e-02 | 6.04e-02 | 3.63e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 16 | 6.76e-01 | -6.04e-02 | 8.83e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 16 | 6.76e-01 | -6.04e-02 | 8.83e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 14 | 6.96e-01 | 6.03e-02 | 8.95e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 6 | 7.98e-01 | -6.03e-02 | 9.32e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 686 | 7.65e-03 | 6.03e-02 | 9.66e-02 |
| GOCC DYNEIN COMPLEX | 32 | 5.55e-01 | -6.03e-02 | 8.22e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 11 | 7.29e-01 | -6.03e-02 | 9.09e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 6.58e-01 | -6.03e-02 | 8.73e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 253 | 9.99e-02 | 6.03e-02 | 3.98e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 10 | 7.41e-01 | -6.03e-02 | 9.12e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 53 | 4.49e-01 | 6.02e-02 | 7.55e-01 |
| GOBP STEM CELL DIVISION | 22 | 6.25e-01 | -6.01e-02 | 8.59e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 191 | 1.53e-01 | 6.01e-02 | 4.85e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 15 | 6.87e-01 | -6.01e-02 | 8.89e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 15 | 6.87e-01 | 6.00e-02 | 8.89e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 90 | 3.26e-01 | 6.00e-02 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 745 | 5.81e-03 | 6.00e-02 | 8.00e-02 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 28 | 5.83e-01 | 6.00e-02 | 8.36e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 281 | 8.50e-02 | 5.99e-02 | 3.67e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 88 | 3.32e-01 | -5.99e-02 | 6.69e-01 |
| GOBP DCMP CATABOLIC PROCESS | 5 | 8.17e-01 | 5.99e-02 | 9.40e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 7.84e-01 | -5.98e-02 | 9.25e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 8.17e-01 | 5.98e-02 | 9.40e-01 |
| GOBP BODY FLUID SECRETION | 44 | 4.93e-01 | 5.97e-02 | 7.83e-01 |
| GOMF C X C CHEMOKINE RECEPTOR ACTIVITY | 5 | 8.17e-01 | -5.97e-02 | 9.40e-01 |
| GOCC LYSOSOMAL LUMEN | 61 | 4.20e-01 | 5.97e-02 | 7.35e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 44 | 4.94e-01 | -5.97e-02 | 7.83e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 7.57e-01 | -5.96e-02 | 9.17e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 7.70e-01 | 5.96e-02 | 9.22e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 10 | 7.44e-01 | 5.96e-02 | 9.13e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 12 | 7.21e-01 | -5.96e-02 | 9.05e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 100 | 3.04e-01 | -5.96e-02 | 6.47e-01 |
| GOCC APICAL JUNCTION COMPLEX | 79 | 3.61e-01 | -5.95e-02 | 6.89e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 31 | 5.67e-01 | 5.95e-02 | 8.29e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 61 | 4.22e-01 | 5.95e-02 | 7.36e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 278 | 8.93e-02 | 5.94e-02 | 3.75e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 8 | 7.71e-01 | 5.94e-02 | 9.22e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 37 | 5.32e-01 | -5.94e-02 | 8.06e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 48 | 4.77e-01 | 5.93e-02 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 40 | 5.16e-01 | 5.93e-02 | 7.97e-01 |
| GOMF FLOPPASE ACTIVITY | 15 | 6.91e-01 | 5.92e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 10 | 7.46e-01 | 5.92e-02 | 9.14e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 193 | 1.57e-01 | 5.92e-02 | 4.92e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 59 | 4.32e-01 | 5.92e-02 | 7.44e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 264 | 9.90e-02 | 5.92e-02 | 3.97e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 66 | 4.06e-01 | 5.92e-02 | 7.25e-01 |
| GOBP T CELL ACTIVATION | 430 | 3.66e-02 | 5.91e-02 | 2.39e-01 |
| GOCC PRESPLICEOSOME | 16 | 6.82e-01 | 5.91e-02 | 8.87e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 7.87e-01 | -5.91e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 143 | 2.24e-01 | 5.91e-02 | 5.73e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 70 | 3.94e-01 | 5.90e-02 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 11 | 7.35e-01 | 5.90e-02 | 9.11e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 12 | 7.24e-01 | 5.90e-02 | 9.07e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 9 | 7.60e-01 | -5.89e-02 | 9.18e-01 |
| GOMF HORMONE BINDING | 30 | 5.77e-01 | -5.89e-02 | 8.32e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 5 | 8.20e-01 | 5.89e-02 | 9.40e-01 |
| GOBP JNK CASCADE | 119 | 2.69e-01 | -5.88e-02 | 6.19e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 7.60e-01 | 5.87e-02 | 9.18e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 10 | 7.48e-01 | 5.87e-02 | 9.15e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 19 | 6.58e-01 | 5.87e-02 | 8.73e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 11 | 7.36e-01 | -5.87e-02 | 9.11e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 143 | 2.27e-01 | 5.87e-02 | 5.76e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 8.04e-01 | 5.86e-02 | 9.34e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 17 | 6.76e-01 | 5.86e-02 | 8.83e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 16 | 6.85e-01 | 5.86e-02 | 8.89e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 6 | 8.04e-01 | -5.85e-02 | 9.34e-01 |
| GOBP LIPID IMPORT INTO CELL | 15 | 6.95e-01 | 5.85e-02 | 8.94e-01 |
| GOBP L AMINO ACID TRANSPORT | 52 | 4.66e-01 | -5.85e-02 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 81 | 3.63e-01 | 5.85e-02 | 6.92e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 14 | 7.05e-01 | 5.85e-02 | 9.00e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 10 | 7.49e-01 | -5.85e-02 | 9.15e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 106 | 2.99e-01 | 5.84e-02 | 6.44e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 296 | 8.50e-02 | 5.84e-02 | 3.67e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 7 | 7.89e-01 | 5.84e-02 | 9.28e-01 |
| GOBP SUCKLING BEHAVIOR | 7 | 7.89e-01 | -5.84e-02 | 9.28e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 7.16e-01 | 5.83e-02 | 9.03e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 168 | 1.93e-01 | -5.83e-02 | 5.39e-01 |
| GOMF ANTIPORTER ACTIVITY | 90 | 3.40e-01 | 5.83e-02 | 6.76e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 7.50e-01 | 5.83e-02 | 9.15e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 6.78e-01 | 5.82e-02 | 8.84e-01 |
| GOBP CONVERGENT EXTENSION | 10 | 7.50e-01 | -5.82e-02 | 9.15e-01 |
| GOBP KIDNEY MORPHOGENESIS | 41 | 5.19e-01 | -5.82e-02 | 7.99e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 121 | 2.70e-01 | 5.82e-02 | 6.20e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 161 | 2.04e-01 | 5.82e-02 | 5.51e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 659 | 1.17e-02 | 5.81e-02 | 1.25e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 110 | 2.93e-01 | -5.81e-02 | 6.40e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 191 | 1.67e-01 | 5.81e-02 | 5.03e-01 |
| GOCC ASTER | 9 | 7.63e-01 | -5.81e-02 | 9.19e-01 |
| GOBP FATTY ACID TRANSPORT | 54 | 4.61e-01 | 5.81e-02 | 7.63e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 11 | 7.39e-01 | -5.80e-02 | 9.12e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 11 | 7.39e-01 | -5.80e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 12 | 7.28e-01 | 5.79e-02 | 9.09e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 9 | 7.63e-01 | 5.79e-02 | 9.19e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 44 | 5.06e-01 | -5.79e-02 | 7.91e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 463 | 3.38e-02 | 5.79e-02 | 2.31e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 8 | 7.77e-01 | 5.79e-02 | 9.23e-01 |
| GOMF COBALAMIN BINDING | 6 | 8.06e-01 | -5.79e-02 | 9.35e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 40 | 5.26e-01 | 5.79e-02 | 8.03e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 71 | 3.99e-01 | -5.79e-02 | 7.21e-01 |
| GOBP PLACENTA DEVELOPMENT | 83 | 3.63e-01 | 5.79e-02 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 8 | 7.77e-01 | -5.79e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 524 | 2.45e-02 | 5.78e-02 | 1.93e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 61 | 4.35e-01 | 5.78e-02 | 7.46e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 44 | 5.08e-01 | 5.77e-02 | 7.91e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 402 | 4.83e-02 | 5.77e-02 | 2.77e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 24 | 6.25e-01 | 5.77e-02 | 8.58e-01 |
| GOCC GATOR2 COMPLEX | 5 | 8.23e-01 | 5.77e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 81 | 3.70e-01 | -5.77e-02 | 6.97e-01 |
| GOBP MRNA CATABOLIC PROCESS | 210 | 1.52e-01 | -5.76e-02 | 4.82e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 474 | 3.29e-02 | 5.76e-02 | 2.27e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 43 | 5.14e-01 | 5.75e-02 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 403 | 4.91e-02 | 5.75e-02 | 2.79e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 19 | 6.65e-01 | -5.74e-02 | 8.77e-01 |
| GOBP ANIMAL ORGAN FORMATION | 25 | 6.19e-01 | -5.74e-02 | 8.55e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 11 | 7.42e-01 | -5.74e-02 | 9.12e-01 |
| GOMF MANGANESE ION BINDING | 54 | 4.66e-01 | -5.74e-02 | 7.65e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 7.93e-01 | -5.74e-02 | 9.30e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 8 | 7.79e-01 | 5.74e-02 | 9.24e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 52 | 4.75e-01 | -5.73e-02 | 7.72e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 14 | 7.11e-01 | 5.73e-02 | 9.02e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 81 | 3.73e-01 | -5.73e-02 | 7.00e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 207 | 1.58e-01 | -5.71e-02 | 4.92e-01 |
| GOBP REGULATION OF JNK CASCADE | 93 | 3.42e-01 | -5.71e-02 | 6.77e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 12 | 7.32e-01 | 5.71e-02 | 9.10e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 10 | 7.55e-01 | 5.71e-02 | 9.17e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 28 | 6.01e-01 | -5.71e-02 | 8.46e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 17 | 6.84e-01 | -5.71e-02 | 8.88e-01 |
| GOCC BOX C D RNP COMPLEX | 5 | 8.25e-01 | -5.69e-02 | 9.44e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 8.09e-01 | -5.69e-02 | 9.37e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 681 | 1.21e-02 | 5.69e-02 | 1.28e-01 |
| GOBP RESPONSE TO COCAINE | 22 | 6.44e-01 | 5.69e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 143 | 2.41e-01 | -5.69e-02 | 5.90e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 39 | 5.39e-01 | 5.69e-02 | 8.10e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 10 | 7.55e-01 | 5.69e-02 | 9.17e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 38 | 5.44e-01 | 5.69e-02 | 8.14e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 47 | 5.01e-01 | 5.68e-02 | 7.88e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 33 | 5.72e-01 | -5.68e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 23 | 6.37e-01 | -5.68e-02 | 8.63e-01 |
| GOBP CARTILAGE DEVELOPMENT | 88 | 3.58e-01 | -5.68e-02 | 6.88e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 11 | 7.45e-01 | 5.67e-02 | 9.14e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 41 | 5.30e-01 | 5.67e-02 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 15 | 7.04e-01 | 5.67e-02 | 8.99e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 20 | 6.61e-01 | 5.67e-02 | 8.75e-01 |
| GOMF DEATH RECEPTOR BINDING | 15 | 7.04e-01 | -5.67e-02 | 8.99e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 9 | 7.69e-01 | -5.66e-02 | 9.21e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 349 | 7.07e-02 | 5.66e-02 | 3.35e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 7 | 7.96e-01 | 5.66e-02 | 9.31e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 24 | 6.32e-01 | 5.65e-02 | 8.62e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1103 | 1.83e-03 | 5.65e-02 | 3.58e-02 |
| GOBP T CELL CHEMOTAXIS | 18 | 6.78e-01 | 5.65e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 116 | 2.94e-01 | -5.65e-02 | 6.40e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 155 | 2.27e-01 | -5.64e-02 | 5.76e-01 |
| GOMF RNA POLYMERASE BINDING | 55 | 4.71e-01 | 5.62e-02 | 7.69e-01 |
| GOBP NEURON PROJECTION EXTENSION | 97 | 3.40e-01 | -5.62e-02 | 6.76e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 47 | 5.06e-01 | 5.62e-02 | 7.91e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 52 | 4.84e-01 | -5.61e-02 | 7.77e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 7 | 7.97e-01 | 5.61e-02 | 9.31e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 7 | 7.97e-01 | -5.61e-02 | 9.31e-01 |
| GOBP RESPONSE TO METAL ION | 208 | 1.64e-01 | 5.61e-02 | 4.99e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.12e-01 | 5.61e-02 | 9.38e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 132 | 2.67e-01 | 5.60e-02 | 6.18e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 8.28e-01 | 5.60e-02 | 9.45e-01 |
| GOCC CAVEOLA | 42 | 5.30e-01 | 5.60e-02 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 7 | 7.97e-01 | -5.60e-02 | 9.31e-01 |
| GOBP ODONTOGENESIS | 47 | 5.07e-01 | -5.59e-02 | 7.91e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 361 | 6.94e-02 | 5.59e-02 | 3.33e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 27 | 6.15e-01 | -5.59e-02 | 8.52e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 12 | 7.38e-01 | -5.58e-02 | 9.11e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 7.60e-01 | -5.58e-02 | 9.18e-01 |
| GOMF ATPASE INHIBITOR ACTIVITY | 5 | 8.29e-01 | 5.58e-02 | 9.45e-01 |
| GOCC OUTER MEMBRANE | 199 | 1.76e-01 | 5.58e-02 | 5.17e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 62 | 4.48e-01 | 5.58e-02 | 7.54e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 9 | 7.72e-01 | 5.58e-02 | 9.22e-01 |
| GOMF PEPTIDASE ACTIVITY | 312 | 9.17e-02 | 5.58e-02 | 3.80e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 7.09e-01 | -5.58e-02 | 9.01e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 43 | 5.27e-01 | 5.57e-02 | 8.03e-01 |
| GOMF METHYL CPG BINDING | 21 | 6.59e-01 | 5.57e-02 | 8.73e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 9 | 7.72e-01 | -5.57e-02 | 9.22e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 7.18e-01 | -5.57e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 16 | 7.00e-01 | 5.57e-02 | 8.96e-01 |
| GOBP STEROL HOMEOSTASIS | 41 | 5.37e-01 | 5.57e-02 | 8.09e-01 |
| GOCC KATANIN COMPLEX | 5 | 8.29e-01 | -5.57e-02 | 9.45e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 16 | 7.00e-01 | 5.57e-02 | 8.96e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 9 | 7.73e-01 | 5.57e-02 | 9.22e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 48 | 5.05e-01 | -5.56e-02 | 7.91e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 305 | 9.62e-02 | 5.56e-02 | 3.90e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 737 | 1.10e-02 | 5.56e-02 | 1.20e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 29 | 6.04e-01 | 5.56e-02 | 8.48e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 5 | 8.30e-01 | -5.55e-02 | 9.45e-01 |
| GOBP NADH METABOLIC PROCESS | 6 | 8.14e-01 | -5.55e-02 | 9.39e-01 |
| GOCC GOLGI LUMEN | 25 | 6.32e-01 | -5.54e-02 | 8.62e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 34 | 5.77e-01 | -5.54e-02 | 8.31e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 32 | 5.88e-01 | 5.53e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 21 | 6.61e-01 | -5.53e-02 | 8.75e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 9 | 7.74e-01 | 5.53e-02 | 9.23e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 8.15e-01 | 5.53e-02 | 9.39e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 104 | 3.31e-01 | -5.52e-02 | 6.68e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 81 | 3.91e-01 | 5.52e-02 | 7.12e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 82 | 3.88e-01 | -5.52e-02 | 7.10e-01 |
| GOBP FIBRINOLYSIS | 7 | 8.00e-01 | -5.52e-02 | 9.33e-01 |
| GOBP LIPID LOCALIZATION | 273 | 1.18e-01 | 5.52e-02 | 4.25e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 61 | 4.57e-01 | 5.52e-02 | 7.61e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 94 | 3.56e-01 | 5.51e-02 | 6.87e-01 |
| GOBP EYE MORPHOGENESIS | 69 | 4.29e-01 | -5.51e-02 | 7.42e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 453 | 4.58e-02 | 5.51e-02 | 2.68e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 20 | 6.70e-01 | -5.51e-02 | 8.79e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 23 | 6.48e-01 | -5.51e-02 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 832 | 7.66e-03 | 5.51e-02 | 9.66e-02 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 89 | 3.70e-01 | -5.51e-02 | 6.96e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 15 | 7.12e-01 | -5.51e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 20 | 6.70e-01 | 5.50e-02 | 8.80e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 189 | 1.93e-01 | 5.50e-02 | 5.39e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 60 | 4.62e-01 | 5.50e-02 | 7.64e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 134 | 2.73e-01 | 5.49e-02 | 6.22e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 319 | 9.34e-02 | 5.49e-02 | 3.83e-01 |
| GOBP VESICLE TARGETING | 60 | 4.63e-01 | 5.48e-02 | 7.64e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 7.33e-01 | 5.47e-02 | 9.10e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 35 | 5.76e-01 | -5.47e-02 | 8.31e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 49 | 5.08e-01 | -5.47e-02 | 7.91e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 90 | 3.71e-01 | 5.47e-02 | 6.97e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 45 | 5.26e-01 | 5.46e-02 | 8.03e-01 |
| GOBP NCRNA PROCESSING | 392 | 6.48e-02 | 5.46e-02 | 3.24e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 8.17e-01 | 5.46e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 5 | 8.32e-01 | -5.46e-02 | 9.46e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 17 | 6.97e-01 | -5.46e-02 | 8.95e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 8.33e-01 | 5.46e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 16 | 7.06e-01 | 5.45e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 20 | 6.73e-01 | -5.45e-02 | 8.81e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 13 | 7.34e-01 | -5.45e-02 | 9.10e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 212 | 1.73e-01 | 5.45e-02 | 5.12e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 8.17e-01 | 5.45e-02 | 9.40e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 27 | 6.25e-01 | -5.44e-02 | 8.58e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 286 | 1.15e-01 | 5.44e-02 | 4.19e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 93 | 3.65e-01 | 5.44e-02 | 6.93e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 10 | 7.66e-01 | -5.44e-02 | 9.21e-01 |
| GOBP REGULATION OF TRANSPORT | 974 | 4.60e-03 | 5.44e-02 | 6.83e-02 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 24 | 6.45e-01 | 5.44e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 36 | 5.73e-01 | 5.43e-02 | 8.30e-01 |
| GOCC BRUSH BORDER | 55 | 4.87e-01 | -5.43e-02 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 20 | 6.75e-01 | -5.43e-02 | 8.82e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 806 | 9.69e-03 | 5.42e-02 | 1.12e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 30 | 6.08e-01 | 5.42e-02 | 8.50e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 233 | 1.56e-01 | 5.41e-02 | 4.91e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 442 | 5.27e-02 | 5.41e-02 | 2.88e-01 |
| GOBP SEX DIFFERENTIATION | 136 | 2.77e-01 | 5.40e-02 | 6.27e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.19e-01 | -5.40e-02 | 9.40e-01 |
| GOMF CALMODULIN BINDING | 113 | 3.22e-01 | 5.40e-02 | 6.62e-01 |
| GOCC OMEGASOME | 5 | 8.35e-01 | -5.40e-02 | 9.47e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 21 | 6.69e-01 | 5.39e-02 | 8.78e-01 |
| GOMF OPSONIN BINDING | 8 | 7.92e-01 | 5.38e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 189 | 2.04e-01 | 5.37e-02 | 5.51e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 46 | 5.29e-01 | 5.37e-02 | 8.04e-01 |
| GOBP RNA 3 END PROCESSING | 89 | 3.82e-01 | 5.37e-02 | 7.07e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 7.80e-01 | -5.37e-02 | 9.24e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 81 | 4.04e-01 | 5.37e-02 | 7.23e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 540 | 3.42e-02 | 5.37e-02 | 2.32e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 30 | 6.11e-01 | 5.37e-02 | 8.50e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 7.69e-01 | -5.37e-02 | 9.21e-01 |
| GOBP LUNG MORPHOGENESIS | 26 | 6.36e-01 | -5.36e-02 | 8.63e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 674 | 1.88e-02 | 5.36e-02 | 1.65e-01 |
| GOCC RNA CAP BINDING COMPLEX | 19 | 6.86e-01 | -5.36e-02 | 8.89e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 14 | 7.29e-01 | -5.35e-02 | 9.09e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 140 | 2.75e-01 | 5.35e-02 | 6.25e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 6.31e-01 | 5.35e-02 | 8.61e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 151 | 2.58e-01 | 5.34e-02 | 6.08e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 99 | 3.59e-01 | 5.34e-02 | 6.88e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 30 | 6.13e-01 | 5.34e-02 | 8.51e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 146 | 2.66e-01 | 5.34e-02 | 6.17e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 30 | 6.13e-01 | 5.34e-02 | 8.51e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 8.07e-01 | -5.34e-02 | 9.36e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 105 | 3.46e-01 | 5.33e-02 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 14 | 7.30e-01 | -5.33e-02 | 9.09e-01 |
| GOBP TRABECULA MORPHOGENESIS | 22 | 6.66e-01 | 5.32e-02 | 8.77e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 81 | 4.09e-01 | -5.31e-02 | 7.27e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 16 | 7.13e-01 | 5.31e-02 | 9.02e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 12 | 7.50e-01 | -5.31e-02 | 9.15e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 44 | 5.43e-01 | 5.31e-02 | 8.13e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 5 | 8.37e-01 | 5.30e-02 | 9.48e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 58 | 4.85e-01 | -5.30e-02 | 7.78e-01 |
| GOMF SNARE BINDING | 74 | 4.31e-01 | 5.30e-02 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 28 | 6.29e-01 | 5.28e-02 | 8.60e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 10 | 7.72e-01 | -5.28e-02 | 9.22e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 34 | 5.94e-01 | 5.28e-02 | 8.42e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 8 | 7.96e-01 | 5.28e-02 | 9.31e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 8 | 7.96e-01 | 5.28e-02 | 9.31e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 5 | 8.38e-01 | 5.28e-02 | 9.48e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 5 | 8.38e-01 | 5.28e-02 | 9.48e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 24 | 6.55e-01 | 5.28e-02 | 8.71e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 36 | 5.84e-01 | 5.28e-02 | 8.36e-01 |
| GOBP GOLGI RIBBON FORMATION | 9 | 7.84e-01 | -5.28e-02 | 9.25e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 6 | 8.23e-01 | -5.27e-02 | 9.43e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 39 | 5.69e-01 | 5.27e-02 | 8.29e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 17 | 7.07e-01 | -5.27e-02 | 9.00e-01 |
| GOBP NEPHRON MORPHOGENESIS | 29 | 6.23e-01 | -5.27e-02 | 8.57e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 105 | 3.52e-01 | 5.27e-02 | 6.84e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 27 | 6.36e-01 | -5.26e-02 | 8.63e-01 |
| GOBP PROTEIN METHYLATION | 68 | 4.53e-01 | 5.26e-02 | 7.59e-01 |
| GOBP AMYLOID BETA CLEARANCE | 26 | 6.43e-01 | 5.26e-02 | 8.65e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 150 | 2.68e-01 | 5.26e-02 | 6.18e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 89 | 3.93e-01 | -5.25e-02 | 7.14e-01 |
| GOBP REGULATION OF MYELINATION | 28 | 6.31e-01 | 5.25e-02 | 8.61e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 210 | 1.92e-01 | 5.24e-02 | 5.37e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 41 | 5.62e-01 | 5.24e-02 | 8.25e-01 |
| GOCC CYTOPLASMIC REGION | 164 | 2.48e-01 | -5.24e-02 | 5.96e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 325 | 1.06e-01 | 5.24e-02 | 4.06e-01 |
| GOBP APOPTOTIC PROCESS | 1278 | 2.07e-03 | 5.23e-02 | 3.85e-02 |
| GOBP INTERLEUKIN 12 PRODUCTION | 48 | 5.32e-01 | -5.22e-02 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 93 | 3.85e-01 | 5.22e-02 | 7.08e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 7.54e-01 | 5.22e-02 | 9.17e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 54 | 5.08e-01 | -5.21e-02 | 7.91e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 12 | 7.55e-01 | -5.21e-02 | 9.17e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 28 | 6.34e-01 | 5.20e-02 | 8.62e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 35 | 5.95e-01 | 5.20e-02 | 8.42e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 23 | 6.66e-01 | -5.20e-02 | 8.77e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 7.36e-01 | 5.20e-02 | 9.11e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 8 | 7.99e-01 | -5.20e-02 | 9.32e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 12 | 7.55e-01 | -5.20e-02 | 9.17e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 29 | 6.28e-01 | 5.19e-02 | 8.60e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 157 | 2.63e-01 | 5.19e-02 | 6.13e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 976 | 6.80e-03 | 5.19e-02 | 8.90e-02 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 13 | 7.46e-01 | 5.19e-02 | 9.15e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 286 | 1.33e-01 | 5.18e-02 | 4.50e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 11 | 7.66e-01 | 5.18e-02 | 9.21e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 690 | 2.16e-02 | 5.18e-02 | 1.78e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 73 | 4.45e-01 | 5.18e-02 | 7.52e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 20 | 6.89e-01 | -5.17e-02 | 8.90e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 16 | 7.20e-01 | 5.17e-02 | 9.05e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 16 | 7.20e-01 | -5.17e-02 | 9.05e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 21 | 6.82e-01 | -5.17e-02 | 8.86e-01 |
| GOBP MATURATION OF SSU RRNA | 50 | 5.28e-01 | 5.17e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 27 | 6.42e-01 | 5.17e-02 | 8.65e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 105 | 3.61e-01 | 5.17e-02 | 6.89e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 202 | 2.07e-01 | 5.16e-02 | 5.55e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 96 | 3.83e-01 | 5.16e-02 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 8.42e-01 | -5.16e-02 | 9.50e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 60 | 4.90e-01 | 5.16e-02 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 266 | 1.50e-01 | 5.15e-02 | 4.79e-01 |
| GOMF U4 SNRNA BINDING | 6 | 8.27e-01 | -5.15e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 22 | 6.76e-01 | -5.14e-02 | 8.83e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 28 | 6.38e-01 | 5.14e-02 | 8.63e-01 |
| GOMF INTERLEUKIN 1 BINDING | 5 | 8.42e-01 | -5.13e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 7 | 8.14e-01 | 5.13e-02 | 9.39e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 26 | 6.51e-01 | 5.13e-02 | 8.69e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 159 | 2.66e-01 | 5.12e-02 | 6.17e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 230 | 1.83e-01 | 5.12e-02 | 5.26e-01 |
| GOCC CATENIN COMPLEX | 10 | 7.80e-01 | 5.11e-02 | 9.24e-01 |
| GOMF MIRNA BINDING | 32 | 6.17e-01 | -5.11e-02 | 8.53e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 17 | 7.16e-01 | 5.10e-02 | 9.03e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 99 | 3.82e-01 | -5.09e-02 | 7.07e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 15 | 7.33e-01 | -5.09e-02 | 9.10e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 10 | 7.81e-01 | -5.09e-02 | 9.24e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 43 | 5.64e-01 | -5.09e-02 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 53 | 5.22e-01 | 5.08e-02 | 8.01e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 21 | 6.87e-01 | -5.08e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 6 | 8.30e-01 | 5.08e-02 | 9.45e-01 |
| GOBP NCRNA METABOLIC PROCESS | 526 | 4.81e-02 | 5.08e-02 | 2.77e-01 |
| GOBP FERTILIZATION | 72 | 4.57e-01 | 5.07e-02 | 7.61e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 182 | 2.40e-01 | 5.07e-02 | 5.88e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 8.30e-01 | 5.07e-02 | 9.45e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 36 | 5.99e-01 | 5.06e-02 | 8.45e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 8.17e-01 | 5.06e-02 | 9.40e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 35 | 6.04e-01 | 5.06e-02 | 8.48e-01 |
| GOBP NK T CELL DIFFERENTIATION | 11 | 7.71e-01 | 5.06e-02 | 9.22e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 6 | 8.30e-01 | 5.06e-02 | 9.45e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 6 | 8.30e-01 | -5.06e-02 | 9.45e-01 |
| GOBP RESPONSE TO CHEMOKINE | 44 | 5.62e-01 | 5.06e-02 | 8.25e-01 |
| GOBP CELL CHEMOTAXIS | 171 | 2.55e-01 | -5.06e-02 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 7 | 8.17e-01 | 5.05e-02 | 9.40e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 49 | 5.41e-01 | 5.05e-02 | 8.12e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 8.17e-01 | -5.05e-02 | 9.40e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 71 | 4.63e-01 | 5.04e-02 | 7.64e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 12 | 7.62e-01 | -5.04e-02 | 9.19e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 7.53e-01 | 5.04e-02 | 9.17e-01 |
| GOBP CHLORIDE TRANSPORT | 46 | 5.55e-01 | 5.04e-02 | 8.21e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 9 | 7.94e-01 | 5.04e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 7.83e-01 | -5.03e-02 | 9.25e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 4.83e-01 | 5.03e-02 | 7.77e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 207 | 2.14e-01 | 5.03e-02 | 5.62e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 10 | 7.83e-01 | 5.03e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 61 | 4.97e-01 | -5.03e-02 | 7.86e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 8.06e-01 | 5.03e-02 | 9.35e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 64 | 4.87e-01 | 5.02e-02 | 7.79e-01 |
| GOBP CHOLESTEROL EFFLUX | 30 | 6.34e-01 | 5.02e-02 | 8.62e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 59 | 5.05e-01 | 5.02e-02 | 7.91e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 7.73e-01 | 5.02e-02 | 9.22e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 30 | 6.34e-01 | -5.02e-02 | 8.62e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 93 | 4.03e-01 | 5.02e-02 | 7.23e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 40 | 5.83e-01 | 5.02e-02 | 8.36e-01 |
| GOBP DEVELOPMENTAL GROWTH | 369 | 1.00e-01 | -5.01e-02 | 3.98e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 13 | 7.55e-01 | 5.01e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 21 | 6.91e-01 | 5.01e-02 | 8.92e-01 |
| GOBP GLIAL CELL PROLIFERATION | 36 | 6.03e-01 | -5.01e-02 | 8.47e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 54 | 5.25e-01 | -5.01e-02 | 8.02e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 8.46e-01 | 5.01e-02 | 9.52e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 9 | 7.95e-01 | 5.01e-02 | 9.31e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 10 | 7.84e-01 | 5.00e-02 | 9.25e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 8.32e-01 | -5.00e-02 | 9.46e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 11 | 7.74e-01 | 4.99e-02 | 9.23e-01 |
| GOMF BETA CATENIN BINDING | 60 | 5.04e-01 | -4.99e-02 | 7.90e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 24 | 6.72e-01 | 4.99e-02 | 8.81e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 47 | 5.54e-01 | -4.99e-02 | 8.21e-01 |
| GOBP PARAXIAL MESODERM MORPHOGENESIS | 6 | 8.33e-01 | 4.98e-02 | 9.46e-01 |
| GOBP MOTOR BEHAVIOR | 17 | 7.22e-01 | -4.98e-02 | 9.06e-01 |
| GOBP POLYOL METABOLIC PROCESS | 68 | 4.78e-01 | 4.98e-02 | 7.74e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 7 | 8.20e-01 | 4.97e-02 | 9.40e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 10 | 7.86e-01 | -4.97e-02 | 9.26e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 14 | 7.48e-01 | -4.97e-02 | 9.15e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 5 | 8.48e-01 | -4.96e-02 | 9.52e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 83 | 4.36e-01 | -4.95e-02 | 7.46e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 23 | 6.81e-01 | 4.95e-02 | 8.86e-01 |
| GOCC COHESIN COMPLEX | 9 | 7.97e-01 | 4.95e-02 | 9.31e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 17 | 7.24e-01 | -4.94e-02 | 9.07e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 5 | 8.48e-01 | -4.94e-02 | 9.52e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 95 | 4.06e-01 | -4.94e-02 | 7.25e-01 |
| GOBP GOLGI ORGANIZATION | 128 | 3.35e-01 | 4.94e-02 | 6.72e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 7.77e-01 | 4.94e-02 | 9.23e-01 |
| GOBP SEXUAL REPRODUCTION | 555 | 4.83e-02 | 4.94e-02 | 2.77e-01 |
| GOBP NEURON REMODELING | 5 | 8.48e-01 | 4.94e-02 | 9.52e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 8.09e-01 | 4.94e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 101 | 3.92e-01 | 4.94e-02 | 7.14e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 10 | 7.87e-01 | -4.93e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 12 | 7.67e-01 | 4.93e-02 | 9.21e-01 |
| GOCC ZONULA ADHERENS | 5 | 8.49e-01 | -4.93e-02 | 9.52e-01 |
| GOBP RNA DESTABILIZATION | 94 | 4.09e-01 | -4.93e-02 | 7.28e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 36 | 6.09e-01 | 4.93e-02 | 8.50e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 15 | 7.41e-01 | -4.92e-02 | 9.12e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 10 | 7.87e-01 | -4.92e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 14 | 7.50e-01 | -4.92e-02 | 9.15e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 7.25e-01 | 4.92e-02 | 9.08e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 12 | 7.68e-01 | 4.92e-02 | 9.21e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 17 | 7.26e-01 | -4.91e-02 | 9.08e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 55 | 5.29e-01 | 4.91e-02 | 8.04e-01 |
| GOBP GLUCOSE IMPORT | 44 | 5.73e-01 | -4.91e-02 | 8.30e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 14 | 7.51e-01 | 4.91e-02 | 9.16e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 9 | 7.99e-01 | 4.91e-02 | 9.32e-01 |
| GOCC SARCOLEMMA | 72 | 4.73e-01 | 4.90e-02 | 7.70e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 9 | 7.99e-01 | 4.90e-02 | 9.32e-01 |
| GOBP CHOLESTEROL STORAGE | 17 | 7.27e-01 | 4.90e-02 | 9.08e-01 |
| GOMF I SMAD BINDING | 13 | 7.60e-01 | 4.90e-02 | 9.18e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 7.12e-01 | -4.89e-02 | 9.02e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 10 | 7.89e-01 | 4.89e-02 | 9.28e-01 |
| GOBP GLYCOSYLATION | 158 | 2.90e-01 | 4.89e-02 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 612 | 4.07e-02 | 4.89e-02 | 2.50e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 53 | 5.39e-01 | -4.88e-02 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 25 | 6.73e-01 | 4.87e-02 | 8.81e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 11 | 7.80e-01 | 4.87e-02 | 9.24e-01 |
| GOBP ZYMOGEN ACTIVATION | 30 | 6.45e-01 | 4.86e-02 | 8.66e-01 |
| GOBP PEROXISOMAL TRANSPORT | 22 | 6.93e-01 | 4.86e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 28 | 6.56e-01 | -4.86e-02 | 8.73e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 39 | 6.00e-01 | 4.86e-02 | 8.45e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 11 | 7.80e-01 | 4.86e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 13 | 7.62e-01 | -4.86e-02 | 9.19e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 10 | 7.91e-01 | -4.85e-02 | 9.28e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 17 | 7.29e-01 | -4.85e-02 | 9.09e-01 |
| GOBP LIPID METABOLIC PROCESS | 840 | 1.83e-02 | 4.85e-02 | 1.63e-01 |
| GOCC RECYCLING ENDOSOME | 145 | 3.15e-01 | 4.85e-02 | 6.56e-01 |
| GOMF GLYCOLIPID BINDING | 17 | 7.29e-01 | 4.85e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 88 | 4.32e-01 | 4.85e-02 | 7.44e-01 |
| GOMF MRNA BINDING | 262 | 1.79e-01 | -4.84e-02 | 5.20e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 5 | 8.52e-01 | 4.83e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 25 | 6.77e-01 | 4.81e-02 | 8.83e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 68 | 4.93e-01 | -4.81e-02 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 14 | 7.55e-01 | -4.81e-02 | 9.17e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 8 | 8.14e-01 | 4.81e-02 | 9.39e-01 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 8.52e-01 | -4.81e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 8.38e-01 | 4.81e-02 | 9.48e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 8.03e-01 | -4.81e-02 | 9.34e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 44 | 5.81e-01 | -4.81e-02 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 18 | 7.24e-01 | -4.80e-02 | 9.07e-01 |
| GOMF CARBOHYDRATE BINDING | 135 | 3.37e-01 | 4.80e-02 | 6.73e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 40 | 6.00e-01 | -4.80e-02 | 8.45e-01 |
| GOCC BASEMENT MEMBRANE | 26 | 6.72e-01 | 4.80e-02 | 8.81e-01 |
| GOMF MONOSACCHARIDE BINDING | 46 | 5.74e-01 | 4.80e-02 | 8.30e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 21 | 7.04e-01 | -4.80e-02 | 8.99e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 7.18e-01 | 4.79e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 27 | 6.67e-01 | 4.78e-02 | 8.78e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 40 | 6.01e-01 | 4.78e-02 | 8.46e-01 |
| GOBP MOLTING CYCLE | 46 | 5.75e-01 | -4.78e-02 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 8.04e-01 | 4.78e-02 | 9.34e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 8.04e-01 | -4.77e-02 | 9.34e-01 |
| GOBP GASTRULATION | 96 | 4.20e-01 | -4.77e-02 | 7.35e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 9 | 8.05e-01 | -4.76e-02 | 9.35e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 67 | 5.01e-01 | -4.76e-02 | 7.88e-01 |
| GOCC VESICLE COAT | 53 | 5.50e-01 | 4.75e-02 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 45 | 5.82e-01 | -4.75e-02 | 8.35e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 42 | 5.95e-01 | 4.75e-02 | 8.42e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 13 | 7.68e-01 | 4.73e-02 | 9.21e-01 |
| GOBP RESPONSE TO PEPTIDE | 310 | 1.54e-01 | 4.73e-02 | 4.86e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 421 | 9.78e-02 | 4.73e-02 | 3.94e-01 |
| GOBP POTASSIUM ION TRANSPORT | 78 | 4.71e-01 | 4.73e-02 | 7.68e-01 |
| GOCC CHROMAFFIN GRANULE | 7 | 8.29e-01 | 4.73e-02 | 9.45e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 69 | 4.98e-01 | -4.73e-02 | 7.86e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 205 | 2.45e-01 | 4.72e-02 | 5.93e-01 |
| GOBP TAXIS | 240 | 2.09e-01 | -4.72e-02 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 55 | 5.45e-01 | 4.72e-02 | 8.15e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 580 | 5.43e-02 | 4.72e-02 | 2.93e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 16 | 7.44e-01 | 4.71e-02 | 9.13e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 73 | 4.87e-01 | 4.71e-02 | 7.79e-01 |
| GOBP ARTERY DEVELOPMENT | 43 | 5.93e-01 | -4.71e-02 | 8.42e-01 |
| GOBP SELECTIVE AUTOPHAGY | 88 | 4.45e-01 | 4.71e-02 | 7.53e-01 |
| GOBP ERAD PATHWAY | 94 | 4.30e-01 | 4.71e-02 | 7.43e-01 |
| GOBP GLAND DEVELOPMENT | 225 | 2.25e-01 | 4.71e-02 | 5.74e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 66 | 5.09e-01 | -4.71e-02 | 7.91e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 23 | 6.96e-01 | 4.71e-02 | 8.95e-01 |
| GOCC CYTOSOLIC REGION | 17 | 7.37e-01 | 4.71e-02 | 9.11e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 7 | 8.29e-01 | 4.70e-02 | 9.45e-01 |
| GOBP LACTATION | 25 | 6.84e-01 | 4.70e-02 | 8.88e-01 |
| GOCC SECONDARY LYSOSOME | 16 | 7.45e-01 | -4.70e-02 | 9.14e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 17 | 7.37e-01 | 4.70e-02 | 9.11e-01 |
| GOBP RESPONSE TO ISCHEMIA | 42 | 5.99e-01 | 4.70e-02 | 8.44e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 5 | 8.56e-01 | -4.70e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 17 | 7.38e-01 | 4.70e-02 | 9.11e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 66 | 5.10e-01 | 4.69e-02 | 7.92e-01 |
| GOMF CYTOKINE BINDING | 83 | 4.60e-01 | -4.69e-02 | 7.63e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 7 | 8.30e-01 | -4.68e-02 | 9.45e-01 |
| GOBP MESODERM DEVELOPMENT | 56 | 5.45e-01 | 4.68e-02 | 8.15e-01 |
| GOMF BUBBLE DNA BINDING | 6 | 8.43e-01 | 4.68e-02 | 9.50e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 21 | 7.11e-01 | -4.67e-02 | 9.02e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 62 | 5.25e-01 | 4.67e-02 | 8.02e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 9 | 8.08e-01 | 4.67e-02 | 9.37e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 22 | 7.05e-01 | 4.67e-02 | 9.00e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 67 | 5.10e-01 | 4.66e-02 | 7.92e-01 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 7 | 8.31e-01 | -4.66e-02 | 9.45e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 111 | 3.97e-01 | -4.66e-02 | 7.19e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 127 | 3.66e-01 | 4.65e-02 | 6.94e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 28 | 6.70e-01 | 4.65e-02 | 8.80e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 25 | 6.88e-01 | -4.65e-02 | 8.90e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 374 | 1.25e-01 | 4.64e-02 | 4.39e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 7.90e-01 | -4.64e-02 | 9.28e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 17 | 7.40e-01 | 4.64e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 11 | 7.90e-01 | 4.64e-02 | 9.28e-01 |
| GOMF KINASE BINDING | 566 | 6.12e-02 | 4.64e-02 | 3.15e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 8.58e-01 | 4.63e-02 | 9.56e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 83 | 4.66e-01 | -4.63e-02 | 7.65e-01 |
| GOCC NEURON PROJECTION TERMINUS | 55 | 5.53e-01 | -4.63e-02 | 8.21e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 21 | 7.14e-01 | -4.63e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 14 | 7.65e-01 | -4.62e-02 | 9.20e-01 |
| GOBP COGNITION | 150 | 3.30e-01 | 4.62e-02 | 6.67e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 6 | 8.45e-01 | -4.62e-02 | 9.51e-01 |
| GOBP REGULATION OF AXONOGENESIS | 88 | 4.55e-01 | -4.61e-02 | 7.60e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 15 | 7.57e-01 | -4.61e-02 | 9.17e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 263 | 2.00e-01 | 4.61e-02 | 5.47e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 8.45e-01 | 4.61e-02 | 9.51e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 120 | 3.85e-01 | -4.60e-02 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 49 | 5.77e-01 | -4.60e-02 | 8.32e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 8.45e-01 | 4.60e-02 | 9.51e-01 |
| GOBP REGULATION OF AXON EXTENSION | 55 | 5.56e-01 | -4.60e-02 | 8.22e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 8.11e-01 | -4.60e-02 | 9.38e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 9 | 8.11e-01 | 4.59e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 14 | 7.66e-01 | 4.59e-02 | 9.21e-01 |
| GOBP NEUTROPHIL MIGRATION | 72 | 5.01e-01 | 4.59e-02 | 7.88e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 14 | 7.67e-01 | 4.58e-02 | 9.21e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 51 | 5.72e-01 | 4.58e-02 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 294 | 1.79e-01 | 4.57e-02 | 5.21e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 379 | 1.28e-01 | 4.57e-02 | 4.45e-01 |
| GOMF PROTEIN KINASE C BINDING | 32 | 6.55e-01 | -4.57e-02 | 8.72e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 8 | 8.23e-01 | -4.56e-02 | 9.43e-01 |
| GOBP PHOSPHORYLATION | 1054 | 1.38e-02 | 4.56e-02 | 1.38e-01 |
| GOBP REGULATION OF HEART GROWTH | 33 | 6.51e-01 | -4.55e-02 | 8.70e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 330 | 1.58e-01 | 4.54e-02 | 4.92e-01 |
| GOBP CELL ACTIVATION | 775 | 3.35e-02 | 4.54e-02 | 2.30e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 8.60e-01 | 4.54e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 7 | 8.35e-01 | -4.54e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 36 | 6.38e-01 | -4.53e-02 | 8.63e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 11 | 7.95e-01 | -4.53e-02 | 9.31e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 41 | 6.16e-01 | 4.53e-02 | 8.53e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 16 | 7.54e-01 | -4.53e-02 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 53 | 5.69e-01 | 4.52e-02 | 8.29e-01 |
| GOBP INSULIN METABOLIC PROCESS | 10 | 8.04e-01 | -4.52e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 17 | 7.47e-01 | 4.52e-02 | 9.15e-01 |
| GOBP MAST CELL PROLIFERATION | 6 | 8.48e-01 | -4.52e-02 | 9.52e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 8.61e-01 | 4.51e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 647 | 5.26e-02 | -4.51e-02 | 2.88e-01 |
| GOCC ANCHORING JUNCTION | 555 | 7.19e-02 | 4.50e-02 | 3.37e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 5 | 8.62e-01 | 4.50e-02 | 9.57e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 73 | 5.07e-01 | -4.49e-02 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 53 | 5.72e-01 | 4.49e-02 | 8.29e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 38 | 6.32e-01 | 4.49e-02 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 22 | 7.16e-01 | 4.49e-02 | 9.03e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 12 | 7.88e-01 | -4.48e-02 | 9.28e-01 |
| GOBP CARTILAGE CONDENSATION | 5 | 8.62e-01 | 4.48e-02 | 9.57e-01 |
| GOBP CELL AGGREGATION | 5 | 8.62e-01 | 4.48e-02 | 9.57e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 7 | 8.37e-01 | 4.48e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 16 | 7.57e-01 | 4.48e-02 | 9.17e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 125 | 3.89e-01 | -4.47e-02 | 7.11e-01 |
| GOCC CELL CELL CONTACT ZONE | 41 | 6.21e-01 | -4.47e-02 | 8.56e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 57 | 5.61e-01 | 4.46e-02 | 8.25e-01 |
| GOBP SNRNA TRANSPORT | 6 | 8.50e-01 | -4.46e-02 | 9.53e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 14 | 7.73e-01 | -4.45e-02 | 9.22e-01 |
| GOBP LEARNING | 68 | 5.26e-01 | 4.45e-02 | 8.03e-01 |
| GOCC NUCLEOLUS | 877 | 2.72e-02 | 4.45e-02 | 2.04e-01 |
| GOMF PRIMARY MIRNA BINDING | 10 | 8.08e-01 | -4.45e-02 | 9.37e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 97 | 4.50e-01 | 4.45e-02 | 7.56e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 22 | 7.18e-01 | 4.45e-02 | 9.05e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 399 | 1.30e-01 | 4.44e-02 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 8.63e-01 | -4.44e-02 | 9.57e-01 |
| GOMF FMN BINDING | 9 | 8.18e-01 | 4.44e-02 | 9.40e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 8.64e-01 | 4.44e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 862 | 2.90e-02 | 4.44e-02 | 2.12e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 19 | 7.38e-01 | -4.44e-02 | 9.11e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 40 | 6.28e-01 | 4.43e-02 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 13 | 7.82e-01 | -4.43e-02 | 9.25e-01 |
| GOMF PROTEIN KINASE A BINDING | 38 | 6.37e-01 | -4.42e-02 | 8.63e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 7.08e-01 | 4.42e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 11 | 8.00e-01 | 4.42e-02 | 9.33e-01 |
| GOCC PARASPECKLES | 8 | 8.29e-01 | -4.42e-02 | 9.45e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 81 | 4.93e-01 | -4.42e-02 | 7.82e-01 |
| GOBP REPRODUCTION | 749 | 4.19e-02 | 4.41e-02 | 2.55e-01 |
| GOMF R SMAD BINDING | 20 | 7.33e-01 | 4.41e-02 | 9.10e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 48 | 5.98e-01 | -4.41e-02 | 8.44e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 8.52e-01 | 4.41e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 21 | 7.27e-01 | -4.41e-02 | 9.08e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 30 | 6.76e-01 | -4.41e-02 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 18 | 7.47e-01 | 4.40e-02 | 9.15e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 14 | 7.76e-01 | -4.40e-02 | 9.23e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 8.40e-01 | 4.39e-02 | 9.50e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 55 | 5.73e-01 | -4.39e-02 | 8.30e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 33 | 6.63e-01 | 4.39e-02 | 8.76e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 414 | 1.28e-01 | 4.39e-02 | 4.44e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 21 | 7.28e-01 | -4.39e-02 | 9.09e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 6.68e-01 | -4.38e-02 | 8.78e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 8.41e-01 | -4.38e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 59 | 5.62e-01 | 4.37e-02 | 8.25e-01 |
| GOMF CAMP BINDING | 10 | 8.11e-01 | 4.37e-02 | 9.38e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 9 | 8.21e-01 | 4.37e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 37 | 6.46e-01 | -4.37e-02 | 8.66e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 8.21e-01 | 4.37e-02 | 9.41e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 34 | 6.60e-01 | 4.36e-02 | 8.75e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 961 | 2.40e-02 | 4.36e-02 | 1.90e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 5 | 8.66e-01 | -4.36e-02 | 9.58e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 49 | 5.98e-01 | 4.36e-02 | 8.44e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 7 | 8.42e-01 | -4.35e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 5 | 8.66e-01 | -4.35e-02 | 9.58e-01 |
| GOBP DEFENSE RESPONSE | 1071 | 1.79e-02 | 4.35e-02 | 1.60e-01 |
| GOBP CELL RECOGNITION | 64 | 5.48e-01 | 4.35e-02 | 8.17e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 29 | 6.85e-01 | -4.35e-02 | 8.89e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 88 | 4.81e-01 | 4.35e-02 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 11 | 8.03e-01 | -4.35e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 7 | 8.42e-01 | -4.34e-02 | 9.50e-01 |
| GOCC TRANSPORT VESICLE | 268 | 2.23e-01 | 4.34e-02 | 5.73e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 53 | 5.85e-01 | 4.34e-02 | 8.38e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 83 | 4.96e-01 | -4.33e-02 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 104 | 4.46e-01 | 4.33e-02 | 7.53e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 116 | 4.22e-01 | 4.33e-02 | 7.35e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 7.72e-01 | 4.32e-02 | 9.22e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 152 | 3.59e-01 | -4.32e-02 | 6.88e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 52 | 5.90e-01 | 4.32e-02 | 8.39e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 120 | 4.14e-01 | 4.32e-02 | 7.31e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 45 | 6.16e-01 | 4.32e-02 | 8.53e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 513 | 9.65e-02 | 4.32e-02 | 3.91e-01 |
| GOMF KINASE ACTIVITY | 547 | 8.67e-02 | 4.32e-02 | 3.70e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 88 | 4.85e-01 | -4.31e-02 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 41 | 6.33e-01 | -4.31e-02 | 8.62e-01 |
| GOBP APPENDAGE DEVELOPMENT | 91 | 4.79e-01 | -4.30e-02 | 7.74e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 22 | 7.27e-01 | -4.30e-02 | 9.08e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 217 | 2.77e-01 | 4.30e-02 | 6.26e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 138 | 3.84e-01 | 4.30e-02 | 7.08e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 30 | 6.84e-01 | 4.30e-02 | 8.88e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 5 | 8.68e-01 | -4.29e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1045 | 2.09e-02 | 4.29e-02 | 1.75e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 16 | 7.66e-01 | 4.29e-02 | 9.21e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 57 | 5.76e-01 | 4.29e-02 | 8.31e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 9 | 8.24e-01 | 4.29e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 85 | 4.96e-01 | -4.28e-02 | 7.85e-01 |
| GOBP EATING BEHAVIOR | 13 | 7.89e-01 | 4.28e-02 | 9.28e-01 |
| GOMF DELTA CATENIN BINDING | 5 | 8.69e-01 | -4.27e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 32 | 6.76e-01 | 4.27e-02 | 8.83e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 74 | 5.26e-01 | -4.26e-02 | 8.03e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 22 | 7.29e-01 | 4.26e-02 | 9.09e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 30 | 6.86e-01 | -4.26e-02 | 8.89e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.69e-01 | -4.26e-02 | 9.58e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 169 | 3.42e-01 | 4.25e-02 | 6.77e-01 |
| GOMF SULFUR COMPOUND BINDING | 120 | 4.23e-01 | -4.24e-02 | 7.36e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 10 | 8.16e-01 | 4.24e-02 | 9.40e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 66 | 5.52e-01 | 4.24e-02 | 8.20e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 485 | 1.12e-01 | 4.24e-02 | 4.16e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 21 | 7.37e-01 | 4.23e-02 | 9.11e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 104 | 4.57e-01 | -4.23e-02 | 7.61e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 5 | 8.70e-01 | 4.23e-02 | 9.58e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 11 | 8.09e-01 | -4.22e-02 | 9.37e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 64 | 5.60e-01 | 4.21e-02 | 8.25e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 8.18e-01 | 4.20e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 96 | 4.78e-01 | -4.20e-02 | 7.73e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 37 | 6.59e-01 | 4.20e-02 | 8.73e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 8.47e-01 | -4.20e-02 | 9.52e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 58 | 5.81e-01 | -4.20e-02 | 8.34e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 8.71e-01 | -4.19e-02 | 9.59e-01 |
| GOMF TRNA BINDING | 66 | 5.56e-01 | -4.19e-02 | 8.22e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 10 | 8.19e-01 | 4.19e-02 | 9.40e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 5 | 8.71e-01 | -4.18e-02 | 9.59e-01 |
| GOBP RESPONSE TO STARVATION | 154 | 3.71e-01 | 4.18e-02 | 6.98e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 44 | 6.32e-01 | 4.18e-02 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 104 | 4.62e-01 | 4.18e-02 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 90 | 4.95e-01 | -4.17e-02 | 7.84e-01 |
| GOMF LIPASE ACTIVITY | 69 | 5.50e-01 | 4.17e-02 | 8.18e-01 |
| GOBP REGULATION OF CELL ADHESION | 497 | 1.14e-01 | 4.17e-02 | 4.19e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 191 | 3.22e-01 | 4.16e-02 | 6.62e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 61 | 5.74e-01 | 4.16e-02 | 8.30e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 7.95e-01 | -4.16e-02 | 9.31e-01 |
| GOBP GLIAL CELL MIGRATION | 38 | 6.58e-01 | 4.16e-02 | 8.73e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 43 | 6.37e-01 | 4.16e-02 | 8.63e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 17 | 7.67e-01 | -4.16e-02 | 9.21e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 8.49e-01 | -4.15e-02 | 9.52e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 6 | 8.60e-01 | 4.15e-02 | 9.57e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 16 | 7.74e-01 | -4.15e-02 | 9.23e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 6 | 8.60e-01 | 4.15e-02 | 9.57e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 22 | 7.37e-01 | -4.14e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 42 | 6.44e-01 | -4.13e-02 | 8.66e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 16 | 7.75e-01 | -4.12e-02 | 9.23e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 41 | 6.48e-01 | -4.12e-02 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 119 | 4.39e-01 | -4.12e-02 | 7.48e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 55 | 5.98e-01 | 4.11e-02 | 8.44e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 8.62e-01 | 4.11e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 7 | 8.51e-01 | -4.11e-02 | 9.53e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 31 | 6.93e-01 | -4.11e-02 | 8.93e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 7 | 8.51e-01 | 4.10e-02 | 9.53e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 91 | 5.01e-01 | 4.08e-02 | 7.89e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 396 | 1.66e-01 | -4.08e-02 | 5.00e-01 |
| GOCC MOTILE CILIUM | 134 | 4.16e-01 | -4.08e-02 | 7.32e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 461 | 1.36e-01 | -4.08e-02 | 4.53e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 7 | 8.52e-01 | -4.07e-02 | 9.53e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 20 | 7.53e-01 | -4.07e-02 | 9.17e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 5 | 8.75e-01 | -4.07e-02 | 9.61e-01 |
| GOCC PLASMA MEMBRANE REGION | 631 | 8.41e-02 | 4.06e-02 | 3.65e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 143 | 4.02e-01 | -4.06e-02 | 7.22e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 19 | 7.59e-01 | -4.06e-02 | 9.18e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 39 | 6.61e-01 | 4.06e-02 | 8.75e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 49 | 6.23e-01 | 4.06e-02 | 8.57e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 180 | 3.49e-01 | 4.06e-02 | 6.83e-01 |
| GOMF CERAMIDE BINDING | 13 | 8.01e-01 | -4.04e-02 | 9.33e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 262 | 2.62e-01 | 4.04e-02 | 6.13e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 357 | 1.93e-01 | 4.03e-02 | 5.38e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 128 | 4.32e-01 | 4.03e-02 | 7.44e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 90 | 5.10e-01 | 4.02e-02 | 7.92e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 7.87e-01 | 4.02e-02 | 9.27e-01 |
| GOCC CAJAL BODY | 57 | 6.00e-01 | 4.02e-02 | 8.45e-01 |
| GOBP RESPONSE TO WOUNDING | 296 | 2.36e-01 | 4.02e-02 | 5.87e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 43 | 6.49e-01 | 4.01e-02 | 8.68e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 16 | 7.81e-01 | 4.01e-02 | 9.24e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 14 | 7.95e-01 | -4.01e-02 | 9.31e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 241 | 2.85e-01 | -4.01e-02 | 6.34e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 11 | 8.18e-01 | 4.01e-02 | 9.40e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 16 | 7.82e-01 | 4.00e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 25 | 7.29e-01 | -4.00e-02 | 9.09e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 6 | 8.65e-01 | -4.00e-02 | 9.57e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 190 | 3.44e-01 | 3.99e-02 | 6.79e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 39 | 6.66e-01 | -3.99e-02 | 8.77e-01 |
| GOBP XENOBIOTIC TRANSPORT | 23 | 7.41e-01 | -3.99e-02 | 9.12e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 19 | 7.64e-01 | 3.98e-02 | 9.19e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 157 | 3.91e-01 | -3.98e-02 | 7.12e-01 |
| GOBP STEM CELL DEVELOPMENT | 39 | 6.68e-01 | -3.98e-02 | 8.78e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 27 | 7.21e-01 | 3.98e-02 | 9.05e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 22 | 7.47e-01 | -3.97e-02 | 9.15e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 8.20e-01 | -3.97e-02 | 9.40e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 57 | 6.05e-01 | 3.97e-02 | 8.48e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 17 | 7.77e-01 | 3.96e-02 | 9.24e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 369 | 1.94e-01 | 3.96e-02 | 5.39e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 231 | 3.01e-01 | 3.96e-02 | 6.46e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 8.37e-01 | 3.96e-02 | 9.48e-01 |
| GOBP RRNA METABOLIC PROCESS | 242 | 2.91e-01 | 3.95e-02 | 6.38e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 474 | 1.43e-01 | 3.95e-02 | 4.67e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 219 | 3.15e-01 | 3.95e-02 | 6.57e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 103 | 4.89e-01 | -3.95e-02 | 7.81e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 8.67e-01 | -3.94e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 25 | 7.33e-01 | -3.94e-02 | 9.10e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 107 | 4.82e-01 | -3.94e-02 | 7.76e-01 |
| GOCC TERMINAL BOUTON | 18 | 7.72e-01 | -3.94e-02 | 9.22e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 136 | 4.29e-01 | -3.94e-02 | 7.42e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 7 | 8.57e-01 | 3.94e-02 | 9.56e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 890 | 4.95e-02 | 3.93e-02 | 2.80e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 8.47e-01 | 3.93e-02 | 9.52e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 33 | 6.96e-01 | 3.93e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 769 | 6.68e-02 | 3.93e-02 | 3.27e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 7 | 8.57e-01 | 3.93e-02 | 9.56e-01 |
| GOMF APOLIPOPROTEIN BINDING | 5 | 8.79e-01 | 3.93e-02 | 9.62e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 22 | 7.50e-01 | -3.93e-02 | 9.15e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 26 | 7.29e-01 | -3.93e-02 | 9.09e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 42 | 6.60e-01 | 3.93e-02 | 8.75e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 74 | 5.60e-01 | -3.92e-02 | 8.25e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 22 | 7.50e-01 | -3.92e-02 | 9.15e-01 |
| GOBP PROTEIN TARGETING | 286 | 2.56e-01 | 3.92e-02 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 33 | 6.97e-01 | 3.92e-02 | 8.95e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 46 | 6.46e-01 | 3.92e-02 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 11 | 8.22e-01 | -3.91e-02 | 9.42e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 61 | 5.98e-01 | 3.91e-02 | 8.44e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 528 | 1.27e-01 | 3.91e-02 | 4.43e-01 |
| GOBP VITAMIN TRANSPORT | 22 | 7.52e-01 | -3.90e-02 | 9.16e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 8.69e-01 | -3.90e-02 | 9.58e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 17 | 7.81e-01 | -3.89e-02 | 9.24e-01 |
| GOBP PLATELET ACTIVATION | 77 | 5.56e-01 | 3.88e-02 | 8.22e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 56 | 6.16e-01 | -3.88e-02 | 8.52e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 10 | 8.32e-01 | -3.87e-02 | 9.46e-01 |
| GOBP TOOTH MINERALIZATION | 10 | 8.32e-01 | 3.87e-02 | 9.46e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 26 | 7.33e-01 | 3.87e-02 | 9.10e-01 |
| GOCC NSL COMPLEX | 11 | 8.24e-01 | 3.87e-02 | 9.43e-01 |
| GOBP PANCREAS DEVELOPMENT | 33 | 7.00e-01 | -3.87e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 28 | 7.23e-01 | -3.87e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 9 | 8.41e-01 | 3.86e-02 | 9.50e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 5 | 8.81e-01 | -3.86e-02 | 9.63e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 99 | 5.08e-01 | -3.86e-02 | 7.91e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 8.81e-01 | -3.86e-02 | 9.63e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 48 | 6.44e-01 | -3.86e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 12 | 8.17e-01 | -3.85e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 81 | 5.49e-01 | 3.85e-02 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 16 | 7.90e-01 | 3.85e-02 | 9.28e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 8.03e-01 | 3.85e-02 | 9.34e-01 |
| GOBP ASSOCIATIVE LEARNING | 40 | 6.74e-01 | -3.85e-02 | 8.81e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 8.25e-01 | 3.85e-02 | 9.44e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 18 | 7.78e-01 | 3.85e-02 | 9.24e-01 |
| GOBP REGULATION OF GLIOGENESIS | 53 | 6.28e-01 | -3.85e-02 | 8.60e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 64 | 5.95e-01 | 3.85e-02 | 8.42e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 80 | 5.53e-01 | 3.84e-02 | 8.21e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 26 | 7.35e-01 | 3.84e-02 | 9.11e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 33 | 7.03e-01 | 3.84e-02 | 8.98e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 22 | 7.55e-01 | -3.84e-02 | 9.17e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 23 | 7.50e-01 | 3.84e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 344 | 2.24e-01 | -3.84e-02 | 5.73e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 253 | 2.95e-01 | 3.84e-02 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 102 | 5.04e-01 | -3.84e-02 | 7.90e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 11 | 8.26e-01 | 3.84e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 901 | 5.40e-02 | 3.83e-02 | 2.92e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 7 | 8.61e-01 | 3.83e-02 | 9.57e-01 |
| GOCC RECEPTOR COMPLEX | 205 | 3.46e-01 | -3.83e-02 | 6.80e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 8.11e-01 | 3.83e-02 | 9.38e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 135 | 4.44e-01 | -3.83e-02 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 255 | 2.95e-01 | 3.82e-02 | 6.40e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 6 | 8.71e-01 | 3.82e-02 | 9.59e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 690 | 9.02e-02 | 3.82e-02 | 3.77e-01 |
| GOCC SITE OF POLARIZED GROWTH | 118 | 4.74e-01 | 3.82e-02 | 7.71e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 12 | 8.19e-01 | -3.82e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 121 | 4.69e-01 | 3.82e-02 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 164 | 4.00e-01 | 3.82e-02 | 7.21e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 16 | 7.92e-01 | 3.81e-02 | 9.29e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 24 | 7.47e-01 | -3.81e-02 | 9.15e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 7.68e-01 | 3.81e-02 | 9.21e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 15 | 7.98e-01 | 3.81e-02 | 9.32e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 62 | 6.05e-01 | 3.80e-02 | 8.48e-01 |
| GOBP FACE DEVELOPMENT | 31 | 7.14e-01 | -3.80e-02 | 9.02e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 46 | 6.56e-01 | 3.80e-02 | 8.73e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 16 | 7.93e-01 | 3.79e-02 | 9.30e-01 |
| GOBP L ALANINE TRANSPORT | 7 | 8.62e-01 | 3.79e-02 | 9.57e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 203 | 3.53e-01 | 3.79e-02 | 6.85e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 16 | 7.93e-01 | -3.79e-02 | 9.30e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 9 | 8.44e-01 | -3.79e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 97 | 5.20e-01 | 3.79e-02 | 7.99e-01 |
| GOBP HOMEOSTATIC PROCESS | 995 | 4.67e-02 | 3.78e-02 | 2.71e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 185 | 3.76e-01 | -3.78e-02 | 7.03e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 46 | 6.58e-01 | 3.78e-02 | 8.73e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 136 | 4.48e-01 | 3.77e-02 | 7.54e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 61 | 6.11e-01 | -3.77e-02 | 8.50e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 182 | 3.82e-01 | 3.77e-02 | 7.07e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 61 | 6.11e-01 | 3.77e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 29 | 7.26e-01 | 3.76e-02 | 9.08e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 7 | 8.63e-01 | -3.76e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 6 | 8.73e-01 | -3.75e-02 | 9.60e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 861 | 6.48e-02 | 3.75e-02 | 3.24e-01 |
| GOBP GLAND MORPHOGENESIS | 53 | 6.37e-01 | -3.75e-02 | 8.63e-01 |
| GOBP ADENOSINE TO INOSINE EDITING | 5 | 8.85e-01 | 3.75e-02 | 9.64e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 225 | 3.35e-01 | 3.75e-02 | 6.71e-01 |
| GOBP ENDOSOME ORGANIZATION | 86 | 5.49e-01 | 3.74e-02 | 8.18e-01 |
| GOBP PHENOTYPIC SWITCHING | 5 | 8.85e-01 | -3.74e-02 | 9.64e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 81 | 5.61e-01 | 3.74e-02 | 8.25e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 98 | 5.23e-01 | -3.74e-02 | 8.01e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 8.46e-01 | 3.73e-02 | 9.52e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 8.64e-01 | -3.73e-02 | 9.57e-01 |
| GOBP DOSAGE COMPENSATION | 28 | 7.33e-01 | -3.73e-02 | 9.10e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 206 | 3.58e-01 | 3.73e-02 | 6.88e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 108 | 5.05e-01 | 3.72e-02 | 7.91e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 25 | 7.48e-01 | -3.72e-02 | 9.15e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 25 | 7.48e-01 | -3.72e-02 | 9.15e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 21 | 7.68e-01 | -3.71e-02 | 9.21e-01 |
| GOCC MEMBRANE MICRODOMAIN | 174 | 4.00e-01 | 3.71e-02 | 7.21e-01 |
| GOBP GLYCOLIPID TRANSPORT | 7 | 8.65e-01 | 3.71e-02 | 9.57e-01 |
| GOBP TRANSLATIONAL ELONGATION | 60 | 6.20e-01 | 3.71e-02 | 8.55e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 103 | 5.17e-01 | 3.70e-02 | 7.97e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 8.56e-01 | 3.70e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 83 | 5.60e-01 | 3.70e-02 | 8.25e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 9 | 8.48e-01 | 3.70e-02 | 9.52e-01 |
| GOBP CD40 SIGNALING PATHWAY | 13 | 8.17e-01 | -3.70e-02 | 9.40e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 9 | 8.48e-01 | -3.70e-02 | 9.52e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 23 | 7.59e-01 | 3.69e-02 | 9.18e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 218 | 3.50e-01 | 3.69e-02 | 6.83e-01 |
| GOBP RNA CATABOLIC PROCESS | 257 | 3.12e-01 | -3.68e-02 | 6.54e-01 |
| GOBP EXIT FROM MITOSIS | 28 | 7.36e-01 | -3.68e-02 | 9.11e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 8.12e-01 | 3.68e-02 | 9.38e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 78 | 5.75e-01 | -3.68e-02 | 8.31e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 69 | 5.98e-01 | 3.68e-02 | 8.44e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 62 | 6.17e-01 | -3.67e-02 | 8.53e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 96 | 5.35e-01 | 3.67e-02 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 28 | 7.37e-01 | 3.66e-02 | 9.11e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 10 | 8.41e-01 | -3.66e-02 | 9.50e-01 |
| GOBP AMIDE TRANSPORT | 177 | 4.02e-01 | -3.66e-02 | 7.22e-01 |
| GOBP RESPONSE TO PROGESTERONE | 25 | 7.52e-01 | 3.66e-02 | 9.16e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 48 | 6.61e-01 | 3.66e-02 | 8.75e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 18 | 7.88e-01 | -3.66e-02 | 9.28e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 21 | 7.72e-01 | -3.66e-02 | 9.22e-01 |
| GOBP NEPHRON DEVELOPMENT | 63 | 6.16e-01 | 3.66e-02 | 8.53e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 119 | 4.92e-01 | 3.65e-02 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 234 | 3.37e-01 | 3.65e-02 | 6.73e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 8.77e-01 | 3.65e-02 | 9.61e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 11 | 8.34e-01 | -3.65e-02 | 9.47e-01 |
| GOMF CALCIUM ION BINDING | 279 | 2.97e-01 | 3.65e-02 | 6.42e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 145 | 4.50e-01 | 3.64e-02 | 7.56e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 83 | 5.67e-01 | -3.64e-02 | 8.29e-01 |
| GOCC INHIBITORY SYNAPSE | 5 | 8.88e-01 | -3.64e-02 | 9.65e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 443 | 1.92e-01 | 3.64e-02 | 5.37e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 8.35e-01 | -3.64e-02 | 9.47e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 245 | 3.29e-01 | -3.63e-02 | 6.67e-01 |
| GOBP ACROSOME ASSEMBLY | 13 | 8.21e-01 | -3.63e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 327 | 2.61e-01 | 3.63e-02 | 6.12e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 10 | 8.43e-01 | 3.63e-02 | 9.50e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 90 | 5.53e-01 | 3.62e-02 | 8.21e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 7 | 8.68e-01 | -3.62e-02 | 9.58e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 29 | 7.36e-01 | 3.62e-02 | 9.11e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 5 | 8.89e-01 | -3.61e-02 | 9.66e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 10 | 8.43e-01 | 3.61e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 12 | 8.29e-01 | 3.60e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 313 | 2.75e-01 | 3.60e-02 | 6.25e-01 |
| GOCC AUTOLYSOSOME | 12 | 8.29e-01 | 3.60e-02 | 9.45e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 8.03e-01 | 3.60e-02 | 9.34e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 39 | 6.98e-01 | -3.60e-02 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 6 | 8.79e-01 | -3.60e-02 | 9.62e-01 |
| GOMF GALACTOSIDE BINDING | 6 | 8.79e-01 | 3.60e-02 | 9.62e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 416 | 2.12e-01 | 3.59e-02 | 5.60e-01 |
| GOBP SIGNAL RELEASE | 229 | 3.51e-01 | -3.59e-02 | 6.84e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 137 | 4.70e-01 | -3.59e-02 | 7.68e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 36 | 7.10e-01 | -3.58e-02 | 9.02e-01 |
| GOMF RAGE RECEPTOR BINDING | 9 | 8.53e-01 | -3.58e-02 | 9.54e-01 |
| GOMF STEROL BINDING | 46 | 6.75e-01 | 3.57e-02 | 8.82e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 8.70e-01 | -3.57e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 78 | 5.86e-01 | -3.57e-02 | 8.38e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 8.70e-01 | -3.57e-02 | 9.58e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 12 | 8.31e-01 | 3.57e-02 | 9.45e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 10 | 8.45e-01 | -3.57e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 9 | 8.53e-01 | 3.56e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 187 | 4.02e-01 | 3.56e-02 | 7.22e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 20 | 7.83e-01 | 3.56e-02 | 9.25e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 8 | 8.62e-01 | 3.55e-02 | 9.57e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 131 | 4.84e-01 | -3.55e-02 | 7.77e-01 |
| GOMF SNRNA BINDING | 45 | 6.81e-01 | 3.55e-02 | 8.86e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 11 | 8.39e-01 | -3.54e-02 | 9.48e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 21 | 7.79e-01 | 3.54e-02 | 9.24e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 327 | 2.73e-01 | 3.54e-02 | 6.22e-01 |
| GOBP AXON EXTENSION | 72 | 6.05e-01 | -3.53e-02 | 8.48e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 40 | 6.99e-01 | 3.53e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 22 | 7.74e-01 | 3.53e-02 | 9.23e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 39 | 7.03e-01 | 3.53e-02 | 8.99e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 8.55e-01 | 3.52e-02 | 9.55e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 45 | 6.84e-01 | 3.51e-02 | 8.88e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 34 | 7.23e-01 | 3.51e-02 | 9.07e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 71 | 6.10e-01 | -3.51e-02 | 8.50e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 123 | 5.03e-01 | 3.50e-02 | 7.90e-01 |
| GOBP RNA PROCESSING | 854 | 8.68e-02 | 3.49e-02 | 3.70e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 30 | 7.41e-01 | 3.49e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 8 | 8.64e-01 | -3.49e-02 | 9.57e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 742 | 1.10e-01 | 3.49e-02 | 4.12e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 10 | 8.49e-01 | 3.48e-02 | 9.52e-01 |
| GOBP AXIS SPECIFICATION | 38 | 7.11e-01 | 3.48e-02 | 9.02e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 8.65e-01 | 3.48e-02 | 9.57e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 48 | 6.77e-01 | -3.48e-02 | 8.83e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 8.57e-01 | -3.47e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 18 | 7.99e-01 | -3.47e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 478 | 1.97e-01 | -3.47e-02 | 5.43e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 6 | 8.83e-01 | -3.46e-02 | 9.64e-01 |
| GOMF FIBRONECTIN BINDING | 11 | 8.43e-01 | 3.46e-02 | 9.50e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 57 | 6.52e-01 | -3.46e-02 | 8.70e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 167 | 4.42e-01 | 3.46e-02 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 76 | 6.03e-01 | -3.46e-02 | 8.47e-01 |
| GOBP BONE RESORPTION | 40 | 7.06e-01 | 3.45e-02 | 9.00e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 14 | 8.23e-01 | 3.45e-02 | 9.43e-01 |
| GOBP BONE MINERALIZATION | 58 | 6.50e-01 | -3.45e-02 | 8.69e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 13 | 8.30e-01 | -3.44e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 33 | 7.32e-01 | 3.44e-02 | 9.10e-01 |
| GOBP CILIUM ORGANIZATION | 281 | 3.23e-01 | 3.44e-02 | 6.62e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 23 | 7.75e-01 | -3.44e-02 | 9.23e-01 |
| GOCC LEADING EDGE MEMBRANE | 114 | 5.27e-01 | -3.44e-02 | 8.03e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 107 | 5.40e-01 | 3.43e-02 | 8.11e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 12 | 8.37e-01 | -3.43e-02 | 9.48e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 7.54e-01 | 3.42e-02 | 9.17e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 12 | 8.38e-01 | 3.42e-02 | 9.48e-01 |
| GOBP TRNA 3 END PROCESSING | 7 | 8.76e-01 | 3.41e-02 | 9.61e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 7.59e-01 | -3.41e-02 | 9.18e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 296 | 3.15e-01 | 3.41e-02 | 6.56e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 67 | 6.29e-01 | -3.41e-02 | 8.61e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 6.99e-01 | -3.41e-02 | 8.96e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 82 | 5.94e-01 | 3.41e-02 | 8.42e-01 |
| GOBP FILOPODIUM ASSEMBLY | 45 | 6.93e-01 | 3.41e-02 | 8.93e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 8.85e-01 | 3.40e-02 | 9.64e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 6 | 8.85e-01 | 3.40e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 45 | 6.93e-01 | -3.40e-02 | 8.93e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 174 | 4.40e-01 | -3.40e-02 | 7.49e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 16 | 8.14e-01 | -3.40e-02 | 9.39e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 6 | 8.86e-01 | -3.40e-02 | 9.64e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 43 | 7.00e-01 | 3.39e-02 | 8.97e-01 |
| GOMF PROLINE RICH REGION BINDING | 13 | 8.32e-01 | 3.39e-02 | 9.46e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 39 | 7.14e-01 | -3.39e-02 | 9.02e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 28 | 7.57e-01 | 3.38e-02 | 9.17e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 15 | 8.21e-01 | 3.38e-02 | 9.41e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 37 | 7.22e-01 | -3.38e-02 | 9.06e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 192 | 4.20e-01 | -3.38e-02 | 7.35e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 36 | 7.26e-01 | 3.38e-02 | 9.08e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 60 | 6.52e-01 | 3.37e-02 | 8.70e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 115 | 5.33e-01 | -3.37e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 17 | 8.10e-01 | 3.37e-02 | 9.38e-01 |
| GOBP ADULT BEHAVIOR | 67 | 6.34e-01 | -3.36e-02 | 8.62e-01 |
| GOCC EXOCYTIC VESICLE | 125 | 5.17e-01 | 3.36e-02 | 7.97e-01 |
| GOCC NUCLEAR MEMBRANE | 250 | 3.62e-01 | 3.36e-02 | 6.90e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 144 | 4.87e-01 | 3.36e-02 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 8 | 8.69e-01 | 3.36e-02 | 9.58e-01 |
| GOCC FIBRILLAR CENTER | 129 | 5.11e-01 | 3.35e-02 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 287 | 3.30e-01 | 3.35e-02 | 6.67e-01 |
| GOCC X CHROMOSOME | 7 | 8.78e-01 | 3.35e-02 | 9.62e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 33 | 7.39e-01 | -3.35e-02 | 9.12e-01 |
| GOBP ORGANIC CATION TRANSPORT | 27 | 7.63e-01 | 3.35e-02 | 9.19e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 8.97e-01 | 3.34e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 8.70e-01 | 3.34e-02 | 9.58e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 6 | 8.87e-01 | -3.34e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 74 | 6.20e-01 | 3.34e-02 | 8.55e-01 |
| GOBP WATER TRANSPORT | 8 | 8.70e-01 | 3.33e-02 | 9.58e-01 |
| GOBP ORGANELLE DISASSEMBLY | 130 | 5.13e-01 | 3.33e-02 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 200 | 4.18e-01 | -3.33e-02 | 7.33e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 10 | 8.55e-01 | 3.33e-02 | 9.55e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 481 | 2.14e-01 | 3.33e-02 | 5.64e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 39 | 7.20e-01 | 3.32e-02 | 9.05e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 15 | 8.24e-01 | -3.32e-02 | 9.43e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 432 | 2.39e-01 | 3.32e-02 | 5.88e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 24 | 7.78e-01 | 3.32e-02 | 9.24e-01 |
| GOBP RESPONSE TO ACTIVITY | 38 | 7.23e-01 | 3.32e-02 | 9.07e-01 |
| GOBP REGULATION OF MITOPHAGY | 14 | 8.30e-01 | 3.32e-02 | 9.45e-01 |
| GOBP PALLIUM DEVELOPMENT | 113 | 5.44e-01 | 3.31e-02 | 8.14e-01 |
| GOCC SMAD PROTEIN COMPLEX | 6 | 8.88e-01 | 3.31e-02 | 9.65e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 5 | 8.98e-01 | -3.31e-02 | 9.71e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 16 | 8.19e-01 | 3.31e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 145 | 4.92e-01 | -3.31e-02 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 8.19e-01 | 3.31e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 61 | 6.55e-01 | 3.31e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 8.99e-01 | -3.29e-02 | 9.71e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 980 | 8.53e-02 | 3.29e-02 | 3.68e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 141 | 5.00e-01 | 3.29e-02 | 7.88e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 8 | 8.72e-01 | -3.29e-02 | 9.59e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 8.89e-01 | -3.29e-02 | 9.66e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 47 | 6.97e-01 | 3.29e-02 | 8.95e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 6 | 8.89e-01 | -3.29e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 58 | 6.66e-01 | 3.28e-02 | 8.77e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 9 | 8.65e-01 | -3.28e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 89 | 5.93e-01 | 3.28e-02 | 8.42e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 33 | 7.44e-01 | 3.28e-02 | 9.13e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 157 | 4.79e-01 | 3.28e-02 | 7.74e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 15 | 8.26e-01 | 3.28e-02 | 9.44e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 30 | 7.56e-01 | 3.27e-02 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 29 | 7.61e-01 | 3.27e-02 | 9.18e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 17 | 8.16e-01 | 3.27e-02 | 9.40e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 16 | 8.21e-01 | -3.27e-02 | 9.41e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 8.90e-01 | 3.27e-02 | 9.66e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 59 | 6.65e-01 | 3.26e-02 | 8.77e-01 |
| GOBP TISSUE HOMEOSTASIS | 149 | 4.93e-01 | -3.26e-02 | 7.82e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 111 | 5.54e-01 | 3.26e-02 | 8.21e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 8 | 8.73e-01 | -3.26e-02 | 9.59e-01 |
| GOBP SEGMENT SPECIFICATION | 6 | 8.90e-01 | -3.26e-02 | 9.66e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 697 | 1.48e-01 | 3.25e-02 | 4.76e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 15 | 8.28e-01 | -3.25e-02 | 9.45e-01 |
| GOMF STEROID BINDING | 61 | 6.62e-01 | 3.24e-02 | 8.75e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 13 | 8.40e-01 | 3.24e-02 | 9.49e-01 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 10 | 8.59e-01 | 3.24e-02 | 9.57e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 95 | 5.86e-01 | 3.24e-02 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 30 | 7.60e-01 | 3.23e-02 | 9.18e-01 |
| GOBP VIRAL GENE EXPRESSION | 94 | 5.90e-01 | 3.22e-02 | 8.39e-01 |
| GOBP REGULATION OF LIPID STORAGE | 33 | 7.49e-01 | -3.22e-02 | 9.15e-01 |
| GOBP RESPONSE TO BACTERIUM | 355 | 3.00e-01 | -3.22e-02 | 6.44e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 380 | 2.84e-01 | 3.22e-02 | 6.32e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 32 | 7.53e-01 | 3.22e-02 | 9.17e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 102 | 5.75e-01 | 3.21e-02 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 18 | 8.13e-01 | -3.21e-02 | 9.39e-01 |
| GOCC TRANS GOLGI NETWORK | 201 | 4.34e-01 | 3.21e-02 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 12 | 8.47e-01 | 3.21e-02 | 9.52e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 18 | 8.14e-01 | -3.21e-02 | 9.39e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 69 | 6.45e-01 | -3.21e-02 | 8.66e-01 |
| GOBP REGULATION OF PH | 70 | 6.43e-01 | 3.20e-02 | 8.66e-01 |
| GOBP POSITIVE CHEMOTAXIS | 23 | 7.91e-01 | 3.20e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 36 | 7.40e-01 | -3.19e-02 | 9.12e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 19 | 8.10e-01 | 3.19e-02 | 9.38e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 18 | 8.15e-01 | -3.19e-02 | 9.40e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 264 | 3.75e-01 | 3.18e-02 | 7.02e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 7.75e-01 | -3.18e-02 | 9.23e-01 |
| GOBP RESPONSE TO RADIATION | 292 | 3.52e-01 | 3.18e-02 | 6.84e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 8 | 8.76e-01 | 3.18e-02 | 9.61e-01 |
| GOBP CYTOKINE PRODUCTION | 524 | 2.18e-01 | 3.17e-02 | 5.67e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 39 | 7.33e-01 | -3.16e-02 | 9.10e-01 |
| GOBP AMIDE METABOLIC PROCESS | 911 | 1.10e-01 | -3.16e-02 | 4.13e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 8.27e-01 | 3.16e-02 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 28 | 7.72e-01 | 3.16e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 118 | 5.54e-01 | 3.16e-02 | 8.21e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 8.94e-01 | -3.15e-02 | 9.68e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1039 | 9.11e-02 | 3.15e-02 | 3.79e-01 |
| GOMF SH2 DOMAIN BINDING | 31 | 7.62e-01 | -3.15e-02 | 9.19e-01 |
| GOCC APICAL PART OF CELL | 211 | 4.32e-01 | 3.15e-02 | 7.44e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 8.94e-01 | -3.15e-02 | 9.68e-01 |
| GOBP ORGANIC ANION TRANSPORT | 220 | 4.23e-01 | 3.14e-02 | 7.36e-01 |
| GOMF GAMMA CATENIN BINDING | 6 | 8.94e-01 | 3.14e-02 | 9.68e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 26 | 7.82e-01 | 3.14e-02 | 9.24e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 11 | 8.57e-01 | -3.14e-02 | 9.56e-01 |
| GOBP PIGMENTATION | 73 | 6.43e-01 | 3.14e-02 | 8.66e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 147 | 5.13e-01 | 3.14e-02 | 7.94e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 24 | 7.90e-01 | 3.13e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 210 | 4.35e-01 | -3.13e-02 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 244 | 4.01e-01 | -3.13e-02 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 90 | 6.09e-01 | -3.13e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 18 | 8.19e-01 | -3.12e-02 | 9.40e-01 |
| GOBP STEROID METABOLIC PROCESS | 166 | 4.89e-01 | -3.12e-02 | 7.81e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 5 | 9.04e-01 | 3.12e-02 | 9.72e-01 |
| GOCC SIDE OF MEMBRANE | 395 | 2.91e-01 | 3.11e-02 | 6.38e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 11 | 8.58e-01 | -3.11e-02 | 9.56e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 22 | 8.01e-01 | 3.11e-02 | 9.33e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 26 | 7.84e-01 | 3.11e-02 | 9.25e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 7 | 8.87e-01 | 3.10e-02 | 9.65e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 273 | 3.80e-01 | 3.10e-02 | 7.06e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 17 | 8.25e-01 | -3.10e-02 | 9.44e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 38 | 7.41e-01 | -3.10e-02 | 9.12e-01 |
| GOBP MITOCHONDRIAL FUSION | 33 | 7.59e-01 | 3.09e-02 | 9.18e-01 |
| GOBP MEMBRANE BIOGENESIS | 45 | 7.20e-01 | -3.09e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 8.80e-01 | 3.09e-02 | 9.62e-01 |
| GOBP MACROPHAGE PROLIFERATION | 7 | 8.87e-01 | -3.09e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 100 | 5.94e-01 | -3.09e-02 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 9 | 8.73e-01 | 3.09e-02 | 9.59e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 224 | 4.28e-01 | 3.08e-02 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 12 | 8.53e-01 | -3.08e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 130 | 5.45e-01 | 3.08e-02 | 8.15e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 11 | 8.60e-01 | -3.08e-02 | 9.57e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 6 | 8.96e-01 | 3.08e-02 | 9.70e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 58 | 6.86e-01 | -3.08e-02 | 8.89e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 114 | 5.71e-01 | 3.07e-02 | 8.29e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 8.66e-01 | -3.07e-02 | 9.58e-01 |
| GOBP B CELL ACTIVATION | 206 | 4.49e-01 | 3.07e-02 | 7.55e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 46 | 7.19e-01 | 3.07e-02 | 9.05e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 17 | 8.27e-01 | 3.07e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 372 | 3.13e-01 | 3.06e-02 | 6.55e-01 |
| GOBP NECROPTOTIC PROCESS | 35 | 7.54e-01 | 3.06e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 58 | 6.88e-01 | 3.05e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 13 | 8.49e-01 | 3.05e-02 | 9.52e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 105 | 5.90e-01 | 3.05e-02 | 8.39e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 8 | 8.81e-01 | -3.05e-02 | 9.63e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 20 | 8.14e-01 | -3.05e-02 | 9.39e-01 |
| GOBP AMINE TRANSPORT | 36 | 7.53e-01 | -3.04e-02 | 9.17e-01 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 6 | 8.98e-01 | 3.04e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 428 | 2.85e-01 | 3.03e-02 | 6.33e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 162 | 5.07e-01 | -3.03e-02 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 157 | 5.14e-01 | 3.03e-02 | 7.95e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 196 | 4.67e-01 | 3.02e-02 | 7.66e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 6 | 8.98e-01 | -3.02e-02 | 9.71e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 15 | 8.40e-01 | -3.02e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 26 | 7.90e-01 | 3.02e-02 | 9.28e-01 |
| GOMF JUN KINASE BINDING | 8 | 8.83e-01 | -3.02e-02 | 9.63e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 10 | 8.69e-01 | -3.01e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 18 | 8.25e-01 | -3.01e-02 | 9.44e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 57 | 6.95e-01 | 3.01e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 526 | 2.41e-01 | 3.01e-02 | 5.90e-01 |
| GOCC CILIARY BASAL BODY | 126 | 5.61e-01 | -3.01e-02 | 8.25e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 28 | 7.83e-01 | -3.00e-02 | 9.25e-01 |
| GOBP SEROTONIN TRANSPORT | 9 | 8.76e-01 | 3.00e-02 | 9.61e-01 |
| GOCC SYNAPTIC MEMBRANE | 154 | 5.22e-01 | 3.00e-02 | 8.01e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 10 | 8.70e-01 | -2.99e-02 | 9.58e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 21 | 8.13e-01 | 2.99e-02 | 9.39e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 14 | 8.47e-01 | -2.99e-02 | 9.52e-01 |
| GOBP GLIAL CELL ACTIVATION | 35 | 7.60e-01 | 2.98e-02 | 9.18e-01 |
| GOBP RESPONSE TO UV C | 12 | 8.58e-01 | 2.98e-02 | 9.56e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 8.58e-01 | 2.98e-02 | 9.56e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 192 | 4.78e-01 | 2.97e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 137 | 5.49e-01 | -2.97e-02 | 8.17e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 97 | 6.14e-01 | 2.97e-02 | 8.52e-01 |
| GOBP VASOCONSTRICTION | 30 | 7.79e-01 | -2.96e-02 | 9.24e-01 |
| GOCC POLE PLASM | 13 | 8.54e-01 | 2.95e-02 | 9.54e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 34 | 7.66e-01 | -2.95e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 9.01e-01 | 2.95e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 48 | 7.24e-01 | -2.94e-02 | 9.07e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 229 | 4.44e-01 | 2.94e-02 | 7.52e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 12 | 8.60e-01 | 2.94e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 131 | 5.62e-01 | 2.94e-02 | 8.25e-01 |
| GOCC NEURON SPINE | 91 | 6.28e-01 | 2.94e-02 | 8.60e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 21 | 8.16e-01 | -2.94e-02 | 9.40e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 24 | 8.04e-01 | 2.93e-02 | 9.34e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 8.73e-01 | 2.93e-02 | 9.59e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 13 | 8.55e-01 | -2.93e-02 | 9.55e-01 |
| GOCC KINETOCHORE MICROTUBULE | 18 | 8.30e-01 | 2.93e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 5 | 9.10e-01 | -2.92e-02 | 9.74e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 30 | 7.82e-01 | -2.92e-02 | 9.25e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 17 | 8.35e-01 | 2.92e-02 | 9.47e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 64 | 6.87e-01 | -2.91e-02 | 8.89e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 6 | 9.02e-01 | -2.91e-02 | 9.71e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 53 | 7.14e-01 | -2.91e-02 | 9.02e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 56 | 7.07e-01 | -2.91e-02 | 9.00e-01 |
| GOBP VESICLE CARGO LOADING | 27 | 7.94e-01 | 2.91e-02 | 9.30e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 392 | 3.26e-01 | 2.91e-02 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 31 | 7.79e-01 | 2.91e-02 | 9.24e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 67 | 6.81e-01 | -2.91e-02 | 8.86e-01 |
| GOCC NUCLEAR BODY | 722 | 1.88e-01 | 2.91e-02 | 5.33e-01 |
| GOBP MRNA PROCESSING | 431 | 3.04e-01 | 2.90e-02 | 6.47e-01 |
| GOCC PRESYNAPSE | 296 | 3.92e-01 | 2.90e-02 | 7.14e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 8 | 8.87e-01 | 2.89e-02 | 9.65e-01 |
| GOBP BRAIN MORPHOGENESIS | 21 | 8.19e-01 | -2.89e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 64 | 6.90e-01 | -2.88e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 8 | 8.88e-01 | -2.88e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 11 | 8.69e-01 | 2.88e-02 | 9.58e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 64 | 6.91e-01 | -2.88e-02 | 8.91e-01 |
| GOBP SECRETION | 512 | 2.68e-01 | 2.88e-02 | 6.19e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 103 | 6.15e-01 | 2.87e-02 | 8.52e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 18 | 8.33e-01 | -2.87e-02 | 9.46e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 34 | 7.72e-01 | -2.87e-02 | 9.22e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 425 | 3.14e-01 | 2.87e-02 | 6.55e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 43 | 7.45e-01 | 2.87e-02 | 9.14e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 17 | 8.38e-01 | 2.86e-02 | 9.48e-01 |
| GOCC GTPASE COMPLEX | 25 | 8.04e-01 | 2.86e-02 | 9.34e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 16 | 8.43e-01 | -2.86e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 33 | 7.76e-01 | -2.86e-02 | 9.23e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 6 | 9.04e-01 | 2.86e-02 | 9.72e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 57 | 7.10e-01 | 2.85e-02 | 9.01e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 240 | 4.48e-01 | -2.85e-02 | 7.54e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 274 | 4.18e-01 | 2.85e-02 | 7.34e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 5 | 9.12e-01 | -2.85e-02 | 9.75e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 34 | 7.74e-01 | 2.85e-02 | 9.23e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 29 | 7.91e-01 | 2.84e-02 | 9.29e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 20 | 8.26e-01 | -2.84e-02 | 9.44e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 33 | 7.78e-01 | 2.83e-02 | 9.24e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 10 | 8.77e-01 | -2.83e-02 | 9.61e-01 |
| GOBP OVULATION CYCLE PROCESS | 20 | 8.27e-01 | -2.83e-02 | 9.44e-01 |
| GOBP REGULATION OF CELL SHAPE | 95 | 6.35e-01 | 2.82e-02 | 8.63e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 5 | 9.13e-01 | -2.82e-02 | 9.75e-01 |
| GOBP COPPER ION TRANSPORT | 12 | 8.66e-01 | -2.82e-02 | 9.58e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 124 | 5.89e-01 | 2.81e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 53 | 7.24e-01 | -2.81e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 13 | 8.61e-01 | 2.81e-02 | 9.57e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 37 | 7.68e-01 | -2.81e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 8.46e-01 | -2.81e-02 | 9.52e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 43 | 7.50e-01 | -2.81e-02 | 9.16e-01 |
| GOBP REGULATION OF OSSIFICATION | 60 | 7.09e-01 | -2.78e-02 | 9.01e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 8.13e-01 | 2.78e-02 | 9.39e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 44 | 7.50e-01 | -2.78e-02 | 9.15e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 10 | 8.79e-01 | 2.78e-02 | 9.62e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 10 | 8.79e-01 | 2.78e-02 | 9.62e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 102 | 6.28e-01 | -2.78e-02 | 8.60e-01 |
| GOCC CIS GOLGI NETWORK | 53 | 7.27e-01 | -2.78e-02 | 9.08e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 9 | 8.85e-01 | 2.78e-02 | 9.64e-01 |
| GOBP EXPORT FROM CELL | 489 | 2.97e-01 | 2.78e-02 | 6.42e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 6 | 9.06e-01 | 2.77e-02 | 9.73e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 17 | 8.43e-01 | -2.77e-02 | 9.50e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 12 | 8.68e-01 | 2.77e-02 | 9.58e-01 |
| GOBP TUBE MORPHOGENESIS | 443 | 3.20e-01 | -2.77e-02 | 6.60e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 14 | 8.57e-01 | -2.77e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 217 | 4.83e-01 | 2.77e-02 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 13 | 8.63e-01 | 2.77e-02 | 9.57e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 8.86e-01 | -2.76e-02 | 9.65e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 454 | 3.16e-01 | 2.76e-02 | 6.58e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 344 | 3.83e-01 | 2.75e-02 | 7.08e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 14 | 8.59e-01 | -2.75e-02 | 9.57e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 203 | 5.03e-01 | 2.74e-02 | 7.90e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 63 | 7.08e-01 | 2.74e-02 | 9.01e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 37 | 7.74e-01 | -2.73e-02 | 9.23e-01 |
| GOBP PEPTIDE CROSS LINKING | 7 | 9.01e-01 | 2.73e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 97 | 6.43e-01 | -2.73e-02 | 8.66e-01 |
| GOBP SYNAPTIC SIGNALING | 346 | 3.86e-01 | 2.72e-02 | 7.09e-01 |
| GOBP NUCLEOTIDE SALVAGE | 17 | 8.46e-01 | 2.72e-02 | 9.52e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 35 | 7.80e-01 | 2.72e-02 | 9.24e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 29 | 8.00e-01 | -2.72e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 9 | 8.88e-01 | 2.72e-02 | 9.65e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 18 | 8.42e-01 | -2.72e-02 | 9.50e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 52 | 7.35e-01 | -2.72e-02 | 9.11e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 46 | 7.50e-01 | 2.72e-02 | 9.15e-01 |
| GOBP HIPPO SIGNALING | 30 | 7.97e-01 | 2.71e-02 | 9.31e-01 |
| GOBP REGULATION OF TUBE SIZE | 54 | 7.31e-01 | 2.71e-02 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 22 | 8.26e-01 | 2.71e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 708 | 2.25e-01 | 2.70e-02 | 5.74e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 19 | 8.39e-01 | 2.69e-02 | 9.49e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 20 | 8.35e-01 | 2.69e-02 | 9.47e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 6 | 9.09e-01 | 2.68e-02 | 9.74e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 133 | 5.94e-01 | 2.68e-02 | 8.42e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 9.02e-01 | 2.68e-02 | 9.71e-01 |
| GOBP RESPONSE TO KETONE | 118 | 6.16e-01 | 2.68e-02 | 8.52e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 8.96e-01 | -2.68e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 21 | 8.32e-01 | 2.68e-02 | 9.46e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 26 | 8.13e-01 | 2.68e-02 | 9.39e-01 |
| GOMF U1 SNRNP BINDING | 6 | 9.10e-01 | -2.66e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 9 | 8.90e-01 | -2.66e-02 | 9.66e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 232 | 4.89e-01 | 2.65e-02 | 7.80e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 19 | 8.42e-01 | -2.64e-02 | 9.50e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 46 | 7.57e-01 | 2.64e-02 | 9.17e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 16 | 8.55e-01 | -2.64e-02 | 9.55e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 14 | 8.64e-01 | -2.64e-02 | 9.57e-01 |
| GOBP HISTONE H4 ACETYLATION | 12 | 8.74e-01 | 2.63e-02 | 9.60e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 8 | 8.97e-01 | 2.63e-02 | 9.70e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 941 | 1.77e-01 | 2.63e-02 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 75 | 6.94e-01 | -2.63e-02 | 8.94e-01 |
| GOBP PRE MIRNA PROCESSING | 14 | 8.65e-01 | -2.63e-02 | 9.57e-01 |
| GOBP SEROTONIN UPTAKE | 5 | 9.19e-01 | -2.62e-02 | 9.76e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 8.65e-01 | 2.62e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION | 5 | 9.19e-01 | -2.62e-02 | 9.76e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 7.60e-01 | 2.61e-02 | 9.18e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 6 | 9.12e-01 | 2.61e-02 | 9.75e-01 |
| GOBP T CELL DIFFERENTIATION | 249 | 4.81e-01 | -2.60e-02 | 7.75e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 95 | 6.61e-01 | 2.60e-02 | 8.75e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 18 | 8.49e-01 | 2.60e-02 | 9.52e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 16 | 8.57e-01 | 2.60e-02 | 9.56e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 246 | 4.85e-01 | 2.60e-02 | 7.78e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 76 | 6.96e-01 | 2.60e-02 | 8.95e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 24 | 8.26e-01 | 2.59e-02 | 9.44e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 16 | 8.58e-01 | 2.59e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 22 | 8.34e-01 | 2.58e-02 | 9.47e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 24 | 8.27e-01 | -2.57e-02 | 9.45e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 14 | 8.68e-01 | -2.57e-02 | 9.58e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 30 | 8.08e-01 | 2.57e-02 | 9.37e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 41 | 7.77e-01 | 2.56e-02 | 9.23e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 30 | 8.08e-01 | 2.56e-02 | 9.37e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 9.07e-01 | 2.56e-02 | 9.73e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 8 | 9.00e-01 | -2.56e-02 | 9.71e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 26 | 8.22e-01 | -2.56e-02 | 9.42e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 68 | 7.16e-01 | 2.55e-02 | 9.03e-01 |
| GOCC BBSOME | 8 | 9.00e-01 | 2.55e-02 | 9.71e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 10 | 8.89e-01 | 2.54e-02 | 9.66e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 42 | 7.76e-01 | -2.54e-02 | 9.23e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 49 | 7.58e-01 | 2.54e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 168 | 5.72e-01 | -2.54e-02 | 8.29e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 16 | 8.61e-01 | 2.54e-02 | 9.57e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 8 | 9.01e-01 | -2.53e-02 | 9.71e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 34 | 7.99e-01 | -2.53e-02 | 9.32e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 36 | 7.93e-01 | 2.53e-02 | 9.30e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 27 | 8.21e-01 | -2.52e-02 | 9.41e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 9.08e-01 | -2.52e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 49 | 7.60e-01 | 2.52e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 963 | 1.92e-01 | 2.52e-02 | 5.37e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 21 | 8.42e-01 | 2.52e-02 | 9.50e-01 |
| GOBP PROTEIN NEDDYLATION | 27 | 8.21e-01 | 2.51e-02 | 9.41e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 8 | 9.02e-01 | -2.51e-02 | 9.71e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 53 | 7.52e-01 | 2.51e-02 | 9.17e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 103 | 6.61e-01 | 2.50e-02 | 8.75e-01 |
| GOBP GROWTH | 540 | 3.24e-01 | -2.50e-02 | 6.63e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 6 | 9.16e-01 | -2.50e-02 | 9.76e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 42 | 7.80e-01 | -2.50e-02 | 9.24e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 6 | 9.16e-01 | -2.49e-02 | 9.76e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 41 | 7.83e-01 | -2.49e-02 | 9.25e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 44 | 7.75e-01 | -2.49e-02 | 9.23e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 12 | 8.82e-01 | -2.48e-02 | 9.63e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 587 | 3.10e-01 | 2.48e-02 | 6.52e-01 |
| GOMF CARD DOMAIN BINDING | 12 | 8.82e-01 | 2.47e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 20 | 8.48e-01 | 2.47e-02 | 9.52e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 51 | 7.61e-01 | -2.46e-02 | 9.18e-01 |
| GOBP ESTROUS CYCLE | 8 | 9.04e-01 | 2.46e-02 | 9.72e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 368 | 4.21e-01 | 2.46e-02 | 7.35e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 58 | 7.47e-01 | -2.45e-02 | 9.15e-01 |
| GOBP CELLULAR EXTRAVASATION | 49 | 7.67e-01 | 2.45e-02 | 9.21e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 6 | 9.17e-01 | 2.44e-02 | 9.76e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 124 | 6.39e-01 | 2.44e-02 | 8.63e-01 |
| GOBP ENDODERM DEVELOPMENT | 39 | 7.92e-01 | 2.44e-02 | 9.30e-01 |
| GOBP VACUOLE FUSION | 11 | 8.89e-01 | 2.43e-02 | 9.66e-01 |
| GOBP EMBRYO DEVELOPMENT | 624 | 3.04e-01 | 2.43e-02 | 6.47e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 151 | 6.07e-01 | 2.43e-02 | 8.50e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 9.12e-01 | -2.42e-02 | 9.75e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 15 | 8.71e-01 | -2.42e-02 | 9.59e-01 |
| GOCC DISTAL AXON | 153 | 6.07e-01 | 2.41e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 9.26e-01 | -2.41e-02 | 9.79e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 9.19e-01 | 2.41e-02 | 9.76e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 107 | 6.68e-01 | -2.41e-02 | 8.78e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 12 | 8.85e-01 | 2.40e-02 | 9.64e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 34 | 8.09e-01 | 2.40e-02 | 9.37e-01 |
| GOCC PERIKARYON | 64 | 7.41e-01 | -2.39e-02 | 9.12e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 84 | 7.06e-01 | 2.39e-02 | 9.00e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 9 | 9.01e-01 | -2.39e-02 | 9.71e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 44 | 7.85e-01 | 2.38e-02 | 9.25e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 156 | 6.08e-01 | -2.38e-02 | 8.50e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 9.14e-01 | -2.37e-02 | 9.75e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 8.41e-01 | 2.37e-02 | 9.50e-01 |
| GOBP SYNAPSE ASSEMBLY | 80 | 7.15e-01 | 2.37e-02 | 9.03e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 25 | 8.38e-01 | 2.36e-02 | 9.48e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 21 | 8.51e-01 | 2.36e-02 | 9.53e-01 |
| GOBP MRNA POLYADENYLATION | 23 | 8.44e-01 | 2.36e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 38 | 8.01e-01 | 2.36e-02 | 9.34e-01 |
| GOBP PROTEIN STABILIZATION | 172 | 5.94e-01 | 2.36e-02 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 43 | 7.89e-01 | 2.36e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 135 | 6.36e-01 | -2.36e-02 | 8.63e-01 |
| GOBP RHYTHMIC BEHAVIOR | 22 | 8.48e-01 | 2.35e-02 | 9.52e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 18 | 8.63e-01 | 2.35e-02 | 9.57e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 76 | 7.24e-01 | -2.35e-02 | 9.07e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 158 | 6.12e-01 | -2.35e-02 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 26 | 8.37e-01 | 2.34e-02 | 9.48e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 21 | 8.53e-01 | 2.33e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 314 | 4.79e-01 | 2.33e-02 | 7.74e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 38 | 8.04e-01 | -2.33e-02 | 9.34e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 56 | 7.63e-01 | -2.33e-02 | 9.19e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 149 | 6.26e-01 | 2.32e-02 | 8.59e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 6 | 9.22e-01 | 2.32e-02 | 9.77e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 13 | 8.85e-01 | 2.32e-02 | 9.64e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 10 | 8.99e-01 | -2.31e-02 | 9.71e-01 |
| GOCC ESC E Z COMPLEX | 9 | 9.04e-01 | -2.31e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 9.16e-01 | -2.31e-02 | 9.76e-01 |
| GOBP CELL GROWTH | 298 | 4.95e-01 | -2.31e-02 | 7.84e-01 |
| GOBP STEM CELL DIFFERENTIATION | 133 | 6.47e-01 | 2.31e-02 | 8.67e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 13 | 8.86e-01 | 2.31e-02 | 9.64e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 99 | 6.92e-01 | 2.30e-02 | 8.93e-01 |
| GOBP METANEPHROS DEVELOPMENT | 28 | 8.33e-01 | 2.30e-02 | 9.46e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 8 | 9.10e-01 | -2.30e-02 | 9.74e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 9.22e-01 | 2.30e-02 | 9.77e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 15 | 8.78e-01 | 2.30e-02 | 9.62e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 35 | 8.14e-01 | 2.30e-02 | 9.39e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 9.17e-01 | 2.29e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 88 | 7.12e-01 | -2.28e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 9 | 9.06e-01 | 2.28e-02 | 9.73e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 75 | 7.33e-01 | 2.28e-02 | 9.10e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 48 | 7.85e-01 | 2.27e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 46 | 7.90e-01 | -2.27e-02 | 9.28e-01 |
| GOBP MESENDODERM DEVELOPMENT | 5 | 9.30e-01 | 2.27e-02 | 9.82e-01 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 9.30e-01 | 2.27e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 138 | 6.46e-01 | 2.27e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 93 | 7.06e-01 | -2.26e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 21 | 8.58e-01 | -2.26e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 9.30e-01 | 2.26e-02 | 9.82e-01 |
| GOBP LIPID STORAGE | 59 | 7.64e-01 | -2.26e-02 | 9.19e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 8.84e-01 | -2.26e-02 | 9.64e-01 |
| GOCC CILIARY MEMBRANE | 35 | 8.18e-01 | 2.25e-02 | 9.40e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 461 | 4.11e-01 | 2.25e-02 | 7.29e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 7 | 9.18e-01 | 2.25e-02 | 9.76e-01 |
| GOMF SMAD BINDING | 58 | 7.68e-01 | -2.25e-02 | 9.21e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 35 | 8.18e-01 | 2.24e-02 | 9.40e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 16 | 8.77e-01 | 2.24e-02 | 9.61e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 185 | 6.01e-01 | 2.24e-02 | 8.45e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 6 | 9.24e-01 | 2.23e-02 | 9.79e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 9.19e-01 | -2.23e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 20 | 8.63e-01 | 2.23e-02 | 9.57e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 45 | 7.96e-01 | 2.23e-02 | 9.31e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 162 | 6.26e-01 | 2.23e-02 | 8.59e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 9.19e-01 | -2.22e-02 | 9.76e-01 |
| GOCC MICROVILLUS | 47 | 7.93e-01 | -2.21e-02 | 9.30e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 92 | 7.14e-01 | -2.21e-02 | 9.02e-01 |
| GOBP MICROTUBULE SEVERING | 7 | 9.19e-01 | 2.21e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 43 | 8.02e-01 | -2.21e-02 | 9.34e-01 |
| GOMF CTPASE ACTIVITY | 5 | 9.32e-01 | -2.21e-02 | 9.82e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 8.95e-01 | -2.21e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 63 | 7.62e-01 | 2.21e-02 | 9.19e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 93 | 7.14e-01 | -2.20e-02 | 9.02e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 9 | 9.09e-01 | -2.20e-02 | 9.73e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 11 | 8.99e-01 | -2.20e-02 | 9.71e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 156 | 6.36e-01 | -2.20e-02 | 8.63e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 224 | 5.72e-01 | 2.20e-02 | 8.29e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 369 | 4.72e-01 | 2.19e-02 | 7.69e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 165 | 6.28e-01 | 2.19e-02 | 8.60e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 110 | 6.92e-01 | 2.19e-02 | 8.93e-01 |
| GOBP PEPTIDE TRANSPORT | 130 | 6.68e-01 | -2.19e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1267 | 2.01e-01 | 2.18e-02 | 5.49e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1179 | 2.17e-01 | 2.17e-02 | 5.65e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 106 | 7.00e-01 | -2.17e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 11 | 9.01e-01 | -2.17e-02 | 9.71e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 14 | 8.88e-01 | -2.17e-02 | 9.65e-01 |
| GOMF ZINC ION BINDING | 565 | 3.82e-01 | 2.17e-02 | 7.08e-01 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 9.27e-01 | -2.17e-02 | 9.79e-01 |
| GOBP PONS DEVELOPMENT | 6 | 9.27e-01 | -2.16e-02 | 9.80e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 377 | 4.75e-01 | 2.15e-02 | 7.72e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 5 | 9.34e-01 | -2.15e-02 | 9.83e-01 |
| GOMF LIM DOMAIN BINDING | 5 | 9.34e-01 | -2.15e-02 | 9.83e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 9 | 9.11e-01 | -2.15e-02 | 9.75e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 48 | 7.97e-01 | 2.15e-02 | 9.31e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 22 | 8.62e-01 | 2.15e-02 | 9.57e-01 |
| GOBP NCRNA TRANSCRIPTION | 98 | 7.14e-01 | 2.14e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 179 | 6.22e-01 | -2.14e-02 | 8.56e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 27 | 8.47e-01 | 2.14e-02 | 9.52e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 16 | 8.82e-01 | -2.14e-02 | 9.63e-01 |
| GOBP BONE REMODELING | 46 | 8.02e-01 | 2.14e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 744 | 3.27e-01 | 2.13e-02 | 6.65e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 30 | 8.40e-01 | -2.13e-02 | 9.49e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 50 | 7.95e-01 | -2.13e-02 | 9.31e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 87 | 7.32e-01 | -2.13e-02 | 9.10e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 443 | 4.46e-01 | 2.13e-02 | 7.53e-01 |
| GOBP MYOBLAST MIGRATION | 8 | 9.17e-01 | 2.12e-02 | 9.76e-01 |
| GOCC SNARE COMPLEX | 40 | 8.17e-01 | 2.12e-02 | 9.40e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 100 | 7.15e-01 | 2.11e-02 | 9.03e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 449 | 4.47e-01 | -2.10e-02 | 7.54e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 15 | 8.88e-01 | 2.10e-02 | 9.65e-01 |
| GOBP SENSORY PERCEPTION | 198 | 6.11e-01 | -2.10e-02 | 8.50e-01 |
| GOMF FLIPPASE ACTIVITY | 13 | 8.96e-01 | 2.10e-02 | 9.70e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 6 | 9.29e-01 | 2.10e-02 | 9.81e-01 |
| GOBP CELL MORPHOGENESIS | 530 | 4.12e-01 | 2.10e-02 | 7.30e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 9.04e-01 | 2.10e-02 | 9.72e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 9.29e-01 | 2.10e-02 | 9.81e-01 |
| GOBP CENTROSOME SEPARATION | 12 | 9.00e-01 | 2.10e-02 | 9.71e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 7 | 9.24e-01 | 2.10e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 269 | 5.56e-01 | -2.09e-02 | 8.22e-01 |
| GOBP RESPONSE TO FUNGUS | 29 | 8.45e-01 | 2.09e-02 | 9.51e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 64 | 7.72e-01 | -2.09e-02 | 9.22e-01 |
| GOCC SYNAPSE | 783 | 3.25e-01 | -2.09e-02 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 124 | 6.88e-01 | -2.09e-02 | 8.90e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 9.09e-01 | 2.09e-02 | 9.73e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 32 | 8.39e-01 | -2.08e-02 | 9.48e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 106 | 7.13e-01 | 2.07e-02 | 9.02e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 20 | 8.73e-01 | 2.07e-02 | 9.59e-01 |
| GOBP MESENCHYME DEVELOPMENT | 146 | 6.68e-01 | 2.06e-02 | 8.78e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 16 | 8.87e-01 | -2.05e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 7 | 9.25e-01 | 2.05e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 97 | 7.27e-01 | 2.05e-02 | 9.08e-01 |
| GOBP RNA SPLICING | 404 | 4.82e-01 | 2.05e-02 | 7.76e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 608 | 3.93e-01 | 2.05e-02 | 7.14e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 17 | 8.84e-01 | 2.05e-02 | 9.64e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 15 | 8.91e-01 | -2.05e-02 | 9.66e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 244 | 5.83e-01 | 2.05e-02 | 8.36e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 18 | 8.81e-01 | 2.04e-02 | 9.63e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 88 | 7.42e-01 | -2.03e-02 | 9.12e-01 |
| GOMF THIOESTERASE BINDING | 9 | 9.16e-01 | -2.03e-02 | 9.76e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 21 | 8.72e-01 | -2.02e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 633 | 3.89e-01 | 2.02e-02 | 7.11e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 325 | 5.33e-01 | 2.02e-02 | 8.06e-01 |
| GOBP SYNAPSE ORGANIZATION | 225 | 6.02e-01 | 2.02e-02 | 8.46e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 47 | 8.12e-01 | 2.01e-02 | 9.38e-01 |
| GOBP RESPONSE TO AXON INJURY | 44 | 8.18e-01 | 2.01e-02 | 9.40e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 45 | 8.16e-01 | 2.00e-02 | 9.40e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 5 | 9.38e-01 | 2.00e-02 | 9.84e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 147 | 6.77e-01 | 1.99e-02 | 8.83e-01 |
| GOBP RESPONSE TO LIPID | 520 | 4.40e-01 | 1.99e-02 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 36 | 8.36e-01 | -1.99e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 271 | 5.75e-01 | 1.99e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 13 | 9.01e-01 | -1.98e-02 | 9.71e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 9.33e-01 | -1.98e-02 | 9.83e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 14 | 8.98e-01 | -1.98e-02 | 9.71e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 9.18e-01 | -1.98e-02 | 9.76e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 12 | 9.06e-01 | 1.97e-02 | 9.73e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 27 | 8.59e-01 | -1.97e-02 | 9.57e-01 |
| GOBP SPROUTING ANGIOGENESIS | 66 | 7.82e-01 | 1.97e-02 | 9.25e-01 |
| GOBP SERINE TRANSPORT | 9 | 9.19e-01 | -1.97e-02 | 9.76e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.19e-01 | -1.97e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 83 | 7.57e-01 | 1.97e-02 | 9.17e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 9.34e-01 | -1.96e-02 | 9.83e-01 |
| GOCC PLATELET ALPHA GRANULE | 47 | 8.17e-01 | -1.95e-02 | 9.40e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 129 | 7.02e-01 | -1.95e-02 | 8.98e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 8.74e-01 | 1.95e-02 | 9.60e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 27 | 8.61e-01 | 1.95e-02 | 9.57e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 11 | 9.11e-01 | -1.95e-02 | 9.74e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 206 | 6.31e-01 | -1.95e-02 | 8.61e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 23 | 8.72e-01 | -1.95e-02 | 9.59e-01 |
| GOBP HEART MORPHOGENESIS | 116 | 7.18e-01 | -1.95e-02 | 9.04e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 15 | 8.96e-01 | 1.94e-02 | 9.70e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 172 | 6.61e-01 | -1.94e-02 | 8.75e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 26 | 8.64e-01 | -1.94e-02 | 9.57e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 213 | 6.26e-01 | -1.94e-02 | 8.59e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 6 | 9.35e-01 | 1.93e-02 | 9.83e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 24 | 8.70e-01 | -1.93e-02 | 9.58e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 9 | 9.20e-01 | -1.93e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 75 | 7.73e-01 | -1.93e-02 | 9.22e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 25 | 8.67e-01 | -1.93e-02 | 9.58e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 33 | 8.48e-01 | 1.93e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 17 | 8.91e-01 | 1.93e-02 | 9.66e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 13 | 9.04e-01 | 1.93e-02 | 9.72e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 19 | 8.84e-01 | 1.93e-02 | 9.64e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 33 | 8.48e-01 | -1.92e-02 | 9.52e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 19 | 8.85e-01 | 1.92e-02 | 9.64e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 52 | 8.11e-01 | 1.92e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 57 | 8.03e-01 | 1.91e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 508 | 4.65e-01 | 1.91e-02 | 7.65e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 9.30e-01 | -1.91e-02 | 9.82e-01 |
| GOCC NUCLEAR SPECK | 366 | 5.34e-01 | -1.90e-02 | 8.07e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 17 | 8.92e-01 | 1.90e-02 | 9.67e-01 |
| GOBP RESPONSE TO LEUCINE | 13 | 9.06e-01 | -1.90e-02 | 9.73e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 9.26e-01 | -1.89e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 158 | 6.82e-01 | 1.89e-02 | 8.87e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 6 | 9.36e-01 | 1.89e-02 | 9.84e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 15 | 8.99e-01 | -1.89e-02 | 9.71e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 25 | 8.70e-01 | 1.89e-02 | 9.58e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 8.78e-01 | 1.89e-02 | 9.62e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 8 | 9.27e-01 | -1.88e-02 | 9.79e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 82 | 7.69e-01 | -1.88e-02 | 9.21e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 88 | 7.61e-01 | -1.88e-02 | 9.18e-01 |
| GOCC COPI VESICLE COAT | 13 | 9.07e-01 | -1.88e-02 | 9.73e-01 |
| GOBP GRANULOCYTE MIGRATION | 89 | 7.60e-01 | 1.87e-02 | 9.18e-01 |
| GOBP RNA DECAPPING | 18 | 8.91e-01 | 1.87e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 85 | 7.66e-01 | 1.87e-02 | 9.21e-01 |
| GOBP LEUKOCYTE MIGRATION | 234 | 6.24e-01 | 1.87e-02 | 8.58e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 10 | 9.19e-01 | 1.86e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 29 | 8.62e-01 | 1.86e-02 | 9.57e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 9.19e-01 | 1.86e-02 | 9.76e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 10 | 9.19e-01 | 1.86e-02 | 9.76e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 257 | 6.09e-01 | -1.86e-02 | 8.50e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 13 | 9.08e-01 | 1.86e-02 | 9.73e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 36 | 8.47e-01 | 1.86e-02 | 9.52e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 84 | 7.69e-01 | 1.86e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 9.43e-01 | -1.86e-02 | 9.85e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 22 | 8.80e-01 | -1.85e-02 | 9.63e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 27 | 8.68e-01 | 1.85e-02 | 9.58e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 24 | 8.75e-01 | 1.85e-02 | 9.61e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 8.92e-01 | 1.85e-02 | 9.67e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 6 | 9.38e-01 | -1.85e-02 | 9.84e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 206 | 6.49e-01 | -1.84e-02 | 8.68e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 84 | 7.70e-01 | -1.84e-02 | 9.22e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 26 | 8.71e-01 | -1.84e-02 | 9.59e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 5 | 9.43e-01 | 1.83e-02 | 9.85e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 8.96e-01 | -1.83e-02 | 9.70e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 38 | 8.46e-01 | -1.83e-02 | 9.51e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 57 | 8.12e-01 | 1.82e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 162 | 6.91e-01 | 1.82e-02 | 8.91e-01 |
| GOBP TISSUE REMODELING | 87 | 7.71e-01 | 1.81e-02 | 9.22e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 14 | 9.07e-01 | -1.81e-02 | 9.73e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 33 | 8.57e-01 | 1.81e-02 | 9.56e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 32 | 8.60e-01 | 1.81e-02 | 9.57e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 68 | 7.97e-01 | 1.81e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 29 | 8.66e-01 | -1.80e-02 | 9.58e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 6 | 9.39e-01 | -1.80e-02 | 9.84e-01 |
| GOBP CELL FATE COMMITMENT | 107 | 7.48e-01 | 1.80e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 9.45e-01 | 1.80e-02 | 9.85e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 119 | 7.36e-01 | -1.79e-02 | 9.11e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 22 | 8.84e-01 | -1.79e-02 | 9.64e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 21 | 8.87e-01 | -1.79e-02 | 9.65e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 8.69e-01 | -1.77e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 66 | 8.04e-01 | -1.77e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 31 | 8.65e-01 | 1.77e-02 | 9.57e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 10 | 9.23e-01 | -1.77e-02 | 9.78e-01 |
| GOBP RIBOSOME BIOGENESIS | 308 | 5.97e-01 | -1.76e-02 | 8.44e-01 |
| GOCC RUFFLE MEMBRANE | 79 | 7.88e-01 | 1.75e-02 | 9.28e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 12 | 9.16e-01 | -1.75e-02 | 9.76e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 12 | 9.16e-01 | -1.75e-02 | 9.76e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 13 | 9.13e-01 | 1.75e-02 | 9.75e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 9.46e-01 | 1.75e-02 | 9.85e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 159 | 7.04e-01 | -1.75e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 46 | 8.38e-01 | 1.75e-02 | 9.48e-01 |
| GOBP FUCOSYLATION | 11 | 9.20e-01 | 1.75e-02 | 9.76e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 85 | 7.82e-01 | 1.74e-02 | 9.24e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 9.32e-01 | 1.74e-02 | 9.82e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1336 | 2.95e-01 | 1.74e-02 | 6.40e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 26 | 8.78e-01 | 1.74e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 73 | 7.98e-01 | 1.73e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 5 | 9.47e-01 | -1.73e-02 | 9.85e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 6 | 9.41e-01 | -1.73e-02 | 9.85e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 9.42e-01 | 1.73e-02 | 9.85e-01 |
| GOBP OSSIFICATION | 212 | 6.66e-01 | -1.73e-02 | 8.77e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 271 | 6.26e-01 | -1.73e-02 | 8.59e-01 |
| GOMF HORMONE ACTIVITY | 12 | 9.18e-01 | 1.72e-02 | 9.76e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 9.37e-01 | -1.72e-02 | 9.84e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 9.37e-01 | 1.72e-02 | 9.84e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 264 | 6.32e-01 | 1.72e-02 | 8.62e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 49 | 8.36e-01 | -1.72e-02 | 9.47e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 14 | 9.12e-01 | -1.71e-02 | 9.75e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 128 | 7.38e-01 | 1.71e-02 | 9.12e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 66 | 8.10e-01 | 1.71e-02 | 9.38e-01 |
| GOBP BEHAVIOR | 302 | 6.11e-01 | -1.71e-02 | 8.50e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 175 | 6.98e-01 | -1.71e-02 | 8.96e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 91 | 7.79e-01 | 1.71e-02 | 9.24e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 9.42e-01 | -1.70e-02 | 9.85e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 37 | 8.58e-01 | 1.70e-02 | 9.56e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 24 | 8.85e-01 | -1.70e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1066 | 3.55e-01 | 1.70e-02 | 6.87e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 12 | 9.19e-01 | 1.70e-02 | 9.76e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 9.30e-01 | -1.70e-02 | 9.81e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 35 | 8.62e-01 | 1.70e-02 | 9.57e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 156 | 7.15e-01 | -1.70e-02 | 9.03e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 25 | 8.83e-01 | 1.70e-02 | 9.64e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 6 | 9.43e-01 | -1.70e-02 | 9.85e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 38 | 8.57e-01 | 1.69e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 5 | 9.48e-01 | -1.69e-02 | 9.86e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 9.38e-01 | 1.69e-02 | 9.84e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 19 | 8.99e-01 | -1.68e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 85 | 7.89e-01 | -1.68e-02 | 9.28e-01 |
| GOBP EPITHELIAL CELL MATURATION | 11 | 9.23e-01 | -1.68e-02 | 9.78e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 36 | 8.62e-01 | 1.68e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 14 | 9.14e-01 | -1.68e-02 | 9.75e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 9.39e-01 | 1.68e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 425 | 5.56e-01 | 1.67e-02 | 8.22e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 672 | 4.64e-01 | -1.67e-02 | 7.65e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 73 | 8.05e-01 | -1.67e-02 | 9.35e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 9.48e-01 | -1.67e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 892 | 4.05e-01 | -1.67e-02 | 7.24e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 15 | 9.11e-01 | 1.66e-02 | 9.75e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 71 | 8.11e-01 | 1.64e-02 | 9.38e-01 |
| GOMF GABA RECEPTOR BINDING | 12 | 9.22e-01 | -1.64e-02 | 9.77e-01 |
| GOBP TUBE DEVELOPMENT | 559 | 5.12e-01 | -1.64e-02 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 8 | 9.36e-01 | -1.63e-02 | 9.84e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 130 | 7.48e-01 | -1.63e-02 | 9.15e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 7 | 9.41e-01 | 1.63e-02 | 9.85e-01 |
| GOMF SPECTRIN BINDING | 15 | 9.13e-01 | -1.63e-02 | 9.75e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 95 | 7.85e-01 | 1.62e-02 | 9.26e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 6 | 9.45e-01 | 1.62e-02 | 9.85e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 6 | 9.45e-01 | 1.62e-02 | 9.85e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 15 | 9.13e-01 | 1.62e-02 | 9.75e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 9.33e-01 | -1.62e-02 | 9.83e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 8.43e-01 | 1.62e-02 | 9.50e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 485 | 5.46e-01 | -1.61e-02 | 8.15e-01 |
| GOCC GOLGI CIS CISTERNA | 13 | 9.20e-01 | 1.61e-02 | 9.76e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 9.27e-01 | -1.60e-02 | 9.79e-01 |
| GOBP MIRNA PROCESSING | 40 | 8.61e-01 | 1.60e-02 | 9.57e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 9 | 9.34e-01 | -1.60e-02 | 9.83e-01 |
| GOBP RESPONSE TO CALCIUM ION | 81 | 8.04e-01 | -1.60e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 564 | 5.21e-01 | 1.59e-02 | 8.00e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 22 | 8.97e-01 | 1.59e-02 | 9.70e-01 |
| GOBP ORGANIC ACID TRANSPORT | 171 | 7.21e-01 | -1.59e-02 | 9.05e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 9.10e-01 | -1.58e-02 | 9.74e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 81 | 8.06e-01 | -1.58e-02 | 9.35e-01 |
| GOMF TRANSITION METAL ION BINDING | 698 | 4.83e-01 | 1.58e-02 | 7.76e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 56 | 8.39e-01 | 1.57e-02 | 9.48e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 355 | 6.13e-01 | 1.57e-02 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 20 | 9.04e-01 | -1.56e-02 | 9.72e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 25 | 8.93e-01 | -1.56e-02 | 9.68e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 250 | 6.73e-01 | 1.56e-02 | 8.81e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 67 | 8.26e-01 | 1.55e-02 | 9.44e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 482 | 5.63e-01 | 1.55e-02 | 8.25e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 8 | 9.39e-01 | 1.55e-02 | 9.84e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 31 | 8.82e-01 | -1.55e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 17 | 9.12e-01 | 1.55e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 67 | 8.27e-01 | 1.54e-02 | 9.44e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 50 | 8.50e-01 | -1.54e-02 | 9.53e-01 |
| GOCC ACROSOMAL VESICLE | 61 | 8.35e-01 | -1.54e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 22 | 9.01e-01 | 1.54e-02 | 9.71e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 19 | 9.08e-01 | -1.54e-02 | 9.73e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 151 | 7.45e-01 | -1.54e-02 | 9.14e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 131 | 7.62e-01 | -1.54e-02 | 9.19e-01 |
| GOBP STEM CELL PROLIFERATION | 60 | 8.37e-01 | -1.53e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 50 | 8.51e-01 | 1.53e-02 | 9.53e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 19 | 9.08e-01 | 1.53e-02 | 9.73e-01 |
| GOCC SET1C COMPASS COMPLEX | 13 | 9.24e-01 | 1.53e-02 | 9.78e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 38 | 8.71e-01 | 1.53e-02 | 9.59e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 48 | 8.55e-01 | -1.52e-02 | 9.55e-01 |
| GOBP CARNITINE TRANSPORT | 5 | 9.53e-01 | -1.52e-02 | 9.87e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 9.53e-01 | 1.52e-02 | 9.87e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 37 | 8.73e-01 | -1.52e-02 | 9.59e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 118 | 7.76e-01 | 1.52e-02 | 9.23e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 70 | 8.27e-01 | 1.51e-02 | 9.44e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 28 | 8.90e-01 | 1.51e-02 | 9.66e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 59 | 8.41e-01 | 1.51e-02 | 9.50e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 146 | 7.54e-01 | 1.51e-02 | 9.17e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 9.22e-01 | 1.51e-02 | 9.77e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 25 | 8.96e-01 | -1.51e-02 | 9.70e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 649 | 5.17e-01 | 1.50e-02 | 7.97e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 192 | 7.20e-01 | -1.50e-02 | 9.05e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 23 | 9.02e-01 | 1.49e-02 | 9.71e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 20 | 9.08e-01 | -1.49e-02 | 9.73e-01 |
| GOCC MEDIATOR COMPLEX | 37 | 8.76e-01 | -1.48e-02 | 9.61e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 7 | 9.46e-01 | 1.48e-02 | 9.85e-01 |
| GOBP CELL MATURATION | 85 | 8.14e-01 | 1.48e-02 | 9.39e-01 |
| GOBP NEURON MIGRATION | 91 | 8.08e-01 | -1.48e-02 | 9.37e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 215 | 7.10e-01 | 1.48e-02 | 9.01e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 18 | 9.14e-01 | 1.47e-02 | 9.75e-01 |
| GOMF CHEMOKINE BINDING | 21 | 9.07e-01 | 1.47e-02 | 9.73e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 9.36e-01 | -1.47e-02 | 9.84e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 42 | 8.70e-01 | -1.47e-02 | 9.58e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 35 | 8.81e-01 | 1.46e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 83 | 8.18e-01 | 1.46e-02 | 9.40e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 9.51e-01 | 1.46e-02 | 9.87e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 57 | 8.49e-01 | 1.46e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 15 | 9.23e-01 | -1.45e-02 | 9.77e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 10 | 9.37e-01 | 1.45e-02 | 9.84e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 17 | 9.18e-01 | -1.45e-02 | 9.76e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 50 | 8.60e-01 | -1.45e-02 | 9.57e-01 |
| GOMF COPPER ION BINDING | 32 | 8.88e-01 | -1.44e-02 | 9.65e-01 |
| GOBP REGULATION OF GROWTH | 357 | 6.41e-01 | -1.44e-02 | 8.65e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 108 | 7.96e-01 | 1.44e-02 | 9.31e-01 |
| GOCC DENDRITIC TREE | 330 | 6.54e-01 | -1.44e-02 | 8.71e-01 |
| GOBP REGULATION OF CELL GROWTH | 253 | 6.94e-01 | -1.44e-02 | 8.94e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 10 | 9.37e-01 | 1.44e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 183 | 7.39e-01 | 1.43e-02 | 9.12e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 70 | 8.36e-01 | 1.43e-02 | 9.48e-01 |
| GOBP HEMOPOIESIS | 667 | 5.33e-01 | 1.43e-02 | 8.06e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 80 | 8.25e-01 | -1.43e-02 | 9.44e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 25 | 9.02e-01 | 1.43e-02 | 9.71e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 47 | 8.66e-01 | -1.42e-02 | 9.58e-01 |
| GOBP NEURAL TUBE PATTERNING | 23 | 9.06e-01 | -1.42e-02 | 9.73e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 9.45e-01 | 1.42e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 9.56e-01 | -1.41e-02 | 9.88e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 9.25e-01 | -1.41e-02 | 9.79e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 9.20e-01 | -1.41e-02 | 9.76e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 19 | 9.15e-01 | -1.41e-02 | 9.76e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 22 | 9.09e-01 | -1.41e-02 | 9.73e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 9 | 9.42e-01 | -1.41e-02 | 9.85e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 54 | 8.58e-01 | 1.40e-02 | 9.56e-01 |
| GOCC AXON INITIAL SEGMENT | 10 | 9.39e-01 | 1.40e-02 | 9.84e-01 |
| GOBP TRNA CATABOLIC PROCESS | 15 | 9.26e-01 | 1.39e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 5 | 9.57e-01 | 1.39e-02 | 9.88e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 9 | 9.43e-01 | 1.39e-02 | 9.85e-01 |
| GOBP ETHER METABOLIC PROCESS | 19 | 9.17e-01 | -1.38e-02 | 9.76e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 5 | 9.57e-01 | -1.38e-02 | 9.88e-01 |
| GOCC POSTSYNAPSE | 347 | 6.61e-01 | -1.38e-02 | 8.75e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 9 | 9.43e-01 | 1.38e-02 | 9.85e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 13 | 9.32e-01 | 1.38e-02 | 9.82e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 9.58e-01 | -1.37e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 55 | 8.60e-01 | -1.37e-02 | 9.57e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 19 | 9.18e-01 | 1.37e-02 | 9.76e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 255 | 7.08e-01 | 1.37e-02 | 9.01e-01 |
| GOBP CELL ADHESION | 776 | 5.22e-01 | 1.37e-02 | 8.01e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 20 | 9.16e-01 | 1.36e-02 | 9.76e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 5 | 9.58e-01 | 1.36e-02 | 9.88e-01 |
| GOBP RESPIRATORY BURST | 28 | 9.02e-01 | -1.35e-02 | 9.71e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 26 | 9.05e-01 | -1.35e-02 | 9.73e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 30 | 8.98e-01 | -1.35e-02 | 9.71e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 81 | 8.34e-01 | 1.35e-02 | 9.47e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 24 | 9.09e-01 | -1.35e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 7 | 9.51e-01 | 1.34e-02 | 9.87e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 8 | 9.48e-01 | 1.34e-02 | 9.86e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 20 | 9.17e-01 | -1.34e-02 | 9.76e-01 |
| GOBP RESPONSE TO CAMP | 44 | 8.78e-01 | -1.34e-02 | 9.62e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 29 | 9.01e-01 | -1.34e-02 | 9.71e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 132 | 7.92e-01 | -1.33e-02 | 9.29e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 49 | 8.72e-01 | -1.33e-02 | 9.59e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 12 | 9.36e-01 | 1.33e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 114 | 8.06e-01 | -1.33e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 6 | 9.55e-01 | 1.33e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 9.55e-01 | -1.32e-02 | 9.87e-01 |
| GOMF DIOXYGENASE ACTIVITY | 67 | 8.52e-01 | -1.32e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 6 | 9.55e-01 | -1.32e-02 | 9.87e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 195 | 7.51e-01 | 1.32e-02 | 9.16e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 11 | 9.40e-01 | 1.32e-02 | 9.84e-01 |
| GOCC M BAND | 14 | 9.32e-01 | -1.32e-02 | 9.82e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 89 | 8.30e-01 | 1.32e-02 | 9.45e-01 |
| GOBP OVULATION CYCLE | 28 | 9.04e-01 | -1.32e-02 | 9.72e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 16 | 9.27e-01 | 1.32e-02 | 9.80e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 293 | 6.99e-01 | -1.32e-02 | 8.96e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 85 | 8.34e-01 | 1.31e-02 | 9.47e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 43 | 8.82e-01 | 1.31e-02 | 9.63e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 8 | 9.49e-01 | 1.31e-02 | 9.87e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 9 | 9.46e-01 | 1.31e-02 | 9.85e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 23 | 9.14e-01 | -1.30e-02 | 9.75e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 9.53e-01 | -1.30e-02 | 9.87e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 28 | 9.06e-01 | -1.30e-02 | 9.73e-01 |
| GOBP ORGAN GROWTH | 90 | 8.33e-01 | -1.29e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 486 | 6.29e-01 | -1.29e-02 | 8.60e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 311 | 6.97e-01 | 1.29e-02 | 8.95e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 8 | 9.50e-01 | -1.29e-02 | 9.87e-01 |
| GOBP CAMP METABOLIC PROCESS | 11 | 9.41e-01 | -1.29e-02 | 9.85e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 16 | 9.29e-01 | 1.29e-02 | 9.81e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 87 | 8.37e-01 | 1.28e-02 | 9.48e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 40 | 8.89e-01 | 1.28e-02 | 9.66e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 46 | 8.81e-01 | -1.27e-02 | 9.63e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 13 | 9.37e-01 | 1.27e-02 | 9.84e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 96 | 8.30e-01 | -1.27e-02 | 9.45e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 38 | 8.92e-01 | 1.27e-02 | 9.67e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 72 | 8.52e-01 | 1.27e-02 | 9.54e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 385 | 6.71e-01 | -1.27e-02 | 8.80e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 8 | 9.50e-01 | 1.27e-02 | 9.87e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 25 | 9.13e-01 | 1.27e-02 | 9.75e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 74 | 8.51e-01 | -1.26e-02 | 9.53e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 161 | 7.82e-01 | 1.26e-02 | 9.25e-01 |
| GOBP SNRNA TRANSCRIPTION | 17 | 9.28e-01 | 1.26e-02 | 9.81e-01 |
| GOBP RHYTHMIC PROCESS | 180 | 7.72e-01 | 1.26e-02 | 9.22e-01 |
| GOBP NEUROGENESIS | 922 | 5.23e-01 | 1.26e-02 | 8.01e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 83 | 8.44e-01 | -1.25e-02 | 9.50e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 157 | 7.87e-01 | 1.25e-02 | 9.27e-01 |
| GOBP MACROPHAGE ACTIVATION | 67 | 8.60e-01 | 1.25e-02 | 9.57e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 34 | 9.00e-01 | -1.24e-02 | 9.71e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 15 | 9.34e-01 | -1.24e-02 | 9.83e-01 |
| GOBP MAPK CASCADE | 443 | 6.57e-01 | -1.24e-02 | 8.73e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 92 | 8.38e-01 | -1.24e-02 | 9.48e-01 |
| GOBP RESPONSE TO SALT | 197 | 7.66e-01 | 1.23e-02 | 9.21e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 10 | 9.46e-01 | 1.23e-02 | 9.85e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 61 | 8.68e-01 | 1.23e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 29 | 9.09e-01 | -1.23e-02 | 9.73e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 9.52e-01 | 1.23e-02 | 9.87e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 9.58e-01 | -1.23e-02 | 9.88e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 26 | 9.14e-01 | -1.23e-02 | 9.75e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 122 | 8.16e-01 | 1.22e-02 | 9.40e-01 |
| GOBP CIRCADIAN RHYTHM | 132 | 8.09e-01 | -1.22e-02 | 9.37e-01 |
| GOBP DENDRITIC CELL MIGRATION | 21 | 9.23e-01 | -1.22e-02 | 9.78e-01 |
| GOBP NEURON FATE COMMITMENT | 16 | 9.33e-01 | 1.22e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 7 | 9.55e-01 | -1.22e-02 | 9.87e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 9.59e-01 | -1.21e-02 | 9.88e-01 |
| GOBP NEURON DEVELOPMENT | 611 | 6.13e-01 | 1.21e-02 | 8.51e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 26 | 9.15e-01 | -1.21e-02 | 9.76e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 7 | 9.56e-01 | -1.20e-02 | 9.87e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 8 | 9.53e-01 | 1.20e-02 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 26 | 9.16e-01 | -1.19e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 70 | 8.63e-01 | -1.19e-02 | 9.57e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.51e-01 | -1.19e-02 | 9.87e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 9.51e-01 | 1.19e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 14 | 9.39e-01 | 1.18e-02 | 9.84e-01 |
| GOBP TRANSCYTOSIS | 14 | 9.39e-01 | -1.18e-02 | 9.84e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 56 | 8.79e-01 | 1.18e-02 | 9.62e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 83 | 8.53e-01 | 1.18e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 17 | 9.33e-01 | -1.18e-02 | 9.83e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 130 | 8.17e-01 | -1.18e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 5 | 9.64e-01 | 1.18e-02 | 9.90e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 53 | 8.83e-01 | -1.17e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 60 | 8.76e-01 | 1.17e-02 | 9.61e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 243 | 7.56e-01 | 1.16e-02 | 9.17e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 87 | 8.52e-01 | -1.16e-02 | 9.53e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 7 | 9.58e-01 | 1.16e-02 | 9.88e-01 |
| GOBP TRANSPORT OF VIRUS | 15 | 9.38e-01 | -1.16e-02 | 9.84e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 63 | 8.74e-01 | 1.16e-02 | 9.60e-01 |
| GOBP MITOPHAGY | 35 | 9.06e-01 | -1.15e-02 | 9.73e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 43 | 8.97e-01 | 1.14e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 16 | 9.37e-01 | -1.14e-02 | 9.84e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 793 | 5.90e-01 | 1.14e-02 | 8.39e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 9 | 9.53e-01 | -1.14e-02 | 9.87e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 16 | 9.37e-01 | 1.14e-02 | 9.84e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 13 | 9.44e-01 | -1.13e-02 | 9.85e-01 |
| GOBP TOLERANCE INDUCTION TO SELF ANTIGEN | 5 | 9.65e-01 | 1.13e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 35 | 9.08e-01 | -1.13e-02 | 9.73e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 30 | 9.15e-01 | 1.12e-02 | 9.76e-01 |
| GOBP RESPONSE TO COBALT ION | 9 | 9.54e-01 | -1.12e-02 | 9.87e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 31 | 9.14e-01 | -1.12e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 35 | 9.09e-01 | 1.12e-02 | 9.73e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 5 | 9.65e-01 | -1.12e-02 | 9.90e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 21 | 9.29e-01 | -1.12e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 78 | 8.65e-01 | -1.11e-02 | 9.57e-01 |
| GOCC AXON | 352 | 7.21e-01 | 1.11e-02 | 9.06e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 9.62e-01 | -1.11e-02 | 9.90e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 66 | 8.76e-01 | 1.11e-02 | 9.61e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 10 | 9.52e-01 | -1.11e-02 | 9.87e-01 |
| GOBP AXON DEVELOPMENT | 250 | 7.63e-01 | -1.11e-02 | 9.19e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 7 | 9.60e-01 | -1.11e-02 | 9.89e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 22 | 9.29e-01 | 1.11e-02 | 9.81e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 77 | 8.67e-01 | -1.10e-02 | 9.58e-01 |
| GOCC DENDRITIC SHAFT | 21 | 9.30e-01 | 1.10e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 9.57e-01 | -1.10e-02 | 9.88e-01 |
| GOCC AMPHISOME MEMBRANE | 10 | 9.52e-01 | 1.10e-02 | 9.87e-01 |
| GOCC CATION CHANNEL COMPLEX | 66 | 8.79e-01 | -1.08e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 331 | 7.37e-01 | 1.08e-02 | 9.11e-01 |
| GOCC MICROVILLUS MEMBRANE | 16 | 9.41e-01 | 1.08e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 14 | 9.45e-01 | -1.07e-02 | 9.85e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 40 | 9.07e-01 | 1.07e-02 | 9.73e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 70 | 8.77e-01 | 1.07e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 12 | 9.49e-01 | 1.06e-02 | 9.87e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 6 | 9.64e-01 | 1.06e-02 | 9.90e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 9.59e-01 | 1.06e-02 | 9.88e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 551 | 6.74e-01 | -1.06e-02 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 12 | 9.50e-01 | -1.05e-02 | 9.87e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 8 | 9.59e-01 | -1.05e-02 | 9.88e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 92 | 8.62e-01 | -1.05e-02 | 9.57e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 49 | 8.99e-01 | 1.05e-02 | 9.71e-01 |
| GOBP TRACHEA DEVELOPMENT | 11 | 9.52e-01 | -1.04e-02 | 9.87e-01 |
| GOBP MRNA METABOLIC PROCESS | 641 | 6.55e-01 | 1.04e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 12 | 9.50e-01 | -1.04e-02 | 9.87e-01 |
| GOBP GENERATION OF NEURONS | 778 | 6.25e-01 | 1.04e-02 | 8.59e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 146 | 8.29e-01 | 1.04e-02 | 9.45e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 15 | 9.44e-01 | 1.04e-02 | 9.85e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 14 | 9.46e-01 | -1.04e-02 | 9.85e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 9.55e-01 | 1.04e-02 | 9.87e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 213 | 7.95e-01 | 1.04e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 10 | 9.55e-01 | -1.03e-02 | 9.87e-01 |
| GOBP MUSCLE HYPERTROPHY | 57 | 8.93e-01 | 1.03e-02 | 9.68e-01 |
| GOBP SKIN DEVELOPMENT | 127 | 8.42e-01 | -1.03e-02 | 9.50e-01 |
| GOMF AMYLOID BETA BINDING | 48 | 9.02e-01 | -1.03e-02 | 9.71e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 12 | 9.51e-01 | -1.02e-02 | 9.87e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 9 | 9.58e-01 | 1.02e-02 | 9.88e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 25 | 9.31e-01 | -1.01e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 9 | 9.59e-01 | 1.00e-02 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 34 | 9.20e-01 | 1.00e-02 | 9.76e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 6 | 9.66e-01 | 9.99e-03 | 9.90e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 887 | 6.20e-01 | -9.95e-03 | 8.55e-01 |
| GOCC CILIUM | 409 | 7.32e-01 | -9.94e-03 | 9.10e-01 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 9.69e-01 | 9.88e-03 | 9.92e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 17 | 9.44e-01 | 9.83e-03 | 9.85e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 269 | 7.83e-01 | 9.81e-03 | 9.25e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 9.62e-01 | 9.80e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 12 | 9.53e-01 | -9.79e-03 | 9.87e-01 |
| GOBP CELL MOTILITY | 924 | 6.21e-01 | 9.72e-03 | 8.56e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 5 | 9.70e-01 | -9.70e-03 | 9.92e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 12 | 9.54e-01 | -9.68e-03 | 9.87e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 17 | 9.45e-01 | 9.65e-03 | 9.85e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 24 | 9.35e-01 | 9.59e-03 | 9.84e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 6 | 9.68e-01 | -9.57e-03 | 9.91e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 158 | 8.36e-01 | 9.57e-03 | 9.48e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 19 | 9.43e-01 | -9.54e-03 | 9.85e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 239 | 8.02e-01 | 9.47e-03 | 9.34e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 169 | 8.32e-01 | -9.45e-03 | 9.46e-01 |
| GOBP MALATE METABOLIC PROCESS | 7 | 9.65e-01 | -9.44e-03 | 9.90e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 18 | 9.45e-01 | -9.43e-03 | 9.85e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 7 | 9.66e-01 | 9.40e-03 | 9.90e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 56 | 9.03e-01 | 9.39e-03 | 9.72e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 98 | 8.73e-01 | -9.39e-03 | 9.59e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 244 | 8.02e-01 | 9.34e-03 | 9.34e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 83 | 8.83e-01 | -9.33e-03 | 9.64e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 103 | 8.70e-01 | 9.31e-03 | 9.58e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 14 | 9.52e-01 | -9.31e-03 | 9.87e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 11 | 9.57e-01 | 9.30e-03 | 9.88e-01 |
| GOBP GAMETE GENERATION | 403 | 7.53e-01 | 9.20e-03 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 15 | 9.51e-01 | -9.20e-03 | 9.87e-01 |
| GOBP GRANULOCYTE ACTIVATION | 34 | 9.26e-01 | -9.18e-03 | 9.79e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 16 | 9.50e-01 | 9.14e-03 | 9.87e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 29 | 9.32e-01 | -9.13e-03 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 13 | 9.55e-01 | 9.11e-03 | 9.87e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 36 | 9.25e-01 | -9.03e-03 | 9.79e-01 |
| GOBP TUBULIN DEACETYLATION | 19 | 9.46e-01 | -9.00e-03 | 9.85e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 28 | 9.34e-01 | 8.99e-03 | 9.83e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 63 | 9.02e-01 | 8.96e-03 | 9.71e-01 |
| GOBP BONE DEVELOPMENT | 104 | 8.75e-01 | -8.95e-03 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 335 | 7.80e-01 | -8.93e-03 | 9.24e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 118 | 8.67e-01 | 8.92e-03 | 9.58e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 216 | 8.22e-01 | 8.91e-03 | 9.42e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 46 | 9.17e-01 | -8.90e-03 | 9.76e-01 |
| GOBP GLIOGENESIS | 187 | 8.34e-01 | 8.89e-03 | 9.47e-01 |
| GOBP VASCULATURE DEVELOPMENT | 381 | 7.67e-01 | 8.89e-03 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 152 | 8.50e-01 | 8.88e-03 | 9.53e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 9.38e-01 | -8.86e-03 | 9.84e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 202 | 8.29e-01 | 8.84e-03 | 9.45e-01 |
| GOMF RIBOSOME BINDING | 102 | 8.78e-01 | 8.81e-03 | 9.62e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 9.70e-01 | -8.79e-03 | 9.92e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 9.73e-01 | -8.76e-03 | 9.93e-01 |
| GOCC CELL BODY | 285 | 8.03e-01 | 8.64e-03 | 9.34e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 586 | 7.24e-01 | -8.61e-03 | 9.07e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 25 | 9.41e-01 | 8.57e-03 | 9.85e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 9.74e-01 | 8.56e-03 | 9.93e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 72 | 9.00e-01 | 8.56e-03 | 9.71e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 15 | 9.54e-01 | 8.55e-03 | 9.87e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 18 | 9.50e-01 | -8.48e-03 | 9.87e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 146 | 8.61e-01 | 8.44e-03 | 9.57e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 9 | 9.65e-01 | -8.44e-03 | 9.90e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 31 | 9.36e-01 | 8.40e-03 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 9 | 9.65e-01 | 8.39e-03 | 9.90e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 535 | 7.44e-01 | 8.33e-03 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 16 | 9.54e-01 | -8.32e-03 | 9.87e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 9 | 9.66e-01 | -8.32e-03 | 9.90e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 33 | 9.34e-01 | 8.30e-03 | 9.83e-01 |
| GOBP NEUROMUSCULAR PROCESS | 74 | 9.02e-01 | 8.29e-03 | 9.71e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 76 | 9.01e-01 | -8.27e-03 | 9.71e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 12 | 9.60e-01 | -8.26e-03 | 9.89e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 233 | 8.29e-01 | 8.24e-03 | 9.45e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 84 | 8.97e-01 | -8.18e-03 | 9.70e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 6 | 9.72e-01 | -8.16e-03 | 9.93e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 11 | 9.63e-01 | 8.13e-03 | 9.90e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 32 | 9.37e-01 | 8.10e-03 | 9.84e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 12 | 9.61e-01 | -8.05e-03 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 6 | 9.73e-01 | 7.99e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 98 | 8.92e-01 | 7.98e-03 | 9.67e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 14 | 9.59e-01 | -7.98e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 30 | 9.40e-01 | 7.97e-03 | 9.84e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 28 | 9.42e-01 | 7.96e-03 | 9.85e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 231 | 8.36e-01 | -7.95e-03 | 9.47e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 299 | 8.14e-01 | -7.94e-03 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1071 | 6.70e-01 | -7.84e-03 | 8.79e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 9.66e-01 | -7.77e-03 | 9.90e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 21 | 9.51e-01 | -7.77e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 18 | 9.55e-01 | -7.66e-03 | 9.87e-01 |
| GOBP ACTION POTENTIAL | 58 | 9.20e-01 | 7.64e-03 | 9.76e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 10 | 9.67e-01 | -7.62e-03 | 9.91e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 5 | 9.77e-01 | 7.59e-03 | 9.95e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 9 | 9.69e-01 | -7.59e-03 | 9.91e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 361 | 8.06e-01 | 7.57e-03 | 9.35e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 111 | 8.91e-01 | 7.54e-03 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 35 | 9.39e-01 | 7.49e-03 | 9.84e-01 |
| GOBP RENAL SYSTEM PROCESS | 44 | 9.32e-01 | -7.49e-03 | 9.82e-01 |
| GOBP HEAD DEVELOPMENT | 421 | 7.93e-01 | -7.48e-03 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 57 | 9.22e-01 | 7.46e-03 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 79 | 9.09e-01 | -7.43e-03 | 9.73e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 8 | 9.71e-01 | 7.40e-03 | 9.92e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 33 | 9.41e-01 | 7.40e-03 | 9.85e-01 |
| GOBP RESPONSE TO CYTOKINE | 600 | 7.60e-01 | 7.38e-03 | 9.18e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 13 | 9.63e-01 | 7.38e-03 | 9.90e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 10 | 9.68e-01 | -7.30e-03 | 9.91e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 71 | 9.15e-01 | 7.29e-03 | 9.76e-01 |
| GOBP NEUROBLAST PROLIFERATION | 37 | 9.39e-01 | -7.29e-03 | 9.84e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 45 | 9.33e-01 | -7.24e-03 | 9.83e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 8 | 9.72e-01 | -7.18e-03 | 9.92e-01 |
| GOBP TRANSLATIONAL TERMINATION | 15 | 9.62e-01 | 7.16e-03 | 9.89e-01 |
| GOCC ACROSOMAL MEMBRANE | 10 | 9.69e-01 | -7.11e-03 | 9.92e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 14 | 9.64e-01 | -7.03e-03 | 9.90e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 34 | 9.43e-01 | 7.03e-03 | 9.85e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 34 | 9.43e-01 | 7.03e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 226 | 8.56e-01 | -7.02e-03 | 9.56e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 109 | 9.00e-01 | -6.96e-03 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 9.76e-01 | -6.96e-03 | 9.95e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 14 | 9.64e-01 | 6.95e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 32 | 9.46e-01 | -6.95e-03 | 9.85e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 120 | 8.97e-01 | 6.89e-03 | 9.70e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 9.66e-01 | -6.88e-03 | 9.90e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 193 | 8.70e-01 | -6.86e-03 | 9.58e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 474 | 8.01e-01 | 6.81e-03 | 9.33e-01 |
| GOBP VACUOLAR LOCALIZATION | 70 | 9.22e-01 | 6.78e-03 | 9.77e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 32 | 9.47e-01 | -6.76e-03 | 9.86e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 62 | 9.27e-01 | -6.75e-03 | 9.79e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 104 | 9.05e-01 | -6.75e-03 | 9.73e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 16 | 9.63e-01 | -6.73e-03 | 9.90e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 177 | 8.79e-01 | 6.65e-03 | 9.62e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 134 | 8.95e-01 | 6.63e-03 | 9.69e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 10 | 9.71e-01 | 6.60e-03 | 9.92e-01 |
| GOCC NEURON PROJECTION | 684 | 7.71e-01 | -6.60e-03 | 9.22e-01 |
| GOCC CELL SURFACE | 417 | 8.18e-01 | -6.59e-03 | 9.40e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 12 | 9.69e-01 | -6.57e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 40 | 9.43e-01 | 6.57e-03 | 9.85e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 18 | 9.62e-01 | 6.57e-03 | 9.89e-01 |
| GOBP SOMITE DEVELOPMENT | 38 | 9.44e-01 | 6.55e-03 | 9.85e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 24 | 9.56e-01 | 6.54e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 740 | 7.65e-01 | -6.54e-03 | 9.19e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 9 | 9.73e-01 | 6.45e-03 | 9.93e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 43 | 9.42e-01 | -6.44e-03 | 9.85e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 9.73e-01 | -6.42e-03 | 9.93e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 307 | 8.47e-01 | 6.42e-03 | 9.52e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 17 | 9.64e-01 | 6.40e-03 | 9.90e-01 |
| GOCC SPERM MIDPIECE | 29 | 9.53e-01 | -6.39e-03 | 9.87e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 45 | 9.41e-01 | 6.37e-03 | 9.85e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 14 | 9.68e-01 | 6.28e-03 | 9.91e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 16 | 9.65e-01 | 6.25e-03 | 9.90e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 158 | 8.93e-01 | -6.24e-03 | 9.68e-01 |
| GOBP CELL CELL ADHESION | 506 | 8.12e-01 | 6.23e-03 | 9.38e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 9.79e-01 | 6.20e-03 | 9.95e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 121 | 9.06e-01 | 6.19e-03 | 9.73e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 516 | 8.11e-01 | -6.19e-03 | 9.38e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 298 | 8.55e-01 | -6.17e-03 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 90 | 9.20e-01 | -6.17e-03 | 9.76e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 42 | 9.45e-01 | -6.16e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 38 | 9.48e-01 | 6.13e-03 | 9.86e-01 |
| GOMF PROTEASE BINDING | 93 | 9.19e-01 | 6.09e-03 | 9.76e-01 |
| GOBP SINGLE FERTILIZATION | 53 | 9.39e-01 | -6.06e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 287 | 8.60e-01 | -6.06e-03 | 9.57e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 51 | 9.41e-01 | 6.04e-03 | 9.85e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 9.75e-01 | -6.03e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 157 | 8.97e-01 | -5.99e-03 | 9.70e-01 |
| GOBP CELL CELL SIGNALING | 789 | 7.78e-01 | -5.98e-03 | 9.24e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 92 | 9.22e-01 | 5.95e-03 | 9.77e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 59 | 9.37e-01 | -5.94e-03 | 9.84e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 21 | 9.63e-01 | 5.92e-03 | 9.90e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 22 | 9.62e-01 | -5.91e-03 | 9.89e-01 |
| GOBP RESPONSE TO SALT STRESS | 15 | 9.68e-01 | -5.90e-03 | 9.91e-01 |
| GOBP INSULIN SECRETION | 109 | 9.15e-01 | 5.89e-03 | 9.76e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 36 | 9.51e-01 | 5.88e-03 | 9.87e-01 |
| GOBP RUFFLE ASSEMBLY | 33 | 9.53e-01 | 5.87e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 19 | 9.65e-01 | -5.84e-03 | 9.90e-01 |
| GOBP TISSUE MORPHOGENESIS | 300 | 8.65e-01 | 5.74e-03 | 9.57e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 231 | 8.81e-01 | -5.73e-03 | 9.63e-01 |
| GOBP REGULATION OF NEUROGENESIS | 212 | 8.86e-01 | 5.71e-03 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 17 | 9.68e-01 | -5.70e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 105 | 9.20e-01 | -5.67e-03 | 9.76e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 37 | 9.53e-01 | 5.64e-03 | 9.87e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 119 | 9.16e-01 | 5.64e-03 | 9.76e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 5 | 9.83e-01 | 5.63e-03 | 9.96e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 17 | 9.68e-01 | 5.63e-03 | 9.91e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 15 | 9.70e-01 | 5.62e-03 | 9.92e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 13 | 9.72e-01 | 5.62e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 9.70e-01 | -5.61e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 261 | 8.76e-01 | 5.61e-03 | 9.61e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 9.81e-01 | 5.57e-03 | 9.96e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 24 | 9.63e-01 | 5.55e-03 | 9.90e-01 |
| GOBP MOLTING CYCLE PROCESS | 41 | 9.51e-01 | 5.52e-03 | 9.87e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 46 | 9.49e-01 | -5.44e-03 | 9.87e-01 |
| GOMF FK506 BINDING | 8 | 9.79e-01 | 5.44e-03 | 9.95e-01 |
| GOMF MACROLIDE BINDING | 8 | 9.79e-01 | 5.44e-03 | 9.95e-01 |
| GOBP CELL PART MORPHOGENESIS | 364 | 8.63e-01 | 5.31e-03 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 5 | 9.84e-01 | 5.30e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 24 | 9.64e-01 | 5.30e-03 | 9.90e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 330 | 8.70e-01 | -5.29e-03 | 9.58e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 6 | 9.82e-01 | -5.28e-03 | 9.96e-01 |
| GOBP LIPID DIGESTION | 6 | 9.82e-01 | -5.28e-03 | 9.96e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 6 | 9.82e-01 | -5.28e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 10 | 9.77e-01 | -5.22e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 5 | 9.84e-01 | -5.22e-03 | 9.96e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 84 | 9.35e-01 | -5.19e-03 | 9.83e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 65 | 9.42e-01 | -5.19e-03 | 9.85e-01 |
| GOBP DENDRITE MORPHOGENESIS | 82 | 9.35e-01 | 5.18e-03 | 9.84e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 7 | 9.81e-01 | 5.17e-03 | 9.96e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 18 | 9.70e-01 | 5.16e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 22 | 9.67e-01 | -5.13e-03 | 9.91e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 7 | 9.81e-01 | -5.11e-03 | 9.96e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 164 | 9.11e-01 | 5.08e-03 | 9.74e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 52 | 9.50e-01 | -5.07e-03 | 9.87e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 17 | 9.71e-01 | 5.05e-03 | 9.92e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 9.83e-01 | -5.03e-03 | 9.96e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 56 | 9.50e-01 | 4.88e-03 | 9.87e-01 |
| GOBP DETECTION OF CELL DENSITY | 5 | 9.85e-01 | -4.84e-03 | 9.97e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 107 | 9.31e-01 | 4.83e-03 | 9.82e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 18 | 9.72e-01 | -4.80e-03 | 9.92e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 219 | 9.03e-01 | -4.78e-03 | 9.72e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 9.79e-01 | 4.78e-03 | 9.95e-01 |
| GOBP DOPAMINE SECRETION | 11 | 9.78e-01 | 4.76e-03 | 9.95e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 87 | 9.39e-01 | 4.73e-03 | 9.84e-01 |
| GOMF MANNOSIDASE ACTIVITY | 14 | 9.76e-01 | 4.70e-03 | 9.94e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 445 | 8.66e-01 | 4.70e-03 | 9.58e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 9.72e-01 | -4.66e-03 | 9.92e-01 |
| GOBP HEART DEVELOPMENT | 317 | 8.87e-01 | 4.66e-03 | 9.65e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 136 | 9.26e-01 | -4.64e-03 | 9.79e-01 |
| GOCC MYELIN SHEATH | 31 | 9.65e-01 | 4.61e-03 | 9.90e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 41 | 9.60e-01 | -4.53e-03 | 9.89e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 9.81e-01 | -4.51e-03 | 9.96e-01 |
| GOBP RRNA TRANSPORT | 5 | 9.86e-01 | -4.48e-03 | 9.97e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 7 | 9.84e-01 | 4.46e-03 | 9.96e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 78 | 9.46e-01 | -4.45e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 42 | 9.60e-01 | 4.43e-03 | 9.89e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 5 | 9.86e-01 | 4.43e-03 | 9.97e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 17 | 9.75e-01 | 4.42e-03 | 9.94e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 7 | 9.84e-01 | -4.40e-03 | 9.96e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 7 | 9.84e-01 | -4.40e-03 | 9.96e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 9.76e-01 | 4.38e-03 | 9.94e-01 |
| GOCC CELL PROJECTION MEMBRANE | 194 | 9.17e-01 | -4.37e-03 | 9.76e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 15 | 9.77e-01 | 4.37e-03 | 9.95e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 130 | 9.32e-01 | -4.35e-03 | 9.82e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 12 | 9.79e-01 | 4.35e-03 | 9.95e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 76 | 9.48e-01 | 4.34e-03 | 9.86e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 53 | 9.57e-01 | -4.33e-03 | 9.88e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 44 | 9.61e-01 | 4.31e-03 | 9.89e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 159 | 9.26e-01 | -4.30e-03 | 9.79e-01 |
| GOBP LOCOMOTION | 692 | 8.49e-01 | -4.29e-03 | 9.52e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 72 | 9.50e-01 | 4.26e-03 | 9.87e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 16 | 9.77e-01 | 4.18e-03 | 9.95e-01 |
| GOBP INFLAMMATORY RESPONSE | 489 | 8.76e-01 | -4.14e-03 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 10 | 9.82e-01 | -4.13e-03 | 9.96e-01 |
| GOBP MUSCLE ADAPTATION | 59 | 9.57e-01 | 4.07e-03 | 9.88e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 139 | 9.35e-01 | 4.01e-03 | 9.83e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 309 | 9.04e-01 | -3.99e-03 | 9.72e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 72 | 9.54e-01 | -3.97e-03 | 9.87e-01 |
| GOBP PYRUVATE TRANSPORT | 6 | 9.87e-01 | -3.83e-03 | 9.97e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 5 | 9.89e-01 | 3.72e-03 | 9.98e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 78 | 9.55e-01 | -3.72e-03 | 9.87e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 67 | 9.58e-01 | 3.70e-03 | 9.88e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 52 | 9.63e-01 | 3.70e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 13 | 9.82e-01 | -3.67e-03 | 9.96e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 9.88e-01 | -3.66e-03 | 9.97e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 125 | 9.44e-01 | -3.62e-03 | 9.85e-01 |
| GOMF CHEMOKINE ACTIVITY | 13 | 9.82e-01 | -3.61e-03 | 9.96e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 237 | 9.26e-01 | 3.53e-03 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 36 | 9.71e-01 | 3.53e-03 | 9.92e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 42 | 9.69e-01 | -3.51e-03 | 9.91e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 11 | 9.84e-01 | -3.48e-03 | 9.96e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 78 | 9.58e-01 | -3.48e-03 | 9.88e-01 |
| GOBP REGULATION OF SECRETION | 321 | 9.16e-01 | 3.45e-03 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 20 | 9.79e-01 | -3.40e-03 | 9.95e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 447 | 9.03e-01 | 3.38e-03 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 15 | 9.82e-01 | 3.36e-03 | 9.96e-01 |
| GOBP TISSUE MIGRATION | 177 | 9.39e-01 | -3.36e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 6 | 9.89e-01 | -3.32e-03 | 9.98e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.89e-01 | 3.27e-03 | 9.98e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 100 | 9.56e-01 | 3.21e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 16 | 9.82e-01 | -3.19e-03 | 9.96e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 15 | 9.83e-01 | -3.16e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 72 | 9.64e-01 | -3.12e-03 | 9.90e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 9 | 9.87e-01 | 3.11e-03 | 9.97e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 9.84e-01 | -3.08e-03 | 9.96e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 134 | 9.51e-01 | 3.07e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 19 | 9.82e-01 | -3.07e-03 | 9.96e-01 |
| GOBP GERM CELL DEVELOPMENT | 169 | 9.45e-01 | 3.06e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 9.90e-01 | 3.05e-03 | 9.98e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 92 | 9.60e-01 | -3.02e-03 | 9.89e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 80 | 9.63e-01 | -2.96e-03 | 9.90e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 14 | 9.85e-01 | -2.94e-03 | 9.96e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 57 | 9.69e-01 | 2.93e-03 | 9.92e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 22 | 9.81e-01 | 2.92e-03 | 9.96e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 27 | 9.79e-01 | 2.89e-03 | 9.95e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 209 | 9.44e-01 | -2.83e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 20 | 9.83e-01 | -2.82e-03 | 9.96e-01 |
| GOBP STEROL METABOLIC PROCESS | 89 | 9.64e-01 | -2.79e-03 | 9.90e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 58 | 9.71e-01 | 2.77e-03 | 9.92e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 9.89e-01 | -2.75e-03 | 9.98e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 79 | 9.66e-01 | -2.75e-03 | 9.90e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 11 | 9.88e-01 | 2.67e-03 | 9.97e-01 |
| GOCC CILIARY BASE | 28 | 9.81e-01 | 2.58e-03 | 9.96e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 59 | 9.73e-01 | -2.58e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 208 | 9.50e-01 | 2.54e-03 | 9.87e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 74 | 9.70e-01 | -2.54e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 27 | 9.82e-01 | -2.54e-03 | 9.96e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 16 | 9.86e-01 | 2.51e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 69 | 9.71e-01 | 2.51e-03 | 9.92e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 17 | 9.86e-01 | -2.51e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 7 | 9.91e-01 | 2.49e-03 | 9.98e-01 |
| GOBP RUFFLE ORGANIZATION | 44 | 9.77e-01 | -2.48e-03 | 9.95e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 194 | 9.54e-01 | 2.43e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 14 | 9.87e-01 | -2.42e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 386 | 9.36e-01 | -2.39e-03 | 9.84e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 9.93e-01 | -2.37e-03 | 9.98e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 41 | 9.79e-01 | 2.36e-03 | 9.95e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 9.92e-01 | -2.34e-03 | 9.98e-01 |
| GOBP RECEPTOR RECYCLING | 37 | 9.81e-01 | -2.32e-03 | 9.96e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 52 | 9.77e-01 | -2.30e-03 | 9.95e-01 |
| GOBP MRNA 3 END PROCESSING | 48 | 9.79e-01 | 2.21e-03 | 9.95e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 23 | 9.85e-01 | -2.19e-03 | 9.97e-01 |
| GOMF AMP BINDING | 12 | 9.90e-01 | -2.17e-03 | 9.98e-01 |
| GOBP SPERMATID DIFFERENTIATION | 99 | 9.70e-01 | -2.17e-03 | 9.92e-01 |
| GOMF PROTEOGLYCAN BINDING | 14 | 9.89e-01 | -2.08e-03 | 9.98e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 73 | 9.76e-01 | -2.07e-03 | 9.94e-01 |
| GOBP MALE GAMETE GENERATION | 308 | 9.51e-01 | -2.06e-03 | 9.87e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 8 | 9.92e-01 | 2.05e-03 | 9.98e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 55 | 9.79e-01 | -2.02e-03 | 9.95e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 5 | 9.94e-01 | 2.02e-03 | 9.99e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 70 | 9.77e-01 | 2.01e-03 | 9.95e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 9.92e-01 | 1.98e-03 | 9.98e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 36 | 9.84e-01 | -1.96e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 8 | 9.92e-01 | -1.94e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 11 | 9.91e-01 | 1.89e-03 | 9.98e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 115 | 9.73e-01 | 1.85e-03 | 9.93e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 42 | 9.84e-01 | 1.82e-03 | 9.96e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 43 | 9.84e-01 | 1.81e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 67 | 9.80e-01 | -1.80e-03 | 9.96e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 14 | 9.91e-01 | 1.75e-03 | 9.98e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 48 | 9.83e-01 | -1.73e-03 | 9.96e-01 |
| GOBP EOSINOPHIL MIGRATION | 11 | 9.92e-01 | -1.72e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 40 | 9.85e-01 | 1.67e-03 | 9.97e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 9.91e-01 | -1.62e-03 | 9.98e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 8 | 9.94e-01 | 1.61e-03 | 9.99e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 42 | 9.87e-01 | -1.43e-03 | 9.97e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 9.93e-01 | 1.42e-03 | 9.98e-01 |
| GOBP DEMETHYLATION | 41 | 9.88e-01 | -1.41e-03 | 9.97e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 43 | 9.87e-01 | 1.39e-03 | 9.97e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 434 | 9.62e-01 | -1.36e-03 | 9.89e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 40 | 9.88e-01 | -1.35e-03 | 9.97e-01 |
| GOBP DEVELOPMENTAL MATURATION | 161 | 9.77e-01 | 1.31e-03 | 9.95e-01 |
| GOMF KINESIN BINDING | 31 | 9.90e-01 | 1.28e-03 | 9.98e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 9.91e-01 | -1.27e-03 | 9.98e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 77 | 9.85e-01 | -1.26e-03 | 9.96e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 5 | 9.96e-01 | -1.23e-03 | 9.99e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 13 | 9.94e-01 | -1.21e-03 | 9.99e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 131 | 9.81e-01 | -1.19e-03 | 9.96e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 46 | 9.89e-01 | 1.19e-03 | 9.98e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 7 | 9.96e-01 | 1.15e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 26 | 9.92e-01 | -1.14e-03 | 9.98e-01 |
| GOBP NUCLEOPHAGY | 18 | 9.93e-01 | -1.13e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 7 | 9.96e-01 | -1.13e-03 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 65 | 9.88e-01 | -1.12e-03 | 9.97e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 46 | 9.90e-01 | -1.09e-03 | 9.98e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 393 | 9.71e-01 | 1.08e-03 | 9.92e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 9 | 9.96e-01 | 1.06e-03 | 9.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 9 | 9.96e-01 | 1.06e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 53 | 9.89e-01 | -1.06e-03 | 9.98e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 6 | 9.96e-01 | -1.05e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 806 | 9.62e-01 | -1.01e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 80 | 9.88e-01 | -9.89e-04 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 15 | 9.95e-01 | 9.87e-04 | 9.99e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 9.97e-01 | 9.77e-04 | 9.99e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 21 | 9.94e-01 | 9.57e-04 | 9.99e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 16 | 9.95e-01 | 9.53e-04 | 9.99e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 15 | 9.95e-01 | -9.39e-04 | 9.99e-01 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 5 | 9.97e-01 | 9.38e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 11 | 9.96e-01 | 9.20e-04 | 9.99e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 13 | 9.96e-01 | -8.91e-04 | 9.99e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 409 | 9.76e-01 | 8.73e-04 | 9.94e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 102 | 9.88e-01 | -8.55e-04 | 9.97e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 9.97e-01 | 8.31e-04 | 9.99e-01 |
| GOBP MEMORY | 52 | 9.92e-01 | -8.00e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 632 | 9.73e-01 | -7.97e-04 | 9.93e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 51 | 9.92e-01 | -7.90e-04 | 9.98e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 7 | 9.97e-01 | 7.75e-04 | 1.00e+00 |
| GOBP DENDRITE DEVELOPMENT | 143 | 9.87e-01 | 7.68e-04 | 9.97e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 52 | 9.93e-01 | 7.15e-04 | 9.99e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 9.98e-01 | 7.03e-04 | 1.00e+00 |
| GOBP REGULATION OF LOCOMOTION | 601 | 9.81e-01 | -5.79e-04 | 9.96e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 589 | 9.81e-01 | 5.73e-04 | 9.96e-01 |
| GOBP REGULATION OF CELL SIZE | 116 | 9.92e-01 | -5.72e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 90 | 9.93e-01 | 5.70e-04 | 9.98e-01 |
| GOBP INSULIN PROCESSING | 5 | 9.98e-01 | 5.57e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 11 | 9.97e-01 | 5.46e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 26 | 9.96e-01 | -5.08e-04 | 9.99e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 30 | 9.96e-01 | -5.04e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 39 | 9.97e-01 | 4.03e-04 | 9.99e-01 |
| GOCC CENTRIOLAR SATELLITE | 93 | 9.95e-01 | 3.98e-04 | 9.99e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 139 | 9.94e-01 | 3.40e-04 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 5 | 9.99e-01 | -3.22e-04 | 1.00e+00 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 23 | 9.98e-01 | 3.19e-04 | 1.00e+00 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 20 | 9.98e-01 | -3.15e-04 | 1.00e+00 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 9 | 9.99e-01 | -3.09e-04 | 1.00e+00 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 136 | 9.96e-01 | 2.73e-04 | 9.99e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 5 | 9.99e-01 | 2.64e-04 | 1.00e+00 |
| GOBP INTERLEUKIN 6 PRODUCTION | 95 | 9.97e-01 | 2.53e-04 | 9.99e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 47 | 9.98e-01 | 2.16e-04 | 1.00e+00 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 9.99e-01 | -2.14e-04 | 1.00e+00 |
| GOBP MRNA MODIFICATION | 31 | 9.99e-01 | -1.94e-04 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 9.99e-01 | 1.47e-04 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 38 | 9.99e-01 | 1.28e-04 | 1.00e+00 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 23 | 9.99e-01 | -8.29e-05 | 1.00e+00 |
| GOCC DYNACTIN COMPLEX | 8 | 1.00e+00 | 5.50e-05 | 1.00e+00 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 31 | 1.00e+00 | -5.21e-05 | 1.00e+00 |
| GOBP RESPONSE TO TUMOR CELL | 32 | 1.00e+00 | 2.75e-05 | 1.00e+00 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 79 | 1.00e+00 | 2.24e-05 | 1.00e+00 |
| GOBP LIVER MORPHOGENESIS | 14 | 1.00e+00 | 0.00e+00 | 1.00e+00 |
| GOBP MRNA METHYLATION | 18 | 1.00e+00 | 0.00e+00 | 1.00e+00 |
Detailed Gene set reports
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT
Top enriched genes
Click HERE to show all gene set members
GOBP MITOCHONDRIAL DNA REPAIR
Top enriched genes
Click HERE to show all gene set members
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT
Top enriched genes
Click HERE to show all gene set members
GOMF T CELL RECEPTOR BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP GAS TRANSPORT
Top enriched genes
Click HERE to show all gene set members
GOBP OXYGEN TRANSPORT
Top enriched genes
Click HERE to show all gene set members
GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC MCM COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC IKAPPAB KINASE COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION
Top enriched genes
Click HERE to show all gene set members
GOMF TAP BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF DNA DUPLEX UNWINDING
Top enriched genes
Click HERE to show all gene set members
GOCC IGM IMMUNOGLOBULIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOMF NITRIC OXIDE SYNTHASE BINDING
Top enriched genes
Click HERE to show all gene set members
GOCC POLYSOMAL RIBOSOME
Top enriched genes
Click HERE to show all gene set members
GOCC CYTOSOLIC RIBOSOME
Top enriched genes
Click HERE to show all gene set members
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION
Top enriched genes
Click HERE to show all gene set members
GOMF MHC CLASS IB PROTEIN BINDING
Top enriched genes
Click HERE to show all gene set members
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION
Top enriched genes
Click HERE to show all gene set members
GOCC CONDENSIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC ARP2 3 PROTEIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC IGA IMMUNOGLOBULIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
Top enriched genes
Click HERE to show all gene set members
GOBP MIDDLE EAR MORPHOGENESIS
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF PLASMA MEMBRANE REPAIR
Top enriched genes
Click HERE to show all gene set members
GOCC MHC CLASS I PROTEIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF CHROMOSOME CONDENSATION
Top enriched genes
Click HERE to show all gene set members
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION
Top enriched genes
Click HERE to show all gene set members
GOMF TRANSFERRIN RECEPTOR BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP PROTEIN AUTOPROCESSING
Top enriched genes
Click HERE to show all gene set members
GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION
Top enriched genes
Click HERE to show all gene set members
GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY
Top enriched genes
Click HERE to show all gene set members
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY
Top enriched genes
Click HERE to show all gene set members
GOBP DETOXIFICATION OF COPPER ION
Top enriched genes
Click HERE to show all gene set members
GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY
Top enriched genes
Click HERE to show all gene set members
GOBP ZYMOGEN INHIBITION
Top enriched genes
Click HERE to show all gene set members
GOBP RESPONSE TO CORTICOSTERONE
Top enriched genes
Click HERE to show all gene set members
GOCC REPLISOME
Top enriched genes
Click HERE to show all gene set members
GOBP MEIOTIC CHROMOSOME CONDENSATION
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME
Top enriched genes
Click HERE to show all gene set members
GOCC PROTEASOME CORE COMPLEX
Top enriched genes
Click HERE to show all gene set members
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.3.3 (2024-02-29)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4 GGally_2.2.1
## [3] ggplot2_3.5.0 reshape2_1.4.4
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] gplots_3.1.3.1 kableExtra_1.4.0
## [11] limma_3.58.1 mitch_1.15.0
## [13] DESeq2_1.42.0 muscat_1.16.0
## [15] beeswarm_0.4.0 stringi_1.8.3
## [17] SingleCellExperiment_1.24.0 SummarizedExperiment_1.32.0
## [19] Biobase_2.62.0 GenomicRanges_1.54.1
## [21] GenomeInfoDb_1.38.6 IRanges_2.36.0
## [23] S4Vectors_0.40.2 BiocGenerics_0.48.1
## [25] MatrixGenerics_1.14.0 matrixStats_1.2.0
## [27] hdf5r_1.3.9 Seurat_5.0.1
## [29] SeuratObject_5.0.1 sp_2.1-3
## [31] plyr_1.8.9
##
## loaded via a namespace (and not attached):
## [1] spatstat.sparse_3.0-3 bitops_1.0-7
## [3] httr_1.4.7 RColorBrewer_1.1-3
## [5] doParallel_1.0.17 numDeriv_2016.8-1.1
## [7] backports_1.4.1 tools_4.3.3
## [9] sctransform_0.4.1 utf8_1.2.4
## [11] R6_2.5.1 lazyeval_0.2.2
## [13] uwot_0.1.16 mgcv_1.9-1
## [15] GetoptLong_1.0.5 withr_3.0.0
## [17] prettyunits_1.2.0 gridExtra_2.3
## [19] progressr_0.14.0 cli_3.6.2
## [21] spatstat.explore_3.2-6 fastDummies_1.7.3
## [23] labeling_0.4.3 sass_0.4.8
## [25] mvtnorm_1.2-4 spatstat.data_3.0-4
## [27] blme_1.0-5 ggridges_0.5.6
## [29] pbapply_1.7-2 systemfonts_1.0.5
## [31] svglite_2.1.3 scater_1.30.1
## [33] parallelly_1.37.0 rstudioapi_0.15.0
## [35] generics_0.1.3 shape_1.4.6
## [37] ica_1.0-3 spatstat.random_3.2-2
## [39] Matrix_1.6-5 ggbeeswarm_0.7.2
## [41] fansi_1.0.6 abind_1.4-5
## [43] lifecycle_1.0.4 yaml_2.3.8
## [45] edgeR_4.0.15 SparseArray_1.2.4
## [47] Rtsne_0.17 grid_4.3.3
## [49] promises_1.2.1 crayon_1.5.2
## [51] miniUI_0.1.1.1 lattice_0.22-5
## [53] beachmat_2.18.1 cowplot_1.1.3
## [55] pillar_1.9.0 knitr_1.45
## [57] ComplexHeatmap_2.18.0 rjson_0.2.21
## [59] boot_1.3-28.1 corpcor_1.6.10
## [61] future.apply_1.11.1 codetools_0.2-19
## [63] leiden_0.4.3.1 glue_1.7.0
## [65] data.table_1.15.2 vctrs_0.6.5
## [67] png_0.1-8 spam_2.10-0
## [69] Rdpack_2.6 gtable_0.3.4
## [71] cachem_1.0.8 xfun_0.42
## [73] rbibutils_2.2.16 S4Arrays_1.2.0
## [75] mime_0.12 survival_3.5-8
## [77] iterators_1.0.14 statmod_1.5.0
## [79] ellipsis_0.3.2 fitdistrplus_1.1-11
## [81] ROCR_1.0-11 nlme_3.1-164
## [83] pbkrtest_0.5.2 bit64_4.0.5
## [85] EnvStats_2.8.1 progress_1.2.3
## [87] RcppAnnoy_0.0.22 bslib_0.6.1
## [89] TMB_1.9.10 irlba_2.3.5.1
## [91] vipor_0.4.7 KernSmooth_2.23-22
## [93] colorspace_2.1-0 ggrastr_1.0.2
## [95] tidyselect_1.2.0 bit_4.0.5
## [97] compiler_4.3.3 BiocNeighbors_1.20.2
## [99] xml2_1.3.6 DelayedArray_0.28.0
## [101] plotly_4.10.4 scales_1.3.0
## [103] caTools_1.18.2 remaCor_0.0.18
## [105] lmtest_0.9-40 stringr_1.5.1
## [107] digest_0.6.34 goftest_1.2-3
## [109] spatstat.utils_3.0-4 minqa_1.2.6
## [111] variancePartition_1.32.5 rmarkdown_2.25
## [113] aod_1.3.3 XVector_0.42.0
## [115] RhpcBLASctl_0.23-42 htmltools_0.5.7
## [117] pkgconfig_2.0.3 lme4_1.1-35.1
## [119] sparseMatrixStats_1.14.0 highr_0.10
## [121] fastmap_1.1.1 rlang_1.1.3
## [123] GlobalOptions_0.1.2 htmlwidgets_1.6.4
## [125] shiny_1.8.0 DelayedMatrixStats_1.24.0
## [127] farver_2.1.1 jquerylib_0.1.4
## [129] zoo_1.8-12 jsonlite_1.8.8
## [131] BiocParallel_1.36.0 BiocSingular_1.18.0
## [133] RCurl_1.98-1.14 magrittr_2.0.3
## [135] scuttle_1.12.0 GenomeInfoDbData_1.2.11
## [137] dotCall64_1.1-1 patchwork_1.2.0
## [139] munsell_0.5.0 Rcpp_1.0.12
## [141] viridis_0.6.5 reticulate_1.35.0
## [143] zlibbioc_1.48.0 MASS_7.3-60.0.1
## [145] ggstats_0.5.1 listenv_0.9.1
## [147] ggrepel_0.9.5 deldir_2.0-2
## [149] splines_4.3.3 tensor_1.5
## [151] hms_1.1.3 circlize_0.4.15
## [153] locfit_1.5-9.8 igraph_2.0.2
## [155] spatstat.geom_3.2-8 RcppHNSW_0.6.0
## [157] ScaledMatrix_1.10.0 evaluate_0.23
## [159] nloptr_2.0.3 foreach_1.5.2
## [161] httpuv_1.6.14 RANN_2.6.1
## [163] tidyr_1.3.1 purrr_1.0.2
## [165] polyclip_1.10-6 future_1.33.1
## [167] clue_0.3-65 scattermore_1.2
## [169] rsvd_1.0.5 broom_1.0.5
## [171] xtable_1.8-4 fANCOVA_0.6-1
## [173] RSpectra_0.16-1 later_1.3.2
## [175] viridisLite_0.4.2 lmerTest_3.1-3
## [177] glmmTMB_1.1.9 cluster_2.1.6
## [179] globals_0.16.2END of report